
<html lang="en"     class="pb-page"  data-request-id="45d0616c-8fb2-4ce9-a9b4-c3aafc60a049"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01938;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2020.63.issue-1;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structure–Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters" /></meta><meta name="dc.Creator" content="Predrag  Kalaba" /></meta><meta name="dc.Creator" content="Marija  Ilić" /></meta><meta name="dc.Creator" content="Nilima Y.  Aher" /></meta><meta name="dc.Creator" content="Vladimir  Dragačević" /></meta><meta name="dc.Creator" content="Marcus  Wieder" /></meta><meta name="dc.Creator" content="Martin  Zehl" /></meta><meta name="dc.Creator" content="Judith  Wackerlig" /></meta><meta name="dc.Creator" content="Stanislav  Beyl" /></meta><meta name="dc.Creator" content="Simone B.  Sartori" /></meta><meta name="dc.Creator" content="Karl  Ebner" /></meta><meta name="dc.Creator" content="Alexander  Roller" /></meta><meta name="dc.Creator" content="Natalie  Lukic" /></meta><meta name="dc.Creator" content="Tetyana  Beryozkina" /></meta><meta name="dc.Creator" content="Eduardo Rene Perez  Gonzalez" /></meta><meta name="dc.Creator" content="Philip  Neill" /></meta><meta name="dc.Creator" content="Jawad Akbar  Khan" /></meta><meta name="dc.Creator" content="Vasiliy  Bakulev" /></meta><meta name="dc.Creator" content="Johann Jakob  Leban" /></meta><meta name="dc.Creator" content="Steffen  Hering" /></meta><meta name="dc.Creator" content="Christian  Pifl" /></meta><meta name="dc.Creator" content="Nicolas  Singewald" /></meta><meta name="dc.Creator" content="Jana  Lubec" /></meta><meta name="dc.Creator" content="Ernst  Urban" /></meta><meta name="dc.Creator" content="Harald H.  Sitte" /></meta><meta name="dc.Creator" content="Thierry  Langer" /></meta><meta name="dc.Creator" content="Gert  Lubec" /></meta><meta name="dc.Description" content="Atypical dopamine reuptake inhibitors, such as modafinil, are used for the treatment of sleeping disorders and investigated as potential therapeutics against cocaine addiction and for cognitive enh..." /></meta><meta name="Description" content="Atypical dopamine reuptake inhibitors, such as modafinil, are used for the treatment of sleeping disorders and investigated as potential therapeutics against cocaine addiction and for cognitive enh..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 16, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01938" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01938" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01938" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01938" /></link>
        
    
    

<title>Structure–Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01938" /></meta><meta property="og:title" content="Structure–Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0018.jpeg" /></meta><meta property="og:description" content="Atypical dopamine reuptake inhibitors, such as modafinil, are used for the treatment of sleeping disorders and investigated as potential therapeutics against cocaine addiction and for cognitive enhancement. Our continuous effort to find modafinil analogues with higher inhibitory activity on and selectivity toward the dopamine transporter (DAT) has previously led to the promising thiazole-containing derivatives CE-103, CE-111, CE-123, and CE-125. Here, we describe the synthesis and activity of a series of compounds based on these scaffolds, which resulted in several new selective DAT inhibitors and gave valuable insights into the structure–activity relationships. Introduction of the second chiral center and subsequent chiral separations provided all four stereoisomers, whereby the S-configuration on both generally exerted the highest activity and selectivity on DAT. The representative compound of this series was further characterized by in silico, in vitro, and in vivo studies that have demonstrated both safety and efficacy profile of this compound class." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01938"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01938">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01938&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01938&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01938&amp;href=/doi/10.1021/acs.jmedchem.9b01938" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 391-417</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01862" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01046" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Predrag Kalaba</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Predrag Kalaba</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Predrag++Kalaba">Predrag Kalaba</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marija Ilić</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marija Ilić</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marija++Ili%C4%87">Marija Ilić</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nilima Y. Aher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nilima Y. Aher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nilima+Y.++Aher">Nilima Y. Aher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vladimir Dragačević</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vladimir Dragačević</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vladimir++Draga%C4%8Devi%C4%87">Vladimir Dragačević</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marcus Wieder</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marcus Wieder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marcus++Wieder">Marcus Wieder</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2631-8415" title="Orcid link">http://orcid.org/0000-0003-2631-8415</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin Zehl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Zehl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Währinger Straße 38, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Zehl">Martin Zehl</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9685-0373" title="Orcid link">http://orcid.org/0000-0001-9685-0373</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Judith Wackerlig</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Judith Wackerlig</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Judith++Wackerlig">Judith Wackerlig</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stanislav Beyl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stanislav Beyl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stanislav++Beyl">Stanislav Beyl</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Simone B. Sartori</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Simone B. Sartori</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Molecular Biosciences Innsbruck (CMBI), Department of Pharmacology and Toxicology, Institute of Pharmacy, Leopold Franzens University Innsbruck, 6020 Innsbruck, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Simone+B.++Sartori">Simone B. Sartori</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karl Ebner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karl Ebner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Molecular Biosciences Innsbruck (CMBI), Department of Pharmacology and Toxicology, Institute of Pharmacy, Leopold Franzens University Innsbruck, 6020 Innsbruck, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karl++Ebner">Karl Ebner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexander Roller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexander Roller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-ray Structure Analysis Centre, Faculty of Chemistry, University of Vienna, Währinger Straße 38, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexander++Roller">Alexander Roller</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Natalie Lukic</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Natalie Lukic</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-ray Structure Analysis Centre, Faculty of Chemistry, University of Vienna, Währinger Straße 38, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Natalie++Lukic">Natalie Lukic</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tetyana Beryozkina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tetyana Beryozkina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Ural Federal University Named after the First President of Russia B. N. Yeltsin, 19 Mira st., Yekaterinburg 620002, Russia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tetyana++Beryozkina">Tetyana Beryozkina</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9917-6748" title="Orcid link">http://orcid.org/0000-0002-9917-6748</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eduardo Rene Perez Gonzalez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eduardo Rene Perez Gonzalez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Fine Organic Chemistry, Department of Chemistry and Biochemistry, Faculty of Science and Technology, University of Sao Paulo State, Roberto Simonsen 305, CEP 19060-900, Presidente Prudente, SP, Brazil</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eduardo+Rene+Perez++Gonzalez">Eduardo Rene Perez Gonzalez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Philip Neill</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philip Neill</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philip++Neill">Philip Neill</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jawad Akbar Khan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jawad Akbar Khan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jawad+Akbar++Khan">Jawad Akbar Khan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vasiliy Bakulev</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vasiliy Bakulev</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Ural Federal University Named after the First President of Russia B. N. Yeltsin, 19 Mira st., Yekaterinburg 620002, Russia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vasiliy++Bakulev">Vasiliy Bakulev</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3312-7783" title="Orcid link">http://orcid.org/0000-0002-3312-7783</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Johann Jakob Leban</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Johann Jakob Leban</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Johann+Jakob++Leban">Johann Jakob Leban</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Steffen Hering</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Steffen Hering</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Steffen++Hering">Steffen Hering</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christian Pifl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christian Pifl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Brain Research, Medical University of Vienna, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Pifl">Christian Pifl</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicolas Singewald</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicolas Singewald</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Molecular Biosciences Innsbruck (CMBI), Department of Pharmacology and Toxicology, Institute of Pharmacy, Leopold Franzens University Innsbruck, 6020 Innsbruck, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Singewald">Nicolas Singewald</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jana Lubec</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jana Lubec</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Laboratory, Paracelsus Medical University, A-5020 Salzburg, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jana++Lubec">Jana Lubec</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ernst Urban</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ernst Urban</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ernst++Urban">Ernst Urban</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Harald H. Sitte</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Harald H. Sitte</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Harald+H.++Sitte">Harald H. Sitte</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1339-7444" title="Orcid link">http://orcid.org/0000-0002-1339-7444</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thierry Langer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thierry Langer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Langer">Thierry Langer</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5242-1240" title="Orcid link">http://orcid.org/0000-0002-5242-1240</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Gert Lubec</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gert Lubec</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Laboratory, Paracelsus Medical University, A-5020 Salzburg, Austria</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#ea8d8f989ec4869f888f89aa869f888f89868b88c4898587"><span class="__cf_email__" data-cfemail="44232136306a28312621270428312621272825266a272b29">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gert++Lubec">Gert Lubec</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6333-9461" title="Orcid link">http://orcid.org/0000-0002-6333-9461</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01938&amp;href=/doi/10.1021%2Facs.jmedchem.9b01938" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 391–417</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 16, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 November 2019</li><li><span class="item_label"><b>Published</b> online</span>16 December 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 January 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01938" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01938</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D391%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPredrag%2BKalaba%252C%2BMarija%2BIli%25C4%2587%252C%2BNilima%2BY.%2BAher%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D1%26contentID%3Dacs.jmedchem.9b01938%26title%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BNovel%2BThiazole-Based%2BModafinil%2BAnalogues%2BActing%2Bat%2BMonoamine%2BTransporters%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D417%26publicationDate%3DJanuary%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01938"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1151</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01938" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Predrag&quot;,&quot;last_name&quot;:&quot;Kalaba&quot;},{&quot;first_name&quot;:&quot;Marija&quot;,&quot;last_name&quot;:&quot;Ilić&quot;},{&quot;first_name&quot;:&quot;Nilima&quot;,&quot;last_name&quot;:&quot;Y. Aher&quot;},{&quot;first_name&quot;:&quot;Vladimir&quot;,&quot;last_name&quot;:&quot;Dragačević&quot;},{&quot;first_name&quot;:&quot;Marcus&quot;,&quot;last_name&quot;:&quot;Wieder&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Zehl&quot;},{&quot;first_name&quot;:&quot;Judith&quot;,&quot;last_name&quot;:&quot;Wackerlig&quot;},{&quot;first_name&quot;:&quot;Stanislav&quot;,&quot;last_name&quot;:&quot;Beyl&quot;},{&quot;first_name&quot;:&quot;Simone&quot;,&quot;last_name&quot;:&quot;B. Sartori&quot;},{&quot;first_name&quot;:&quot;Karl&quot;,&quot;last_name&quot;:&quot;Ebner&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;Roller&quot;},{&quot;first_name&quot;:&quot;Natalie&quot;,&quot;last_name&quot;:&quot;Lukic&quot;},{&quot;first_name&quot;:&quot;Tetyana&quot;,&quot;last_name&quot;:&quot;Beryozkina&quot;},{&quot;first_name&quot;:&quot;Eduardo&quot;,&quot;last_name&quot;:&quot;Rene Perez Gonzalez&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;Neill&quot;},{&quot;first_name&quot;:&quot;Jawad&quot;,&quot;last_name&quot;:&quot;Akbar Khan&quot;},{&quot;first_name&quot;:&quot;Vasiliy&quot;,&quot;last_name&quot;:&quot;Bakulev&quot;},{&quot;first_name&quot;:&quot;Johann&quot;,&quot;last_name&quot;:&quot;Jakob Leban&quot;},{&quot;first_name&quot;:&quot;Steffen&quot;,&quot;last_name&quot;:&quot;Hering&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Pifl&quot;},{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Singewald&quot;},{&quot;first_name&quot;:&quot;Jana&quot;,&quot;last_name&quot;:&quot;Lubec&quot;},{&quot;first_name&quot;:&quot;Ernst&quot;,&quot;last_name&quot;:&quot;Urban&quot;},{&quot;first_name&quot;:&quot;Harald&quot;,&quot;last_name&quot;:&quot;H. Sitte&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Langer&quot;},{&quot;first_name&quot;:&quot;Gert&quot;,&quot;last_name&quot;:&quot;Lubec&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;391-417&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01938&quot;},&quot;abstract&quot;:&quot;Atypical dopamine reuptake inhibitors, such as modafinil, are used for the treatment of sleeping disorders and investigated as potential therapeutics against cocaine addiction and for cognitive enhancement. Our continuous effort to find modafinil analogues with higher inhibitory activity on and selectivity toward the dopamine transporter (DAT) has previously led to the promising thiazole-containing derivatives CE-103, CE-111, CE-123, and CE-125. Here, we describe the synthesis and activity of a series of compounds based on these scaffolds, which resulted in several new selective DAT inhibitors and gave valuable insights into the structure–activity relationships. Introduction of the second chiral center and subsequent chiral separations provided all four stereoisomers, whereby the S-configuration on both generally exerted the highest activity and selectivity on DAT. The representative compound of this series was further characterized by in silico, in vitro, and in vivo studies that have demonstrated both safet&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01938&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01938" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01938&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01938" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01938&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01938" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01938&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01938&amp;href=/doi/10.1021/acs.jmedchem.9b01938" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01938" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01938" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01938%26sid%3Dliteratum%253Aachs%26pmid%3D31841637%26genre%3Darticle%26aulast%3DKalaba%26date%3D2020%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BNovel%2BThiazole-Based%2BModafinil%2BAnalogues%2BActing%2Bat%2BMonoamine%2BTransporters%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D1%26spage%3D391%26epage%3D417%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/jmcmar.2020.63.issue-1/20200109/jmcmar.2020.63.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Atypical dopamine reuptake inhibitors, such as modafinil, are used for the treatment of sleeping disorders and investigated as potential therapeutics against cocaine addiction and for cognitive enhancement. Our continuous effort to find modafinil analogues with higher inhibitory activity on and selectivity toward the dopamine transporter (DAT) has previously led to the promising thiazole-containing derivatives CE-103, CE-111, CE-123, and CE-125. Here, we describe the synthesis and activity of a series of compounds based on these scaffolds, which resulted in several new selective DAT inhibitors and gave valuable insights into the structure–activity relationships. Introduction of the second chiral center and subsequent chiral separations provided all four stereoisomers, whereby the <i>S</i>-configuration on both generally exerted the highest activity and selectivity on DAT. The representative compound of this series was further characterized by <i>in silico</i>, <i>in vitro</i>, and <i>in vivo</i> studies that have demonstrated both safety and efficacy profile of this compound class.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Modafinil (<b>1</b>) (2-[(diphenylmethyl)sulfinyl]acetamide by IUPAC nomenclature) is an innovative wake-promoting agent initially marketed in France in the early 1990s for the treatment of narcolepsy (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In 1998, it was approved by the United States Food and Drug Administration (FDA) as a novel agent to treat daytime sleepiness caused by narcolepsy or by shift work sleep disorder.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In the U.S., military research in modafinil as potential alternative to amphetamines for enhancing alertness and reducing battle fatigue is ongoing, and its use in Air Force missions has already been approved.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Along with methylphenidate, it gained high popularity in the past decade among shift workers, students, and others, who are taking these drugs as nootropics to improve performance during the exams or in the work place.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> Although the media attention has diminished lately, it was not the case with off-label use of modafinil as a cognitive-enhancing drug. Indeed, the results of two surveys recently published in <i>JAMA</i> reveal high use of modafinil among German surgeons and undergraduates of the University of Maryland.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Due to its reported low abuse liability, modafinil has also been suggested for the treatment of mental illnesses such as attention-deficit/hyperactivity disorder (ADHD).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of (±) modafinil (<b>1</b>), JJC8-016 (<b>2</b>), CE-103 (<b>3</b>), CE-111 (<b>4</b>), CE-125 (<b>5</b>), and CE-123 (<b>6</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Modafinil is a racemic mixture of the <i>R</i>- and <i>S</i>-enantiomers in equimolar ratio (1:1), while <i>R</i>-modafinil (FDA approved in June 2007) is a pure enantiomer, which displays slightly increased pharmacological potency as a wakefulness-inducing agent compared to the racemic mixture.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> The difference is more obvious in the pharmacokinetic profile as pointed out by recent human studies that showed that <i>R</i>-modafinil is the metabolically more stable and longer-acting enantiomer.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Despite being brought to the market 2 decades ago, modafinil’s mode of action remained unknown and controversially discussed for years.<a onclick="showRef(event, 'ref2 ref10'); return false;" href="javascript:void(0);" class="ref ref2 ref10">(2,10)</a> Studies using radioligand binding assays (Mignot et al.,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> 1994) as well as cell-based (Madras et al., 2006) and synaptosome-based uptake inhibition assays (Zolkowska et al., 2009) have identified the dopamine transporter (DAT) as a major target to which modafinil binds.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> It was Loland et al. who have provided more detailed insight into modafinil’s mode of action. They confirmed that modafinil and both of its enantiomers inhibit dopamine reuptake in a cell-based assay, with the <i>R</i>-enantiomer being almost 3-fold more potent than the <i>S</i>-enantiomer. In the same study, they have also demonstrated that the binding site for modafinil and the central binding site for dopamine overlap and that <i>R</i>- and <i>S</i>-modafinil preferentially bind to a different DAT conformational isomer than cocaine.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Furthermore, modafinil does not act as a substrate for DAT and does not cause efflux of dopamine, a hallmark that clearly distinguishes it̀s pharmacological profile from those of amphetamine and amphetamine-like psychostimulants.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> Owing to its unique binding mode and exclusive pharmacological profile, modafinil has been classified as an atypical dopamine reuptake inhibitor.<a onclick="showRef(event, 'ref14 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref18">(14,18)</a></div><div class="NLM_p">These findings made modafinil an interesting scaffold for medicinal chemistry, leading to a large number of derivatives that have been synthesized and tested for their biological activity in the recent years.<a onclick="showRef(event, 'ref6 ref7 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref19 ref20 ref21 ref22">(6,7,19−22)</a> In particular, much of the work in the United States has focused on development of modafinil analogues as potential therapeutics against cocaine addiction.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> From this research, compound JJC8-016 (<b>2</b>) has emerged as an atypical dopamine reuptake inhibitor that has no cocaine-like abuse potential (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> An independent line of research has focused on the activity of modafinil and its analogues in animal paradigms of working and spatial memory.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33">(25−33)</a></div><div class="NLM_p">We have previously reported a series of modafinil derivatives in which the carboxamide moiety has been replaced with various five- and six-membered aromatic heterocycles.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Compounds of this series have demonstrated (I) higher activity and better selectivity toward DAT than modafinil when tested by reuptake inhibition assay, (II) absence of amphetamine- and cocaine-like properties when tested in efflux and binding assays, as well as (III) absence of neurotoxicity when tested <i>in vivo</i>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In addition, carboxamide replacement with substituted and unsubstituted thiazoles led to the discovery of compounds with an improved <i>in vitro</i> and in <i>vivo</i> profile.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33">(30−33)</a> For example, CE-103 (<b>3</b>) exerted comparable <i>in vitro</i> activity on DAT (IC<sub>50</sub> = 15 μM) as modafinil, with negligible effects on serotonin and norepinephrine transporter (SERT and NET) and it was able to decrease working memory errors in the radial arm maze (RAM) significantly at doses of 1 mg/kg and 10 mg/kg body weight when given intraperitoneally compared to vehicle control (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Similarly, CE-111 (<b>4</b>) and CE-125 (<b>5</b>) showed higher reuptake inhibition activity on DAT (IC<sub>50</sub> = 3.2 μM and 4.1 μM, respectively) compared to modafinil and negligible activity on SERT and NET (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Both compounds were able to improve the memory performance on the 8th and 9th day on the RAM at 1 mg/kg body weight (ip) and on the 8th, 9th, and 10th day at 10 mg/kg (ip) when compared to the control group.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> Another thiazole-containing analogue, CE-123 (<b>6</b>), was previously shown to inhibit dopamine reuptake (IC<sub>50</sub> = 4.6 μM) while showing almost negligible effects on reuptake of dopamine and serotonin <i>in vitro</i>. As compared to <i>R</i>-modafinil, it reached higher concentrations in the brain and had a smaller elimination rate. <i>In vivo</i> drug efficacy of CE-123 was demonstrated in male Sprague-Dawley rats in hole-board task, a spatial memory paradigm. The compound was able to enhance both memory acquisition as well as memory retrieval.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Interestingly, the <i>S</i>-enantiomer of CE-123 showed an almost 8-fold higher <i>in vitro</i> activity on DAT than the <i>R</i>-enantiomer. In male rats, <i>S</i>-CE-123 demonstrated increased cognitive flexibility with diminished impulsivity compared to <i>R</i>-modafinil as determined by an attentional set-shifting task (ASST) and a five-choice serial-reaction time task (5-CSRTT).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p last">On the basis of the above-described results, the aim of this study was to generate a novel series of modafinil analogues with further improved activity and selectivity toward DAT. To that end, the structure–activity relationship (SAR) on DAT, SERT,and NET was explored by replacing the carboxamide function of modafinil with a series of substituted and unsubstituted thiazoles and by modifying the diphenylmethyl group. We also sought to explore the influence of introducing one additional chiral center on the activity of such analogues. The four pure stereoisomers of such an analogue were obtained, their absolute configuration was determined by single crystal X-ray diffraction analysis, their reuptake inhibition activity was tested, and the compounds were docked within the binding pocket of human DAT homology model. Furthermore, the compounds of this series were screened by <i>in silico</i> methods for their activity on the hERG channel and the most potent DAT reuptake inhibitors were tested <i>in vitro</i> in order to verify the <i>in silico</i> results. Finally, we have performed a pharmacokinetic study of the most potent analogue.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23768" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23768" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic pathway of novel thiazole-containing modafinil analogues without substitution on phenyl rings <b>12a</b>–<b>s</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The starting compound, diphenylmethyl-<i>S</i>-isothiuronium hydrobromide (<b>9</b>), was alkylated with both plain and substituted 2-, 4-, or 5-(chloromethyl)thiazoles to provide intermediates <b>11a</b>–<b>s</b> in 31% to >95% yield. Intermediates were subsequently oxidized, and final sulfoxide-containing products <b>12a</b>–<b>s</b> were obtained in 11% to >95% yield.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>11a</b>–<b>s</b> and <b>12a</b>–<b>s</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 48% HBr, MeOH, reflux, 4 h; (b) MeOH, K<sub>2</sub>CO<sub>3</sub>, rt 48 h; (c) CH<sub>3</sub>COOH, 30% H<sub>2</sub>O<sub>2</sub>, rt overnight.</p></p></figure><div class="NLM_p">Synthesis of 2-[(9<i>H</i>-fluoren-9-ylsulfinyl)methyl]-1,3-thiazole (<b>17</b>) was achieved via a similar synthetic route as depicted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The first step involves conversion of 9-hydroxyfluorene (<b>13</b>) with thiourea and 48% HBr to the corresponding thiouronium salt (<b>14</b>). The second step is an alkylation reaction with 2-(chloromethyl)thiazole to give the intermediate (<b>16</b>). The final step is an oxidation reaction in CH<sub>3</sub>COOH with H<sub>2</sub>O<sub>2</sub> that gave the final product <b>17</b> in 67% yield.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>16</b> and <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 48% HBr, H<sub>2</sub>O, 100–105 °C, 1 h; (b) 1,4-dioxane, NaOH, 70 °C, 5 h; (c) CH<sub>3</sub>COOH, 30% H<sub>2</sub>O<sub>2</sub>, rt 24 h.</p></p></figure><div class="NLM_p">Thiazole-containing analogues with monosubstitution on one or both phenyl rings (<b>24a</b>–<b>m</b>) were obtained as depicted in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Conversion of the chloromethylthiazoles <b>18a</b>–<b>e</b> with thioacetic acid (<b>19</b>) to yield the acylated intermediates <b>20a</b>–<b>e</b> and then deprotection and isolation of the desired plane and substituted thiomethylthiazoles <b>21a</b>–<b>e</b> were the first steps. In the subsequent reaction, <b>21a</b>–<b>e</b> were condensed with substituted diphenylmethyl alcohols <b>22a</b>–<b>m</b> to yield intermediates <b>23a</b>–<b>m</b> (yield 22% to >95%). In the final step, oxidation of the appropriate sulfenyl moiety gave the desired products <b>24a</b>–<b>m</b> in 11–92% yield.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>23a</b>–<b>m</b> and <b>24a</b>–<b>m</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, NaI, acetone, 35–40 °C, 3 h; (b) NaOH, EtOH, reflux, 2 h; (c) BF<sub>3</sub>·Et<sub>2</sub>O, CH<sub>3</sub>COOH, rt overnight; (d) CH<sub>3</sub>COOH, 30% H<sub>2</sub>O<sub>2</sub>, rt overnight.</p></p></figure><div class="NLM_p">Compounds <b>31c</b>–<b>f</b> were obtained as depicted in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. 4-(Chloromethyl)thiazole (<b>18a</b>) was reacted with thioacetic acid (<b>19</b>) to yield acylated compound <b>20a</b>, which was hydrolyzed under alkaline conditions to corresponding mercaptan <b>21a</b>. Thiazol-4-ylmethanethiol was further condensed with (4-bromophenyl)(phenyl)methanol (<b>22i</b>) to yield racemic 4-({[(4-bromophenyl)(phenyl)methyl]thio}methyl)thiazole (<b>23i</b>) in 25% yield. In the following step, compound <b>23i</b> was separated into the enantiomers <b>30a</b> and <b>30b</b> using chiral HPLC on a CHIRALPAK IA semipreparative column (10 mm diameter × 20 cm length) (Daicel Inc., Tokyo, Japan) and ACN as the mobile phase. Each of the enantiomers was further oxidized to yield again racemic compounds <b>31a</b> and <b>31b</b>, respectively, that were finally separated using CHIRALPACK IA semipreparative column into the individual stereoisomers <b>31c</b>–<b>f</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>31c</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, NaI, acetone, 35–40 °C, 3 h; (b) NaOH, EtOH, reflux, 2 h; (c) BF<sub>3</sub>·Et<sub>2</sub>O, CH<sub>3</sub>COOH, rt overnight; (d) chiral separations, Chiralpak IA column, isocratic 100% ACN as mobile phase; (e) CH<sub>3</sub>COOH, H<sub>2</sub>O<sub>2</sub>, rt overnight; (f) chiral separations, Chiralpak IA column, isocratic absolute EtOH as mobile phase for <b>31c</b> and <b>31d</b>, isocratic 80% EtOAc, 20% hexane as mobile phase for <b>31e</b> and <b>31f</b>.</p></p></figure><div class="NLM_p">Compounds <b>24h</b>, <b>24k</b>, and <b>24l</b> were separated into individual (less retained and more retained) enantiomers <b>32a</b>, <b>32b</b>, <b>33a</b>, <b>33b</b>, <b>34a</b>, and <b>34b</b>, respectively, by means of chiral-phase high performance liquid chromatography (HPLC).</div><div class="NLM_p">Compounds <b>42a</b>–<b>f</b> to <b>45a</b>–<b>f</b> were obtained as depicted in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Thiazol-5-ylmethanethiol <b>(36)</b> was reacted with para-monosubstituted diphenyl alcohols (<b>35a</b>–<b>f</b>) to yield racemic monosubstituted sulfide intermediates (<b>37a</b>–<b>f</b>) in 22–87% yield. Each intermediate was separated into individual enantiomers (<b>38a</b>–<b>f</b> and <b>39a</b>–<b>f</b>), by means of chiral-phase HPLC, that were subsequently oxidized to corresponding sulfoxide-containing derivatives (<b>40a</b>–<b>f</b> and <b>41a</b>–<b>f</b>) with 81–95% and 76–95% yields, respectively. Racemic products were further separated into individual enantiomers (<b>42a</b>–<b>f</b>, <b>43a</b>–<b>f</b>, <b>44a</b>–<b>f</b>, and <b>45a</b>–<b>f</b>) by another round of chiral-based separations.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Strategy for Compounds <b>42a</b>–<b>f</b> to <b>45a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) BF<sub>3</sub>·Et<sub>2</sub>O, CH<sub>3</sub>COOH, reflux, 3 h; (b) chiral-phase HPLC; (c) CH<sub>3</sub>COOH, H<sub>2</sub>O<sub>2</sub>, rt overnight; (d) chiral-phase HPLC.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discssion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> SARs of Racemates on Reuptake Inhibition of Monoamine Transporters</h3><div class="NLM_p">All sulfoxide-containing end products (<b>12a</b>–<b>i</b>, <b>11j</b>, <b>12k</b>–<b>s</b>, <b>17</b>, <b>24a</b>–<b>m</b>) were tested for their reuptake inhibition potential on HEK293 cells with stable expression of human DAT, NET, and SERT isoforms, as described in detail under the <a class="ref internalNav" href="#sec5" aria-label="Experimental Procedures">Experimental Procedures</a> section. The obtained values were compared to those of the parent compounds modafinil (<b>1</b>) (DAT IC<sub>50</sub> = 11.5 ± 4.3 μM; NET IC<sub>50</sub> = 284 ± 24 μM; SERT, not specific in tested concentration range)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and <i>R</i>-modafinil (DAT IC<sub>50</sub> = 6.6 ± 0.8 μM; NET IC<sub>50</sub> = 170 ± 90 μM; SERT IC<sub>50</sub> = 232 ± 197 μM)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and correlated to the chemical modifications. SAR study was aimed to elucidate the effect of (i) replacing the carboxamide with various substituted and unsubstituted thiazoles linked via positions 2, 4, and 5 as well as of (ii) introducing substituents on one or both phenyl rings. The results are summarized and presented in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of hDAT-, hNET-, and hSERT-Mediated Uptake of Respective Radioligands by Thiazole-Containing Analogues (Bridged on Position 4 of Thiazole)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0014.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values represent data three independent experiments, each performed in triplicate. NA: not active in used concentration range.</p></div></div><div></div></div><div class="NLM_p">Heterocyclic replacement of the carboxamide moiety with unsubstituted thiazole on position 4 yielded the compound <b>12a</b>, which exerted activity (DAT IC<sub>50</sub> = 6.7 ± 1.4 μM) comparable to that of <i>R</i>-modafinil and almost 1-fold better than that of <b>1</b>. Furthermore, this analogue showed negligible activity on NET and SERT (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Interestingly, most of the racemic compounds herein reported were found not to inhibit the uptake of [<sup>3</sup>H]-serotonin by SERT, with the exception of weak activity of <b>12k</b> (SERT IC<sub>50</sub> = 201 ± 79 μM) and <b>24h</b> (SERT IC<sub>50</sub> = 221 ± 13 μM).</div><div class="NLM_p">Introduction of a methyl group in position 2 yielded the previously reported compound <b>4</b> with slightly higher activity on DAT (IC<sub>50</sub> = 3.2 μM) than <b>12a</b>. Substitution on the same position with larger aliphatic groups such as ethyl, <i>n</i>-propyl, isopropyl, and <i>n</i>-butyl yielded analogues <b>12e</b> (IC<sub>50</sub> = 14.6 ± 0.9 μM), <b>12f</b> (IC<sub>50</sub> = 28.4 ± 1.9 μM), <b>12d</b> (IC<sub>50</sub> = 24.3 ± 1.7 μM), and <b>12g</b> (IC<sub>50</sub> = 13.5 ± 2.8 μM), respectively, with decreased activity on DAT. Out of them, only <b>12g</b> exerted weak activity on NET (IC<sub>50</sub> = 164 ± 57 μM). Substitution with a chlorine atom on the same position yielded the selective DAT inhibitor <b>12i</b> with an activity (IC<sub>50</sub> = 3.0 ± 1.0 μM) as good as that of compound <b>4</b>. Introduction of a five-membered aromatic heterocycle, i.e., thiophene bound through position 2, gave compound <b>12b</b> with an inhibitory activity on DAT (IC<sub>50</sub> = 7.0 ± 2.3 μM) comparable to that of <i>R</i>-modafinil and <b>12a</b>.</div><div class="NLM_p">Further modification of <b>4</b> by introducing a second methyl group in position 5 gave compound <b>12c</b> and led to a significantly decreased activity on DAT. The same was observed upon extension of the bridge to the sulfoxide by exchanging the methylene with an ethylene group as in compound <b>12h</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">Previously, it was reported that the replacement of the sulfoxide moiety with a sulfide function in modafinil analogues may have minor effects on DAT binding but should lead to increased affinities at SERT and NET.<a onclick="showRef(event, 'ref6 ref20'); return false;" href="javascript:void(0);" class="ref ref6 ref20">(6,20)</a> To evaluate whether our newly synthesized compounds would fall under this concept, compound <b>11j</b> was tested for monoamine transporters reuptake inhibition activity and compared to its sulfoxide counterpart <b>4</b>. While we have indeed observed enhanced reuptake inhibition on NET, now activity was detected on SERT and a significantly decreased inhibition activity was measured on DAT (IC<sub>50</sub> = 91.4 ± 2.2 μM). On the basis of these findings, none of the other thioether intermediates were tested for bioactivity.</div><div class="NLM_p">Compounds <b>5</b> and <b>12a</b> were further modified by introducing substitutions on both para-positions of the phenyl rings. In the case of <b>12a</b>, substitution with either methyl groups or strong electron-withdrawing groups such as fluorine and chlorine (<b>24f</b>, <b>24e</b>, and <b>24a</b>, respectively) only had minor effects on the reuptake inhibition activity on DAT (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Different results were obtained upon modification of <b>5</b>, where introduction of chlorine to give <b>24b</b> yielded a 2- to 3-fold reduced but still good reuptake inhibition activity on DAT (IC<sub>50</sub> = 14.0 ± 5.5 μM), while electron-donating methoxy groups, as in <b>24g</b>, led to a strong drop in activity (DAT IC<sub>50</sub> = 105 ± 24 μM) and the methyl groups in <b>24c</b> completely abolished the activity.</div><div class="NLM_p">A much smaller series of compounds was synthesized based on the structure of CE-103 (<b>3</b>), with the thiazole linked via position 2. Introduction of a single methyl group on position 5 as well as of two methyl groups on positions 4 and 5 of the thiazole yielded analogues <b>12l</b> and <b>12k</b>, respectively. However, both showed decreased activity on DAT compared to the unsubstituted compound <b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Analogous to <b>12a</b>, substitution with methyl groups on the para-positions of both phenyl rings (<b>24m</b>) led to a decrease in activity, while substitution with chlorine atoms on the same position (<b>24j</b>) yielded a slightly increased activity on DAT (IC<sub>50</sub> = 9.6 ± 1.4 μM), which is similar to those of <b>1</b> and <i>R</i>-modafinil. Replacement of the diphenylmethyl with a fluorenyl moiety yielded analogue <b>17</b> with no activity on DAT, NET, and SERT. This clearly demonstrates that the free rotation of the phenyl groups is crucial for activity, indicating that they need to be oriented in a nonplanar configuration to fit into the binding pocket of the monoamine transporters.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of hDAT-, hNET-, and hSERT-Mediated Uptake of Respective Radioligands by Thiazole-Containing Analogues (Bridged on Position 2 of Thiazole)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0015.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values represent data from three independent experiments, each performed in triplicate. NA: not active in used concentration range.</p></div></div><div></div></div><div class="NLM_p">In the final series, analogues of CE-123 (<b>6</b>) bridged via position 5 of thiazole were explored (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Introduction of methyl groups either on position 2, 4, or 2 and 4 on the thiazole yielded analogues <b>12m</b>, <b>12r</b>, and <b>12s</b>, respectively, which all showed strongly reduced activity on DAT compared to <b>1</b>, <b>6</b>, and <i>R</i>-modafinil. Introduction of both electron-withdrawing and -donating groups on position 2 of the thiazole, as in analogues <b>12n</b>, <b>12o</b>, and <b>12q</b>, also only led to reduction of activity on DAT. More differentiated results were obtained with modifications on the para-positions of both phenyl rings. Compared to <b>6</b>, strong electron-donating methoxy groups as in <b>24d</b> strongly decreased the activity on DAT; methyl groups as in <b>24l</b> and F atoms as in <b>24k</b> slightly reduced the activity, and strongly electron-withdrawing groups such as Cl led to equal or slightly improved activity as shown for <b>24h</b>. However, the latter was also moderately active on NET (IC<sub>50</sub> = 45.5 ± 4.2 μM) and thus less selective toward DAT. Attaching the bulky adamantyl group to C-2 of the thiazole was performed to probe the available space within the binding pocket, but the obtained analogue <b>12p</b> showed too low solubility to be tested in biological assays.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition of hDAT-, hNET-, and hSERT-Mediated Uptake of Respective Radioligands by Thiazole-Containing Analogues (Bridged on Position 5 of Thiazole)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0016.gif" alt="" id="gr16" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values represent data from three independent experiments, each performed in triplicate. NA: not active in used concentration range. NT: not tested.</p></div></div><div></div></div><div class="NLM_p">In summary, substituting the carboxamide group of modafinil with various thiazole derivatives while keeping the diphenylmethyl moiety unmodified yielded three additional racemic compounds (<b>12a</b>, <b>12b</b>, and <b>12i</b>) that showed selective inhibitory activities toward DAT with an IC<sub>50</sub> in the range of 1–10 μM. Interestingly, while the plain thiazoles linked via positions 2, 4, and 5 showed relatively similar activities on DAT with IC<sub>50</sub> values of 14.7 μM (CE-103), 6.66 ± 1.44 μM (<b>12a</b>), and 4.61 ± 0.14 μM (CE-123), respectively, they differed strongly upon substitution on the C-atoms of the heterocycle. While all such derivatives of CE-103 and CE-123 showed a severely reduced activity on DAT, <b>12a</b> can easily accept various substituents on C-2 of thiazole to give analogs with only slightly reduced or even somewhat improved activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p last">On the basis of four of the most active structures of above, namely, CE-103, <b>12a</b>, CE-123, and CE-125, we further tested the effect of symmetric substitution in para-position of the two phenyl rings. This yielded another six analogues (<b>24a</b>, <b>24e</b>, <b>24f</b>, <b>24h</b>, <b>24j</b>, and <b>24k</b>) with IC<sub>50</sub> values below 10 μM. Unfortunately, only a minor improvement in activity on DAT could be obtained in this way, and even that goes in hand with decreased selectivity when taking into account the activity on NET and SERT.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> SARs of Enantiopure Compounds at DAT, NET, and SERT</h3><div class="NLM_p">As has been proven for modafinil, where the <i>R</i>-enantiomer is more active, and CE-123, where the <i>S</i>-enantiomer showed an almost 8-fold higher <i>in vitro</i> activity, enantiopure DAT inhibitors can be more active than the racemic mixture. Also, providing solely the more active enantiomer as drug can reduce or abolish side effects if these are mainly caused by the other enantiomer. To test whether the enantiomers of our novel thiazole-based modafinil analogues also show significant differences in their activity, racemic compounds <b>24h</b>, <b>24k</b>, and <b>24l</b> were separated by chiral-phase HPLC. In all three cases, there was indeed a big difference, ranging from approximately ∼4-fold to ∼50-fold, in the activity of the two enantiomers (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). <b>32a</b>, <b>32b</b>, and <b>33b</b> could be successfully crystallized and their absolute configuration was determined by single crystal X-ray diffraction analysis, showing that at least for two more compounds of this series the <i>S</i>-configuration of the sulfoxide yields the higher activity.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition of hDAT-, hNET-, and hSERT-Mediated Uptake of Respective Radioligands by Single Stereoisomers of Thiazole-Containing Analogues<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0017.gif" alt="" id="gr17" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Configurations given in parentheses are indirectly determined by measuring only the other stereoisomer(s). IC<sub>50</sub> values represent data from three independent experiments, each performed in triplicate. NA: not active in used concentration range.</p></div></div><div></div></div><div class="NLM_p">In our previous study, we aimed to explore the influence of introducing an additional chiral center into a thiophene-containing modafinil analogue on its activity toward monoamine transporters. However, despite promising results for one pure stereoisomer, lack of a complete data set for all four separated stereoisomers due to very low solubility of some of them prevented a fully conclusive analysis.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Thus, the same strategy was applied to two of the better soluble thiazole-containing modafinil analogues. CE-123 was modified by introduction of either a methoxy, methyl, fluoro, chloro, bromo, or trifluoromethyl group on the para-position of only one of the phenyl rings. The individual stereoisomers were tested, and where possible, the absolute configuration was determined (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_p">Again, the four stereoisomers of each of the six analogous showed remarkable differences in both activity and selectivity, and in every case, the most active stereoisomer was more promising in terms of activity and selectivity than the corresponding symmetrically modified analogues. For this set of very similar compounds, general trends are seen regarding the effect of the configuration on both the S and the C atoms. Those stereoisomers, shown to have <i>S</i>-configuration on both atoms (<i>S</i>,<i>S</i>), showed the highest activity on DAT, followed by the molecules with <i>S</i>-configuration on the sulfoxide and <i>R</i>-configuration on the chiral carbon (<i>S</i>,<i>R</i>). In all cases, the <i>R</i>,<i>S</i>-configuration gave by far the lowest activity. For optimization of the selectivity, it is interesting that the SAR is different regarding activity on DAT, NET, and SERT. The SERT is nearly exclusively inhibited by the <i>R</i>,<i>R</i>-stereoisomers, and <b>43d</b> actually inhibits SERT more effectively than DAT. The trend for NET is much less clear, but usually <i>S</i>,<i>S</i>-stereoisomers, which are most active on DAT, did also hit NET but with lower IC<sub>50</sub> values. Surprisingly, the most promising CE-123 derivative tested so far, which possesses a single Br-atom in para-position of one of the phenyls and <i>S</i>,<i>S</i>-configuration (<b>42e</b>), shows neglectable activity on NET while inhibiting DAT with an IC<sub>50</sub> of only 1.6 ± 0.6 μM.</div><div class="NLM_p">To test if these findings can be translated to the thiazole-containing analogues bridged on position 4 of thiazole, i.e., CE-111, CE-125, and <b>12a</b>, the H atom in para-position of one of the phenyl rings of <b>12a</b> was substituted by a Br atom. Already the racemic mixture showed improved activity on DAT (IC<sub>50</sub> = 1.85 ± 1.20 μM). Chiral HPLC separation of the racemic thioether intermediate <b>30</b>, followed by introduction of the second chiral center by oxidation of the sulfur, and another chiral HPLC separation gave individual stereoisomers <b>31c</b>–<b>f</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The SAR regarding the configuration on the two chiral centers was nearly the same as described above except that here the <i>R</i>,<i>R</i>-stereoisomer was more active on DAT than the <i>S</i>,<i>R</i>-stereoisomer. <b>31e</b>, which was demonstrated by single crystal X-ray diffraction analysis to have <i>S</i>,<i>S</i>-configuration, showed the highest activity on DAT (IC<sub>50</sub> = 0.65 ± 0.07 μM) of all tested compounds in this series while being at the same time 100-fold less active on NET (IC<sub>50</sub> = 73 ± 9 μM) and exerting negligible activity on SERT (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative reuptake inhibition curves of compounds <b>31c</b>–<b>f</b>. <b>31c</b>–<b>f</b> represent individual stereoisomers with significant difference in activity and selectivity toward DAT (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">With its submicromolar activity, <b>31e</b> is a 10-fold more potent DAT inhibitor compared to <i>R</i>-modafinil and almost 20-fold more active than modafinil. For these reasons, <b>31e</b> was selected for further characterization.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Molecular Docking of the Four Stereoisomers <b>31c</b>–<b>f</b></h3><div class="NLM_p">An overlay of the best scored docking poses of compounds <b>31c</b>–<b>f</b> in the binding pocket of an hDAT homology model is shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. The poses are very similar with the exception of <b>31d</b>, which orientates differently in the binding pocket. The interaction patterns of the four stereoisomers of <b>31c</b>–<b>f</b> are shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. What should be highlighted is that the interaction between the transporter and all four ligands is mostly governed by the interaction between primarily hydrophobic amino acids and the phenyl rings of molecules <b>31c</b>–<b>f</b>. The exception is the observation of an additional hydrogen bond interaction between <b>31d</b> and Ser149.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. The highest scored docked poses of <b>31c</b> (cyane), <b>31d</b> (yellow), <b>31e</b> (orange), <b>31f</b> (pink) are shown as overlay in the binding pocket of the hDAT homology model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Interactions of the highest scored pose of <b>31c</b>–<b>f</b> in the binding pocket of hDAT. Red lines indicate hydrogen bond donor interactions, and yellow highlights hydrophobic interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In general, it can be said that from the position of the ligand in the binding pocket and the mostly entropic governed interactions, methods that incorporate entropic contributions (e.g., relative binding free energy) might be needed for further lead development.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>In Silico</i> hERG Channel Activity Profiling</h3><div class="NLM_p">The Inte:Ligand Tox Pharmacophore DB<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> was used for toxicity profiling of all 37 synthesized compounds, but no significant effect on hERG channel was predicted for any of them (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Heat map of compounds screened using the Inte:Ligand hERG eTox pharmacophore model, showing no relevant fit of any of the compounds to the query (white boxes).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>In Vitro</i> Effect of <b>31c</b>–<b>f</b> on Action Potential Parameters</h3><div class="NLM_p">In order to investigate the effect of enantiopure analogues <b>31c</b>–<b>f</b> on action potential (AP) parameters, the APs of Cor.4U hiPSC-CMs cells in the presence of 0.01, 0.1, 1, or 10 μM <b>31c</b>–<b>f</b> were measured by means of a voltage-sensitive fluorescence dye. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, none of the tested compounds caused early after depolarizations (EADs) or changes in action potential duration or shape even when applied at 10 μM concentration.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Representable APs in control (black) and recorded 30 min after application of either vehicle (0.1% of DMSO) or test compounds <b>31c</b>–<b>f</b> at 10 μM (red). None of the drugs affected action potential parameters.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Effect of <b>31e</b> on Dopamine Release</h3><div class="NLM_p">In superfusion experiments on HEK293 cells stably expressing the human DAT preloaded with the metabolically inert transporter substrate [<sup>3</sup>H]1-methyl-4-phenylpyridinium ([<sup>3</sup>H]MPP<sup>+</sup>) 3 μM <span class="smallcaps smallerCapital">d</span>-amphetamine increased tritium efflux (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, circles) whereas 10 μM <b>31e</b> suppressed efflux (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, squares) and blocked <span class="smallcaps smallerCapital">d</span>-amphetamine-induced release (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> triangles). Thus, <b>31e</b> did not induce reverse transport as elicited by the prototypic releasing drug <span class="smallcaps smallerCapital">d</span>-amphetamine but acted as a pure uptake inhibitory drug blocking the reverse transport induced by <span class="smallcaps smallerCapital">d</span>-amphetamine. The inhibitory action of <b>31e</b> on basal efflux of [<sup>3</sup>H]MPP<sup>+</sup> may be due to a blockade of a basal DAT-mediated efflux of the transporter substrate observed under our experimental conditions.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>31e</b> and <span class="smallcaps smallerCapital">d</span>-amphetamine, as well as their interaction, on release by human DAT. HEK293 cells stably expressing DAT were loaded with [<sup>3</sup>H]MPP<sup>+</sup> and superfused, and 4 min fractions of superfusate were collected. After two or three fractions of basal efflux, cells were exposed to buffers containing 10 μM <b>31e</b> (triangles), 3 μM <span class="smallcaps smallerCapital">d</span>-amphetamine (circles), or both (squares) for three or four fractions as indicated by the bars below. Symbols represent the mean ± SEM of seven to eight observations of three independent experiments: *<i>P</i> < 0.05, **<i>P</i> < 0.001 vs basal efflux (mean values of fractions at 0 and 5 min) by paired Student’s <i>t</i> test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>In Vitro</i> Neurotoxicity of <b>31e</b></h3><div class="NLM_p">Compound <b>31e</b> was evaluated in the neurite outgrowth assay using cryopreserved rat cortical neurons (QBM Cell Science), and the evaluation was performed by Cyprotex (Massachusetts, USA, Study Number CYP2052-R1). The positive control, nocodazole, had an IC<sub>50</sub> of 2.22 μM for valid neuron count, an IC<sub>50</sub> of 0.097 μM for mean neurite average length, and an IC<sub>50</sub> of 0.0997 μM for neurite total length per neuron. The negative control, chlorpromazine, had an IC<sub>50</sub> of 7.99 μM for valid neuron count, an IC<sub>50</sub> of 9.022 μM for mean neurite average length, and an IC<sub>50</sub> of 13.8 μM for neurite total length per neuron. Nocodazole was positive for substantially effecting neurite outgrowth while nominally effecting cell viability. Chlorpromazine’s effect on neurite outgrowth was not independent of its effect on cell viability (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). <b>31e</b> had nominal effects (>100 μM) on all three end points when tested at a top concentration of 100 μM.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Results for Valid Neuron Count, Mean Neurite Average Length, and Neurite Total Length per Neuron</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">top concn tested (μM)</th><th class="colsep0 rowsep0" align="center">valid neuron count, IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">mean neurite avg length, IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">neurite total length per neuron, IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nocodazole</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2.22</td><td class="colsep0 rowsep0" align="left">0.097</td><td class="colsep0 rowsep0" align="left">0.0997</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chlorpromazine</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">7.99</td><td class="colsep0 rowsep0" align="left">9.022</td><td class="colsep0 rowsep0" align="left">13.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31e</b></td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div></div><div class="NLM_p last">The obtained results clearly demonstrate a wide difference (>100-fold) between active concentration of compound <b>31e</b> and concentration needed to exert a toxic effect. This renders compound <b>31e</b> suitable for further <i>in vivo</i> investigations.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Plasma and Brain Levels of <b>31e</b></h3><div class="NLM_p">Pharmacokinetic analysis of the most potent DAT inhibitor <b>31e</b> was performed by Evotec (Hamburg, Germany) in Sprague-Dawley rats after single intraperitoneal administration at 7.5 mg/kg. In parallel, a brain penetration assessment was performed on three satellite groups. The results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Plasma and Brain Levels of <b>31e</b> in Sprague-Dawley Rats after a Single Intraperitoneal Administration of 7.5 mg/kg</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">concentration of <b>31e</b> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">time (h)</th><th class="colsep0 rowsep0" align="center">plasma</th><th class="colsep0 rowsep0" align="center">SD</th><th class="colsep0 rowsep0" align="center">brain</th><th class="colsep0 rowsep0" align="center">SD</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2203</td><td class="colsep0 rowsep0" align="left">193</td><td class="colsep0 rowsep0" align="left">803</td><td class="colsep0 rowsep0" align="left">131</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1211</td><td class="colsep0 rowsep0" align="left">712</td><td class="colsep0 rowsep0" align="left">409</td><td class="colsep0 rowsep0" align="left">223</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">89.6</td><td class="colsep0 rowsep0" align="left">28.1</td><td class="colsep0 rowsep0" align="left">44.3</td><td class="colsep0 rowsep0" align="left">25.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">23.8</td><td class="colsep0 rowsep0" align="left">17.1</td><td class="colsep0 rowsep0" colspan="2" align="center">BLQ<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">BLQ: below level of quantification.</p></div></div></div><div class="NLM_p last">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, low μM levels of <b>31e</b> were reached in plasma after 1 and 3 h, which rapidly decreased thereafter. In comparison, as shown previously, ∼3.9 μg/mL of <i>R</i>-modafinil was detected in plasma 1 h after intraperitoneal administration (10 mg/kg body weight) in male Sprague-Dawley rats.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Furthermore, the half-life of <b>31e</b> was determined to be 1.6 ± 0.4 h and was longer as previously shown for <i>R</i>-modafinil (<i>t</i><sub>1/2</sub> = 0.4 ± 0.2 h) and for <b>6</b> (<i>t</i><sub>1/2</sub> = 0.9 h).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Total drug exposure over time, represented as AUC<sub>(0-inf)</sub>, was determined to be 5843 ± 1439 and was higher than that of <i>R</i>-modafinil (AUC<sub>(0-inf)</sub> = 1175 ± 1803) but lower than that of <b>6</b> (AUC<sub>(0-inf)</sub> = 13,519).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> There are several possible explanations for being so. First, the administered dose of <b>31e</b> was 7.5 mg/kg body weight, i.e., 25% lower than dose for <i>R</i>-modafinil and <b>6</b>. Second, while <i>R</i>-modafinil and <b>6</b> were dissolved in DMSO/Tween 80/saline (10:15:75), <b>31e</b> was dissolved using a DMSO-free formulation (40% Kolliphor EL in water). The necessity of DMSO-free formulations of hydrophobic substances is due to the recent findings that even small amounts of DMSO may modulate CNS function <i>in vitro</i>, <i>in vivo</i>, and <i>ex vivo</i>.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> In the brain, <b>31e</b> reached concentration of 803 ± 103 nM at 1 h, 409 ± 223 nM at 3 h, and 44.3 ± 25.1 nM at 7 h. A single intraperitoneal administration of 7.5 mg/kg body weight of <b>31e</b> is thus sufficient to reach a level in the brain that is somewhat above the IC<sub>50</sub> for DAT but far below the IC<sub>50</sub> for NET. This compound can thus be expected to exert its desired modafinil-like biological effects <i>in vivo</i>. Other pharmacokinetic parameters are available in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>In Vivo</i> Brain Microdialysis</h3><div class="NLM_p">In order to further evaluate drug induced changes in extracellular dopamine levels, i.e., to further estimate drug efficacy <i>in vivo</i>, <b>31e</b> was administered in two doses (1 and 10 mg/kg bodyweight) intraperitoneally into free moving male Sprague-Dawley rats and dopamine levels were measured in the nucleus accumbens (NAcb). NAcb extracellular DA levels were stable 1 h prior first drug injection [time effect, <i>F</i>(2,34) = 1.650, <i>P</i> = 0.207] and did not differ between the two treatment groups [treatment effect, <i>F</i>(1,17) = 0.971, <i>P</i> = 0.338; treatment × time interaction, <i>F</i>(2,34) = 0.767, <i>P</i> = 0.473)] reaching an average concentration of 3.5 ± 0.27 fmol/5 μL microdialysate. Perfusion with aCSF containing 100 mM KCl caused a pronounced increase in extracellular DA levels in the NAcb as compared with basaline and pre-KCl conditions (KCl effect, <i>F</i>(2,34) = 19.241, <i>P</i> < 0.001; treatment effect, <i>F</i>(1,17) = 0.538, <i>P</i> = 0.473; treatment × KCl interaction, <i>F</i>(2,34) = 0.475, <i>P</i> = 0.626; <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A) indicating functionality of the microdialysis system in each animal. Post-test analysis revealed that while the low dose of <b>31e</b> (1 mg/kg ip) did not significantly affect extracellular DA levels, the higher dose of <b>31e</b> (10 mg/kg ip) increased DA concentrations in NAcb microdialysates that peaked at approximately 20% above baseline values 50 min after injection (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B).</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Extracellular dopamine (DA) levels in the nucleus accumbens (NAcb) after systemic injection of <b>31e</b>. (A) Effect of local high potassium on DA concentrations in microdialysates. (B) The higher dose (10 mg/kg ip) but not the low dose (1 mg/kg ip) of <b>31e</b> increased extracellular DA levels peaking at 50 min after injection. The arrow denotes the time of injection. Data are relative to baseline DA levels and presented as the mean ± SEM: <i>N</i> = 9–10; <sup>a</sup><i>P</i> < 0.08, *<i>P</i> < 0.05, **<i>P</i> < 0.01 analyzed by two-way ANOVA with repeated measurements followed by a Fisher‘s LSD test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the current study, a novel series of dopamine reuptake inhibitors based on the modafinil scaffold has been synthesized. Replacement of the carboxamide group of modafinil with a series of substituted and unsubstituted thiazoles and additional modifications in terms of introduction of substitutions on both para-positions of the phenyl rings yielded analogues with somewhat improved activity and nevertheless higher selectivity (DAT vs NET and SERT) compared to modafinil and its R-enantiomer. Observations derived from SAR analysis further indicate that (i) the sulfoxide moiety is important for the activity on DAT and (ii) extension of the bridge to the sulfoxide by exchanging the methylene with an ethylene group significantly decreases activity on DAT. Interestingly, introduction of an additional chiral center led to the discovery of most potent new racemic compound <b>24i</b>, with an IC<sub>50</sub> of 1.85 μM on DAT. Upon purification and testing of individual stereoisomers, analogue <b>31e</b> was identified as a selective DAT inhibitor with submicromolar activity (IC<sub>50</sub> = 0.65 ± 0.07 μM). The absolute configuration of <b>31e</b> was attributed by means of single crystal X-ray diffraction analysis and was determined to have <i>S</i> configuration on both the chiral C and S atom. The strong correlation of activity on DAT, SERT, and NET with the absolute configuration was confirmed by showing the identical trend in additional six quadruples of stereoisomers. Docking studies of the four individual stereoisomers <b>31c</b>–<b>f</b> and the inactivity of a derivate with a fluorenyl instead of the diphenylmethyl moiety (<b>17</b>) demonstrate the importance of the two phenyl rings to adopt a nonplanar conformation in the binding pocket. The strong differences in activity and selectivity of the four stereoisomers strongly indicate that further fine-tuning of the asymmetric substituents on the phenyl rings of enantiopure thiazole-based modafinil analogues is the way to go and should enable increasing the DAT activity without simultaneously enhancing activity on NET and SERT to the same extent. On the other hand, this SAR could allow the design of compounds with dual target profile that inhibit both DAT and SERT, as observed for <b>43d</b>. This could benefit aged people suffering from both cognitive decline and depression. Obviously, even when considering only chemically similar derivatives, there is still a huge chemical space left to be explored, such as combinations of different substituents on both phenyl rings. In the end, asymmetric synthesis strategies that avoid chiral separation by HPLC will have to be developed, as shown for the dual serotonin–norepinephrine reuptake inhibitor (+)-synosutine,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> to enable successful scale up.</div><div class="NLM_p last">The most active compound from this series <b>31e</b> was selected for further characterization. <i>In silico</i> predictions indicated no significant effect on the hERG channel, and <i>in vitro</i> studies have showed that <b>31e</b> does not cause early after depolarizations (EADs) or changes in action potential duration or shape. In addition, superfusion experiments clearly demonstrated that <b>31e</b> does not induce reversed transport of dopamine, which is characteristic for amphetamine-like dopamine reuptake inhibitors. <b>31e</b> showed nominal effects (>100 μM) on all three end points when tested at a top concentration of 100 μM in neurite outgrowth assay indicating a very wide range between activity and neurotoxicity effects to be more than 100-fold. This rendered <b>31e</b> suitable for further in vivo investigations. A pharmacokinetic study demonstrated that <b>31e</b> reaches necessary levels in the brain to exert its effect on DAT, while the <i>in vivo</i> microdialysis study demonstrated efficacy of <b>31e</b> to elevate dopamine levels within nucleus accumbens of freely moving rats.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Synthesis</h3><div class="NLM_p">Reaction conditions and yields were not systematically optimized. Anhydrous solvents were purchased from Sigma-Aldrich and were used as such without further purification. All other chemicals and reagents were purchased from Sigma-Aldrich, TCI Europe/Germany, Synthonix, Acros Organics, Activate Scientific, Fluorochem, Enamine, and Alfa Aesar.</div><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance 500 NMR spectrometer (UltraShield) using a 5 mm switchable probe (PA BBO 500SB BBF-H-D-05-Z, 1H, BB = <sup>19</sup>F and <sup>31</sup>P–<sup>15</sup>N) with <i>z</i> axis gradients and automatic tuning and matching accessory (Bruker BioSpin). The resonance frequency for <sup>1</sup>H NMR was 500.13 MHz and for <sup>13</sup>C NMR 125.75 MHz. All measurements were performed for a solution in fully deuterated chloroform or DMSO at 298 K. Standard 1D and gradient-enhanced (ge) 2D experiments, like double quantum filtered (DQF) COSY, NOESY, HSQC, and HMBC, were used as supplied by the manufacturer. Chemical shifts are referenced internally to the residual, nondeuterated solvent signal for chloroform <sup>1</sup>H (δ = 7.26 ppm) or DMSO <sup>1</sup>H (δ = 2.50 ppm) and to the carbon signal of the solvent for chloroform <sup>13</sup>C (δ = 77.00 ppm) or DMSO <sup>13</sup>C (δ = 39.57 ppm).</div><div class="NLM_p">For compound <b>24d</b>, NMR spectra were recorded on a Bruker Avance III 400 NMR spectrometer (UltraShield) using a 5 mm switchable probe (BBFO<sup>PLUS</sup>, BB/19F, 1H/D) with <i>z</i> axis gradients and automatic tuning and matching accessory (Bruker BioSpin). The resonance frequency for <sup>1</sup>H NMR was 400.23 MHz and for <sup>13</sup>C NMR 100.64 MHz. All measurements were performed for a solution in fully deuterated chloroform or methanol at 298 K. Standard 1D and gradient-enhanced (ge) 2D experiments, like double quantum filtered (DQF) COSY, NOESY, HSQC, and HMBC, were used as supplied by the manufacturer. Chemical shifts are referenced internally to the residual, nondeuterated solvent signal for chloroform <sup>1</sup>H (δ 7.26 ppm) or methanol <sup>1</sup>H (δ 3.31 ppm) and to the carbon signal of the solvent for chloroform <sup>13</sup>C (δ 77.00 ppm) or methanol <sup>13</sup>C (δ 49.00 ppm).</div><div class="NLM_p">HRESIMS spectra were obtained on either a maXis HD or a maXis UHR ESI-Qq-TOF mass spectrometer (Bruker Daltonics, Bremen, Germany). Samples were dissolved to 20 μg/mL in either MeOH or ACN/MeOH/H<sub>2</sub>O 99:99:2 (v/v/v) and directly infused into the ESI source with a syringe pump. The ESI ion source was operated as follows: capillary voltage, 0.9–4.5 kV (individually optimized); nebulizer, 0.4 bar (N<sub>2</sub>); dry gas flow, 4 L/min (N<sub>2</sub>); and dry temperature, 180 or 200 °C. Mass spectra were recorded in the range of <i>m</i>/<i>z</i> 50–1550 in the positive-ion mode. The sum formulas were determined using Bruker Compass DataAnalysis based on the mass accuracy (Δ<i>m</i>/<i>z</i> ≤ 2 ppm) and isotopic pattern matching (SmartFormula algorithm).</div><div class="NLM_p last">The purity of the compounds was determined by HPLC either on an UltiMate 3000 series system equipped with VWD detector (Dionex/Thermo Fisher Scientific, Germering, Germany) or on a LC-2010A HT liquid chromatograph device (Shimadzu Corporation, Tokyo, Japan). Separation was carried out on an Acclaim 120 C18, 2.1 mm × 150 mm, 3 μm HPLC column (Thermo Fisher Scientific) using LC–MS-grade water and acetonitrile as mobile phases A and B, respectively. The sample components were separated and eluted with a linear gradient from 10% to 90% B in 25 min followed by an isocratic column cleaning and re-equilibration step. The flow rate was 0.2 mL/min, and the column oven temperature was set to 25 °C. The purity was determined from the UV chromatogram (254 nm) as the ratio of the peak area of the compound to the total peak area (i.e., the sum of the areas of all peaks that were not present in the solvent blank). On the basis of the HPLC data, all final compounds are ≥95% pure. Melting points were measured on Leica Galen III apparatus (Leica Biosystems, Germany).</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> [(Diphenylmethyl)sulfanyl]methanimideamide (<b>9</b>)</h3><div class="NLM_p last">Diphenylmethanol (<b>7</b>) (30.9 g, 168 mmol) and thiourea (<b>8</b>) (14.7 g, 194 mmol) were mixed in a 1 L three-neck round bottomed flask and dissolved in 150 mL of MeOH. The reaction mixture was refluxed for 0.5 h, then 48% HBr (87.4 mL, 772 mmol) was added dropwise over 1 h, followed by stirring under reflux for an additional 2.5 h. After cooling to room temperature, MeOH was removed in vacuum. A pale-yellow product was obtained and suspended in 100 mL of DCM under stirring for 0.5 h at room temperature. The product was filtered and washed with cold DCM. The solid residue was suspended in 100 mL of water and stirred for 0.5 h at room temperature. Finally, the product was filtered under reduced pressure, washed with cold water, and dried under high vacuum to give 38.4 g of a white, powdered solid (yield 71%).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-[(Benzhydrylthio)methyl]thiazole (<b>11a</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (1.9 g, 5.6 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 4.06 g) and 4-(chloromethyl)thiazole (1.0 g, 5.88 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and dried under reduced pressure to give 1.46 g of <b>11a</b> (yield 84%).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-[(Benzhydrylthio)methyl]-2-(thiophen-2-yl)thiazole (<b>11b</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (1.6 g, 5.0 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 3.45 g) and 4-(chloromethyl)-2-(thiophen-2-yl)-1,3-thiazole (1.08 g, 5.0 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and purified by flash chromatography on silica gel (5% MeOH in DCM) to give 1.24 g of solid <b>11b</b> (yield 65%).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-[(Benzhydrylthio)methyl]-2,5-dimethylthiazole (<b>11c</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (1.7 g, 6.2 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 4.28 g) and 4-(chloromethyl)-2,5-dimethylthiazole (1.0 g, 6.2 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and dried under reduced pressure to give 1.0 g of <b>11c</b> (yield 49%).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-[(Benzhydrylthio)methyl]-2-isopropylthiazole (<b>11d</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (1.84 g, 5.7 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 3.94 g) and 4-(chloromethyl)-2-isopropylthiazole (1.0 g, 5.7 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and purified by flash chromatography on silica gel (hexane/EtOAc, 9:1) to give 1.4 g of solid crystalline <b>11d</b> (yield 72%).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-[(Benzhydrylthio)methyl]-2-ethylthiazole (<b>11e</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (2.0 g, 6.2 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 3.4 g) and 4-(chloromethyl)-2-ethylthiazole (1.0 g, 6.2 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and dried under reduced pressure to give 1.46 g of solid <b>11e</b> (yield 74%).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-[(Benzhydrylthio)methyl]-2-propylthiazole (<b>11f</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (1.8 g, 5.8 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 3.1 g) and 4-(chloromethyl)-2-propylthiazole (1.0 g, 5.8 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and dried under reduced pressure to give 1.0 g of solid <b>11f</b> (yield 51%).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 4-[(Benzhydrylthio)methyl]-2-butylthiazole (<b>11g</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (2.5 g, 7.9 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 5.5 g) and 2-butyl-4-(chloromethyl)thiazole (1.5 g, 7.9 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and purified by flash chromatography on silica gel (5% MeOH in DCM) to give 2.7 g of solid product <b>11g</b> (yield 98%).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 4-[2-(Benzhydrylthio)ethyl]-2-methylthiazole (<b>11h</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (4.0 g, 12.4 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 8.6 g) and 4-(chloroethyl)-2-methylthiazole (2.0 g, 12.4 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and dried under reduced pressure to give 3.9 g of solid <b>11h</b> (yield 98%).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-[(Benzhydrylthio)methyl]-2-chlorothiazole (<b>11i</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (0.96 g, 2.9 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 2.0 g) and 2-chloro-4-(chloromethyl)thiazole (0.5 g, 2.9 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and dried under reduced pressure to give 0.9 g of solid <b>11i</b> (yield 91%).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 4-[(Benzhydrylthio)methyl]-2-methylthiazole (<b>11j</b>)</h3><div class="NLM_p last">Synthesis procedure as previously reported.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Ret. time 24.5 min, purity 99.6%. HRESIMS <i>m</i>/<i>z</i> 334.0694 [M + Na]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>17</sub>NNaS<sub>2</sub><sup>+</sup>, 334.0695, Δ = 0.1 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.41–7.22 (m, 10H), 6.78 (s, 1H), 5.16 (s, 1H), 3.70 (s, 2H), 2.74 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 166.8 (C), 151.7 (C), 140.8 (C), 128.5 (4CH), 128.4 (4CH), 127.2 (2CH), 115.0 (CH), 53.9 (CH), 30.6 (CH<sub>2</sub>), 18.9 (CH<sub>3</sub>).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-[(Benzhydrylthio)methyl]-4,5-dimethylthiazole (<b>11k</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (3.23 g, 10.0 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 6.9 g) and 2-(chloromethyl)-4,5-dimethylthiazole (1.6 g, 10.0 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and purified by flash chromatography on silica gel (5% MeOH in DCM) to give 1.0 g of solid <b>11k</b> (yield 31%).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-[(Benzhydrylthio)methyl]-5-methylthiazole (<b>11l</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (2.18 g, 6.8 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 4.7 g) and 2-(chloromethyl)-5-methylthiazole (1.0 g, 6.8 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and purified by flash chromatography on silica gel (5% MeOH in DCM) to give 1.1 g of solid product <b>11l</b> (yield 49%).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-[(Benzhydrylthio)methyl]-2-methylthiazole (<b>11m</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (2.2 g, 6.8 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 4.7 g) and 5-(chloromethyl)-2-methylthiazole (1.0 g, 6.8 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and purified by flash chromatography on silica gel (2.5% MeOH in DCM) to give 1.15 g of solid product <b>11m</b> (yield 54%).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-[(Benzhydrylthio)methyl]-2-chlorothiazole (<b>11n</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (3.8 g, 11.9 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 8.21 g) and 2-chloro-5-(chloromethyl)thiazole (2.0 g, 11.9 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and dried under reduced pressure to give 2.2 g of solid white <b>11n</b> (yield 56%).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-[(Benzhydrylthio)methyl]-2-(<i>tert</i>-butyl)thiazole (<b>11o</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (1.7 g, 5.3 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 3.6 g) and 2-(<i>tert</i>-butyl)-4-(chloromethyl)thiazole (1.0 g, 5.3 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual products were extracted with EtOAc and concentrated under reduced pressure to give 1.6 g of solid <b>11o</b> (yield 86%).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-[(Benzhydrylthio)methyl]-2-(1-adamantyl)-1,3-thiazole (<b>11p</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (2g, 6.2 mmol) in dioxane (20 mL) and water (20 mL) were added aqueous NaOH (2.5 g in 10 mL of water) and 2-(1-adamantyl)-5-(chloromethyl)-1,3-thiazole (1.65 g, 6.2 mmol) in portions. The reaction mixture was stirred at 90 °C for 2 h. The next day, the dioxane was evaporated, water was added, the reaction product was extracted with CH<sub>2</sub>Cl<sub>2</sub> and purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/petroleum ether, 3:5) to give 2.65 g of the compound <b>11p</b> (yield 99%).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 5-[(Benzhydrylthio)methyl]-2-methoxythiazole (<b>11q</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (3.8 g, 11.9 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 8.2 g) and 5-(chloromethyl)-2-methoxythiazole (2.0 g, 11.9 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and dried under reduced pressure to give 2.2 g of white solid <b>11q</b> (yield 56%).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5-[(Benzhydrylthio)methyl]-4-methylthiazole (<b>11r</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (1.6 g, 4.9 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 3.4 g) and 5-(chloromethyl)-4-methylthiazole (0.73 g, 4.9 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and dried under reduced pressure to give 1.53 g of solid <b>11r</b> (yield 99%).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 5-[(Benzhydrylthio)methyl]-2,4-dimethylthiazole (<b>11s</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>9</b> (1.52 g, 4.7 mmol) in MeOH were added solid K<sub>2</sub>CO<sub>3</sub> (5 equiv, 3.45 g) and 5-(chloromethyl)-2,4-dimethylthiazole (0.76 g, 4.7 mmol) in portions. The reaction mixture was stirred at room temperature overnight. The MeOH was evaporated and the residual product was extracted with EtOAc and purified by flash chromatography on silica gel (hexane/EtOAc, 1:1) to give 1.4 g of solid <b>11s</b> (yield 43%).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-[(Benzhydrylsulfinyl)methyl]thiazole (<b>12a</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.56 mL) was added to the solution of <b>11a</b> (1.46 g, 4.9 mmol) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography (5% MeOH in DCM). The product was dried in high vacuum to give 1.1 g of <b>12a</b> as a white solid (yield 71%). Mp 123–126 °C. Ret. time 4.24 min, purity 96.5%. HRESIMS <i>m</i>/<i>z</i> 336.0487 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>NNaOS<sub>2</sub><sup>+</sup>, 336.0847, Δ = 0.0 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.85 (s, 1H), 7.52–7.47 (m, 4H), 7.42–7.23 (m, 7H), 5.06 (s, 1H), 4.11 (d, <i>J</i> = 13.5 Hz, 1H), 3.90 (d, <i>J</i> = 13.5 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 153.1 (CH), 146.1 (C), 135.7 (C), 134.2 (C), 129.7 (2CH), 129.2 (2CH), 128.9 (2CH), 128.7 (2CH), 128.3 (2CH), 119.2 (CH), 70.2 (CH), 51.1 (CH<sub>2</sub>).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 4-[(Benzhydrylsulfinyl)methyl]-2-(thiophen-2-yl)thiazole (<b>12b</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.45 mL) was added to the solution of <b>11b</b> (1.24 g, 3.3 mmol) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (2.5% MeOH in DCM). The product was dried in high vacuum to give 1.2 g of <b>12b</b> as a white solid (yield 92%). Mp 122–126 °C. Ret. time 22.74 min, purity >99.9%. HRESIMS <i>m</i>/<i>z</i> 418.0363 [M + Na]<sup>+</sup> (calcd for C<sub>21</sub>H<sub>17</sub>NNaOS<sub>3</sub><sup>+</sup>, 418.0364, Δ = 0.4 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.57–7.51 (m, 5H), 7.44–7.34 (m, 7H), 7.22 (br s, 1H), 7.12–7.10 (m, 1H), 5.23 (s, 1H), 4.07 (d, <i>J</i> = 13.6 Hz, 1H), 3.84 (d, <i>J</i> = 13.6 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 161.8 (C), 145.2 (C), 137.0 (C), 135.9 (C), 134.3 (C), 129.8 (2CH), 129.1 (2CH-<i>o</i> + 2CH-<i>m</i>), 128.6 (2CH), 128.3 (CH), 128.0 (CH), 127.9 (CH), 126.8 (CH), 118.7 (CH), 69.4 (CH), 50.3 (CH<sub>2</sub>).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 4-[(Benzhydrylthio)methyl]-2,5-dimethylthiazole (<b>12c</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.35 mL) was added to the solution of <b>11c</b> (1.0 g, 3.1 mmol) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.25 g of <b>12c</b> as a white solid (yield 24%). Mp 98–102 °C. Ret. time 3.51 min, purity 98.4%. HRESIMS <i>m</i>/<i>z</i> 364.0798 [M + Na]<sup>+</sup> (calcd for C<sub>19</sub>H<sub>19</sub>NNaOS<sub>2</sub><sup>+</sup>, 364.0800, Δ = 0.7 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.54–7.51 (m, 4H), 7.41–7.31 (m, 6H), 5.16 (s, 1H), 3.90 (d, <i>J</i> = 13.4 Hz, 1H), 3.76 (d, <i>J</i> = 13.4 Hz, 1H), 2.63 (s, 3H), 2.31 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 162.6 (C), 140.4 (C), 136.4 (C), 134.3 (C), 132.9 (C), 129.9 (2CH), 128.9 (2CH), 128.6 (2CH), 128.5 (2CH), 128.2 (CH), 128.1 (CH), 70.0 (CH), 49.9 (CH<sub>2</sub>), 19.1 (CH<sub>3</sub>), 11.5 (CH<sub>3</sub>).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-[(Benzhydrylsulfinyl)methyl]-2-isopropylthiazole (<b>12d</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.33 mL) was added to the solution of <b>11d</b> (1.0 g, 2.9 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.5 g of <b>12d</b> as a white solid (yield 48%). Mp 105–107 °C. Ret. time 21.85 min, purity 99.9%. HRESIMS <i>m</i>/<i>z</i> 378.0959 [M + Na]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>21</sub>NNaOS<sub>2</sub><sup>+</sup>, 378.0957, Δ = 0.5 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.53–7.49 (m, 4H), 7.41–7.37 (m, 4H), 7.35–7.33 (m, 2H), 7.13 (s, 1H), 5.19 (s, 1H), 4.02 (d, <i>J</i> = 13.5 Hz, 1H), 3.80 (d, <i>J</i> = 13.5 Hz, 1H), 3.33–3.29 (m, 1H); 1.44 (s, 3H), 1.43 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 178.2 (C), 144, 3 (C), 136.1 (C), 134.2 (C), 129.9 (2CH), 129.1 (2CH), 129.0 (2CH), 128.6 (2CH), 128.2 (CH), 128.1 (CH), 118.1 (CH), 69.6 (CH), 51.2 (CH<sub>2</sub>), 33.2 (CH), 23.2 (CH<sub>3</sub>), 23.1 (CH<sub>3</sub>).</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 4-[(Benzhydrylsulfinyl)methyl]-2-ethylthiazole (<b>12e</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.46 mL) was added to the solution of <b>11e</b> (1.3 g, 4.0 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 1.35 g of <b>12e</b> as a white solid (yield 99%). Mp 79–83 °C. Ret. time 20.70 min, purity 96.2%. HRESIMS <i>m</i>/<i>z</i> 364.0801 [M + Na]<sup>+</sup> (calcd for C<sub>19</sub>H<sub>19</sub>NNaOS<sub>2</sub><sup>+</sup>, 364.0800, Δ = 0.3 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.51–7.49 (m, 4H), 7.41–7.33 (m, 6H), 7.12 (br s, 1H), 4.01 (d, <i>J</i> = 13.5 Hz, 1H), 3.79 (d, <i>J</i> = 13.5 Hz, 1H), 3.05 (q, <i>J</i> = 7.6 Hz, 2H), 1.42 (t, <i>J</i> = 7.6 Hz, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 173.1 (C), 144.6 (C), 136.0 (C), 134.2 (C), 129.8 (2CH), 129.1 (2CH), 128.9 (2CH), 128.6 (2CH), 128.3 (CH), 128.2 (CH), 118.4 (CH), 70.1 (CH), 51.6 (CH<sub>2</sub>), 26.9 (CH<sub>2</sub>), 14.1 (CH<sub>3</sub>).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-[(Benzhydrylsulfinyl)methyl]-2-propylthiazole (<b>12f</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.40 mL) was added to the solution of <b>11f</b> (1.0 g, 2.9 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 1.0 g of <b>12f</b> as a white powder (yield 96%). Mp 71–73 °C. Ret. time 21.63 min, purity 99.7%. HRESIMS <i>m</i>/<i>z</i> 378.0955 [M + Na]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>21</sub>NNaOS<sub>2</sub><sup>+</sup>, 378.0957, Δ = 0.6 ppm). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.55–7.52 (m, 4H), 7.44–7.40 (m, 4H), 7.37–7.33 (m, 3H), 5.43 (s, 1H), 3.97 (d, <i>J</i> = 13.3 Hz, 1H), 3.76 (d, <i>J</i> = 13.3 Hz, 1H), 2.93 (t, <i>J</i> = 7.4 Hz, 2H), 1.73 (sextet, J = 7.4 Hz, 2H), 0.94 (t, <i>J</i> = 7.4 Hz, 3H); <sup>13</sup>C NMR (125.75 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 170.7 (CH), 145.3 (C), 136.9 (C), 135.2 (C), 129.7 (2CH), 129.0 (2CH), 128.6 (2CH), 128.5 (2CH), 128.0 (CH), 127.9 (CH), 118.9 (CH), 69.5 (CH), 51.7 (CH<sub>2</sub>), 34.4 (CH<sub>2</sub>), 22.7 (CH<sub>2</sub>), 13.4 (CH<sub>3</sub>).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 4-[(Benzhydrylsulfinyl)methyl]-2-butylthiazole (<b>12g</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.7 mL) was added to the solution of <b>11g</b> (2.76 g, 7.8 mmol) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 2.3 g of <b>12g</b> as a white powder (yield 78%). Mp 73–77 °C. Ret. time 24.46 min, purity 98.4%. HRESIMS <i>m</i>/<i>z</i> 392.1111 [M + Na]<sup>+</sup> (calcd for C<sub>21</sub>H<sub>23</sub>NNaOS<sub>2</sub><sup>+</sup>, 392.1113, Δ = 0.5 ppm). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.51–7.49 (m, 4H), 7.41–7.37 (m, 4H), 7.35–7.31 (m, 2H), 7.13 (br s, 1H), 5.43 (s, 1H), 3.97 (d, <i>J</i> = 13.5 Hz, 1H), 3.76 (d, <i>J</i> = 13.5 Hz, 1H), 3.02 (t, <i>J</i> = 7.7 Hz, 2H), 1.80 (p, <i>J</i> = 7.7 Hz, 2H), 1.45 (sextet, <i>J</i> = 7.5 Hz, 2H), 0.90 (t, <i>J</i> = 7.4, 3H); <sup>13</sup>C NMR (125.75 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 170.9 (C), 145.2 (C), 137.0 (C), 135.2 (C), 129.7 (2CH), 129.1 (2CH), 128.6 (2CH), 128.5 (2CH), 128.0 (<i>p</i>-CH), 127.9 (<i>p</i>-CH), 118.9 (CH), 69.1 (CH), 51.7 (CH<sub>2</sub>), 32.1 (CH<sub>2</sub>), 31.4 (CH<sub>2</sub>), 21.5 (CH<sub>2</sub>), 13.6 (CH<sub>3</sub>).</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-[2-(Benzhydrylsulfinyl)ethyl]-2-methylthiazole (<b>12h</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.07 mL) was added to the solution of <b>11h</b> (0.2 g, 0.6 mmol) in glacial acetic acid (5 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.2 g of <b>12h</b> as a yellow solid (yield 90%). Mp 99–104 °C. Ret. time 18.31 min, purity 96.3%. HRESIMS <i>m</i>/<i>z</i> 364.0798 [M + Na]<sup>+</sup> (calcd for C<sub>19</sub>H<sub>19</sub>NNaOS<sub>2</sub><sup>+</sup>, 364.0800, Δ = 0.7 ppm). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.47–7.46 (m, 2H), 7.39–7.31 (m, 8H), 6.85 (br s, 1H), 4.86 (s, 1H), 3.20–3.17 (m, 2H), 3.00–2.95 (m, 1H), 2.84–2.78 (m, 1H), 2.68 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 166.8 (C), 152.5 (C), 135.5 (C), 134.7 (C), 129.3 (2CH), 129.2 (2CH), 128.7 (2CH), 128.6 (2CH), 128.4 (CH), 128.3 (CH), 114.7 (CH), 72.3 (CH), 50.0 (CH<sub>2</sub>), 24.5 (CH<sub>2</sub>), 18.8 (CH<sub>3</sub>).</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-[(Benzhydrylsulfinyl)methyl]-2-chlorothiazole (<b>12i</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.32 mL) was added to the solution of <b>11i</b> (1.0 g, 3.1 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (2.5% MeOH in DCM). The product was dried in high vacuum to give 0.16 g of <b>12i</b> as a pale-yellow solid (yield 15%). Mp 92–95 °C. Ret. time 20.57 min, purity 98.9%. HRESIMS <i>m</i>/<i>z</i> 370.0096 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>14</sub>ClNNaOS<sub>2</sub><sup>+</sup>, 370.0098, Δ = 0.3 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.50–7.47 (m, 4H), 7.43–7.32 (m, 6H), 7.19 (br s, 1H), 5.04 (s, 1H), 3.97 (d, <i>J</i> = 13.6 Hz, 1H), 3.75 (d, <i>J</i> = 13.6 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 152.0 (C), 144.3 (C), 135.4 (C), 135.3 (C), 129.6 (2CH), 129.3 (2CH), 128.9 (2CH), 128.8 (2CH), 128.6 (CH), 128.4 (CH), 121.4 (CH), 71.0 (CH), 51.5 (CH<sub>2</sub>).</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 2-[(Benzhydrylsulfinyl)methyl]-4,5-dimethylthiazole (<b>12k</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.35 mL) was added to the solution of <b>11k</b> (1.0 g, 3.1 mmol) in glacial acetic acid (15 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.5 g of <b>12k</b> as a yellow solid (yield 48%). Mp 96–101 °C. Ret. time 20.34 min, purity 98.2%. HRESIMS <i>m</i>/<i>z</i> 364.0803 [M + Na]<sup>+</sup> (calcd for C<sub>19</sub>H<sub>19</sub>NNaOS<sub>2</sub><sup>+</sup>, 364.0800, Δ = 0.8 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.50–7.48 (m, 4H), 7.42–7.32 (m, 6H), 5.14 (s, 1H), 4.18 (d, <i>J</i> = 13.8 Hz, 1H), 3.95 (d, <i>J</i> = 13.8 Hz, 1H), 2.36 (s, 3H), 2.35 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 153.2 (C), 148.3 (C), 135.4 (C), 133.8 (C), 129.9 (3CH), 129.2 (2CH), 128.9 (2C), 128.7 (2CH), 128.4 (2CH), 70.2 (CH), 52.2 (CH<sub>2</sub>), 14.5 (CH<sub>3</sub>), 11.4 (CH<sub>3</sub>).</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2-[(Benzhydrylsulfinyl)methyl]-5-methylthiazole (<b>12l</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.42 mL) was added to the solution of <b>11l</b> (1.1 g, 3.5 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.12 g of <b>12l</b> as a yellow solid (yield 11%). Mp 82–87 °C. Ret. time 19.19 min, purity 98.5%. HRESIMS <i>m</i>/<i>z</i> 350.0647 [M + Na]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>17</sub>NNaOS<sub>2</sub><sup>+</sup>, 350.0644, Δ = 1.0 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.51–7.46 (m, 5H), 7.43–7.32 (m, 6H), 5.12 (s, 1H), 4.17 (d, <i>J</i> = 13.8 Hz, 1H), 3.95 (d, <i>J</i> = 13.8 Hz, 1H), 2.48 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.9 (C), 141.1 (CH), 136.2 (C), 135.3 (C), 133.8 (C), 129.8 (2CH), 129.2 (2CH), 129.0 (2CH), 128.7 (2CH), 128.4 (CH), 128.3 (CH), 69.7 (CH), 52.0 (CH<sub>2</sub>), 12.0 (CH<sub>3</sub>).</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-[(Benzhydrylsulfinyl)methyl]-2-methylthiazole (<b>12m</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.43 mL) was added to the solution of <b>11m</b> (1.15 g, 3.9 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 1.0 g of <b>12m</b> as a pale-yellow solid (yield 61%). Mp 128–133 °C. Ret. time 17.49 min, purity 97.6%. HRESIMS <i>m</i>/<i>z</i> 350.0651 [M + Na]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>17</sub>NNaOS<sub>2</sub><sup>+</sup>, 350.0644, Δ = 2.0 ppm). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.52–7.49 (m, 4H), 7.45–7.34 (m, 7H), 5.24 (s, 1H), 4.20 (d, <i>J</i> = 14.5 Hz, 1H), 3.80 (d, <i>J</i> = 14.5 Hz, 1H), 2.62 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 166.9 (C), 142.7 (CH), 136.4 (C), 135.1 (C), 129.6 (2CH), 129.2 (2CH), 128.6 (2CH), 128.5 (2C), 128.2 (CH), 128.0 (CH), 126.5 (C), 69.3 (CH), 47.6 (CH<sub>2</sub>), 18.9 (CH<sub>3</sub>).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 5-[(Benzhydrylsulfinyl)methyl]-2-chlorothiazole (<b>12n</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.35 mL) was added to the solution of <b>11n</b> (1.0 g, 3.0 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.5 g of <b>12n</b> as a white powder (yield 48%). Mp 101–104 °C. Ret. time 20.23 min, purity 99.7%. HRESIMS <i>m</i>/<i>z</i> 370.0101 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>14</sub>ClNNaOS<sub>2</sub><sup>+</sup>, 370.0098, Δ = 0.8 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.40–7.35 (m, 10H), 7.29 (s, 1H), 4.68 (s, 1H), 4.04 (d, <i>J</i> = 14.6 Hz, 1H), 3.76 (d, <i>J</i> = 14.6 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 153.7 (C), 141.8 (CH), 134.4 (C), 134.0 (C), 129.6 (2CH), 129.3 (2CH), 128.9 (CH), 128.8 (2CH), 128.6 (CH), 128.5 (2CH), 126.8 (C), 70.1 (CH), 46.8 (CH<sub>2</sub>).</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-[(Benzhydrylsulfinyl)methyl]-2-(<i>tert</i>-butyl)thiazole (<b>12o</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.32 mL) was added to the solution of <b>11o</b> (1.0 g, 2.8 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.4 g of <b>12o</b> as a pale-yellow solid (yield 38%). Mp 99–104 °C. Ret. time 23.83 min, purity 94.9%. HRESIMS <i>m</i>/<i>z</i> 392.1114 [M + Na]<sup>+</sup> (calcd for C<sub>21</sub>H<sub>23</sub>NNaOS<sub>2</sub><sup>+</sup>, 392.1113, Δ = 0.3 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.55 (d, <i>J</i> = 7.8 Hz, 2H), 7.50 (d, <i>J</i> = 7.8 Hz, 2H), 7.41–7.31 (m, 6H), 7.14 (br s, 1H), 5.32 (s, 1H), 4.03 (d, <i>J</i> = 13.5 Hz, 1H), 3.81 (d, <i>J</i> = 13.5 Hz, 1H), 1.49 (s, 9H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 181.4 (C), 143.9 (C), 136.4 (C), 134.0 (C), 130.0 (2CH), 129.1 (2C), 129.0 (2CH), 128.5 (2CH), 128.2 (CH), 128.1 (CH), 118.3 (CH), 68.6 (CH), 50. Six (CH<sub>2</sub>), 37.8 (C), 30.9 (3CH<sub>3</sub>).</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-(Adamantan-1-yl)-5-[(benzhydrylsulfinyl)methyl]thiazole (<b>12p</b>)</h3><div class="NLM_p last">27.6% H<sub>2</sub>O<sub>2</sub> (0.66 mL) was added to the solution of <b>11p</b> (6.2 mmol, 2.65 g) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. The solvent was evaporated in vacuum until dryness. The residue was treated with petroleum ether, and the solid was filtered off and crystallized from EtOAc to yield 1.75 g of <b>12p</b> as a white solid (yield 64%). Mp 161–163 °C. Ret. time 29.85 min, purity 98.8%. HRESIMS <i>m</i>/<i>z</i> 470.1583 [M + Na]<sup>+</sup> (calcd for C<sub>27</sub>H<sub>29</sub>NNaOS<sub>2</sub><sup>+</sup>, 470.1583, Δ = 0.1 ppm). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.55–7.51 (m, 4H), 7.44–7.40 (m, 5H), 7.37–7.33 (m, 2H), 5.48 (s, 1H), 4.00 (d, <i>J</i> = 13.5 Hz, 1H), 3.75 (d, <i>J</i> = 13.5 Hz, 1H), 2.06 (br s, 3H), 1.99 (br s, 6H), 1.75 (br s, 6H); <sup>13</sup>C NMR (125.75 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 180.7 (C), 144.8 (CH), 137.0 (C), 135.0 (C), 129.7 (2CH), 129.1 (2CH), 128.6 (2CH), 128.5 (2CH), 128.0 (CH), 127.9 (CH), 118.2 (C), 68.7 (CH), 51.4 (CH<sub>2</sub>), 42.6 (3CH<sub>2</sub>), 38.9 (C), 36.8 (3CH<sub>2</sub>), 27.9 (3CH).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 5-[(Benzhydrylsulfinyl)methyl]-2-methoxythiazole (<b>12q</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.28 mL) was added to the solution of <b>11q</b> (0.8 g, 2.4 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.42 g of <b>12q</b> as a pale-yellow solid (yield 50%). Mp 107–110 °C. Ret. time 19.04 min, purity >99.9%. HRESIMS <i>m</i>/<i>z</i> 366.0596 [M + Na]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>17</sub>NNaO<sub>2</sub>S<sub>2</sub><sup>+</sup>, 366.0593, Δ = 0.8 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.45–7.33 (m, 10H), 6.89 (s, 1H), 4.78 (s, 1H), 4.09 (s, 3H), 3.95 (d, <i>J</i> = 14.5 Hz, 1H), 3.67 (d, <i>J</i> = 14.5 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 176.4 (CH), 137.7 (C), 134.9 (C), 134.2 (C), 129.4 (<i>o</i>-2CH + <i>m</i>-2CH), 128.8 (2CH), 128.7 (2CH), 128.6 (CH), 128.4 (CH), 116.6 (CH), 69.6 (CH), 58.3 (OCH<sub>3</sub>), 47.6 (CH<sub>2</sub>).</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 5-[(Benzhydrylsulfinyl)methyl]-4-methylthiazole (<b>12r</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.54 mL) was added to the solution of <b>11r</b> (1.6 g, 5.0 mmol) in glacial acetic acid (30 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.8 g of <b>12r</b> as a pale-yellow solid (yield 49%). Mp 110–113 °C. Ret. time 3.06 min, purity 99.0%. HRESIMS <i>m</i>/<i>z</i> 350.0642 [M + Na]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>17</sub>NNaOS<sub>2</sub><sup>+</sup>, 350.0644, Δ = 0.5 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.71 (s, 1H), 7.46–7.34 (m, 10H), 4.80 (s, 1H), 4.04 (d, <i>J</i> = 14.5 Hz, 1H), 3.87 (d, <i>J</i> = 14.5 Hz, 1H), 2.20 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 152.8 (C), 152.4 (CH), 135.2 (C), 134.3 (C), 129.5 (2CH), 129.4 (2CH), 128.8 (2CH), 128.6 (3CH), 128.5 (CH), 118.9 (C), 70.7 (CH), 47.6 (CH<sub>2</sub>), 15.4 (CH<sub>3</sub>).</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 5-[(Benzhydrylsulfinyl)methyl]-2,4-dimethylthiazole (<b>12s</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.5 mL) was added to the solution of <b>11s</b> (1.4 g, 4.3 mmol) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.6 g of <b>12s</b> as a yellow solid (yield 41%). Mp 83–88 °C. Ret. time 18.53 min, purity >99.9%. HRESIMS <i>m</i>/<i>z</i> 364.0804 [M + Na]<sup>+</sup> (calcd for C<sub>19</sub>H<sub>19</sub>NNaOS<sub>2</sub><sup>+</sup>, 364.0800, Δ = 0.9 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.45–7.33 (m, 10H), 3.97 (d, <i>J</i> = 14.4 Hz, 1H), 3.79 (d, <i>J</i> = 14.4 Hz, 1H), 2.66 (s, 3H), 2.10 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 165.5 (C), 151.5 (C), 135.3 (C), 134.3 (C), 129.4 (2CH-<i>o</i> + 2CH-<i>m</i>), 128.8 (2CH), 128.6 (2CH), 128.5 (CH), 128.4 (CH), 117.9 (C), 70.3 (CH), 47.6 (CH<sub>2</sub>), 19.2 (CH<sub>3</sub>), 15.3 (CH<sub>3</sub>).</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 9<i>H</i>-Fluoren-9-yl carbamimidothioate Hydrobromide (<b>14</b>)</h3><div class="NLM_p last">To a vigorously stirred mixture of thiourea (1.65 g, 21.7 mmol), 48% HBr (15 mL), and water (10 mL) at 70–75 °C was added 9-hydroxyfluorene (3 g, 16.5 mmol) in small portions, followed by an additional amount of water (30 mL). The reaction mixture was then heated to 100–105 °C, maintained for another 1 h, and cooled to room temperature. The precipitate was filtered, washed with water, suspended in CH<sub>2</sub>Cl<sub>2</sub>, and filtered again to give 4.96 g (yield 94%) of the corresponding thiouronium salt that was used in the next step without further purification.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 2-{[(9<i>H</i>-Fluoren-9-yl)thio]methyl}thiazole (<b>16</b>)</h3><div class="NLM_p last">To a suspension of thiouronium salt <b>14</b> (2 g, 6.2 mmol) in dioxane (20 mL) was added aqueous NaOH (2.5 g in 20 mL of water) and 2-(chloromethyl)thiazole (<b>15</b>) (0.83 g, 6.2 mmol) in portions. The reaction mixture was stirred at 70 °C for 5 h. The next day, the dioxane was evaporated, and the reaction product was extracted with CH<sub>2</sub>Cl<sub>2</sub> and purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>) to give 1.65 g of compound with minor byproduct (which was removed after oxidation).</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 2-{[(9<i>H</i>-Fluoren-9-yl)sulfinyl]methyl}thiazole (<b>17</b>)</h3><div class="NLM_p last">27.6% H<sub>2</sub>O<sub>2</sub> (0.5 mL) was added to the solution of <b>16</b> (5.59 mmol, 1.65 g) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. The solvent was evaporated in vacuum until dryness. The residue was diluted with water, extracted with CH<sub>2</sub>Cl<sub>2</sub>, dried, and purified by column chromatography (hexane, hexane/CH<sub>2</sub>Cl<sub>2</sub> 1:1, CH<sub>2</sub>Cl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>/EtOAc 1:1) to yield 1.17 g (yield 67%) of final product <b>17</b> as orange crystals. Mp 107–109 °C. Ret. time 17.20 min, purity >98.6% HRESIMS <i>m</i>/<i>z</i> 334.0334 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>13</sub>NNaOS<sub>2</sub><sup>+</sup>, 334.0331, Δ = 0.9 ppm). δ = 8.03 (d, <i>J</i> = 7.6 Hz, 1H), 7.85 (d, <i>J</i> = 7.6 Hz, 1H), 7.81 (d, <i>J</i> = 7.6 Hz, 1H), 7.72 (d, <i>J</i> = 3.2 Hz, 1H), 7.63 (d, <i>J</i> = 7.5 Hz, 1H), 7.55 (t, <i>J</i> = 7.5 Hz, 1H), 7.50–7.43 (m, 2H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.27 (s, 1H), 5.41 (s, 1H), 3.40 (d, <i>J</i> = 13.8 Hz, 1H), 3.35 (d, <i>J</i> = 13.8 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 158.9 (C), 143.2 (CH), 141.7 (C), 141.2 (C), 136.4 (C), 135.6 (C), 129.5 (CH), 129.4 (CH), 128.0 (2CH), 126.7 (CH), 125.7 (CH), 121.0 (CH), 120.9 (CH), 120.5 (CH), 65.6 (CH), 48.4 (CH<sub>2</sub>).</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>S</i>-[(Thiazol-4-yl)methyl] Ethanethioate (<b>20a</b>)</h3><div class="NLM_p last">To a suspension of 4-(chloromethyl)thiazole hydrochloride (<b>18a</b>) (5.1 g, 30 mmol), K<sub>2</sub>CO<sub>3</sub> (8.3 g), and NaI (0.2 g) in acetone (60 mL), thioacetic acid (<b>19</b>) (2.67 g, 35 mmol) was added dropwise, and the resulting mixture was stirred at 35–40 °C under argon for 3 h. The reaction mixture was diluted with water, extracted with CH<sub>2</sub>Cl<sub>2</sub>, filtered with charcoal and the product purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>) to give 5.1 g of the <b>20a</b> as a yellow oil (yield 98%).</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>S</i>-[(Thiazol-2-yl)methyl] Ethanethioate (<b>20b</b>)</h3><div class="NLM_p last">To a suspension of 2-(chloromethyl)thiazole hydrochloride (<b>18b</b>) (5.02 g, 29 mmol), K<sub>2</sub>CO<sub>3</sub> (8.2 g), and NaI (0.2 g) in acetone (60 mL), thioacetic acid (<b>19</b>) (2.55 g, 33 mmol) was added dropwise, and the resulting mixture was stirred at 35–40 °C under argon for 3 h. The reaction mixture was diluted with water, extracted with CH<sub>2</sub>Cl<sub>2</sub>, filtered with charcoal and the product purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>) to give 4.7 g of <b>20b</b> as a yellow oil (yield 93%).</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>S</i>-[(Thiazol-5-yl)methyl] Ethanethioate (<b>20c</b>)</h3><div class="NLM_p last">A mixture of 5-(chloromethyl)-1,3-thiazole hydrochloride (<b>18c</b>) (5.0 g, 29.4 mmol), thioacetic acid (<b>19</b>) (2.65 g, 32.11 mmol), potassium carbonate (10.5 g, 76 mmol), and acetone (100 mL) was stirred overnight at rt. The precipitate was filtered off and washed with acetone. The filtrate and rinse were combined and evaporated in vacuum to minimal volume. Water (50 mL) and DCM (50 mL) were added to the residue, and the mixture was stirred for 15 min. The organic layer was washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated in vacuum. The resulting brownish oil was purified by flash chromatography on silica gel (DCM) to give 3.78 g of <b>20c</b> as a yellowish oil (yield 74%).</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>S</i>-[(2-Methylthiazol-4-yl)methyl] Ethanethioate (<b>20d</b>)</h3><div class="NLM_p last">A mixture of 4-(chloromethyl)-2-methyl-1,3-thiazole hydrochloride (<b>18d</b>) (8.3 g, 45.1 mmol), thioacetic acid (<b>19</b>) (4.0 g, 52.6 mmol), potassium carbonate (16.2 g, 117 mmol), and acetone (160 mL) was stirred overnight at rt. The precipitate was filtered off and washed with acetone. The filtrate and rinse were combined and evaporated in vacuum to minimal volume. The resulting brownish oil was purified by flash chromatography on silica gel (DCM) to give 8.07 g of <b>20d</b> as a yellowish oil (yield 95%).</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>S</i>-[(2-Cyclopropylthiazol-4-yl)methyl] Ethanethioate (<b>20e</b>)</h3><div class="NLM_p last">A solution of 1,3-dichloropropan-2-one (6.28 g, 49 mmol) and cyclopropanecarbothioamide (4.99 g, 49 mmol) in <i>i</i>-PrOH (70 mL) was heated under argon for 5.5 h and then concentrated under reduced pressure. The residue was dissolved in acetone (60 mL), and Cs<sub>2</sub>CO<sub>3</sub> (8.0 g), NaI (0.4 g), and thioacetic acid (4.36 g, 0.057 mol) were added. The resulting mixture was stirred at 35–40 °C under argon for 3 h, diluted with water, and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The extract was concentrated and purified by flash column chromatography (petroleum ether/EtOAc, 8:1) to give 5.5 g of <b>20e</b> as a yellow oil (yield 52%).</div></div><div id="secy" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> General Procedure for Obtaining <b>21a</b>–<b>e</b> Intermediates</h3><div class="NLM_p last"><b>20a</b>–<b>e</b> were dissolved in EtOH, and an amount of 2 equiv of NaOH dissolved in 2–5 mL of H<sub>2</sub>O was added. The reaction mixture was refluxed for 2 h and then extracted with EtOAc upon neutralization to pH 7 with conc HCL. The extract was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and used as such immediately in further steps.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 4-({[Bis(4-chlorophenyl)methyl)thio]methyl}thiazole (<b>23a</b>)</h3><div class="NLM_p last">1.1 g (4.3 mmol) of bis(4-chlorophenyl)methanol and 0.57 g (4.3 mmol) of thiazol-4-ylmethanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (1.2 mL, 4.8 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 1.3 g of <b>23a</b> as a yellow oily product (yield 83%).</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 2-Cyclopropyl-4-({[bis(4-chlorophenyl)methyl]thio}methyl)thiazole (<b>23b</b>)</h3><div class="NLM_p last">0.88 g (3.5 mmol) of bis(4-chlorophenyl)methanol and 0.59 g (3.5 mmol) of (2-cyclopropylthiazol-4-yl)methanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (0.9 mL, 3.85 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 0.38 g of <b>23b</b> as a yellow oil (yield 27%).</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 2-Cyclopropyl-4-({[bis(4-methylphenyl)methyl]thio}methyl)thiazole (<b>23c</b>)</h3><div class="NLM_p last">0.74 g (3.5 mmol) of di-<i>p</i>-tolylmethanol and 0.59 g (3.5 mmol) of (2-cyclopropylthiazol-4-yl)methanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (0.9 mL, 3.85 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (petroleum ether/EtOAc: 2/1) affording 0.3 g of <b>23c</b> as an oily product (yield 23%).</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 5-({[Bis(4-methoxyphenyl)methyl]thio}methyl)thiazole (<b>23d</b>)</h3><div class="NLM_p last">0.75 g (3.0 mmol) of bis(4-methoxyphenyl)methanol and 0.39 g (3.0 mmol) of thiazol-5-ylmethanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (0.86 mL, 3.3 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 0.49 g of <b>23d</b> as an oily product (yield 45%).</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 4-({[Bis(4-fluorophenyl)methyl]thio}methyl)thiazole (<b>23e</b>)</h3><div class="NLM_p last">2.0 g (6.0 mmol) of bis(4-fluorophenyl)methanol and 0.78 g (6.0 mmol) of thiazol-4-ylmethanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (1.7 mL, 6.6 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 1.94 g of <b>23e</b> as an oily product (yield 97%).</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 4-({[Bis(4-methylphenyl)methyl]thio}methyl)thiazole (<b>23f</b>)</h3><div class="NLM_p last">0.65 g (3.0 mmol) of di-<i>p</i>-tolylmethanol and 0.4 g (3.0 mmol) of thiazol-4-ylmethanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (0.9 mL, 3.3 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 0.26 g of <b>23f</b> as an oily product (yield 27%).</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 4-({[Bis(4-methoxyphenyl)methyl]thio}methyl)-2-cyclopropylthiazole (<b>23g</b>)</h3><div class="NLM_p last">0.52 g (2.1 mmol) of bis(4-methoxyphenyl)methanol and 0.87 g (2.1 mmol) of (2-cyclopropylthiazol-4-yl)methanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (0.6 mL, 2.3 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 0.8 g of <b>23g</b> as an oily product (yield 90%).</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 5-({[Bis(4-chlorophenyl)methyl]thio}methyl)thiazole (<b>23h</b>)</h3><div class="NLM_p last">0.85 g (3.4 mmol) of bis(4-chlorophenyl)methanol and 0.44 g (3.4 mmol) of thiazol-5-ylmethanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (0.95 mL, 3.7 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 0.6 g of <b>23.h</b> as an oily product (yield 53%).</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 4-({[(4-Bromophenyl)(phenyl)methyl]thio}methyl)thiazole (<b>23i</b>)</h3><div class="NLM_p last">1.4 g (5.3 mmol) of 4-bromobenzhydrol and 0.7 g (5.3 mmol) of thiazol-4-ylmethanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (1.5 mL, 5.8 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 1.3 g of <b>23i</b> as an oily product (yield 64%).</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 2-({[Bis(4-chlorophenyl)methyl]thio}methyl)thiazole (<b>23j</b>)</h3><div class="NLM_p last">0.68 g (2.7 mmol) of bis(4-chlorophenyl)methanol and 0.35 g (2.7 mmol) of thiazol-2-ylmethanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (0.75 mL, 3.0 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 0.24 g of <b>23j</b> as an oily product (yield 22%).</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 5-({[Bis(4-fluorophenyl)methyl]thio}methyl)thiazole (<b>23k</b>)</h3><div class="NLM_p last">0.65 g (2.9 mmol) of bis(4-fluorophenyl)methanol and 0.38 g (2.9 mmol) of thiazol-5-ylmethanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (0.8 mL, 3.2 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 0.5 g of <b>23k</b> as an oily product (yield 48%).</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 5-({[Bis(4-methylphenyl)methyl]thio}methyl)thiazole (<b>23l</b>)</h3><div class="NLM_p last">0.5 g (2.4 mmol) of di-<i>p</i>-tolylmethanol and 0.31 g (2.4 mmol) of thiazol-5-ylmethanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (0.7 mL, 2.65 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 0.4 g of <b>23l</b> as an oily product (yield 50%).</div></div><div id="sec5_1_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 2-({[Bis(4-methylphenyl)methyl]thio}methyl)thiazole (<b>23m</b>)</h3><div class="NLM_p last">0.6 g (2.9 mmol) of di-<i>p</i>-tolylmethanol and 0.37 g (2.9 mmol) of thiazol-2-ylmethanethiol were dissolved in glacial acetic acid. An amount of 1.1 equiv (0.8 mL, 3.2 mmol) of BF<sub>3</sub>·Et<sub>2</sub>O was added, and the reaction mixture was left under stirring overnight at room temperature. The reaction mixture was then poured over ice, a small amount of water was added, and the acetic acid was neutralized with addition of solid NaHCO<sub>3</sub>. The product was then extracted (3×) with 50 mL of EtOAc. Organic layers were collected, combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was then purified by flash column chromatography on silica gel (2.5% MeOH in DCM) affording 0.57 g of <b>23m</b> as an oily product (yield 61%).</div></div><div id="sec5_1_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 4-({[Bis(4-chlorophenyl)methyl]sulfinyl}methyl)thiazole (<b>24a</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.43 mL) was added to the solution of <b>23a</b> (1.37 g, 3.7 mmol) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.31 g of <b>24a</b> as a yellow solid (yield 24%). Mp 114–117 °C. Ret. time 22.45 min, purity 95.4%. HRESIMS <i>m</i>/<i>z</i> 403.9707 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>13</sub>Cl<sub>2</sub>NNaOS<sub>2</sub><sup>+</sup>, 403.9708, Δ = 0.2 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (s, 1H), 7.43–7.36 (m, 9H), 5. 07 (s, 1H), 4.10 (d, <i>J</i> = 13.5 Hz, 1H), 3.90 (d, <i>J</i> = 13.6 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 150.2 (CH), 145.4 (C), 134.7 (C), 134.5 (C), 133.9 (C), 132.0 (C), 131.1 (2CH), 130.3 (2CH), 129.4 (2CH), 128.9 (2CH), 119.6 (CH), 67.6 (CH), 50.7 (CH<sub>2</sub>).</div></div><div id="sec5_1_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 4-({[Bis(4-chlorophenyl)methyl]sulfinyl}methyl)-2-cyclopropylthiazole (<b>24b</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.9 mL) was added to the solution of <b>23b</b> (0.38 g, 0.9 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (2.5% MeOH in DCM). The product was dried in high vacuum to give 0.26 g of <b>24b</b> as a transparent oil (yield 65%). Ret. time 25.80 min, purity 98.2%. HRESIMS <i>m</i>/<i>z</i> 444.0021 [M + Na]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>17</sub>Cl<sub>2</sub>NNaOS<sub>2</sub><sup>+</sup>, 444.0021, Δ = 0.1 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.42–7.35 (m, 8H), 7.02 (s, 1H), 5.15 (s, 1H), 3.98 (d, <i>J</i> = 13.5 Hz, 1H), 3.76 (d, <i>J</i> = 13.5 Hz, 1H), 2.34 (br s, 1H), 1.25–1.10 (m, 4H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 174.6 (C), 143.5 (C), 134.7 (C), 134.4 (C), 134.3 (C), 131.9, 131.2 (2CH), 130.2 (2CH), 129.3 (2CH), 128.6 (2C), 117.2 (CH), 67.4 (CH), 51.1 (CH<sub>2</sub>), 14.5 (CH), 11.7 (2CH<sub>2</sub>).</div></div><div id="sec5_1_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 4-({[Bis(4-methylphenyl)methyl]sulfinyl}methyl)-2-cyclopropylthiazole (<b>24c</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.95 mL) was added to the solution of <b>23c</b> (0.3 g, 0.82 mmol) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.14 g of <b>24c</b> as a yellow oil (yield 45%). Ret. time 24.32 min, purity 98.8%. HRESIMS <i>m</i>/<i>z</i> 404.1114 [M + Na]<sup>+</sup> (calcd for C<sub>22</sub>H<sub>23</sub>NNaOS<sub>2</sub>, 404.1113, Δ = 0.2 ppm). <sup>1</sup>H (500 MHz, CDCl<sub>3</sub>) δ = 7.39–7.33 (m, 4H), 7.21–7.15 (m, 4H), 7.00 (br s, 1H), 5.03 (s, 1H), 3.96 (d, <i>J</i> = 13.5 Hz, 1H), 3.73 (d, <i>J</i> = 13.5 Hz, 1H), 2.36–2.27 (m, 7H), 1.18–1.13 (m, 2H), 1.10–1.03 (m, 2H); <sup>13</sup>C (125.75 MHz, CDCl<sub>3</sub>) δ = 173.9 (C), 144.5 (C), 138.0 (CH), 133.1 (C), 131.4 (C), 129.7 (2CH), 129.6 (2CH), 129.3 (2CH), 128.8 (2CH), 116.7 (CH), 69.5 (CH), 51.4 (CH<sub>2</sub>), 21.1 (2CH<sub>3</sub>), 14.5 (CH), 11.2 (2CH<sub>2</sub>).</div></div><div id="sec5_1_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 5-({[Bis(4-methoxyphenyl)methyl]sulfinyl}methyl)thiazole (<b>24d</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.16 mL) was added to the solution of <b>23d</b> (0.49 g, 1.37 mmol) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (2.5% MeOH in DCM). The product was dried in high vacuum to give 0.2 g of <b>24d</b> as a yellow oil (yield 40%). Ret. time 14.94 min, purity 98.5%. HRESIMS <i>m</i>/<i>z</i> 396.0699 [M + Na]<sup>+</sup> (calcd for C<sub>19</sub>H<sub>19</sub>NNaO<sub>3</sub>S<sub>2</sub><sup>+</sup>, 396.0699, Δ = 0.1 ppm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.84 (s, 1H), 7.68 (d, <i>J</i> = 0.6 Hz, 1H), 7.30–7.28 (m, 4H), 6.97 (d, <i>J</i> = 11 Hz, 2H), 6.88 (d, <i>J</i> = 11 Hz, 2H), 4.58 (s, 1H), 4.10 (dd, <i>J</i> = 14.5 Hz, 1H), 3.86 (d, <i>J</i> = 14.4 Hz, 1H), 3.83 (s, 3H), 3.78 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ = 159.8 (3CH), 154.8 (CH), 144.06 (CH), 130.5 (2CH), 129.9 (2CH), 126.9 (C), 126.3 (C), 114.9 (2CH), 114.2 (2CH), 68.7 (CH), 55.3 (OCH<sub>3</sub>), 55.2 (OCH<sub>3</sub>), 46.7 (CH<sub>2</sub>).</div></div><div id="sec5_1_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 4-({[Bis(4-fluorophenyl)methyl]sulfinyl}methyl)thiazole (<b>24e</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.7 mL) was added to the solution of <b>23e</b> (1.9 g, 6.0 mmol) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (2.5% MeOH in DCM). The product was dried in high vacuum to give 0.38 g of <b>24e</b> as a white solid (yield 21%). Mp 126–128 °C. Ret. time 18.02 min, purity 97.35%. HRESIMS <i>m</i>/<i>z</i> 372.0304 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>13</sub>F<sub>2</sub>NNaOS<sub>2</sub><sup>+</sup>, 372.0299, Δ = 1.4 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (d, <i>J</i> = 1.9 Hz, 1H), 7.49–7.46 (m, 2H), 7.43–7.41 (m, 2H), 7.37 (d, <i>J</i> = 1.9 Hz, 1H), 7.12–7.06 (m, 4H), 5.08 (s, 1H), 4.09 (d, <i>J</i> = 13.6 Hz, 1H), 3.89 (d, <i>J</i> = 13.6 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 162.8 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 246.8 Hz, CF), 162.5 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 248.9 Hz, CF), 153.3 (CH), 145.6 (C), 131.5 (d, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.2 Hz, 2CH), 131.4 (d, <sup>4</sup><i>J</i>(<sup>13</sup>C,<sup>19</sup>F) = 3.7 Hz, C), 130.7 (d, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.1 Hz, 2CH), 129.5 (d, <sup>4</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.0 Hz, C), 119.5 (CH), 116.2 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 21.5 Hz, 2CH), 115.7 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 21.2, 2CH), 67.5 (CH), 50.7 (CH<sub>2</sub>).</div></div><div id="sec5_1_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 4-({[Bis(4-methylphenyl)methyl]sulfinyl}methyl)thiazole (<b>24f</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.1 mL) was added to the solution of <b>23f</b> (0.26 g, 0.8 mmol) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.15 g of <b>24f</b> as a white solid (yield 54%). Mp 117–120 °C. Ret. time 19.88 min, purity 99.1%. HRESIMS <i>m</i>/<i>z</i> 364.0801 [M + Na]<sup>+</sup> (calcd for C<sub>19</sub>H<sub>19</sub>NNaOS<sub>2</sub><sup>+</sup>, 364.0800, Δ = 0.1 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.84 (s, 1H), 7.38–7.34 (m, 5H), 7.20–7.13 (m, 4H), 4.96 (s, 1H), 4.10 (d, <i>J</i> = 13.3 Hz, 1H), 3.88 (d, <i>J</i> = 13.3 Hz, 1H), 2.34 (s, 3H), 2.32 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 153. 0 (CH), 146.3 (C), 138.1 (C), 138.0 (C), 132.8 (C), 131.4 (C), 129.8 (2CH), 129.4 (2CH), 129.1 (2CH), 128.7 (2CH), 119.1 (CH), 70.1 (CH), 51.2 (CH<sub>2</sub>), 21.1 (2CH<sub>3</sub>).</div></div><div id="sec5_1_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 4-({[Bis(4-methoxyphenyl)methyl]sulfinyl}methyl)-2-cyclopropylthiazole (<b>24g</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.2 mL) was added to the solution of <b>23g</b> (0.8 g, 1.9 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (2.5% MeOH in DCM). The product was dried in high vacuum to give 0.09 g of <b>24g</b> as a yellow oil (yield 11%). Ret. time 23.63 min, purity 98.4%. HRESIMS <i>m</i>/<i>z</i> 436.1010 [M + Na]<sup>+</sup> (calcd for C<sub>22</sub>H<sub>23</sub>NNaO<sub>3</sub>S<sub>2</sub><sup>+</sup>, 436.1012, Δ = 0.3 ppm). <sup>1</sup>H (500 MHz, CDCl<sub>3</sub>) δ = 7.41–7.37 (m, 4H), 7.01 (br s, 1H), 6.92–6.90 (m, 4H), 5.03 (s, 1H), 3.96 (d, <i>J</i> = 13.4 Hz, 1H), 3.80 (s, 6H), 3.73 (d, <i>J</i> = 13.4 Hz, 1H), 2.35–2.28 (m, 1H), 1.18–1.12 (m, 2H), 1.07 (br s, 2H); <sup>13</sup>C (125.75 MHz, CDCl<sub>3</sub>) δ = 173.9 (C), 159.5 (C), 159.3 (C), 130.9 (2CH), 130.1 (2CH), 128.2 (C), 126.4 (C), 116.7 (CH), 114.4 (2CH), 114.0 (2CH), 68.4 (CH), 55.3 (2CH<sub>3</sub>), 51.2 (CH<sub>2</sub>), 14.5 (CH), 11.2 (2CH<sub>2</sub>).</div></div><div id="sec5_1_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 5-({[Bis(4-chlorophenyl)methyl]sulfinyl}methyl)thiazole (<b>24h</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.2 mL) was added to the solution of <b>23h</b> (0.66 g, 1.8 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.18 g of <b>24h</b> as a pale-brown solid (yield 26%). Ret. time 20.52 min, purity 99.3%. HRESIMS <i>m</i>/<i>z</i> 403.9707 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>13</sub>Cl<sub>2</sub>NNaOS<sub>2</sub><sup>+</sup>, 403.9708, Δ = 0.3 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.88 (s, 1H), 7.69 (s, 1H), 7.45 (d, <i>J</i> = 8.3 Hz, 2H), 7.35–7.27 (m, 6H), 4.58 (s, 1H), 4.15 (d, <i>J</i> = 14.5 Hz, 1H), 3.90 (d, <i>J</i> = 14.5 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 151.2 (CH), 144.2 (CH), 135.1 (C), 135.0 (C), 132.8 (C), 131.9 (C), 130.6 (2CH), 130.0 (2CH), 129.9 (2CH), 129.1 (2CH), 124.5 (C), 67.9 (CH), 46.7 (CH<sub>2</sub>).</div></div><div id="sec5_1_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 4-({[(4-Bromophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>24i</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.4 mL) was added to the solution of <b>23i</b> (1.3 g, 3.4 mmol) in glacial acetic acid (20 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 1.22 g of <b>24i</b> as a white solid (yield 92%). Ret. time 19.93 min, purity 97.76%. HRESIMS <i>m</i>/<i>z</i> 413.9591 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>14</sub>BrNNaOS<sub>2</sub><sup>+</sup>, 413.9592, Δ = 0.3 ppm).</div></div><div id="sec5_1_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 2-({[Bis(4-chlorophenyl)methyl]sulfinyl}methyl)thiazole (<b>24j</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.1 mL) was added to the solution of <b>23j</b> (0.24 g, 0.6 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (2.5% MeOH in DCM). The product was dried in high vacuum to give 0.07 g of <b>24j</b> as yellow powder (yield 31%). Ret. time 24.25 min, purity 99.8%. HRESIMS <i>m</i>/<i>z</i> 403.9714 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>13</sub>Cl<sub>2</sub>NNaOS<sub>2</sub><sup>+</sup>, 403.9708, Δ = 1.6 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.91 (d, <i>J</i> = 3.3 Hz, 1H), 7.45–7.36 (m, 9H), 5.14 (s, 1H), 4.25 (d, <i>J</i> = 13.9 Hz, 1H), 4.05 (d, <i>J</i> = 13.9 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 157.2 (C), 143.4 (CH), 134.8 (C), 134.7 (C), 133.4 (C), 131.5 (C), 131.2 (2CH), 130.4 (2CH), 129.5 (2CH), 128.9 (2CH), 121.4 (CH), 67.4 (CH), 51.5 (CH<sub>2</sub>).</div></div><div id="sec5_1_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 5-({[Bis(4-fluorophenyl)methyl]sulfinyl}methyl)thiazole (<b>24k</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.2 mL) was added to the solution of <b>23k</b> (0.5 g, 1.4 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (2.5% MeOH in DCM). The product was dried in high vacuum to give 0.08 g of <b>24k</b> as yellow powder (yield 16%). Mp 103–109 °C. Ret. time 17.64 min, purity 96.1%. HRESIMS <i>m</i>/<i>z</i> 372.0300 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>13</sub>F<sub>2</sub>NNaOS<sub>2</sub><sup>+</sup>, 372.0299, Δ = 0.3 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.87 (s, 1H), 7.68 (s, 1H), 7.37–7.31 (m, 4H), 7.16 (t, <i>J</i> = 8.5 Hz, 2H), 7.06 (t, <i>J</i> = 8.5 Hz, 2H), 4.60 (s, 1H), 4.14 (d, <i>J</i> = 14.5 Hz, 1H), 3.88 (d, <i>J</i> = 14.5 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 162.9 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 247.1 Hz, CF), 162.7 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 248.0 Hz, CF), 155.1 (CH), 144.2 (CH), 131.0 (d, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.0 Hz, 2CH), 130.4 (d, <sup>4</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.4 Hz, C), 130.3 (d, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.1 Hz, 2CH), 129.4 (d, <sup>4</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 2.8 Hz, C), 124.6 (C), 116.8 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 21.7 Hz, 2CH), 115.9 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 21.2, 2CH), 67.7 (CH), 46.6 (CH<sub>2</sub>).</div></div><div id="sec5_1_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> 5-({[Bis(4-methylphenyl)methyl]sulfinyl}methyl)thiazole (<b>24l</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.15 mL) was added to the solution of <b>23l</b> (0.4 g, 1.2 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.14 g of <b>24l</b> as a pale-yellow solid (yield 35%). Mp 107–109 °C. Ret. time 19.46 min, purity 98.4%. HRESIMS <i>m</i>/<i>z</i> 364.0803 [M + Na]<sup>+</sup> (calcd for C<sub>19</sub>H<sub>19</sub>NNaOS<sub>2</sub><sup>+</sup>, 364.0800, Δ = 0.9 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.83 (s, 1H), 7.66 (s, 1H), 7.26–7.22 (m, 6H), 7.17–7.13 (m, 2H), 4.58 (s, 1H), 4.10 (d, <i>J</i> = 14.4 Hz, 1H), 3.86 (d, <i>J</i> = 14.4 Hz, 1H), 2.36 (s, 3H), 2.30 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 154.8 (CH), 144.1 (CH), 138.6 (C), 138.3 (C), 131.9 (C), 131.3 (C), 130.1 (2CH), 129.5 (2CH), 129.2 (2CH), 128.5 (2CH), 125.1 (C), 69.6 (CH), 46.6 (CH<sub>2</sub>), 21.2 (CH<sub>3</sub>), 21.1 (CH<sub>3</sub>).</div></div><div id="sec5_1_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 2-({[Bis(4-methylphenyl)methyl]sulfinyl}methyl)thiazole (<b>24m</b>)</h3><div class="NLM_p last">30% H<sub>2</sub>O<sub>2</sub> (0.2 mL) was added to the solution of <b>23m</b> (0.57 g, 1.8 mmol) in glacial acetic acid (10 mL). The reaction mixture was stirred at room temperature during 24 h. Then, the reaction mixture was neutralized with cold 5% sodium bicarbonate solution. The reaction product was extracted (3 × 50 mL) with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic solution was concentrated under reduced pressure and the residue purified by flash column chromatography on silica gel (5% MeOH in DCM). The product was dried in high vacuum to give 0.18 g of <b>24m</b> as pale yellow-brown solid (yield 30%). Mp 129–131 °C. Ret. time 20.76 min, purity 99.6%. HRESIMS <i>m</i>/<i>z</i> 364.0802 [M + Na]<sup>+</sup> (calcd for C<sub>19</sub>H<sub>19</sub>NNaOS<sub>2</sub><sup>+</sup>, 364.0800, Δ = 0.6 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.88 (s, 1H), 7.39–7.33 (m, 5H), 7.22–7.16 (m, 4H), 5.02 (s, 1H), 4.26 (d, <i>J</i> = 13.8 Hz, 1H), 4.04 (d, <i>J</i> = 13.8 Hz, 1H), 2.35 (s, 3H), 2.32 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 158.2 (C), 143.0 (CH), 138.3 (C), 138.2 (C), 132.3 (C), 130.9 (C), 129.9 (2CH), 129.6 (2CH), 129.4 (2C), 128.8 (2CH), 121.2 (CH), 69.8 (CH), 52.0 (CH<sub>2</sub>), 21.1 (2CH<sub>3</sub>).</div></div><div id="sec5_1_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 4-({(<i>R</i>)-[(<i>R</i>)-(4-Bromophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>31c</b>), 4-({(<i>S</i>)-[(<i>R</i>)-(4-Bromophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>31d</b>), 4-({(<i>S</i>)-[(<i>S</i>)-(4-Bromophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>31e</b>), and 4-({(<i>R</i>)-[(<i>S</i>)-(4-Bromophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>31f</b>)</h3><div class="NLM_p">The starting point for synthesis of <b>31c</b>–<b>f</b> is the same: 4-(chloromethyl)thiazole was reacted with thioacetic acid to yield the thioester <b>27</b>, which was hydrolyzed under alkaline conditions to the corresponding mercaptan <b>29</b>. Thiazol-4-ylmethanethiol (<b>29</b>) was reacted with (4-bromophenyl)(phenyl)methanol (<b>28</b>) to yield racemic 4-({[(4-bromophenyl)(phenyl)methyl]thio}methyl)thiazole (<b>30</b>) in 25% yield. In the following step, compound <b>30</b> was separated using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and acetonitrile as the mobile phase into the individual enantiomers <b>30a</b> and <b>30b</b>. Each of the enantiomers was further oxidized to yield the racemic compounds <b>31a</b> and <b>31b</b>, respectively, that were finally separated using semipreparative HPLC equipped with CHIRALPAK IA column into individual stereoisomers <b>31c</b>–<b>f</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). All separations were carried out at room temperature using a flow rate of 10 mL/min.</div><div class="NLM_p"><b>31c</b>. Ret. time 21.38 min, purity 96.3%. HRESIMS <i>m</i>/<i>z</i> 413.9595 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>14</sub>BrNNaOS<sub>2</sub><sup>+</sup>, 413.9592, Δ = 0.6 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.90 (d, <i>J</i> = 1.95 Hz, 1H), 7.53–7.36 (m, 10H), 5.05 (s, 1H), 4.16 (d, <i>J</i> = 15 Hz, 1H), 3.89 (d, <i>J</i> = 15 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 153.3 (CH), 145.6 (C), 134.9 (C), 133.5 (C), 132.2 (2CH), 130.6 (2CH), 129.7 (2CH), 128.7 (2CH), 128.5 (<i>p</i>-CH), 122.5 (<i>p</i>-C), 119.5 (CH), 69.0 (CH), 50.8 (CH<sub>2</sub>).</div><div class="NLM_p"><b>31d</b>. Ret. time 21.43 min, purity 99.0%. HRESIMS <i>m</i>/<i>z</i> 413.9593 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>14</sub>BrNNaOS<sub>2</sub><sup>+</sup>, 413.9592, Δ = 0.0 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (d, <i>J</i> = 1.9 Hz, 1H), 7.51–7.34 (m, 10H), 5.06 (s, 1H), 4.11 (d, <i>J</i> = 15 Hz, 1H), 3.91 (d, <i>J</i> = 15 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 153.2 (CH), 145.8 (C), 135.2 (C), 133.1 (C), 131.7 (2CH), 131.4 (2CH), 129.3 (2CH), 128.8 (2CH), 128.5 (<i>p</i>-CH), 122.7 (<i>p</i>-C), 119.4 (CH), 69.1 (CH), 50.9 (CH<sub>2</sub>).</div><div class="NLM_p"><b>31e</b>. Ret. time 21.40 min, purity 97.1%. HRESIMS <i>m</i>/<i>z</i> 413.9591 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>14</sub>BrNNaOS<sub>2</sub><sup>+</sup>, 413.9592, Δ = 0.3 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.89 (d, <i>J</i> = 1.95 Hz, 1H), 7.53–7.35 (m, 10H), 5.04 (s, 1H), 4.16 (d, <i>J</i> = 15 Hz, 1H), 3.87 (d, <i>J</i> = 15 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 153.3 (CH), 145.6 (C), 134.9 (C), 133.5 (C), 132.2 (2CH), 130.6 (2CH), 129.7 (2CH), 128.7 (2CH), 128.5 (<i>p</i>-CH), 122.5 (<i>p</i>-C), 119.5 (CH), 69.0 (CH), 50.9 (CH<sub>2</sub>).</div><div class="NLM_p last"><b>31f</b>. Ret. time 21.43 min, purity 98.8%. HRESIMS <i>m</i>/<i>z</i> 413.9592 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>14</sub>BrNNaOS<sub>2</sub><sup>+</sup>, 413.9592, Δ = 0.2 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.89 (d, <i>J</i> = 2.0 Hz, 1H), 7.50–7.35 (m, 10H), 5.08 (s, 1H), 4.13 (d, <i>J</i> = 15 Hz, 1H), 3.92 (d, <i>J</i> = 15 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 153.3 (CH), 145.6 (C), 135.2 (C), 133.1 (C), 131.7 (2CH), 131.4 (2CH), 129.3 (2CH), 128.9 (2CH), 128.5 (<i>p</i>-CH), 122.7 (<i>p</i>-C), 119.5 (CH), 69.2 (CH), 50.9 (CH<sub>2</sub>).</div></div><div id="sec5_1_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> (<i>S</i>)-5-({[Bis(4-chlorophenyl)methyl]sulfinyl}methyl)thiazole (<b>32a</b>)</h3><div class="NLM_p last">The less retained enantiomer of <b>24h</b> was obtained through chiral separations using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and ethyl acetate as the mobile phase into the individual enantiomers. Separations were carried out at room temperature using a flow rate of 10 mL/min. White powder. Mp 137–139 °C. Ret. time 24.02 min, purity 98.36%. HRESIMS <i>m</i>/<i>z</i> 403.9702 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>13</sub>Cl<sub>2</sub>NNaOS<sub>2</sub><sup>+</sup>, 403.9708, Δ = −1.3 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.87 (s, 1H), 7.69 (s, 1H), 7.44 (d, <i>J</i> = 8.5 Hz, 2H), 7.35–7.27 (m, 6H), 4.58 (s, 1H), 4.14 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.1 (CH), 144.2 (CH), 135.1 (C–Cl), 135.0 (C–Cl), 132.8 (C), 131.9 (C), 130.6 (2CH), 130.0 (2CH), 129.9 (2CH), 129.1 (2CH), 124.6 (C), 68.0 (CH), 46.8 (CH<sub>2</sub>).</div></div><div id="sec5_1_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> (<i>R</i>)-5-({[Bis(4-chlorophenyl)methyl]sulfinyl}methyl)thiazole (<b>32b</b>)</h3><div class="NLM_p last">The more retained enantiomer of <b>24h</b> was obtained through chiral separations using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and ethyl acetate as the mobile phase into the individual enantiomers. Separations were carried out at room temperature using a flow rate of 10 mL/min. White powder. Mp 139–141 °C. Ret. time 24.00 min, purity 99.84%. HRESIMS <i>m</i>/<i>z</i> 403.9704 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>13</sub>Cl<sub>2</sub>NNaOS<sub>2</sub><sup>+</sup>, 403.9708, Δ = 0.9 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.87 (s, 1H), 7.69 (s, 1H), 7.44 (d, <i>J</i> = 8.5 Hz, 2H),7.35–7.27 (m, 6H), 4.58 (s, 1H), 4.14 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.1 (CH), 144.2 (CH), 135.1 (C–Cl), 135.0 (C–Cl), 132.8 (C), 131.9 (C), 130.6 (2CH), 130.0 (2CH), 129.9 (2CH), 129.1 (2CH), 124.6 (C), 68.0 (CH), 46.8 (CH<sub>2</sub>).</div></div><div id="sec5_1_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> (<i>S</i>)-5-({[Bis(4-fluorophenyl)methyl]sulfinyl}methyl)thiazole (<b>33a</b>)</h3><div class="NLM_p last">The less retained enantiomer of <b>24k</b> was obtained through chiral separations using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and ethyl acetate as the mobile phase into the individual enantiomers. Separations were carried out at room temperature using a flow rate of 10 mL/min. White powder. Mp 115–117 °C. Ret. time 20.30 min, purity 99.25%. HRESIMS <i>m</i>/<i>z</i> 372.0295 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>13</sub>F<sub>2</sub>NNaOS<sub>2</sub><sup>+</sup>, 372.0299, Δ = −0.9 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.87 (s, 1H), 7.69 (s, 1H), 7.37–7.32 (m, 4H), 7.16 (t, <i>J</i> = 8.5 Hz, 2H), 7.06 (t, <i>J</i> = 8.5 Hz, 2H), 4.61 (s, 1H), 4.13 (d, <i>J</i> = 14.4 Hz, 1H), 3.88 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 162.9 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 248.5 Hz, CF), 162.8 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 249.7 Hz, CF), 155.1 (CH), 144.2 (CH), 131.1 (d, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.1 Hz, 2CH), 130.5 (C), 130.4 (<sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.1 Hz, 2C), 129.5 (d, <sup>4</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.2 Hz, C), 124.7 (C), 116.7 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 21.2 Hz, 2CH), 115.9 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 21.7, 2CH), 67.8 (CH), 46.7 (CH<sub>2</sub>).</div></div><div id="sec5_1_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> (<i>R</i>)-5-({[Bis(4-fluorophenyl)methyl]sulfinyl}methyl)thiazole (<b>33b</b>)</h3><div class="NLM_p last">The more retained enantiomer of <b>24k</b> was obtained through chiral separations using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and ethyl acetate as the mobile phase into the individual enantiomers. Separations were carried out at room temperature using a flow rate of 10 mL/min. White powder. Mp 114–116 °C. Ret. time 20.28 min, purity 99.12%. HRESIMS <i>m</i>/<i>z</i> 372.0296 [M + Na]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>13</sub>F<sub>2</sub>NNaOS<sub>2</sub><sup>+</sup>, 372.0299, Δ = 0.8 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.87 (s, 1H), 7.69 (s, 1H), 7.37–7.31 (m, 4H), 7.16 (t, <i>J</i> = 8.5 Hz, 2H), 7.06 (t, <i>J</i> = 8.5 Hz, 2H), 4.61 (s, 1H), 4.13 (d, <i>J</i> = 14.4 Hz, 1H), 3.88 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 163.9 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 248.6 Hz, CF), 162.7 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 249.7 Hz, CF), 155.0 (CH), 144.2 (CH), 131.1 (d, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.1 Hz, 2CH), 130.5 (C), 130.4 (d, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.1 Hz, 2CH), 129.5 (d, <sup>4</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.3 Hz, 2C), 124.7 (C), 116.7 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 21.3 Hz, 2CH), 115.9 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 21.3, 2CH), 67.8 (CH), 46.7 (CH<sub>2</sub>).</div></div><div id="sec5_1_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Less Retained Enantiomer 5-({[Bis(4-methylphenyl)methyl]sulfinyl}methyl)thiazole (<b>34a</b>)</h3><div class="NLM_p last">The less retained enantiomer of <b>24l</b> was obtained through chiral separations using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and ethyl acetate as the mobile phase into the individual enantiomers. Separations were carried out at room temperature using a flow rate of 10 mL/min. Transparent oil. Ret. time 22.65 min, purity 98.42%. HRESIMS <i>m</i>/<i>z</i> 364.0798 [M + Na]<sup>+</sup> (calcd for C<sub>19</sub>H<sub>19</sub>NNaOS<sub>2</sub><sup>+</sup>, 364.0800, Δ = 0.7 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.83 (s, 1H), 7.66 (s, 1H), 7.26–7.22 (m, 6H), 7.14 (d, <i>J</i> = 8 Hz, 2H), 4.58 (s, 1H), 4.10 (d, <i>J</i> = 14.4 Hz, 1H), 3.87 (d, <i>J</i> = 14.4 Hz, 1H), 2.36 (s, 3H), 2.30 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 154.8 (CH), 144.1 (CH), 138.6 (C), 138.4 (C), 131.9 (C), 131.3 (C), 130.2 (2CH), 129.5 (2CH), 129.2 (2CH), 128.5 (2CH), 125.2 (C), 69.6 (CH), 46.6 (CH<sub>2</sub>), 21.2 (CH<sub>3</sub>), 21.1 (CH<sub>3</sub>).</div></div><div id="sec5_1_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> More Retained Enantiomer 5-({[Bis(4-methylphenyl)methyl]sulfinyl}methyl)thiazole (<b>34b</b>)</h3><div class="NLM_p last">The more retained enantiomer of <b>24l</b> was obtained through chiral separations using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and ethyl acetate as the mobile phase into the individual enantiomers. Separations were carried out at room temperature using a flow rate of 10 mL/min. White powder. Mp 99–102 °C. Ret. time 22.65 min, purity 99.15%. HRESIMS <i>m</i>/<i>z</i> 364.0796 [M + Na]<sup>+</sup> (calcd for C<sub>19</sub>H<sub>19</sub>NNaOS<sub>2</sub><sup>+</sup>, 364.0800, Δ = 1.1 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.83 (s, 1H), 7.66 (s, 1H), 7.26–7.21 (m, 6H), 7.14 (d, <i>J</i> = 8 Hz, 2H), 4.58 (s, 1H), 4.10 (d, <i>J</i> = 14.3 Hz, 1H), 3.87 (d, <i>J</i> = 14.3 Hz, 1H), 2.36 (s, 3H), 2.30 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 154.8 (CH), 144.1 (CH), 138.6 (C), 138.3 (C), 131.9 (C), 131.3 (C), 130.1 (2CH), 129.5 (2CH), 129.2 (2CH), 128.5 (2CH), 125.1 (C), 69.6 (CH), 46.6 (CH<sub>2</sub>), 21.2 (CH<sub>3</sub>), 21.1 (CH<sub>3</sub>).</div></div><div id="sec5_1_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> 5-(4-Trifluoromethylphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>42a</b>), 5-(4-Trifluoromethylphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>43a</b>), 5-({(<i>S</i>)-[(<i>R</i>)-(4-Trifluoromethylphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>44a</b>), and 5-({(<i>R</i>)-[(<i>R</i>)-(4-Trifluoromethylphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>45a</b>)</h3><div class="NLM_p">Thiazol-5-ylmethanethiol (0.5 g, 3.8 mmol) (<b>36</b>) was reacted with (4-trifluorophenyl)(phenyl)methanol (0.9 g, 3.8 mmol) (<b>35a</b>) and boron trifluoride diethyl etherate to yield 1.2 g of racemic 5-({[(4-trifluorophenyl)(phenyl)methyl]thio}methyl)thiazole (<b>37a</b>) in 86% yield. In the following step, compound <b>37a</b> was separated using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and absolute ethanol as the mobile phase into the individual (less retained and more retained) enantiomers <b>38a</b> and <b>39a</b>, respectively. Each of the enantiomers was further oxidized to yield the racemic compounds <b>40a</b> and <b>41a</b> (84% and 90% yield), respectively, that were finally separated using semipreparative HPLC equipped with CHIRALPAK IA column and 100% EtOAc as the mobile phase into individual stereoisomers <b>42a</b>–<b>a</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). All separations were carried out at room temperature using a flow rate of 10 mL/min.</div><div class="NLM_p"><b>42a</b>. White powder. Mp 125–129 °C. Ret. time 22.38 min, purity 99.31%. HRESIMS <i>m</i>/<i>z</i> 382.0550 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>15</sub>F<sub>3</sub>NOS<sub>2</sub><sup>+</sup>, 382.0542, Δ = −2.1 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.87 (s, 1H), 7.70 (s, 1H), 7.70 (d, <i>J</i> = 8.2 Hz, 2H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 7.43–7.36 (m, 5H), 4.70 (s, 1H), 4.15 (d, <i>J</i> = 14.4 Hz, 1H), 3.90 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.0 (CH), 144.2 (CH), 139.2 (C), 132.9 (C), 130.9 (q, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 33 Hz, C), 129.4 (2CH), 129.1 (2CH), 129.0 (2CH), 128.9 (CH), 126.4 (q, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.5 Hz, 2C), 124.9 (C), 123.6 (q, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 270.9 Hz, CF<sub>3</sub>), 68.9 (CH), 47.0 (CH<sub>2</sub>).</div><div class="NLM_p"><b>43a</b>. White powder. Mp 134–137 °C. Ret. time 22.65 min, purity 99.07%. HRESIMS <i>m</i>/<i>z</i> 382.0539 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>15</sub>F<sub>3</sub>NOS<sub>2</sub><sup>+</sup>, 382.0542, Δ = −0.8 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.88 (s, 1H), 7.68 (s, 1H), 7.61 (d, <i>J</i> = 8.3 Hz, 2H), 7.51–7.43 (m, 5H), 7.37–7.39 (m, 2H), 4.69 (s, 1H), 4.16 (d, <i>J</i> = 14.5 Hz, 1H), 3.92 (d, <i>J</i> = 14.5 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.1 (CH), 144.4 (CH), 138.2 (C), 133.8 (C), 130.6 (q, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 32.4 Hz, C), 129.8 (2CH), 129.7 (2CH), 129.2 (CH), 128.7 (2CH), 125.7 (q, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.7 Hz, 2CH), 124.4 (C), 123.9 (q, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 271 Hz, CF<sub>3</sub>), 69.4 (CH), 46.6 (CH<sub>2</sub>).</div><div class="NLM_p"><b>44a</b>. White powder. Mp 132–135 °C. Ret. time 22.63 min, purity 99.03%. HRESIMS <i>m</i>/<i>z</i> 382.0543 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>15</sub>F<sub>3</sub>NOS<sub>2</sub><sup>+</sup>, 382.0542, Δ = 0.4 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.89 (s, 1H), 7.69 (s, 1H), 7.61 (d, <i>J</i> = 8.2 Hz, 2H), 7.51–7.43 (m, 5H), 7.38 (d, <i>J</i> = 8.2 Hz, 2H), 4.69 (s, 1H), 4.17 (d, <i>J</i> = 14.5 Hz, 1H), 3.92 (d, <i>J</i> = 14.5 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.2 (CH), 144.1 (CH), 138.2 (C), 133.8 (C), 130.6 (q, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 32.0 Hz, C), 129.8 (2CH), 129.7 (2CH), 129.2 (CH), 128.6 (2CH), 125.7 (q, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.7 Hz, 2CH), 124.9 (q, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 272.8 Hz, CF<sub>3</sub>), C), 124.5 (C), 69.4(CH), 46.6 (CH<sub>2</sub>).</div><div class="NLM_p last"><b>45a</b>. White powder. Mp 125–128 °C. Ret. time 22.48 min, purity 99.56%. HRESIMS <i>m</i>/<i>z</i> 382.0549 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>15</sub>F<sub>3</sub>NOS<sub>2</sub><sup>+</sup>, 382.0542, Δ = 1.9 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.88 (s, 1H), 7.71–7.69 (m, 3H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 7.35–7.34 (m, 5H), 4.70 (s, 1H), 4.15 (d, <i>J</i> = 14.5 Hz, 1H), 3.90 (d, <i>J</i> = 14.5 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.0 (CH), 143.9 (CH), 139.1 (C), 132.9 (C), 130.9 (q, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 33.1 Hz, C), 129.4 (2CH), 129.1 (2CH), 129.0 (2CH), 128.9 (CH), 126.4 (q, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.7 Hz, 2CH), 125.0 (C), 123.7 (q, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 273.9 Hz, CF<sub>3</sub>), 68.9 (CH), 47.0 (CH<sub>2</sub>).</div></div><div id="sec5_1_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> 5-({(<i>S</i>)-[(<i>S</i>)-(4-Chlorophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>42b</b>), 5-({(<i>R</i>)-[(<i>S</i>)-(4-Chlorophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>43b</b>), 5-({(<i>S</i>)-[(<i>R</i>)-(4-Chlorophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>44b</b>), and 5-({(<i>R</i>)-[(<i>R</i>)-(4-Chlorophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>45b</b>)</h3><div class="NLM_p">The starting point for synthesis of <b>42b</b>–<b>45b</b> is the same: Thiazol-5-ylmethanethiol (0.5 g, 3.8 mmol) (<b>36</b>) was reacted with (4-chlorophenyl)(phenyl)methanol (0.8 g, 3.8 mmol) (<b>35b</b>) and 1.1. equiv of boron trifluoride diethyl etherate to yield 1.1 g of racemic 5-({[(4-chlorophenyl)(phenyl)methyl]thio}methyl)thiazole (<b>37b</b>) in 87% yield. In the following step, compound <b>37b</b> was separated using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and absolute ethanol as the mobile phase into the individual (less retained and more retained) enantiomers <b>38b</b> and <b>39b</b>, respectively. Each of the enantiomers was further oxidized to yield the racemic compounds <b>40b</b> and <b>41b</b> (89% and 85% yield), respectively, that were finally separated using semipreparative HPLC equipped with CHIRALPAK IA column and 100% EtOAc as mobile phase into individual stereoisomers <b>42b</b>–<b>45b</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). All separations were carried out at room temperature using a flow rate of 10 mL/min.</div><div class="NLM_p"><b>42b</b>. White powder. Mp 134–136 °C. Ret. time 21.67 min, purity 99.44%. HRESIMS <i>m</i>/<i>z</i> 348.0275 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>ClNOS<sub>2</sub><sup>+</sup>, 348.0278, Δ = −1.0 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (s, 1H), 7.70 (s, 1H), 7.42 (d, <i>J</i> = 8.5 Hz, 2H), 7.37–7.32 (m, 7H), 4.62 (s, 1H), 4.14 (d, <i>J</i> = 14.3 Hz, 1H), 3.89 (d, <i>J</i> = 14.3 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.0 (CH), 144.2 (CH), 134.8 (C), 133.5 (C), 133.4 (C), 130.0 (2CH), 129.7 (2CH), 129.3 (2CH), 128.9 (2CH), 128.8 (CH), 124.9 (C), 68.8 (CH), 46.8 (CH<sub>2</sub>).</div><div class="NLM_p"><b>43b</b>. White powder. Mp 125–128 °C. Ret. time 21.65 min, purity 98.97%. HRESIMS <i>m</i>/<i>z</i> 348.0276 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>ClNOS<sub>2</sub><sup>+</sup>, 348.0278, Δ = −0.6 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.88 (s, 1H), 7.68 (s, 1H), 7.48–7.41 (m, 3H), 7.36–7.30 (m, 6H), 4.61 (s, 1H), 4.14 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.1 (CH), 144.1 (CH), 134.8 (C), 134.2 (C), 132.6 (C), 130.7 (2CH), 129.7 (2CH), 129.0 (CH), 128.9 (2CH), 128.6 (2CH), 124.7 (C), 69.2 (CH), 46.7 (CH<sub>2</sub>).</div><div class="NLM_p"><b>44b</b>. White powder. Mp 123–125 °C. Ret. time 21.65 min, purity 99.19%. HRESIMS <i>m</i>/<i>z</i> 348.0273 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>ClNOS<sub>2</sub><sup>+</sup>, 348.0278, Δ = −1.4 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.88 (s, 1H), 7.68 (s, 1H), 7.48–7.41 (m, 3H), 7.36–7.30 (m, 6H), 4.61 (s, 1H), 4.14 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.1 (CH), 144.1 (CH), 134.8 (C), 134.2 (C), 132.6 (C), 130.7 (2CH), 129.7 (2CH), 129.0 (CH), 128.9 (2CH), 128.6 (2CH), 124.7 (C), 69.2 (CH), 46.7 (CH<sub>2</sub>).</div><div class="NLM_p last"><b>45b</b>. White powder. Mp 136–139 °C. Ret. time 21.65 min, purity 99.62%. HRESIMS <i>m</i>/<i>z</i> 348.0280 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>ClNOS<sub>2</sub><sup>+</sup>, 348.0278, Δ = −0.5 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (s, 1H), 7.42 (d, <i>J</i> = 8.5 Hz, 2H), 7.38–7.34 (m, 7H), 4.62 (s, 1H), 4.14 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 154.9 (CH), 144.2 (CH), 134.8 (C), 133.5 (C), 133.4 (C), 130.0 (2CH), 129.7 (2CH), 129.3 (2CH), 128.9 (2CH), 128.8 (CH), 124.9 (C), 68.8 (CH), 46.8 (CH<sub>2</sub>).</div></div><div id="sec5_1_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> 5-({(<i>S</i>)-[(<i>R</i>)-(4-Methylyphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>42c</b>), 5-({(<i>R</i>)-[(<i>R</i>)-(4-Methylphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>43c</b>), 5-({(<i>S</i>)-[(<i>S</i>)-(4-Methylphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>44c</b>), and 5-({(<i>R</i>)-[(<i>S</i>)-(4-Methylphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>45c</b>)</h3><div class="NLM_p">The starting point for synthesis of <b>42c</b>–<b>45c</b> is the same: Thiazol-5-ylmethanethiol (0.5 g, 3.8 mmol) (<b>36</b>) was reacted with (4-methylphenyl)(phenyl)methanol (0.7 g, 3.8 mmol) (<b>35c</b>) and 1.1. equiv of boron trifluoride diethyl etharate to yield 1 g of racemic 5-({[(4-methylphenyl)(phenyl)methyl]thio}methyl)thiazole (<b>37c</b>) in 85% yield. In the following step, compound <b>37c</b> was separated using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and ethyl acetate/hexane (1/1, v/v) as the mobile phase into the individual (less retained and more retained) enantiomers <b>38c</b> and <b>39c</b>, respectively. Each of the enantiomers was further oxidized to yield the racemic compounds <b>40c</b> and <b>41c</b> (91% and 76% yield), respectively, that were finally separated using semipreparative HPLC equipped with CHIRALPAK IA column and 100% EtOAc as mobile phase into individual stereoisomers <b>42c</b>–<b>45c</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). All separations were carried out at room temperature using a flow rate of 10 mL/min.</div><div class="NLM_p"><b>42c</b>. White powder. Mp 138–140 °C. Ret. time 20.97 min, purity 99.37%. HRESIMS <i>m</i>/<i>z</i> 328.0823 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>18</sub>NOS<sub>2</sub><sup>+</sup>, 328.0824, Δ = 0.5 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.84 (s, 1H), 7.67 (s, 1H), 7.45–7.42 (m, 2H), 7.40–7.37 (m, 3H), 7.28 (d, <i>J</i> = 8.1 Hz, 2H), 7.17 (d, <i>J</i> = 8.1 Hz, 2H), 4.62 (s, 1H), 4.12 (d, <i>J</i> = 14.4 Hz, 1H), 3.88 (d, <i>J</i> = 14.4 Hz, 1H), 2.32 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 154.8 (CH), 144.1 (CH), 138.5 (C), 135.1 (C), 131.0 (C), 129.6 (2CH), 129.5 (2CH), 129.2 (2CH), 128.7 (CH), 128.6 (2C), 125.1 (C), 69.8 (CH), 46.7 (CH<sub>2</sub>), 21.1 (CH<sub>3</sub>).</div><div class="NLM_p"><b>43c</b>. White powder. Mp 111–115 °C. Ret. time 21.07 min, purity 99.63%. HRESIMS <i>m</i>/<i>z</i> 328.0824 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>18</sub>NOS<sub>2</sub><sup>+</sup>, 328.0824, Δ = −0.0 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.83 (s, 1H), 7.67 (s, 1H), 7.38–7.30 (m, 5H), 7.27–7.23 (m, 4H), 4.61 (s, 1H), 4.11 (d, <i>J</i> = 14.4 Hz, 1H), 3.88 (d, <i>J</i> = 14.4 Hz, 1H), 2.37 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 154.9 (CH), 144.2 (CH), 138.8 (C), 134.4 (C), 131.7 (C), 130.2 (2CH), 129.3 (2CH), 128.8 (2CH), 128.5 (2CH), 128.4 (CH), 125.0 (C), 69.8 (CH), 46.6 (CH<sub>2</sub>), 21.2 (CH<sub>3</sub>).</div><div class="NLM_p"><b>44c</b>. White powder. Mp 109–112 °C. Ret. time 21.07 min, purity 99.64%. HRESIMS <i>m</i>/<i>z</i> 328.0825 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>18</sub>NOS<sub>2</sub><sup>+</sup>, 328.0824, Δ = 0.3 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.83 (s, 1H), 7.67 (s, 1H), 7.38–7.30 (m, 5H), 7.27–7.23 (m, 4H), 4.61 (s, 1H), 4.11 (d, <i>J</i> = 14.4 Hz, 1H), 3.88 (d, <i>J</i> = 14.4 Hz, 1H), 2.37 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 154.9 (CH), 144.2 (CH), 138.8 (C), 134.4 (C), 131.7 (C), 130.2 (2CH), 129.3 (2CH), 128.8 (2CH), 128.5 (2CH), 128.4 (CH), 125.0 (C), 69.8 (CH), 46.6 (CH<sub>2</sub>), 21.2 (CH<sub>3</sub>).</div><div class="NLM_p last"><b>45c</b>. White powder. Mp 138–140 °C. Ret. time 20.98 min, purity 99.62%. HRESIMS <i>m</i>/<i>z</i> 328.0822 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>18</sub>NOS<sub>2</sub><sup>+</sup>, 328.0824, Δ = 0.8 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.84 (s, 1H), 7.67 (s, 1H), 7.45–7.43 (m, 2H), 7.40–7.37 (m, 3H), 7.28 (d, <i>J</i> = 8.1 Hz, 2H), 7.17 (d, <i>J</i> = 8.1 Hz, 2H), 4.62 (s, 1H), 4.12 (d, <i>J</i> = 14.4 Hz, 1H), 3.88 (d, <i>J</i> = 14.4 Hz, 1H), 2.32 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 154.9 (CH), 144.1 (CH), 138.5 (C), 135.1 (C), 131.0 (C), 129.5 (2CH), 129.5 (2CH), 129.2 (2CH), 128.7 (CH), 128.6 (2CH), 125.1 (C), 69.8 (CH), 46.7 (CH<sub>2</sub>), 21.1 (CH<sub>3</sub>).</div></div><div id="sec5_1_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> 5-({(<i>S</i>)-[(<i>R</i>)-(4-Methoxyphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>42d</b>), 5-({(<i>R</i>)-[(<i>R</i>)-(4-Methoxyphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>43d</b>), 5-({(<i>S</i>)-[(<i>S</i>)-(4-Methoxyphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>44d</b>), 5-({(<i>R</i>)-[(<i>S</i>)-(4-Methoxyphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>45d</b>)</h3><div class="NLM_p">The starting point for synthesis of <b>42d</b>–<b>45d</b> is the same: Thiazol-5-ylmethanethiol (0.5 g, 3.8 mmol) (<b>36</b>) was reacted with (4-methoxyphenyl)(phenyl)methanol (0.8 g, 3.8 mmol) (<b>35d</b>) and 1.1 equiv of boron trifluoride diethyl etharate to yield 1 g of racemic 5-({[(4-methoxyphenyl)(phenyl)methyl]thio}methyl)thiazole (<b>37d</b>) in 80% yield. In the following step, compound <b>37d</b> was separated using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and ethyl acetate/hexane (1/1, v/v) as the mobile phase into the individual (less retained and more retained) enantiomers <b>38d</b> and <b>39d</b>, respectively. Each of the enantiomers was further oxidized to yield the racemic compounds <b>40d</b> and <b>41d</b> (95% and 96% yield), respectively, that were finally separated using semipreparative HPLC equipped with CHIRALPAK IA column and 100% EtOAc as mobile phase into individual stereoisomers <b>42d</b>–<b>45d</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). All separations were carried out at room temperature using a flow rate of 10 mL/min.</div><div class="NLM_p"><b>42d</b>. White powder. Mp 120–123 °C. Ret. time 19.40 min, purity 99.56%. HRESIMS <i>m</i>/<i>z</i> 344.0771 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>18</sub>NO<sub>2</sub>S<sub>2</sub><sup>+</sup>, 344.0773, Δ = 0.8 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.85 (s, 1H), 7.67 (s, 1H), 7.46–7.43 (m, 2H), 7.40–7.37 (m, 3H), 7.31 (d, <i>J</i> = 8.8 Hz, 2H), 6.89 (d, <i>J</i> = 8.8 Hz, 2H), 4.60 (s, 1H), 4.12 (d, <i>J</i> = 14.4 Hz, 1H), 3.87 (d, <i>J</i> = 14.4 Hz, 1H), 3.78 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 159.8 (C), 154.8 (CH), 144.1 (CH), 135.1 (C), 130.6 (2CH), 129.5 (2CH), 128.6 (<i>o</i>-2CH + <i>p</i>-CH), 125.8 (C), 125.1 (C), 114.2 (2CH), 69.3 (CH), 55.2 (OCH<sub>3</sub>), 46.7 (CH<sub>2</sub>).</div><div class="NLM_p"><b>43d</b>. White powder. Mp 128–130 °C. Ret. time 19.32 min, purity 98.69%. HRESIMS <i>m</i>/<i>z</i> 344.0773 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>18</sub>NO<sub>2</sub>S<sub>2</sub><sup>+</sup>, 344.0773, Δ = 0.0 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.85 (s, 1H), 7.69 (s, 1H), 7.38–7.30 (m, 7H), 6.97 (d, <i>J</i> = 8.8 Hz, 2H), 4.62 (s, 1H), 4.12 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H), 3.84 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 159.8 (C), 154.9 (CH), 144.1 (CH), 134.5 (C), 129.9 (2CH), 129.3 (2CH), 128.8 (2CH), 128.4 (CH), 126.5 (C), 125.1 (C), 114.9 (2CH), 69.3 (CH), 55.3 (OCH<sub>3</sub>), 46.6 (CH<sub>2</sub>).</div><div class="NLM_p"><b>44d</b>. White powder. Mp 123–126 °C. Ret. time 19.32 min, purity 99.70%. HRESIMS <i>m</i>/<i>z</i> 344.0771 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>18</sub>NO<sub>2</sub>S<sub>2</sub><sup>+</sup>, 344.0773, Δ = −0.6 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.85 (s, 1H), 7.69 (s, 1H), 7.39–7.30 (m, 7H), 6.97 (d, <i>J</i> = 8.8 Hz, 2H), 4.62 (s, 1H), 4.12 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H), 3.83 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 159.8 (C-OCH<sub>3</sub>), 154.9 (CH), 144.1 (CH), 134.5 (C), 129.9 (2CH), 129.3 (2CH), 128.8 (2CH), 128.4 (CH), 126.5 (C), 125.1 (C), 114.9 (2CH), 69.3 (CH), 55.4 (OCH<sub>3</sub>), 46.6 (CH<sub>2</sub>).</div><div class="NLM_p last"><b>45d</b>. White powder. Mp 121–124 °C. Ret. time 19.38 min, purity 98.80%. HRESIMS <i>m</i>/<i>z</i> 344.0772 [M + H]<sup>+</sup> (calcd for C<sub>18</sub>H<sub>18</sub>NO<sub>2</sub>S<sub>2</sub><sup>+</sup>, 344.0773, Δ = −0.6 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.85 (s, 1H), 7.67 (s, 1H), 7.46–7.43 (m, 2H), 7.41–7.37 (m, 3H), 7.31 (d, <i>J</i> = 8.8 Hz, 2H), 6.89 (d, <i>J</i> = 8.8 Hz, 2H), 4.60 (s, 1H), 4.12 (d, <i>J</i> = 14.4 Hz, 1H), 3.87 (d, <i>J</i> = 14.4 Hz, 1H), 3.78 (s, 3H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 159.8 (C-OCH<sub>3</sub>), 154.8 (CH), 144.1 (CH), 135.1 (C), 130.6 (2CH), 129.5 (2CH), 128.6 (<i>m</i>-2CH + <i>p</i>-CH), 125.9 (C), 125.1 (C), 114.2 (2CH), 69.4 (CH), 55.3 (OCH<sub>3</sub>), 46.7 (CH<sub>2</sub>).</div></div><div id="sec5_1_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> 5-({(<i>S</i>)-[(<i>S</i>)-(4-Bromophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>42e</b>), 5-({(<i>R</i>)-[(<i>S</i>)-(4-Bromophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>43e</b>), 5-({(<i>S</i>)-[(<i>R</i>)-(4-Bromophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>44e</b>), and 5-({(<i>R</i>)-[(<i>R</i>)-(4-Bromophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>45e</b>)</h3><div class="NLM_p">The starting point for the synthesis of <b>42e</b>–<b>45e</b> is the same: Thiazol-5-ylmethanethiol (<b>36</b>) was reacted with (4-bromophenyl)(phenyl)methanol (1.5 g, 5.7 mmol) (<b>35e</b>) and 1.1 equiv of boron trifluoride diethyl etharate to yield 0.48 g of racemic 5-({[(4-bromophenyl)(phenyl)methyl]thio}methyl)thiazole (<b>37e</b>) in 22% yield. In the following step, compound <b>37e</b> was separated using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and absolute ethanol as the mobile phase into the individual (less retained and more retained) enantiomers <b>38e</b> and <b>39e</b>, respectively. Each of the enantiomers was further oxidized to yield the racemic compounds <b>40e</b> and <b>41e</b> (81% and 79% yield), respectively, that were finally separated using semipreparative HPLC equipped with CHIRALPAK IA column and 100% EtOAc as mobile phase into individual stereoisomers <b>42e</b>–<b>45e</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). All separations were carried out at room temperature using a flow rate of 10 mL/min.</div><div class="NLM_p"><b>42e</b>. White powder. Mp 138–140 °C. Ret. time 22.23 min, purity 99.53%. HRESIMS <i>m</i>/<i>z</i> 391.9774 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>BrNOS<sub>2</sub><sup>+</sup>, 391.9773, Δ = −0.3 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (s, 1H), 7.70 (s, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 7.38–7.35 (m, 5H), 7.28 (d, <i>J</i> = 8.5 Hz, 2H), 4.61 (s, 1H), 4.14 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.0 (CH), 144.2 (CH), 134.0 (C), 133.4 (C), 132.7 (2CH), 130.3 (2CH), 129.3 (2CH), 128.9 (2CH), 128.8 (CH), 124.9 (C), 122.9 (C), 68.9 (CH), 46.9 (CH<sub>2</sub>).</div><div class="NLM_p"><b>43e</b>. White powder. Mp 138–140 °C. Ret. time 22.22 min, purity 99.56%. HRESIMS <i>m</i>/<i>z</i> 391.9773 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>BrNOS<sub>2</sub><sup>+</sup>, 391.9773, Δ = −0.1 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (s, 1H), 7.67 (s, 1H), 7.49–7.40 (m, 5H), 7.36–7.35 (m, 2H), 7.25 (d, <i>J</i> = 8.5 Hz, 2H), 4.59 (s, 1H), 4.14 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.0 (CH), 144.3 (CH), 134.2 (C), 133.1 (C), 131.9 (2CH), 131.0 (2CH), 129.7 (2CH), 129.0 (CH), 128.6 (2CH), 124.6 (C), 123.0 (C), 69.2 (CH), 46.7 (CH<sub>2</sub>).</div><div class="NLM_p"><b>44e</b>. White powder. Mp 144–147 °C. Ret. time 22.22 min, purity 99.55%. HRESIMS <i>m</i>/<i>z</i> 391.9774 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>BrNOS<sub>2</sub><sup>+</sup>, 391.9773, Δ = 0.3 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (s, 1H), 7.67 (s, 1H), 7.49–7.40 (m, 5H), 7.36–7.35 (m, 2H), 7.25 (d, <i>J</i> = 8.5, 2H), 4.59 (s, 1H), 4.14 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.0 (CH), 144.3 (CH), 134.2 (C), 133.1 (C), 131.9 (2CH), 131.0 (2CH), 129.7 (2CH), 129.0 (CH), 128.6 (2CH), 124.6 (C), 123.0 (C), 69.2 (CH), 46.7 (CH<sub>2</sub>).</div><div class="NLM_p last"><b>45e</b>. White powder. Mp 134–136 °C. Ret. time 22.23 min, purity 99.33%. HRESIMS <i>m</i>/<i>z</i> 391.9774 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>BrNOS<sub>2</sub><sup>+</sup>, 391.9773, Δ = −0.2 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (s, 1H), 7.70 (s, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 7.39–7.39 (m, 5H), 7.28 (d, <i>J</i> = 8.5 Hz, 2H), 4.61 (s, 1H), 4.14 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 155.0 (CH), 144.2 (CH), 134.0 (C), 133.4 (C), 132.7 (2CH), 130.3 (2CH), 129.3 (2CH), 128.9 (2CH), 128.8 (CH), 124.9 (C), 122.9 (C), 68.9 (CH), 46.9 (CH<sub>2</sub>).</div></div><div id="sec5_1_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> 5-({(<i>S</i>)-[(<i>S</i>)-(4-Fluorophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>42f</b>), 5-({(<i>R</i>)-[(<i>S</i>)-(4-Fluorophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>43f</b>), 5-({(<i>S</i>)-[(<i>R</i>)-(4-Fluorophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>44f</b>), and 5-({(<i>R</i>)-[(<i>R</i>)-(4-Fluorophenyl)(phenyl)methyl]sulfinyl}methyl)thiazole (<b>45f</b>)</h3><div class="NLM_p">The starting point for synthesis of <b>42f</b>–<b>45f</b> is the same: Thiazol-5-ylmethanethiol (0.5 g, 3.8 mmol) (<b>36</b>) was reacted with (4-fluorophenyl)(phenyl)methanol (0.7 g, 3.8 mmol) (<b>35f</b>) and boron trifluoride diethyl etherate to yield 1.0 g of racemic 5-({[(4-fluorophenyl)(phenyl)methyl]thio}methyl)thiazole (<b>37f</b>) in 85% yield. In the following step, compound <b>37f</b> was separated using semipreparative HPLC equipped with CHIRALPAK IA column (10 mm ⌀ × 25 cm L) (Daicel Inc., Tokyo, Japan) and absolute ethanol as the mobile phase into the individual (less retained and more retained) enantiomers <b>38f</b> and <b>39f</b>, respectively. Each of the enantiomers was further oxidized to yield the racemic compounds <b>40f</b> and <b>41f</b> (94% and 93% yield), respectively, that were finally separated using semipreparative HPLC equipped with CHIRALPAK IA column into individual stereoisomers <b>42f</b>–<b>45f</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). All separations were carried out at room temperature using a flow rate of 10 mL/min.</div><div class="NLM_p"><b>42f</b>. White powder. Mp 122–123 °C. Ret. time 19.77 min, purity 99.60%. HRESIMS <i>m</i>/<i>z</i> 332.0575 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>FNOS<sub>2</sub><sup>+</sup>, 332.0574, Δ = 0.5 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (s, 1H), 7.69 (s, 1H), 7.40–7.36 (m, 7H), 7.16–7.13 (m, 2H), 4.64 (s, 1H), 4.13 (d, <i>J</i> = 14.4 Hz, 1H), 3.88 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 162.7 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 248.8 Hz, CF), 155.0 (CH), 144.1 (CH), 133.7 (C), 130.8 (d, <sup>4</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.4 Hz, C), 130.4 (d, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.1 Hz, 2CH), 129.3 (2CH), 128.9 (2CH), 128.9 (CH), 125.0 (C), 116.6 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 21.2 Hz, 2CH), 68.8 (CH), 46.8 (CH<sub>2</sub>).</div><div class="NLM_p"><b>43f</b>. White powder. Mp 116–118 °C. Ret. time 19.83 min, purity 99.50%. HRESIMS <i>m</i>/<i>z</i> 332.0575 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>FNOS<sub>2</sub><sup>+</sup>, 332.0574, Δ = −0.5 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (s, 1H), 7.67 (s, 1H), 7.48–7.40 (m, 3H), 3.37–7.33 (m, 4H), 7.06–7.03 (m, 2H), 4.62 (s, 1H), 4.13 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 162.9 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 247.8 Hz, CF), 155.0 (CH), 144.2 (CH), 134.5 (C), 131.1 (d, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.1 Hz, 2CH), 129.9 (d, <sup>4</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.3 Hz, C), 129.7 (2CH), 128.9 (CH), 128.6 (2CH), 124.7 (C), 115.8 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 21.6 Hz, 2CH), 69.0 (CH), 46.6 (CH<sub>2</sub>).</div><div class="NLM_p"><b>44f</b>. White powder. Mp 117–119 °C. Ret. time 19.83 min, purity 99.58%. HRESIMS <i>m</i>/<i>z</i> 332.0573 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>FNOS<sub>2</sub><sup>+</sup>, 332.0574, Δ = 0.3 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (s, 1H), 7.67 (s, 1H), 7.48–7.40 (m, 3H), 7.37–7.34 (m, 4H), 7.06–7.03 (m, 2H), 4.62 (s, 1H), 4.13 (d, <i>J</i> = 14.4 Hz, 1H), 3.87 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 162.9 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 247.7 Hz, CF), 155.0 (CH), 144.2 (CH), 134.5 (C), 131.1 (d, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.2 Hz, 2CH), 129.8 (d, <sup>4</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.3 Hz, C), 129.7 (2CH), 128.9 (CH), 128.6 (2CH), 124.7 (C), 115.8 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 19.0 Hz, 2CH), 69.0 (CH), 46.6 (CH<sub>2</sub>).</div><div class="NLM_p last"><b>45f</b>. White powder. Mp 122–124 °C.Ret. time 19.77 min, purity 99.59%. HRESIMS <i>m</i>/<i>z</i> 332.0574 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>15</sub>FNOS<sub>2</sub><sup>+</sup>, 332.0574, Δ = 0.1 ppm). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.86 (s, 1H), 7.69 (s, 1H), 7.40–7.36 (m, 7H), 7.16–7.13 (m, 2H), 4.64 (s, 1H), 4.13 (d, <i>J</i> = 14.4 Hz, 1H), 3.88 (d, <i>J</i> = 14.4 Hz, 1H); <sup>13</sup>C NMR (125.75 MHz, CDCl<sub>3</sub>) δ = 162.7 (d, <sup>1</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 248.9 Hz, CF), 154.9 (CH), 144.1 (CH), 133.7 (C), 130.8 (d, <sup>4</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 3.4 Hz, C), 130.4 (d, <sup>3</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 8.1 Hz, 2CH), 129.3 (2CH), 129.0 (2CH), 128.7 (CH), 125.0 (C), 116.5 (d, <sup>2</sup><i>J</i>(<sup>13</sup>C, <sup>19</sup>F) = 21.3 Hz, 2CH), 68.8 (CH), 46.8 (CH<sub>2</sub>).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> X-ray Measurements</h3><div class="NLM_p last">The X-ray intensity data were measured on Bruker D8 Venture diffractometer equipped with multilayer monochromator, Mo K/a INCOATEC microfocus sealed tube and Oxford cooling system. The structures were solved by direct methods and refined by full-matrix least-squares techniques. Non-hydrogen atoms were refined with anisotropic displacement parameters. Hydrogen atoms were inserted at calculated positions and refined with riding model. The following software was used: Bruker SAINT software package<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> using a narrow-frame algorithm for frame integration, SADABS<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> for absorption correction, OLEX2<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> for structure solution, refinement, molecular diagrams and graphical user interface Shelxle<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> for refinement and graphical user-interface SHELXS-2013<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> for structure solution, SHELXL-2013<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> for refinement, Platon<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> for symmetry check. Experimental data and CCDC codes can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_001.pdf" class="ext-link">Supporting Information</a>. Crystal data, data collection parameters, and structure refinement details as well as crystal structures visualized are available in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> Monoamine Transporter Uptake Inhibition Assays</h3><div class="NLM_p">Uptake inhibition measurements were performed as described previously.<a onclick="showRef(event, 'ref34 ref46'); return false;" href="javascript:void(0);" class="ref ref34 ref46">(34,46)</a> Dulbecco’s modified Eagle’s medium (DMEM), trypsin, and fetal calf serum (FCS) were purchased from Sigma-Aldrich Handels GmbH (Austria). [<sup>3</sup>H]5-HT (hydroxytryptamine creatinine sulfate; 5-[1,2-<sup>3</sup>H[N]]; 45.3 Ci/mmol), [<sup>3</sup>H]DA (dihydroxyphenylethylamine; 3,4-[ring-2,5,6-<sup>3</sup>[H]]-dopamine; 55.8 Ci/mmol), and [<sup>3</sup>H]MPP<sup>+</sup> (methyl-4-phenylpyridinium iodide; 1-[methyl-3H]; 80 Ci/mmol) were purchased from PerkinElmer, Boston, MA.</div><div class="NLM_p">HEK293 cells stably expressing human isoforms of the dopamine transporter (HEK DATwt), norepinephrine transporter (HEK NETwt), and serotonin transporter (HEK SERTwt) were used for uptake inhibition assays. All cell lines were grown as monolayers in 96-well plates precoated with poly-<span class="smallcaps smallerCapital">d</span>-lysine (PDL) (4 × 10<sup>4</sup> cells/well) 24 h prior to the experiment. On the day of the experiment, the medium was aspirated, and each well was washed with 0.1 mL of warm (30 °C) Krebs-HEPES buffer (KHB; 10 mM HEPES, 120 mM NaCl, 3 mM KCl, 2 mM CaCl<sub>2</sub>·2H<sub>2</sub>O, 2 mM MgCl<sub>2</sub>·6 H<sub>2</sub>O, 5 mM <span class="smallcaps smallerCapital">d</span>-(+)-glucose, pH 7.3). The cells were preincubated for 5 min in KHB containing 1% of dimethyl sulfoxide and increasing concentrations of the test compounds (0.1 μM to 1 mM). After aspiration of the preincubation solution, the cells were incubated in KHB containing increasing concentrations of the compound with the addition of 0.2 μM [<sup>3</sup>H]-dopamine (for HEK DATwt), 0.02 μM [<sup>3</sup>H]-MPP<sup>+</sup> (for HEK NETwt), and 0.2 μM [<sup>3</sup>H]-5-HT (for HEK SERTwt). Incubation times were 1 min for HEK DATwt and HEK SERTwt and 3 min for HEK NETwt. Nonspecific [<sup>3</sup>H]-dopamine and [<sup>3</sup>H]-MPP<sup>+</sup> uptake in the presence of 30 μM cocaine was subtracted from total uptake. Nonspecific [<sup>3</sup>H]-5-HT uptake in the presence of 30 μM paroxetine was subtracted from total uptake. After incubation at room temperature, reactions were stopped by the addition of 0.1 mL of ice-cold KHB. Finally, cells were lysed with 0.3 mL of 1% SDS, and released radioactivity was measured by a liquid scintillation counter (Tri-carb-2300TR, PerkinElmer).</div><div class="NLM_p last">Nonlinear regression analysis (GraphPad Prism version 5.0, GraphPad Software, San Diego, CA, USA) was used for calculation of IC<sub>50</sub> values.</div></div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> <i>In Silico</i> Methods. Homology Modeling</h3><div class="NLM_p last">The homology model of the human dopamine transporter (hDAT) was kindly provided by Prof. Dr. Gerhard Ecker from the University of Vienna, Vienna, Austria. The homology model, first described by Saha et al. 2015,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> is based on the crystallized <i>Drosophila melanogaster</i> DAT (dDAT) structure in complex with nortriptyline (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M48">4M48</a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> Docking</h3><div class="NLM_p last">Molecular docking of compounds <b>31c</b>–<b>f</b> and the hDAT was performed using AutoDock Vina.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The ligands were prepared with flexible bonds using the automatic detection of AutoDock Vina. For the molecular docking run, standard parameters were used, protein flexibility was not regarded, and the exhaustiveness level was set to 16. Water molecules were removed (but ions in the binding site were retained), and the binding site was defined as the center of mass of nortriptyline. The search space was restricted to the protein structure. Interactions between docked ligand and transporter were analyzed using LigandScout 4.3.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> <i>In Silico</i> Toxicity Profiling</h3><div class="NLM_p last">The Inte:Ligand Tox Pharmacophore DB<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> was used for toxicity profiling of compounds within a KNIME<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> workflow.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> <i>In Vitro</i> Action Potential Measurements</h3><div class="NLM_p last">Before the experiments, Cor.4U hiPSC-CMs cells were transiently loaded with the voltage-sensitive dye (VSD) FluoVolt (x0.25, for 30 min at room temperature) in serum-free media (DMEM, Gibco 11 966, supplemented with galactose 10 mM and sodium pyruvate 1 mM). Afterward, the medium containing VSD was replaced by fresh serum-free medium. The multiwell plate was placed in an environmentally controlled stage incubator (37 °C, 5% CO<sub>2</sub>, water-saturated air atmosphere) (Okolab Inc., Burlingame, CA, USA). The FluoVolt fluorescence signal was recorded from a 0.2 mm × 0.2 mm area using a 40× (NA 0.6) objective lens. Excitation wavelength was 470 ± 10 nm using a light-emitting diode (LED), and emitted light was collected by a photomultiplier (PMT) at 510–560 nm. LED, PMT, associated power supplies, and amplifiers were supplied by Cairn Research Ltd. (Kent, U.K.). The fluorescence signal was digitized at 10 kHz. Acute effects of drugs were assessed by exposure to studied drug concentration with matched vehicle controls (DMSO). A 20 s recording was then taken 5 and 30 min after exposure to the drug or vehicle (DMSO 0.1%) with only one concentration applied per well. The procedure was repeated five times. The records were subsequently analyzed offline using Clampfit software.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> Dopamine Release Assay</h3><div class="NLM_p last">Cell culture and superfusion experiments were performed as described recently with minor modifications.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div></div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> Cell Culture</h3><div class="NLM_p last">Human embryonic kidney (HEK) 293 cells were grown in minimum essential medium with Earle’s salts and <span class="smallcaps smallerCapital">l</span>-glutamine, 10% heat inactivated fetal bovine serum, and 50 mg/L gentamicin. Cells were grown in 100 or 60 mm diameter tissue culture dishes (polystyrene, Falcon) at 37 °C under an atmosphere of 5% CO<sub>2</sub>/95% air. The human dopamine transporter/SLC6A3 (DAT) was stably expressed using methods as described previously.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> Superfusion Experiments</h3><div class="NLM_p last">Cells were seeded onto poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated 5 mm diameter glass coverslips in 96-well tissue culture plates (3 × 10<sup>4</sup> cells/well). Two days later cells were loaded with 6 μM [<sup>3</sup>H] MPP<sup>+</sup> (0.2 Ci/mmol) in uptake/superfusion buffer (mmol/L: 4 Tris-HCl; 6.25 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES); 120 NaCl; 5 KCl; 1.2 CaCl<sub>2</sub>; 1.2 MgSO4; 5.6 <span class="smallcaps smallerCapital">d</span>-glucose; 0.5 ascorbic acid; pH 7.1.) at 37 °C for 20 min. After loading, coverslips were transferred to small chambers and superfused (25 °C, 1.0 mL/min) with the uptake buffer mentioned above in a setup as described previously.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> After a washout period of 45 min to establish a stable efflux of radioactivity the experiment was started with the collection of 4 min fractions. (For determination of a releasing effect 10 μM compound <b>31e</b> or 3 μM of the reference releaser <span class="smallcaps smallerCapital">d</span>-amphetamine was added for three fractions to the superfusion buffer after three fractions of baseline and then removed for another three fractions. For <b>31e</b>/<span class="smallcaps smallerCapital">d</span>-amphetamine interaction experiments <b>31e</b> was added to the superfusion buffer one fraction before amphetamine after two fractions of baseline.) At the end of the experiment cells were lysed in 1% SDS. The radioactivity in the superfusate fractions and the SDS-lysates was determined by liquid scintillation counting. Release of tritium was expressed as fractional rate; i.e., the radioactivity released during a fraction was expressed as percentage of the total radioactivity present in the cells at the beginning of that fraction.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> Neurite Outgrowth Assay</h3><div class="NLM_p">Cryopreserved rat cortical neurons (QBM Cell Science, R-Cx-500) were quickly thawed and slowly diluted with neurobasal medium supplemented with <span class="smallcaps smallerCapital">l</span>-glutamine (Invitrogen, catalog no. 25030-081), penicillin–streptomycin (Invitrogen, catalog no. 15140-122), and B27 (NB/B27 medium, Invitrogen, catalog no. 17504-044). After a gentle centrifugation step, the neurons were resuspended with NB/B27 medium at a density of 4.0 × 10<sup>6</sup> cells/mL. One hour prior to treatment, the neurons were plated in 384-well plates (Corning 354663) precoated with a laminin solution (Sigma L2020 1 mg/mL) at a density of 10 000 cells per well. After treatment with test articles and control compounds, the neurons were maintained in a humidified environment at 37 °C with 5% CO<sub>2</sub> for 72 h. At the end of the treatment period, the neurons were fixed for 1 h with a 3.7% formaldehyde solution (Acros Organics, 41073-0010). The neurons were washed with phosphate buffered saline (PBS) (SH30264.02) and permeabilized for 10 min with a 0.5% solution of Triton X-100 (Millipore Sigma, X100). After another wash step, the neurons were stained for 1 h with Hoechst 33342 (ThermoFisher Scientific, H3570) and anti-beta III tubulin antibody, Alexa Fluor 488 conjugate (Millipore Sigma AB15708A4) diluted in a blocking buffer solution (Thermo Scientific 37525). Upon completion of the staining step, the neurons were washed again and the plates were sealed in preparation for the imaging process. The neurons were evaluated for neurite outgrowth and cell health using the high content imaging platform, ArrayScan VTi (Thermo Scientific ArrayScan VTi), with an optimized neuronal profiling bioapplication.</div><div class="NLM_p last">This assay assessed cell health and neurite outgrowth utilizing a neuronal profiling bioapplication applied to images obtained on an ArrayScan VTi. Valid neuron count, mean neurite average length, and neurite total length per neuron were determined and reported. Raw data were normalized to the vehicle control and reported as a normalized % response. Dose–response graphs were generated with GraphPad Prism using a sigmoidal dose–response (variable slope) algorithm.</div></div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> <i>In Vivo</i> Pharmacokinetic and Drug Efficacy Studies. Pharmacokinetic Study of <b>31e</b></h3><div class="NLM_p last">This study was outsourced to Evotec (Hamburg, Germany). Study dates were as following: acclimation start on November 15, 2018; surgery on November 20, 2018; in-life phase start on November 22, 2018; bioanalytical phase start on December 6 and 7, 2018, and pharmacokinetic reporting on December 10, 2018. All experimental procedures and conditions are available in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> Microdialysis in Freely Moving Rats</h3><div class="NLM_p">For microdialysis experiments, male Sprague-Dawley rats (Janvier-Labs, Saint Berthevin, France) weighing 250–350 g were housed under standard laboratory conditions (temperature 22 ± 2 °C, humidity 45–65% with a 12:12 h light-dark cycle lights on at 07:00 h). Animals had free access to food and water. All experimental procedures were approved by the Austrian Animal Experimentation Ethical Committee (Bundesministerium für Wissenschaft, Forschung und Wirtschaft, Kommission für Tierversuchsangelegenheiten) in compliance with international laws and policies.</div><div class="NLM_p">A homemade, U-shaped microdialysis probe consisting of a 9 kDa dialysis membrane (Cuprophan, Membrana, Wuppertal, Germany) was stereotaxically implanted under isoflurane (as inhalant: 5% induction; 2.5% maintenance) anesthesia. The probe was positioned according to the stereotaxic atlas of Paxinos and Watson (1998) with its tip reaching into the right nucleus accumbens (NAcb; implantation coordinates: 1.6 mm rostral to bregma, 1.6 mm lateral to the midline, 7.6 mm below the surface of the skull) and fixed to the skull with two jeweler’s screws and dental cement. After surgery, rats received an analgesic (buprenorphine, 5 mg/kg BW, sc) and were individually housed in transparent plexiglas cages. Animals were handled for 5 min twice daily to familiarize them with the experimental procedure and to minimize nonspecific stress responses during the experiment.</div><div class="NLM_p">Two days after surgery the microdialysis probe was connected to a syringe mounted onto a microprocessor controlled syringe pump (KD-200 series, KD Scientific Inc., Holliston, MA, USA) via a polyethylene tubing system and superfused with sterile artificial cerebrospinal fluid (aCSF; NaCl 140 mM, KCl 3.0 mM, CaCl<sub>2</sub> 1.25 mM, MgCl<sub>2</sub> 1.0 mM, Na<sub>2</sub>HPO<sub>4</sub> 1.2 mM, and NaH<sub>2</sub>PO<sub>4</sub> 0.3 mM; pH 7.4) at a flow rate of 1.0 μL/min. After an equilibration period of 120 min, consecutive 20 min dialysates were collected directly into ice-cooled microtubes containing 6 μL of an antioxidative mixture (100 mM acetic acid, 0.27 mM Na<sub>2</sub>EDTA, and 12.5 μM ascorbic acid), vortexed, and stored at −80 °C until further analysis. All microdialysis experiments were started between 07:15 and 07:30. After six baseline samples (collected from −120 to 0 min), vehicle (30% Kolliphor EL) or <b>31e</b> (1 mg/kg, ip) was administered, and six samples were collected. Subsequently, vehicle (30% Kolliphor EL) or drug was administered at a higher dose (10 mg/kg, ip) and another six microdialysates were collected. During collection of the last two dialysates the probe was perfused with aCSF containing 100 mM KCl in order to elicit local depolarization. At the end of the experiment, rats were euthanized by an overdose of thiopental and brains were removed for histological verification of the placement of microdialysis probes. In all animals, probes were correctly localized within the NAcb.</div><div class="NLM_p">Determination of dopamine was performed by reverse-phase high performance liquid chromatography (RP-HPLC) with electrochemical detection as previously described (detection limit: 0.25 fmol/5 μL sample; Camats-Perna et al., 2019).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The HPLC system consisted of a Shimadzu (Kyoto, Japan) system controller (CBM-20A), degassing unit (DGU-20A3R), and micro HPLC pump (LC-20ADXR) operated at a flow rate of 0.055 mL/min coupled with an Antec Decade II electrochemical detector (Antec Zoeterwoude, The Netherlands) set at +460 mV. The analytical column (NeuroSep 105; 50 mm × 1 mm, 3 μm spherical particles; Antec, Zoeterwoude, The Netherlands) was coupled directly to a Antec SenCell 2 mm glassy carbon working electrode (Antec Zoeterwoude, The Netherlands). The column and detector cell were maintained at 35 °C by a column oven as part of the electrochemical detector. Samples of 5 μL were automatically injected by a SIL-20ACXR refrigerated autosampler (Shimadzu, Japan). The mobile phase consisted of 7% (v/v) methanol, 50 mM phosphoric acid, 50 mM citric acid, 2.36 mM octane–sulfonic acid, 0.1 mM Na<sub>2</sub>EDTA at a pH of 5.6 that was filtered (0.2 μm) before use. Evaluation of dopamine was carried out by comparing peak areas of samples with a set of external standard solutions (range between 100 pM and 5 nM) by using Lab Solution chromatography software (LabSolution CS, Shimadzu, Japan).</div><div class="NLM_p last">The DA content in each 20 min microdialysate was expressed as relative value to the mean absolute DA content of the three samples preceding the first administration of drug or vehicle. Data are presented as the mean ± SEM. Statistical analysis was performed with Statistica Software version 13 (StatSoft GmbH, Hamburg, Germany) using a two-way ANOVA with repeated measurements followed by Fisher’s LSD test. <i>P</i> < 0.05 was considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i126"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01938" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01938?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01938</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">High-resolution mass spectrometry data (pp 2–145), <sup>1</sup>H, <sup>13</sup>C, and 2D NMR spectra (pp 146–1357), HPLC-determined purity data (pp 1358–1428), chiral HPLC data (pp 1429–1468), reuptake inhibition curves (pp 1469–1479), X-ray measurements data (pp 1480–1624), and pharmacokinetic study report (pp 1625–1645) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_001.pdf">jm9b01938_si_001.pdf (57.28 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_002.csv">jm9b01938_si_002.csv (5.11 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01938" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gert Lubec</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Laboratory, Paracelsus Medical University, A-5020 Salzburg, Austria</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6333-9461" title="Orcid link">http://orcid.org/0000-0002-6333-9461</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cbacaeb9bfe5a7bea9aea88ba7bea9aea8a7aaa9e5a8a4a6"><span class="__cf_email__" data-cfemail="d9bebcabadf7b5acbbbcba99b5acbbbcbab5b8bbf7bab6b4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Predrag Kalaba</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marija Ilić</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nilima Y. Aher</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vladimir Dragačević</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcus Wieder</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2631-8415" title="Orcid link">http://orcid.org/0000-0003-2631-8415</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Zehl</span> - <span class="hlFld-Affiliation affiliation">Department
of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Währinger Straße 38, 1090 Vienna, Austria</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9685-0373" title="Orcid link">http://orcid.org/0000-0001-9685-0373</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judith Wackerlig</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stanislav Beyl</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simone B. Sartori</span> - <span class="hlFld-Affiliation affiliation">Center
for Molecular Biosciences Innsbruck (CMBI), Department of Pharmacology
and Toxicology, Institute of Pharmacy, Leopold
Franzens University Innsbruck, 6020 Innsbruck, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karl Ebner</span> - <span class="hlFld-Affiliation affiliation">Center
for Molecular Biosciences Innsbruck (CMBI), Department of Pharmacology
and Toxicology, Institute of Pharmacy, Leopold
Franzens University Innsbruck, 6020 Innsbruck, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander Roller</span> - <span class="hlFld-Affiliation affiliation">X-ray
Structure Analysis Centre, Faculty of Chemistry, University of Vienna, Währinger Straße 38, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natalie Lukic</span> - <span class="hlFld-Affiliation affiliation">X-ray
Structure Analysis Centre, Faculty of Chemistry, University of Vienna, Währinger Straße 38, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tetyana Beryozkina</span> - <span class="hlFld-Affiliation affiliation">Ural Federal
University Named after the First President of Russia B. N. Yeltsin, 19 Mira st., Yekaterinburg 620002, Russia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9917-6748" title="Orcid link">http://orcid.org/0000-0002-9917-6748</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eduardo Rene Perez Gonzalez</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Fine Organic Chemistry, Department of Chemistry and Biochemistry,
Faculty of Science and Technology, University
of Sao Paulo State, Roberto
Simonsen 305, CEP 19060-900, Presidente Prudente, SP, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip Neill</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jawad Akbar Khan</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vasiliy Bakulev</span> - <span class="hlFld-Affiliation affiliation">Ural Federal
University Named after the First President of Russia B. N. Yeltsin, 19 Mira st., Yekaterinburg 620002, Russia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3312-7783" title="Orcid link">http://orcid.org/0000-0002-3312-7783</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johann Jakob Leban</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steffen Hering</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Pifl</span> - <span class="hlFld-Affiliation affiliation">Centre
for Brain Research, Medical University of
Vienna, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Singewald</span> - <span class="hlFld-Affiliation affiliation">Center
for Molecular Biosciences Innsbruck (CMBI), Department of Pharmacology
and Toxicology, Institute of Pharmacy, Leopold
Franzens University Innsbruck, 6020 Innsbruck, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jana Lubec</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Laboratory, Paracelsus Medical University, A-5020 Salzburg, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ernst Urban</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harald H. Sitte</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1339-7444" title="Orcid link">http://orcid.org/0000-0002-1339-7444</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Langer</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5242-1240" title="Orcid link">http://orcid.org/0000-0002-5242-1240</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>P.K., M.I., and N.Y.A. have contributed equally to this manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i128">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are indebted to Anna Fabisikova (University of Vienna, Austria) for helping us perform MS analysis, Andras Miklosi and Sivapraksam R. Saroja for their help with uptake inhibition assays, and Lisa Horvath and Jiajian Cao (University of Vienna, Austria) for their help in measuring melting points. Furthermore, we are very grateful to Prof. Dr. Gerhard Ecker from the University of Vienna (Austria) for providing us the protein homology model of hDAT. Finally, we thank Prof. Wolfgang Lindner for his consultations during separation of stereoisomers. We gratefully acknowledge the Higher Education Commission Pakistan Ph.D. scholarship to J.A.K. We are also grateful to Austrian Science Fund (FWF) for providing Grant P27729 to S.B. and to FAPESP by conceding a postdoctoral grant (2016/10149-0) to Prof. Dr. Eduardo R. P. Gonzalez.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">norepinephrine transporter</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">K<sub>2</sub>CO<sub>3</sub></td><td class="NLM_def"><p class="first last">potassium carbonate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">potassium <i>tert</i>-butoxide</p></td></tr><tr><td class="NLM_term">BF<sub>3</sub>·Et<sub>2</sub>O</td><td class="NLM_def"><p class="first last">boron trifluoride diethyl etherate</p></td></tr><tr><td class="NLM_term">HBr</td><td class="NLM_def"><p class="first last">hydrobromic acid</p></td></tr><tr><td class="NLM_term">CH<sub>3</sub>COOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>O<sub>2</sub></td><td class="NLM_def"><p class="first last">hydrogen peroxide</p></td></tr><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human-ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">AP</td><td class="NLM_def"><p class="first last">action potential</p></td></tr><tr><td class="NLM_term">EAD</td><td class="NLM_def"><p class="first last">early after depolarization</p></td></tr><tr><td class="NLM_term">[<sup>3</sup>H]MPP<sup>+</sup></td><td class="NLM_def"><p class="first last">methyl-4-phenylpyridinium</p></td></tr><tr><td class="NLM_term">KHB</td><td class="NLM_def"><p class="first last">Krebs–Henseleit buffer</p></td></tr><tr><td class="NLM_term">PDL</td><td class="NLM_def"><p class="first last">poly-<span class="smallcaps smallerCapital">d</span>-lysine</p></td></tr><tr><td class="NLM_term">CDCl<sub>3</sub></td><td class="NLM_def"><p class="first last">deuterated chloroform</p></td></tr><tr><td class="NLM_term">DMSO-<i>d</i><sub>6</sub></td><td class="NLM_def"><p class="first last">deuterated dimethyl sulfoxide.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i130">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 56 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minzenberg, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, C. S.</span></span> <span> </span><span class="NLM_article-title">Modafinil: A review of neurochemical actions and effects on cognition</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1477</span>– <span class="NLM_lpage">1502</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1301534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1038%2Fsj.npp.1301534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=17712350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=1477-1502&issue=7&author=M.+J.+Minzenbergauthor=C.+S.+Carter&title=Modafinil%3A+A+review+of+neurochemical+actions+and+effects+on+cognition&doi=10.1038%2Fsj.npp.1301534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil: A Review of Neurochemical Actions and Effects on Cognition</span></div><div class="casAuthors">Minzenberg, Michael J.; Carter, Cameron S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1477-1502</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Modafinil (2-[(Diphenylmethyl) sulfinyl] acetamide, Provigil) is an FDA-approved medication with wake-promoting properties.  Pre-clin. studies of modafinil suggest a complex profile of neurochem. and behavioral effects, distinct from those of amphetamine.  In addn., modafinil shows initial promise for a variety of off-label indications in psychiatry, including treatment-resistant depression, attention-deficit/hyperactivity disorder, and schizophrenia.  Cognitive dysfunction may be a particularly important emerging treatment target for modafinil, across these and other neuropsychiatric disorders.  We aimed to comprehensively review the empirical literature on neurochem. actions of modafinil, and effects on cognition in animal models, healthy adult humans, and clin. populations.  We searched PubMed with the search term modafinil' and reviewed all English-language articles for neurochem., neurophysiol., cognitive, or information-processing exptl. measures.  We addnl. summarized the pharmacokinetic profile of modafinil and clin. efficacy in psychiatric patients.  Modafinil exhibits robust effects on catecholamines, serotonin, glutamate, gamma amino-butyric acid, orexin, and histamine systems in the brain.  Many of these effects may be secondary to catecholamine effects, with some selectivity for cortical over subcortical sites of action.  In addn., modafinil (at well-tolerated doses) improves function in several cognitive domains, including working memory and episodic memory, and other processes dependent on prefrontal cortex and cognitive control.  These effects are obsd. in rodents, healthy adults, and across several psychiatric disorders.  Furthermore, modafinil appears to be well-tolerated, with a low rate of adverse events and a low liability to abuse.  Modafinil has a no. of neurochem. actions in the brain, which may be related to primary effects on catecholaminergic systems.  These effects are in general advantageous for cognitive processes.  Overall, modafinil is an excellent candidate agent for remediation of cognitive dysfunction in neuropsychiatric disorders.  Neuropsychopharmacol. (2008) 33, 1477-1502; doi:10.1038/sj.npp.1301534; published online 22 August 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHENkazvO_x7Vg90H21EOLACvtfcHk0lgnn1KIGMyDwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSrtrc%253D&md5=b3f5ab7df9e6126e05e19a352900b482</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301534%26sid%3Dliteratum%253Aachs%26aulast%3DMinzenberg%26aufirst%3DM.%2BJ.%26aulast%3DCarter%26aufirst%3DC.%2BS.%26atitle%3DModafinil%253A%2520A%2520review%2520of%2520neurochemical%2520actions%2520and%2520effects%2520on%2520cognition%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26issue%3D7%26spage%3D1477%26epage%3D1502%26doi%3D10.1038%2Fsj.npp.1301534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerrard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, R.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of modafinil: a review of current research</span>. <i>Neuropsychiatr. Dis. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=19300566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1WnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=349-364&issue=3&author=P.+Gerrardauthor=R.+Malcolm&title=Mechanisms+of+modafinil%3A+a+review+of+current+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of modafinil: a review of current research</span></div><div class="casAuthors">Gerrard, Paul; Malcolm, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychiatric Disease and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-364</span>CODEN:
                <span class="NLM_cas:coden">NDTEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1176-6328</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  The novel wake-promoting agent modafinil has been in use for the treatment of several sleep disorders for a few years and is now undergoing clin. trials for its use in the treatment of stimulant addiction, but its primary mechanism of action remains elusive.  Previous lab. studies have shown that modafinil has antioxidative and neuroprotective effects, which have not previously been suggested to be related to its wake-promoting effects.  However, recent research indicates that free radicals may be related to sleep induction as well as cellular damage, suggesting that a common target of action may mediate modafinil's ability to oppose both of these effects.  In this review we summarize and discuss previously published research on modafinil's neural, cytoprotective, and cognitive effects, and we propose possible primary biochem. targets that could underlie the effects of modafinil obsd. in these studies.  We also suggest neurocognitive mechanisms responsible for modafinil's cognitive enhancing effects and its therapeutic potential in the treatment of stimulant addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbxuHCZ8GqFbVg90H21EOLACvtfcHk0lh1SyxUmKCyxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1WnsLw%253D&md5=3b9d1c81db02be3d8ecf8c370208bddf</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerrard%26aufirst%3DP.%26aulast%3DMalcolm%26aufirst%3DR.%26atitle%3DMechanisms%2520of%2520modafinil%253A%2520a%2520review%2520of%2520current%2520research%26jtitle%3DNeuropsychiatr.%2520Dis.%2520Treat.%26date%3D2007%26volume%3D3%26issue%3D3%26spage%3D349%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urban, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W. J.</span></span> <span> </span><span class="NLM_article-title">Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain</span>. <i>Front. Syst. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">38</span>, <span class="refDoi"> DOI: 10.3389/fnsys.2014.00038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3389%2Ffnsys.2014.00038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=24860437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A280%3ADC%252BC2cflvFamsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=38&author=K.+R.+Urbanauthor=W.+J.+Gao&title=Performance+enhancement+at+the+cost+of+potential+brain+plasticity%3A+neural+ramifications+of+nootropic+drugs+in+the+healthy+developing+brain&doi=10.3389%2Ffnsys.2014.00038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain</span></div><div class="casAuthors">Urban Kimberly R; Gao Wen-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in systems neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38</span>
        ISSN:<span class="NLM_cas:issn">1662-5137</span>.
    </div><div class="casAbstract">Cognitive enhancement is perhaps one of the most intriguing and controversial topics in neuroscience today.  Currently, the main classes of drugs used as potential cognitive enhancers include psychostimulants (methylphenidate (MPH), amphetamine), but wakefulness-promoting agents (modafinil) and glutamate activators (ampakine) are also frequently used.  Pharmacologically, substances that enhance the components of the memory/learning circuits-dopamine, glutamate (neuronal excitation), and/or norepinephrine-stand to improve brain function in healthy individuals beyond their baseline functioning.  In particular, non-medical use of prescription stimulants such as MPH and illicit use of psychostimulants for cognitive enhancement have seen a recent rise among teens and young adults in schools and college campuses.  However, this enhancement likely comes with a neuronal, as well as ethical, cost.  Altering glutamate function via the use of psychostimulants may impair behavioral flexibility, leading to the development and/or potentiation of addictive behaviors.  Furthermore, dopamine and norepinephrine do not display linear effects; instead, their modulation of cognitive and neuronal function maps on an inverted-U curve.  Healthy individuals run the risk of pushing themselves beyond optimal levels into hyperdopaminergic and hypernoradrenergic states, thus vitiating the very behaviors they are striving to improve.  Finally, recent studies have begun to highlight potential damaging effects of stimulant exposure in healthy juveniles.  This review explains how the main classes of cognitive enhancing drugs affect the learning and memory circuits, and highlights the potential risks and concerns in healthy individuals, particularly juveniles and adolescents.  We emphasize the performance enhancement at the potential cost of brain plasticity that is associated with the neural ramifications of nootropic drugs in the healthy developing brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9mMH7P4hI_--MdeMhXAHkfW6udTcc2eaRIq3sZggcdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflvFamsg%253D%253D&md5=d552cabbeece23291f10b62d98deb3fc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffnsys.2014.00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnsys.2014.00038%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DK.%2BR.%26aulast%3DGao%26aufirst%3DW.%2BJ.%26atitle%3DPerformance%2520enhancement%2520at%2520the%2520cost%2520of%2520potential%2520brain%2520plasticity%253A%2520neural%2520ramifications%2520of%2520nootropic%2520drugs%2520in%2520the%2520healthy%2520developing%2520brain%26jtitle%3DFront.%2520Syst.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D38%26doi%3D10.3389%2Ffnsys.2014.00038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarchick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wideman, C. H.</span></span> <span> </span><span class="NLM_article-title">Modafinil as a cognitive enhancer of spatial working memory in rats</span>. <i>Physiol. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/j.physbeh.2015.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.physbeh.2015.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=25656691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitl2lu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2015&pages=126-130&author=H.+M.+Murphyauthor=D.+Ekstrandauthor=M.+Tarchickauthor=C.+H.+Wideman&title=Modafinil+as+a+cognitive+enhancer+of+spatial+working+memory+in+rats&doi=10.1016%2Fj.physbeh.2015.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil as a cognitive enhancer of spatial working memory in rats</span></div><div class="casAuthors">Murphy, Helen M.; Ekstrand, Dylan; Tarchick, Matthew; Wideman, Cyrilla H.</div><div class="citationInfo"><span class="NLM_cas:title">Physiology & Behavior</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">126-130</span>CODEN:
                <span class="NLM_cas:coden">PHBHA4</span>;
        ISSN:<span class="NLM_cas:issn">0031-9384</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The present expt. examd. the influence of modafinil on working memory in rats.  Control and exptl. rats were placed in cages equipped with a running wheel.  The study was divided into three periods: 1. habituation, 2. exptl. - in which modafinil was orally administered to exptl. animals, and 3. withdrawal.  Spatial working memory was tested utilizing the Morris Water Maze.  Animals were given two trials in each session: 1. a sample trial in which they discovered the location of the platform and 2. a test trial in which they recalled the location of the platform.  Platform placement and starting place location of the rats were changed every session.  Performance of control animals during sample trials and test trials showed no difference in time to reach the platform; whereas, exptl. animals demonstrated faster attainment of the goal during the test trial.  In withdrawal, there was no difference in time between the two trials for exptl. animals.  Wheel running activity of the exptl. group was lower than that of the control group during the exptl. period.  This study supports the hypothesis that modafinil has a pos. effect on working memory in rats.  It is suggested that benefits of modafinil can extend beyond its prescribed usage; however, these advantages of modafinil use should be addressed in discussions related to ethical concerns assocd. with neuroenhancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBq28Wmv2ueLVg90H21EOLACvtfcHk0lh1SyxUmKCyxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitl2lu7k%253D&md5=b6b9fb7ea0d0af6d21fcb3129d074638</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.physbeh.2015.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.physbeh.2015.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DH.%2BM.%26aulast%3DEkstrand%26aufirst%3DD.%26aulast%3DTarchick%26aufirst%3DM.%26aulast%3DWideman%26aufirst%3DC.%2BH.%26atitle%3DModafinil%2520as%2520a%2520cognitive%2520enhancer%2520of%2520spatial%2520working%2520memory%2520in%2520rats%26jtitle%3DPhysiol.%2520Behav.%26date%3D2015%26volume%3D142%26spage%3D126%26epage%3D130%26doi%3D10.1016%2Fj.physbeh.2015.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, J.</span></span> <span> </span><span class="NLM_article-title">Chess study revives debate over cognition-enhancing drugs</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>318</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">784</span>, <span class="refDoi"> DOI: 10.1001/jama.2017.8114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1001%2Fjama.2017.8114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=28813563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A280%3ADC%252BC1cfovFSlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2017&pages=784&issue=9&author=J.+Lyon&title=Chess+study+revives+debate+over+cognition-enhancing+drugs&doi=10.1001%2Fjama.2017.8114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Chess Study Revives Debate Over Cognition-Enhancing Drugs</span></div><div class="casAuthors">Lyon Jeff</div><div class="citationInfo"><span class="NLM_cas:title">JAMA</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">784-786</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwWQ1vrgND9DToTC3aBaesfW6udTcc2eb0HyVrVz3MHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfovFSlug%253D%253D&md5=dc08297ecb8337f635813973c423f89c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Fjama.2017.8114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2017.8114%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DJ.%26atitle%3DChess%2520study%2520revives%2520debate%2520over%2520cognition-enhancing%2520drugs%26jtitle%3DJAMA%26date%3D2017%26volume%3D318%26issue%3D9%26spage%3D784%26doi%3D10.1001%2Fjama.2017.8114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakare, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burzynski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loland, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Novel and high affinity 2-[(diphenylmethyl)sulfynil]acetamide (modafinil) analogues as atypical dopamine transporter inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10676</span>– <span class="NLM_lpage">10691</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01373</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFelu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10676-10691&author=J.+Caoauthor=R.+D.+Slackauthor=O.+M.+Bakareauthor=C.+Burzynskiauthor=R.+Raisauthor=B.+S.+Slusherauthor=T.+Kopajticauthor=A.+Bonifaziauthor=M.+P.+Ellenbergerauthor=H.+Yanoauthor=Y.+Heauthor=G.+H.+Biauthor=Z.+H.+Xiauthor=C.+J.+Lolandauthor=A.+H.+Newman&title=Novel+and+high+affinity+2-%5B%28diphenylmethyl%29sulfynil%5Dacetamide+%28modafinil%29+analogues+as+atypical+dopamine+transporter+inhibitors&doi=10.1021%2Facs.jmedchem.6b01373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors</span></div><div class="casAuthors">Cao, Jianjing; Slack, Rachel D.; Bakare, Oluyomi M.; Burzynski, Caitlin; Rais, Rana; Slusher, Barbara S.; Kopajtic, Theresa; Bonifazi, Alessandro; Ellenberger, Michael P.; Yano, Hideaki; He, Yi; Bi, Guo-Hua; Xi, Zheng-Xiong; Loland, Claus J.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10676-10691</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of pharmacotherapeutic treatments of psychostimulant abuse has remained a challenge, despite significant efforts made toward relevant mechanistic targets, such as the dopamine transporter (DAT).  The atypical DAT inhibitors have received attention due to their promising pharmacol. profiles in animal models of cocaine and methamphetamine abuse.  Herein the authors report a series of modafinil analogs that have an atypical DAT inhibitor profile.  The authors extended SAR by chem. manipulating the oxidn. states of the sulfoxide and the amide functional groups, halogenating the Ph rings, and/or functionalizing the terminal nitrogen with substituted piperazines, resulting in several novel leads such as 1-(4-(2-((bis(4-fluorophenyl)methyl)sulfinyl)ethyl)piperazin-1-yl)-3-phenylpropan-2-ol (compd. 11b), which demonstrated high DAT affinity (Ki = 2.5 nM) and selectivity without producing concomitant locomotor stimulation in mice, as compared to cocaine.  These results are consistent with an atypical DAT inhibitor profile and suggest that 11b may be a potential lead for development as a psychostimulant abuse medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0BwESHNuRbVg90H21EOLACvtfcHk0lh7R1T2dZtIqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFelu7bP&md5=e912f256c764249ad606d83ac9c570fb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01373%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DSlack%26aufirst%3DR.%2BD.%26aulast%3DBakare%26aufirst%3DO.%2BM.%26aulast%3DBurzynski%26aufirst%3DC.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DEllenberger%26aufirst%3DM.%2BP.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DBi%26aufirst%3DG.%2BH.%26aulast%3DXi%26aufirst%3DZ.%2BH.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520and%2520high%2520affinity%25202-%255B%2528diphenylmethyl%2529sulfynil%255Dacetamide%2520%2528modafinil%2529%2520analogues%2520as%2520atypical%2520dopamine%2520transporter%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10676%26epage%3D10691%26doi%3D10.1021%2Facs.jmedchem.6b01373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murillo-Rodríguez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veras, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budde, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, S.</span></span> <span> </span><span class="NLM_article-title">An overview of the clinical uses, pharmacology, and safety of modafinil</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOns7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=151-158&issue=2&author=E.+Murillo-Rodr%C3%ADguezauthor=A.+B.+Verasauthor=N.+B.+Rochaauthor=H.+Buddeauthor=S.+Machado&title=An+overview+of+the+clinical+uses%2C+pharmacology%2C+and+safety+of+modafinil&doi=10.1021%2Facschemneuro.7b00374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil</span></div><div class="casAuthors">Murillo-Rodriguez, Eric; Barciela Veras, Andre; Barbosa Rocha, Nuno; Budde, Henning; Machado, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-158</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Modafinil (MOD) is a drug used for the management of excessive daytime sleepiness obsd. in several sleep disturbances such as shift work sleep disorder, obstructive sleep apnea, restless leg syndrome and narcolepsy.  Addnl., a wide scope of medical uses of MOD have been described such as fatigue in subjects with depression as well as patients under chemotherapy.  Moreover, there also appear to be a cognitive enhancer drug.  In contrast, recent reports have indicated the risk of developing addiction to MOD.  Furthermore, interest of studying potential long-term effects of MOD have raised.  Here, the authors highlight the evidence concerning the medical uses of MOD in the management of sleepiness, fatigue assocd. with depression and cancer as well as combat depletion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF9fHdDuinErVg90H21EOLACvtfcHk0liBvt3lMmEeVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOns7vJ&md5=22926ef163bb11f0e42dcf1d640a2154</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00374%26sid%3Dliteratum%253Aachs%26aulast%3DMurillo-Rodr%25C3%25ADguez%26aufirst%3DE.%26aulast%3DVeras%26aufirst%3DA.%2BB.%26aulast%3DRocha%26aufirst%3DN.%2BB.%26aulast%3DBudde%26aufirst%3DH.%26aulast%3DMachado%26aufirst%3DS.%26atitle%3DAn%2520overview%2520of%2520the%2520clinical%2520uses%252C%2520pharmacology%252C%2520and%2520safety%2520of%2520modafinil%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26issue%3D2%26spage%3D151%26epage%3D158%26doi%3D10.1021%2Facschemneuro.7b00374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Risi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollini, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanganelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronese, A. C.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis and biological evaluation of two modafinil analogues</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9904</span>– <span class="NLM_lpage">9910</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.bmc.2008.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=18954992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSgt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=9904-9910&issue=23&author=C.+De%0ARisiauthor=L.+Ferraroauthor=G.+P.+Polliniauthor=S.+Tanganelliauthor=F.+Valenteauthor=A.+C.+Veronese&title=Efficient+synthesis+and+biological+evaluation+of+two+modafinil+analogues&doi=10.1016%2Fj.bmc.2008.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis and biological evaluation of two modafinil analogues</span></div><div class="casAuthors">De Risi, Carmela; Ferraro, Luca; Pollini, Gian P.; Tanganelli, Sergio; Valente, Filippo; Veronese, Augusto C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9904-9910</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Non classical bioisosters of modafinil featuring interesting biol. profile have been easily produced through replacement of the sulfoxide function with a carbonyl group and modification of the carboxylic acid amide functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIeZRxMkP6rbVg90H21EOLACvtfcHk0liBvt3lMmEeVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSgt7fP&md5=b1d3ca4987f3a7b2febc08c4cfe13f6a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRisi%26aufirst%3DC.%26aulast%3DFerraro%26aufirst%3DL.%26aulast%3DPollini%26aufirst%3DG.%2BP.%26aulast%3DTanganelli%26aufirst%3DS.%26aulast%3DValente%26aufirst%3DF.%26aulast%3DVeronese%26aufirst%3DA.%2BC.%26atitle%3DEfficient%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520two%2520modafinil%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26issue%3D23%26spage%3D9904%26epage%3D9910%26doi%3D10.1016%2Fj.bmc.2008.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinges, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darwish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niebler, G. E.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss</span>. <i>Curr. Med. Res. Opin.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1185/030079906X80378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1185%2F030079906X80378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=16393442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFGqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=159-167&issue=1&author=D.+F.+Dingesauthor=S.+Aroraauthor=M.+Darwishauthor=G.+E.+Niebler&title=Pharmacodynamic+effects+on+alertness+of+single+doses+of+armodafinil+in+healthy+subjects+during+a+nocturnal+period+of+acute+sleep+loss&doi=10.1185%2F030079906X80378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss</span></div><div class="casAuthors">Dinges, David F.; Arora, Sanjay; Darwish, Mona; Niebler, Gwendolyn E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">159-167</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">To assess the pharmacodynamics of armodafinil compared with modafinil and placebo on measures of alertness in healthy volunteers undergoing sleep loss, a double-blind, active- and placebo-controlled, parallel-group study was conducted on, 107 healthy male volunteers (aged 18-40 years) randomized to receive a single oral dose of armodafinil (100, 150, 200, or 300 mg), modafinil (200 mg) or placebo administered at 19:25 h.  The primary outcome was the Maintenance of Wakefulness Test (MWT), administered every 2 h from 22:00-08:00 h.  Secondary outcomes included the Psychomotor Vigilance Task (PVT) and the Karolinska Sleepiness Scale.  Blood samples for pharmacokinetic anal. were collected hourly.  Adverse events were evaluated throughout the 2-day lab. stay and by telephone on day 9.  All four doses of armodafinil and the 200 mg dose of modafinil improved wakefulness as measured by increased MWT latencies (treatment effect, p < 0.0001) and reduced PVT lapses of attention (treatment effect, p < 0.0001).  The magnitude and duration of these effects at the later time points appeared to be dose- and concn.-dependent.  Armodafinil at 200 mg resulted in comparable Cmax, a later tmax, and higher plasma concns. 6-14 h post-drug administration than with 200 mg modafinil.  Following armodafinil, longer MWT latencies and fewer PVT lapses 6-14 h post-drug administration were obsd. compared with modafinil.  Armodafinil doses were well tolerated, with the most common adverse events including abdominal pain, nausea, and headache.  There were reports of tachycardia/palpitations.  Decreased mean sleep efficiency and increased mean blood pressure were also obsd.  Armodafinil improved alertness at all doses studied.  Relative to modafinil 200 mg, armodafinil 200 mg showed a comparable peak plasma concn. with higher concns. 6-14 h post-drug, and improved wakefulness and sustained attention for a longer time post-dose.  Both drugs were well tolerated; however, further research on the efficacy, safety, and tolerability of armodafinil in patients with disorders of excessive sleepiness (ES) is required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpVhC6ONgDNbVg90H21EOLACvtfcHk0lj9Z3op3f-eDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFGqurw%253D&md5=fbe3ad588478d7e18908649a06be3e7c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1185%2F030079906X80378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079906X80378%26sid%3Dliteratum%253Aachs%26aulast%3DDinges%26aufirst%3DD.%2BF.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DDarwish%26aufirst%3DM.%26aulast%3DNiebler%26aufirst%3DG.%2BE.%26atitle%3DPharmacodynamic%2520effects%2520on%2520alertness%2520of%2520single%2520doses%2520of%2520armodafinil%2520in%2520healthy%2520subjects%2520during%2520a%2520nocturnal%2520period%2520of%2520acute%2520sleep%2520loss%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2006%26volume%3D22%26issue%3D1%26spage%3D159%26epage%3D167%26doi%3D10.1185%2F030079906X80378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volkow, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muench, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apelskog-Torres, K.</span></span> <span> </span><span class="NLM_article-title">Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">1148</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1001/jama.2009.351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1001%2Fjama.2009.351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=19293415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVOlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2009&pages=1148-1154&author=N.+D.+Volkowauthor=J.+S.+Fowlerauthor=J.+Loganauthor=D.+Alexoffauthor=W.+Zhuauthor=F.+Telangauthor=G.+J.+Wangauthor=M.+Jayneauthor=J.+M.+Hookerauthor=C.+Wongauthor=+Hubbardauthor=P.+Carterauthor=D.+Warnerauthor=P.+Kingauthor=C.+Sheaauthor=Y.+Xuauthor=L.+Muenchauthor=K.+Apelskog-Torres&title=Effects+of+modafinil+on+dopamine+and+dopamine+transporters+in+the+male+human+brain%3A+clinical+implications&doi=10.1001%2Fjama.2009.351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of modafinil on dopamine and dopamine transporters in the male human brain. Clinical implications</span></div><div class="casAuthors">Volkow, Nora D.; Fowler, Joanna S.; Logan, Jean; Alexoff, David; Zhu, Wei; Telang, Frank; Wang, Gene-Jack; Jayne, Millard; Hooker, Jacob M.; Wong, Christopher; Hubbard, Barbara; Carter, Pauline; Warner, Donald; King, Payton; Shea, Colleen; Xu, Youwen; Muench, Lisa; Apelskog-Torres, Karen</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1148-1154</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Modafinil, a wake-promoting drug used to treat narcolepsy, is increasingly being used as a cognitive enhancer.  Although initially launched as distinct from stimulants that increase extracellular dopamine by targeting dopamine transporters, recent preclin. studies suggest otherwise.  Objective was to measure the acute effects of modafinil at doses used therapeutically (200 mg and 400 mg given orally) on extracellular dopamine and on dopamine transporters in the male human brain.  Design, Setting, and Participants Positron emission tomog. with [11C]raclopride (D2/D3 radioligand sensitive to changes in endogenous dopamine) and [11C]cocaine (dopamine transporter radioligand) was used to measure the effects of modafinil on extracellular dopamine and on dopamine transporters in 10 healthy male participants.  The study took place over an 8-mo period (2007-2008) at Brookhaven National Lab.  Main Outcome Measures Primary outcomes were changes in dopamine D2/D3 receptor and dopamine transporter availability (measured by changes in binding potential) after modafinil when compared with after placebo.  Modafinil decreased mean (SD) [11C]raclopride binding potential in caudate (6.1% [6.5%]; 95% confidence interval [CI], 1.5% to 10.8%; P =.02), putamen (6.7% [4.9%]; 95% CI, 3.2% to 10.3%; P =.002), and nucleus accumbens (19.4% [20%]; 95% CI, 5% to 35%; P =.02), reflecting increases in extracellular dopamine.  Modafinil also decreased [11C]cocaine binding potential in caudate (53.8% [13.8%]; 95% CI, 43.9% to 63.6%; P <.001), putamen (47.2% [11.4%]; 95% CI, 39.1% to 55.4%; P <.001), and nucleus accumbens (39.3% [10%]; 95% CI, 30% to 49%; P =.001), reflecting occupancy of dopamine transporters.  In this pilot study, modafinil blocked dopamine transporters and increased dopamine in the human brain (including the nucleus accumbens).  Because drugs that increase dopamine in the nucleus accumbens have the potential for abuse, and considering the increasing use of modafinil, these results highlight the need for heightened awareness for potential abuse of and dependence on modafinil in vulnerable populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2VFxKbKbpArVg90H21EOLACvtfcHk0lj9Z3op3f-eDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVOlsbY%253D&md5=a8f5a22cc75df00230c83eb666f7e9de</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1001%2Fjama.2009.351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2009.351%26sid%3Dliteratum%253Aachs%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DAlexoff%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DTelang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DJayne%26aufirst%3DM.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DC.%26aulast%3DHubbard%26aulast%3DCarter%26aufirst%3DP.%26aulast%3DWarner%26aufirst%3DD.%26aulast%3DKing%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMuench%26aufirst%3DL.%26aulast%3DApelskog-Torres%26aufirst%3DK.%26atitle%3DEffects%2520of%2520modafinil%2520on%2520dopamine%2520and%2520dopamine%2520transporters%2520in%2520the%2520male%2520human%2520brain%253A%2520clinical%2520implications%26jtitle%3DJAMA%26date%3D2009%26volume%3D301%26spage%3D1148%26epage%3D1154%26doi%3D10.1001%2Fjama.2009.351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mignot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilleminault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dement, W. C.</span></span> <span> </span><span class="NLM_article-title">Modafinil binds to the dopamine uptake carrier site with low affinity</span>. <i>Sleep</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1093/sleep/17.5.436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1093%2Fsleep%2F17.5.436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=7991954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A280%3ADyaK2M%252FosVSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1994&pages=436-437&author=E.+Mignotauthor=S.+Nishinoauthor=C.+Guilleminaultauthor=W.+C.+Dement&title=Modafinil+binds+to+the+dopamine+uptake+carrier+site+with+low+affinity&doi=10.1093%2Fsleep%2F17.5.436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil binds to the dopamine uptake carrier site with low affinity</span></div><div class="casAuthors">Mignot E; Nishino S; Guilleminault C; Dement W C</div><div class="citationInfo"><span class="NLM_cas:title">Sleep</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">436-7</span>
        ISSN:<span class="NLM_cas:issn">0161-8105</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIGv6cQ4HX-Rjv2lLSLOxFfW6udTcc2eZW1JzhtkDjALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FosVSmsA%253D%253D&md5=888ee2341f4b1a375f0ffa25f3d8523d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fsleep%2F17.5.436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fsleep%252F17.5.436%26sid%3Dliteratum%253Aachs%26aulast%3DMignot%26aufirst%3DE.%26aulast%3DNishino%26aufirst%3DS.%26aulast%3DGuilleminault%26aufirst%3DC.%26aulast%3DDement%26aufirst%3DW.%2BC.%26atitle%3DModafinil%2520binds%2520to%2520the%2520dopamine%2520uptake%2520carrier%2520site%2520with%2520low%2520affinity%26jtitle%3DSleep%26date%3D1994%26volume%3D17%26spage%3D436%26epage%3D437%26doi%3D10.1093%2Fsleep%2F17.5.436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madras, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jassen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonab, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischman, A. J.</span></span> <span> </span><span class="NLM_article-title">Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>319</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.106583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1124%2Fjpet.106.106583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=16885432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=561-569&issue=2&author=B.+K.+Madrasauthor=Z.+Xieauthor=Z.+Linauthor=A.+Jassenauthor=H.+Panasauthor=L.+Lynchauthor=R.+Johnsonauthor=E.+Livniauthor=T.+J.+Spencerauthor=A.+A.+Bonabauthor=G.+M.+Millerauthor=A.+J.+Fischman&title=Modafinil+occupies+dopamine+and+norepinephrine+transporters+in+vivo+and+modulates+the+transporters+and+trace+amine+activity+in+vitro&doi=10.1124%2Fjpet.106.106583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro</span></div><div class="casAuthors">Madras, Bertha K.; Xie, Zhihua; Lin, Zhicheng; Jassen, Amy; Panas, Helen; Lynch, Laurie; Johnson, Ryan; Livni, Eli; Spencer, Thomas J.; Bonab, Ali A.; Miller, Gregory M.; Fischman, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">561-569</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">2-[(Diphenylmethyl)sulfinyl]acetamide (modafinil), prescribed principally to treat narcolepsy, is undergoing assessment for other neuropsychiatric disorders and medical conditions.  The neurochem. substrates of modafinil are unresolved.  We postulated that modafinil enhances wakefulness by modulating dopamine (DAT), norepinephrine (NET), or serotonin (SERT) transporter activities.  In vivo, we detd. DAT and NET occupancy by modafinil by positron emission tomog. imaging; in vitro, we detd. modafinil activity at the DAT, NET, SERT, and rhesus monkey trace amine receptor 1 (TA1).  In rhesus monkey, modafinil occupancy of striatal DAT was detected by [11C]2β-carbomethoxy-3β-4-(fluorophenyl)tropane and of thalamic NET by [11C](S,S)-2-(α-(2-methoxyphenoxy)-benzyl)morpholine.  In vitro, modafinil effects in DAT-human embryonic kidney (HEK), NET-HEK, and SERT-HEK cells were investigated alone or combined with the TA1 receptor.  Modafinil (i.v.) occupied striatal DAT sites (5 mg/kg: 35±12%, n = 4; 8 mg/kg: 54±3%, n = 3).  In thalamus, modafinil occupied NET sites (5 mg/kg: 16±7.8%, n = 6; 8 mg/kg: 44±12%; n = 2).  In vitro, modafinil inhibited [3H]dopamine (IC50 = 6.4 μM), [3H]norepinephrine (IC50 = 35.6 μM), and [3H]serotonin (IC50 > 500 μM) transport via the human DAT, NET, and SERT.  Modafinil did not activate the TA1 receptor in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but not in TA1-SERT cells.  The present data provide compelling evidence that modafinil occupies the DAT and NET in living brain of rhesus monkeys and raise the possibility that modafinil affects wakefulness by interacting with catecholamine transporters in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouuXxc1kVsYbVg90H21EOLACvtfcHk0ljAVcLEhZbAIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkur3N&md5=6e0b14f53f5bb138f63f21e19e3939ac</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.106583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.106583%26sid%3Dliteratum%253Aachs%26aulast%3DMadras%26aufirst%3DB.%2BK.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DJassen%26aufirst%3DA.%26aulast%3DPanas%26aufirst%3DH.%26aulast%3DLynch%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DLivni%26aufirst%3DE.%26aulast%3DSpencer%26aufirst%3DT.%2BJ.%26aulast%3DBonab%26aufirst%3DA.%2BA.%26aulast%3DMiller%26aufirst%3DG.%2BM.%26aulast%3DFischman%26aufirst%3DA.%2BJ.%26atitle%3DModafinil%2520occupies%2520dopamine%2520and%2520norepinephrine%2520transporters%2520in%2520vivo%2520and%2520modulates%2520the%2520transporters%2520and%2520trace%2520amine%2520activity%2520in%2520vitro%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26issue%3D2%26spage%3D561%26epage%3D569%26doi%3D10.1124%2Fjpet.106.106583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zolkowska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partilla, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisinzano, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, M. H.</span></span> <span> </span><span class="NLM_article-title">Evidence for the involvement of dopamine transporters in the behavioral stimulant effects of modafinil</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">738</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.146142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1124%2Fjpet.108.146142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=19197004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1OlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=738-746&author=D.+Zolkowskaauthor=R.+Jainauthor=R.+B.+Rothmanauthor=J.+S.+Partillaauthor=B.+L.+Rothauthor=V.+Setolaauthor=T.+E.+Prisinzanoauthor=M.+H.+Baumann&title=Evidence+for+the+involvement+of+dopamine+transporters+in+the+behavioral+stimulant+effects+of+modafinil&doi=10.1124%2Fjpet.108.146142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil</span></div><div class="casAuthors">Zolkowska, Dorota; Jain, Raka; Rothman, Richard B.; Partilla, John S.; Roth, Bryan L.; Setola, Vincent; Prisinzano, Thomas E.; Baumann, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">738-746</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Modafinil is prescribed for numerous medical conditions, but the drug's mechanism of action is unclear.  Here, we examd. the interaction of modafinil with receptors and transporters in vitro and compared pharmacol. effects of the drug with those produced by indirect dopamine (DA) agonists 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) and (+)-methamphetamine (METH).  Modafinil was screened at various receptors and transporters using binding assays.  Transporter-mediated uptake and release were examd. in rat brain synaptosomes.  Effects of modafinil on motor activity and neurochem. were detd. in rats undergoing in vivo microdialysis in nucleus accumbens.  Of the receptors and transporters assayed, modafinil displayed measurable potency only at DA transporters (DAT), inhibiting [3H]DA uptake, with an IC50 value of 4.0 μM.  Accordingly, modafinil pretreatment (10 μM) antagonized METH-induced release of the DAT substrate [3H]1-methyl-4-phenylpyridinium.  I.v. modafinil (20 and 60 mg/kg) produced dose-dependent increases in motor activity and extracellular DA, without affecting serotonin (5-HT).  Analogous results were obsd. for GBR12909 (1 and 3 mg/kg), whereas METH (0.3 and 1 mg/kg) increased DA and 5-HT.  Locomotor effects of all drugs were pos. correlated with dialyzate DA (P < 0.001).  Interestingly, modafinil pretreatment reduced METH-induced ambulation and DA release.  Our data show that modafinil interacts with DAT sites in rat brain, a property shared with agonist medications under investigation for treating cocaine dependence.  Nondopaminergic mechanisms may also contribute to the pharmacol. of modafinil.  Finally, the results suggest that modafinil should be tested as an adjunct for treating METH addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhab522ik-NrVg90H21EOLACvtfcHk0ljAVcLEhZbAIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1OlsL4%253D&md5=0c5af6285ed23382c46a0d35bafbaa3b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.146142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.146142%26sid%3Dliteratum%253Aachs%26aulast%3DZolkowska%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26atitle%3DEvidence%2520for%2520the%2520involvement%2520of%2520dopamine%2520transporters%2520in%2520the%2520behavioral%2520stimulant%2520effects%2520of%2520modafinil%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D738%26epage%3D746%26doi%3D10.1124%2Fjpet.108.146142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loland, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mereu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okunola, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisinzano, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">R-Modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2012.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.biopsych.2012.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=22537794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFelt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=405-413&author=J.+C.+Lolandauthor=M.+Mereuauthor=O.+Okunolaauthor=J.+Caoauthor=T.+E.+Prisinzanoauthor=S.+Mazierauthor=T.+Kopajticauthor=L.+Shiauthor=J.+L.+Katzauthor=G.+Tandaauthor=A.+H.+Newman&title=R-Modafinil+%28armodafinil%29%3A+a+unique+dopamine+uptake+inhibitor+and+potential+medication+for+psychostimulant+abuse&doi=10.1016%2Fj.biopsych.2012.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse</span></div><div class="casAuthors">Loland, Claus J.; Mereu, Maddalena; Okunola, Oluyomi M.; Cao, Jianjing; Prisinzano, Thomas E.; Mazier, Sonia; Kopajtic, Theresa; Shi, Lei; Katz, Jonathan L.; Tanda, Gianluigi; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">405-413</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">(±)-Modafinil has piqued interest as a treatment for attention-deficit/hyperactivity disorder and stimulant dependence.  The R-enantiomer of modafinil might have unique pharmacol. properties that should be further investigated.  (±)-Modafinil and its R-(-)- and S-(+)-enantiomers were synthesized and tested for inhibition of [3H] dopamine (DA) uptake and [3H]WIN 35428 binding in human dopamine transporter (DAT) wild-type and mutants with altered conformational equil.  Data were compared with cocaine and the atypical DA uptake inhibitor, JHW 007.  R- and S-modafinil were also evaluated in microdialysis studies in the mouse nucleus accumbens shell and in a cocaine discrimination procedure.  (±)-, R-, and S-modafinil bind to the DAT and inhibit DA uptake less potently than cocaine, with R-modafinil having approx. threefold higher affinity than its S-enantiomer.  Mol. docking studies revealed subtle differences in binding modes for the enantiomers.  R-modafinil was significantly less potent in the DAT Y156F mutant compared with wild-type DAT, whereas S-modafinil was affected less.  Studies with the Y335A DAT mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than cocaine, which was further supported by [2-(trimethylammonium)ethyl]-methanethiosulfonate reactivity on the DAT E2C I159C.  Microdialysis studies demonstrated that both R- and S-modafinil produced increases in extracellular DA concns. in the nucleus accumbens shell less efficaciously than cocaine and with a longer duration of action.  Both enantiomers fully substituted in mice trained to discriminate cocaine from saline.R-modafinil displays an in vitro profile different from cocaine.  Future trials with R-modafinil as a substitute therapy with the potential benefit of cognitive enhancement for psychostimulant addiction are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjL4KiRs4PUbVg90H21EOLACvtfcHk0ljXQTkLEnDqTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFelt74%253D&md5=78808210fc68d2fbcdd97190f03b63d0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DLoland%26aufirst%3DJ.%2BC.%26aulast%3DMereu%26aufirst%3DM.%26aulast%3DOkunola%26aufirst%3DO.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DMazier%26aufirst%3DS.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DR-Modafinil%2520%2528armodafinil%2529%253A%2520a%2520unique%2520dopamine%2520uptake%2520inhibitor%2520and%2520potential%2520medication%2520for%2520psychostimulant%2520abuse%26jtitle%3DBiol.%2520Psychiatry%26date%3D2012%26volume%3D72%26spage%3D405%26epage%3D413%26doi%3D10.1016%2Fj.biopsych.2012.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattay, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stankevich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skjei, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambataro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrillaga-Romany, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callicott, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apud, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberger, D. R.</span></span> <span> </span><span class="NLM_article-title">Modulatory effects of modafinil on neural circuits regulating emotion and cognition</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2101</span>– <span class="NLM_lpage">2109</span>, <span class="refDoi"> DOI: 10.1038/npp.2010.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1038%2Fnpp.2010.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=20555311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVajs7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=2101-2109&issue=10&author=R.+Rasettiauthor=V.+S.+Mattayauthor=B.+Stankevichauthor=K.+Skjeiauthor=G.+Blasiauthor=F.+Sambataroauthor=I.+C.+Arrillaga-Romanyauthor=T.+E.+Goldbergauthor=J.+H.+Callicottauthor=J.+A.+Apudauthor=D.+R.+Weinberger&title=Modulatory+effects+of+modafinil+on+neural+circuits+regulating+emotion+and+cognition&doi=10.1038%2Fnpp.2010.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Modulatory Effects of Modafinil on Neural Circuits Regulating Emotion and Cognition</span></div><div class="casAuthors">Rasetti, Roberta; Mattay, Venkata S.; Stankevich, Beth; Skjei, Kelsey; Blasi, Giuseppe; Sambataro, Fabio; Arrillaga-Romany, Isabel C.; Goldberg, Terry E.; Callicott, Joseph H.; Apud, Jose A.; Weinberger, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2101-2109</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Modafinil differs from other arousal-enhancing agents in chem. structure, neurochem. profile, and behavioral effects.  Most functional neuroimaging studies to date examd. the effect of modafinil only on information processing underlying executive cognition, but cognitive enhancers in general have been shown to have pronounced effects on emotional behavior, too.  We examd. the effect of modafinil on neural circuits underlying affective processing and cognitive functions.  Healthy volunteers were enrolled in this double-blinded placebo-controlled trial (100 mg/day for 7 days).  They underwent BOLD fMRI while performing an emotion information-processing task that activates the amygdala and two prefrontally dependent cognitive tasks-a working memory (WM) task and a variable attentional control (VAC) task.  A clin. assessment that included measurement of blood pressure, heart rate, the Hamilton anxiety scale, and the profile of mood state (POMS) questionnaire was also performed on each test day.  BOLD fMRI revealed significantly decreased amygdala reactivity to fearful stimuli on modafinil compared with the placebo condition.  During executive cognition tasks, a WM task and a VAC task, modafinil reduced BOLD signal in the prefrontal cortex and anterior cingulate.  Although not statistically significant, there were trends for reduced anxiety, for decreased fatigue-inertia and increased vigor-activity, as well as decreased anger-hostility on modafinil.  Modafinil in low doses has a unique physiol. profile compared with stimulant drugs: it enhances the efficiency of prefrontal cortical cognitive information processing, while dampening reactivity to threatening stimuli in the amygdala, a brain region implicated in anxiety.  Neuropsychopharmacol. (2010) 35, 2101-2109; doi:10.1038/npp.2010.83; published online 16 June 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS8KusPPpSpLVg90H21EOLACvtfcHk0ljXQTkLEnDqTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVajs7nM&md5=858c640f72c28500903e23ec8691c32e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2010.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2010.83%26sid%3Dliteratum%253Aachs%26aulast%3DRasetti%26aufirst%3DR.%26aulast%3DMattay%26aufirst%3DV.%2BS.%26aulast%3DStankevich%26aufirst%3DB.%26aulast%3DSkjei%26aufirst%3DK.%26aulast%3DBlasi%26aufirst%3DG.%26aulast%3DSambataro%26aufirst%3DF.%26aulast%3DArrillaga-Romany%26aufirst%3DI.%2BC.%26aulast%3DGoldberg%26aufirst%3DT.%2BE.%26aulast%3DCallicott%26aufirst%3DJ.%2BH.%26aulast%3DApud%26aufirst%3DJ.%2BA.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DModulatory%2520effects%2520of%2520modafinil%2520on%2520neural%2520circuits%2520regulating%2520emotion%2520and%2520cognition%26jtitle%3DNeuropsychopharmacology%26date%3D2010%26volume%3D35%26issue%3D10%26spage%3D2101%26epage%3D2109%26doi%3D10.1038%2Fnpp.2010.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gervasoni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanni-Mercier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frydman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouvet, M.</span></span> <span> </span><span class="NLM_article-title">Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat</span>. <i>Journal of Sleep Research</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2869.2000.00181.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1046%2Fj.1365-2869.2000.00181.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10733694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A280%3ADC%252BD3c7pvVGisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=89-96&issue=1&author=J.+S.+Linauthor=D.+Gervasoniauthor=Y.+Houauthor=G.+Vanni-Mercierauthor=F.+Rambertauthor=A.+Frydmanauthor=M.+Jouvet&title=Effects+of+amphetamine+and+modafinil+on+the+sleep%2Fwake+cycle+during+experimental+hypersomnia+induced+by+sleep+deprivation+in+the+cat&doi=10.1046%2Fj.1365-2869.2000.00181.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat</span></div><div class="casAuthors">Lin J S; Gervasoni D; Hou Y; Vanni-Mercier G; Rambert F; Frydman A; Jouvet M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of sleep research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-96</span>
        ISSN:<span class="NLM_cas:issn">0962-1105</span>.
    </div><div class="casAbstract">Modafinil is a newly discovered waking substance now being used in the treatment of hypersomnia and narcolepsy.  We have shown previously in the cat that, unlike amphetamine, modafinil induces long-lasting wakefulness (W) without behavioral excitation and subsequent sleep rebound, and that its waking effect does not depend on endogenous catecholamines.  To further characterize the awakening properties of modafinil and current psychostimulants in experimental models of hypersomnia, we examined the effect of oral administration of placebo, modafinil (5 mg kg-1) or amphetamine (1 mg kg-1) on the sleep/wake cycle and power spectral density (PSD) in cats after an 18-h water-tank sleep deprivation period.  We found that the placebo had no effect on the dynamics of sleep recovery, while both modafinil and amphetamine induced suppression of cortical slow activity and a waking state lasting 6-8 h.  After the amphetamine-induced waking period, both deep slow wave sleep (SWS2) and paradoxical sleep (PS) occurred in greater amounts than after placebo and the PSD during SWS was also increased.  Thus, the cumulative time spent in W during a 48-h period was similar to that with placebo, indicating enhanced sleep rebound.  In contrast, after the modafinil-induced W, the occurrence and evolution of SWS2 or PS, as well as the PSD during SWS, were similar to those seen with placebo during the same period, so that the total time spent in W in a 48-h period remained significantly higher than the control level, indicating no additional sleep rebound.  These results indicate that modafinil is effective against somnolence and hypersomnia and does not produce a subsequent increase in sleep and suggest that the pharmacological profile of modafinil is different from that of amphetamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREVEdoXPjOmSEJCPKhJPuqfW6udTcc2eZTP03KFdaHWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7pvVGisQ%253D%253D&md5=a4cbd00ad9ad933bd9fbbef887a23861</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2869.2000.00181.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2869.2000.00181.x%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BS.%26aulast%3DGervasoni%26aufirst%3DD.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DVanni-Mercier%26aufirst%3DG.%26aulast%3DRambert%26aufirst%3DF.%26aulast%3DFrydman%26aufirst%3DA.%26aulast%3DJouvet%26aufirst%3DM.%26atitle%3DEffects%2520of%2520amphetamine%2520and%2520modafinil%2520on%2520the%2520sleep%252Fwake%2520cycle%2520during%2520experimental%2520hypersomnia%2520induced%2520by%2520sleep%2520deprivation%2520in%2520the%2520cat%26jtitle%3DJournal%2520of%2520Sleep%2520Research%26date%3D2000%26volume%3D9%26issue%3D1%26spage%3D89%26epage%3D96%26doi%3D10.1046%2Fj.1365-2869.2000.00181.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span> <span> </span><span class="NLM_article-title">Practical use and risk of modafinil, a novel waking drug</span>. <i>Environ. Health Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">e2012007</span>, <span class="refDoi"> DOI: 10.5620/eht.2012.27.e2012007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.5620%2Feht.2012.27.e2012007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=22375280" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=e2012007&author=D.+Kim&title=Practical+use+and+risk+of+modafinil%2C+a+novel+waking+drug&doi=10.5620%2Feht.2012.27.e2012007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.5620%2Feht.2012.27.e2012007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5620%252Feht.2012.27.e2012007%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26atitle%3DPractical%2520use%2520and%2520risk%2520of%2520modafinil%252C%2520a%2520novel%2520waking%2520drug%26jtitle%3DEnviron.%2520Health%2520Toxicol.%26date%3D2012%26volume%3D27%26spage%3De2012007%26doi%3D10.5620%2Feht.2012.27.e2012007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avelar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckstead, M. J.</span></span> <span> </span><span class="NLM_article-title">Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.neuropharm.2017.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=28625719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2017&pages=410-419&author=A.+J.+Avelarauthor=J.+Caoauthor=A.+H.+Newmanauthor=M.+J.+Beckstead&title=Atypical+dopamine+transporter+inhibitors+R-modafinil+and+JHW+007+differentially+affect+D2+autoreceptor+neurotransmission+and+the+firing+rate+of+midbrain+dopamine+neurons&doi=10.1016%2Fj.neuropharm.2017.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons</span></div><div class="casAuthors">Avelar, Alicia J.; Cao, Jianjing; Newman, Amy Hauck; Beckstead, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">410-419</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Abuse of psychostimulants like cocaine that inhibit dopamine (DA) reuptake through the dopamine transporter (DAT) represents a major public health issue, however FDA-approved pharmacotherapies have yet to be developed.  Recently a class of ligands termed "atypical DAT inhibitors" has gained attention due to their range of effectiveness in increasing extracellular DA levels without demonstrating significant abuse liability.  These compds. not only hold promise as therapeutic agents to treat stimulant use disorders but also as exptl. tools to improve our understanding of DAT function.  Here we used patch clamp electrophysiol. in mouse brain slices to explore the effects of two atypical DAT inhibitors (R-modafinil and JHW 007) on the physiol. of single DA neurons in the substantia nigra and ventral tegmental area.  Despite their commonalities of being DAT inhibitors that lack cocaine-like behavioral profiles, these compds. exhibited surprisingly divergent cellular effects.  Similar to cocaine, R-modafinil slowed DA neuron firing in a D2 receptor-dependent manner and rapidly enhanced the amplitude and duration of D2 receptor-mediated currents in the midbrain.  In contrast, JHW 007 exhibited little effect on firing, slow DAT blockade, and an unexpected inhibition of D2 receptor-mediated currents that may be due to direct D2 receptor antagonism.  Furthermore, pretreatment with JHW 007 blunted the cellular effects of cocaine, suggesting that it may be valuable to investigate similar DAT inhibitors as potential therapeutic agents.  Further exploration of these and other atypical DAT inhibitors may reveal important cellular effects of compds. that will have potential as pharmacotherapies for treating cocaine use disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozyn-HOG4w-rVg90H21EOLACvtfcHk0lgWb_b0B142pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt7zN&md5=6001c7f27aa797f25eae9fe3ee9884a7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DAvelar%26aufirst%3DA.%2BJ.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBeckstead%26aufirst%3DM.%2BJ.%26atitle%3DAtypical%2520dopamine%2520transporter%2520inhibitors%2520R-modafinil%2520and%2520JHW%2520007%2520differentially%2520affect%2520D2%2520autoreceptor%2520neurotransmission%2520and%2520the%2520firing%2520rate%2520of%2520midbrain%2520dopamine%2520neurons%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D123%26spage%3D410%26epage%3D419%26doi%3D10.1016%2Fj.neuropharm.2017.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisinzano, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okunola, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">SARs at the monoamine transporters for a novel series of modafinil analogues</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1021/ml1002025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1002025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12lt7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=48-52&author=J.+Caoauthor=T.+E.+Prisinzanoauthor=O.+M.+Okunolaauthor=T.+Kopajticauthor=M.+Shookauthor=J.+L.+Katzauthor=A.+H.+Newman&title=SARs+at+the+monoamine+transporters+for+a+novel+series+of+modafinil+analogues&doi=10.1021%2Fml1002025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">SARs at the Monoamine Transporters for a Novel Series of Modafinil Analogues</span></div><div class="casAuthors">Cao, Jianjing; Prisinzano, Thomas E.; Okunola, Oluyomi M.; Kopajtic, Theresa; Shook, Matthew; Katz, Jonathan L.; Hauck Newman, Amy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-52</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of modafinil (1) analogs were synthesized wherein (1) para-halo-substitutents were added to the aryl rings, (2) the sulfoxide function was removed, and (3) the primary amide group was replaced with secondary and tertiary amides and amines to investigate the effects of these chem. modifications on dopamine transporter, serotonin transporter, and norepinephrine transporter binding.  In addn., the locomotor-stimulant effects in mice of (±)-modafinil (1) (I), its R- and S-enantiomers, and its para-chloro sulfinylacetamide analog (5c) (II) were compared to those of cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDr9ac-J7nqbVg90H21EOLACvtfcHk0lgWb_b0B142pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12lt7bN&md5=660e546e8524b2e5e8b448ee5bf0e567</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml1002025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002025%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DOkunola%26aufirst%3DO.%2BM.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DShook%26aufirst%3DM.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DSARs%2520at%2520the%2520monoamine%2520transporters%2520for%2520a%2520novel%2520series%2520of%2520modafinil%2520analogues%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D48%26epage%3D52%26doi%3D10.1021%2Fml1002025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okunola-Bakare, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loland, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)- sulfynil]acetamide (modafinil) analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.1021/jm401754x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401754x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1000-1013&author=O.+M.+Okunola-Bakareauthor=J.+Caoauthor=T.+Kopajticauthor=L.+J.+Katzauthor=C.+J.+Lolandauthor=L.+Shiauthor=A.+H.+Newman&title=Elucidation+of+structural+elements+for+selectivity+across+monoamine+transporters%3A+novel+2-%5B%28diphenylmethyl%29-+sulfynil%5Dacetamide+%28modafinil%29+analogues&doi=10.1021%2Fjm401754x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of Structural Elements for Selectivity across Monoamine Transporters: Novel 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues</span></div><div class="casAuthors">Okunola-Bakare, Oluyomi M.; Cao, Jianjing; Kopajtic, Theresa; Katz, Jonathan L.; Loland, Claus J.; Shi, Lei; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1000-1013</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-[(Diphenylmethyl)sulfinyl]acetamide (modafinil, (±)-1) is a unique dopamine uptake inhibitor that binds the dopamine transporter (DAT) differently than cocaine and may have potential for the treatment of psychostimulant abuse.  To further investigate structural requirements for this divergent binding mode, novel thio- and sulfinylacetamide and ethanamine analogs of (±)-1 were synthesized wherein (1) the di-Ph rings were substituted with Me, trifluoromethyl, and halogen substituents and (2) substituents were added to the terminal amide/amine nitrogen.  Halogen substitution of the di-Ph rings of (±)-1 gave several amide analogs with improved binding affinity for DAT and robust selectivity over the serotonin transporter (SERT), whereas affinity improved at SERT over DAT for the p-halo-substituted amine analogs.  Mol. docking studies, using a subset of analogs with DAT and SERT homol. models, and functional data obtained with DAT (A480T) and SERT (T497A) mutants defined a role for TM10 in the substrate/inhibitor S1 binding sites of DAT and SERT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjxRhiOBM-ErVg90H21EOLACvtfcHk0liXl-8G6giXEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyhtrY%253D&md5=8c9679d83c0101e335bd59867b0c2863</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm401754x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401754x%26sid%3Dliteratum%253Aachs%26aulast%3DOkunola-Bakare%26aufirst%3DO.%2BM.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DL.%2BJ.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DElucidation%2520of%2520structural%2520elements%2520for%2520selectivity%2520across%2520monoamine%2520transporters%253A%2520novel%25202-%255B%2528diphenylmethyl%2529-%2520sulfynil%255Dacetamide%2520%2528modafinil%2529%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1000%26epage%3D1013%26doi%3D10.1021%2Fjm401754x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span> <span> </span><span class="NLM_article-title">Simple synthesis of modafinil derivatives and their anti-inflammatory activity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">10446</span>– <span class="NLM_lpage">10458</span>, <span class="refDoi"> DOI: 10.3390/molecules170910446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3390%2Fmolecules170910446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=22945025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlartrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=10446-10458&issue=12&author=J.-C.+Jungauthor=Y.+Leeauthor=J.-Y.+Sonauthor=E.+Limauthor=M.+Jungauthor=S.+Oh&title=Simple+synthesis+of+modafinil+derivatives+and+their+anti-inflammatory+activity&doi=10.3390%2Fmolecules170910446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Simple synthesis of modafinil derivatives and their antiinflammatory activity</span></div><div class="casAuthors">Jung, Jae-Chul; Lee, Yeonju; Son, Jee-Young; Lim, Eunyoung; Jung, Mankil; Oh, Seikwan</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10446-10458</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Simple synthesis of modafinil derivs. [2-[(diphenylmethyl)sulfinyl]acetamide derivs. and analogs] and their biol. activity are described.  The key synthetic strategies involve substitution and coupling reactions.  The authors detd. the antiinflammatory effects of modafinil derivs. in cultured BV2 cells by measuring the inhibition of nitrite prodn. and expression of iNOS (nitric oxide synthase-2) and COX-2 (prostaglandin endoperoxide synthase-2) after LPS stimulation.  It was found that for sulfide analogs introduction of aliph. groups on the amide part resulted in lower antiinflammatory activity compared with cyclic or arom. moieties.  However, for the sulfoxide analogs, introduction of aliph. moieties showed higher antiinflammatory activity than cyclic or arom. fragments in BV-2 microglia cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8z_enCxo33rVg90H21EOLACvtfcHk0liXl-8G6giXEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlartrnL&md5=204969ba0e0e91784aa49e1bec4c6b94</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3390%2Fmolecules170910446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules170910446%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DJ.-C.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DSon%26aufirst%3DJ.-Y.%26aulast%3DLim%26aufirst%3DE.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DOh%26aufirst%3DS.%26atitle%3DSimple%2520synthesis%2520of%2520modafinil%2520derivatives%2520and%2520their%2520anti-inflammatory%2520activity%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26issue%3D12%26spage%3D10446%26epage%3D10458%26doi%3D10.3390%2Fmolecules170910446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakulev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beryozkina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dianova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berseneva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slepukhin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of N-sulfonylamidines of modafinic acid</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">07</span>),  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1054</span>, <span class="refDoi"> DOI: 10.1055/s-0035-1561350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1055%2Fs-0035-1561350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=1046-1054&issue=07&author=V.+Bakulevauthor=G.+Lubecauthor=T.+Beryozkinaauthor=L.+Dianovaauthor=V.+Bersenevaauthor=P.+Slepukhinauthor=J.+Lebanauthor=P.+Kalabaauthor=N.+Aherauthor=M.+Ilicauthor=H.+Sitte&title=Design+and+synthesis+of+N-sulfonylamidines+of+modafinic+acid&doi=10.1055%2Fs-0035-1561350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of N-Sulfonylamidines of Modafinic Acid</span></div><div class="casAuthors">Beryozkina, Tetyana; Bakulev, Vasiliy; Dianova, Lidia; Berseneva, Vera; Slepukhin, Pavel; Leban, Johann; Kalaba, Predrag; Aher, Nilima Yogesh; Ilic, Marija; Sitte, Harald H.; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1046-1054</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">1437-210X</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A design and a convenient approach for the synthesis of novel N-sulfonyl-2-diphenylmethylsulfinylacetamidines have been demonstrated by starting from benzhydrylsulfanylacetic (BSA) acid.  This approach involves a sequential amidation with amines, thionation with Lawesson's reagent, iminosulfonylation with sulfonyl azides, and oxidn. of sulfide fragment with hydrogen peroxide.  The key step of this transformation (reaction of thioamides with sulfonyl azides) was carried out either in ethanol or in the absence of any solvent.  The synthesized compds. were tested in cells for inhibition of dopamine transporter.  Among the synthesized compds., two products were found to be in a similar range of activity as the well-known dopamine transporter inhibitor, modafinil.  The synthesis of the target compds. was achieved using 2-[(diphenylmethyl)thio]-1-(4-morpholinyl)ethanone, 2-[(diphenylmethyl)thio]-1-(1-piperidinyl)ethanone, 2-[(diphenylmethyl)thio]acetamide and azides such as methanesulfonyl azide, 4-(methyl)benzenesulfonyl azide, 2,1,3-benzothiadiazole-4-sulfonyl azide as starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj5VNJAJTPSLVg90H21EOLACvtfcHk0liXl-8G6giXEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWisbk%253D&md5=1877d91dd3650ad251ac1c7537bea624</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1055%2Fs-0035-1561350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0035-1561350%26sid%3Dliteratum%253Aachs%26aulast%3DBakulev%26aufirst%3DV.%26aulast%3DLubec%26aufirst%3DG.%26aulast%3DBeryozkina%26aufirst%3DT.%26aulast%3DDianova%26aufirst%3DL.%26aulast%3DBerseneva%26aufirst%3DV.%26aulast%3DSlepukhin%26aufirst%3DP.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DAher%26aufirst%3DN.%26aulast%3DIlic%26aufirst%3DM.%26aulast%3DSitte%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520N-sulfonylamidines%2520of%2520modafinic%2520acid%26jtitle%3DSynthesis%26date%3D2016%26volume%3D48%26issue%3D07%26spage%3D1046%26epage%3D1054%26doi%3D10.1055%2Fs-0035-1561350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Z.-X.</span></span> <span> </span><span class="NLM_article-title">The novel modafinil analog, JJC8-016, as a potential cocaine abuse pharmacotherapeutic</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1871</span>– <span class="NLM_lpage">1883</span>, <span class="refDoi"> DOI: 10.1038/npp.2017.41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1038%2Fnpp.2017.41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=28266501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt1Srtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=1871-1883&issue=9&author=H.-Y.+Zhangauthor=G.-H.+Biauthor=H.-J.+Yangauthor=Y.+Heauthor=G.+Xueauthor=J.+Caoauthor=G.+Tandaauthor=E.+L.+Gardnerauthor=A.+H.+Newmanauthor=Z.-X.+Xi&title=The+novel+modafinil+analog%2C+JJC8-016%2C+as+a+potential+cocaine+abuse+pharmacotherapeutic&doi=10.1038%2Fnpp.2017.41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic</span></div><div class="casAuthors">Zhang, Hai-Ying; Bi, Guo-Hua; Yang, Hong-Ju; He, Yi; Xue, Gilbert; Cao, Jiajing; Tanda, Gianluigi; Gardner, Eliot L.; Newman, Amy Hauck; Xi, Zheng-Xiong</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1871-1883</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">(±)Modafinil ((±)MOD) and its R-enantiomer (R-modafinil; R-MOD) have been investigated for their potential as treatments for psychostimulant addiction.  We recently reported a series of (±)MOD analogs, of which JJC8-016 (N-(2-((bis(4-fluorophenyl)methyl)thio)ethyl)-3-phenylpropan-1-amine) was selected for further development.  JJC8-016 and R-MOD were evaluated for binding across ∼70 receptors, transporters, and enzymes.  Although at a concn. of 10 μM, there were many hits for JJC8-016, binding affinities in the range of its DAT affinity were only obsd. at the serotonin transporter (SERT), dopamine D2-like, and sigma1 receptors.  R-MOD was more selective, but had much lower affinity at the DAT (Ki=3 μM) than JJC8-016 (Ki=116 nM).  In rats, systemic administration of R-MOD alone (10-30 mg/kg i.p.) dose-dependently increased locomotor activity and elec. brain-stimulation reward, whereas JJC8-016 (10-30 mg/kg i.p.) did not produce these effects.  Strikingly, pretreatment with JJC8-016 dose-dependently inhibited cocaine-enhanced locomotion, cocaine self-administration, and cocaine-induced reinstatement of drug-seeking behavior, whereas R-MOD inhibited cocaine-induced reinstatement only at the high dose of 100 mg/kg.  Notably, JJC8-016 alone neither altered extracellular dopamine in the nucleus accumbens nor maintained self-administration.  It also failed to induce reinstatement of drug-seeking behavior.  These findings suggest that JJC8-016 is a unique DAT inhibitor that has no cocaine-like abuse potential by itself.  Moreover, pretreatment with JJC8-016 significantly inhibits cocaine-taking and cocaine-seeking behavior likely by interfering with cocaine binding to DAT.  In addn., off-target actions may also contribute to its potential therapeutic utility in the treatment of cocaine abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobJMW--ayf-bVg90H21EOLACvtfcHk0lhTXRVZ6zmTMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt1Srtbo%253D&md5=339baa4c98b255f923fb2e5cb0c22cda</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2017.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2017.41%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Y.%26aulast%3DBi%26aufirst%3DG.-H.%26aulast%3DYang%26aufirst%3DH.-J.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DG.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DXi%26aufirst%3DZ.-X.%26atitle%3DThe%2520novel%2520modafinil%2520analog%252C%2520JJC8-016%252C%2520as%2520a%2520potential%2520cocaine%2520abuse%2520pharmacotherapeutic%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26issue%3D9%26spage%3D1871%26epage%3D1883%26doi%3D10.1038%2Fnpp.2017.41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keighron, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quarterman, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarco, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coggiano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleaves, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanettini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanda, G.</span></span> <span> </span><span class="NLM_article-title">Effects of (R)-modafinil and modafinil analogues on dopamine dynamics assessed by voltammetry and microdialysis in the mouse nucleus accumbens Shell</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2012</span>– <span class="NLM_lpage">2021</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00340</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00340" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVahtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2012-2021&issue=4&author=J.+D.+Keighronauthor=J.+C.+Quartermanauthor=J.+Caoauthor=E.+M.+Demarcoauthor=M.+A.+Coggianoauthor=A.+Gleavesauthor=R.+D.+Slackauthor=C.+Zanettiniauthor=A.+H.+Newmanauthor=G.+Tanda&title=Effects+of+%28R%29-modafinil+and+modafinil+analogues+on+dopamine+dynamics+assessed+by+voltammetry+and+microdialysis+in+the+mouse+nucleus+accumbens+Shell&doi=10.1021%2Facschemneuro.8b00340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of (R)-Modafinil and Modafinil Analogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell</span></div><div class="casAuthors">Keighron, Jacqueline D.; Quarterman, Juliana C.; Cao, Jianjing; De Marco, Emily M.; Coggiano, Mark A.; Gleaves, Apre; Slack, Rachel D.; Zanettini, Claudio; Newman, Amy Hauck; Tanda, Gianluigi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2012-2021</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent discoveries have improved our understanding of the physiol. and pathol. roles of the dopamine transporter (DAT); however, only a few drugs are clin. available for DAT-implicated disorders.  Among those drugs, modafinil (MOD) and its (R)-enantiomer (R-MOD) have been used off-label as therapies for psychostimulant use disorders, but they have shown limited effectiveness in clin. trials.  Recent preclin. studies on MOD and R-MOD have led to chem. modified structures aimed toward improving their neurobiol. properties that might lead to more effective therapeutics for stimulant use disorders.  This study examines three MOD analogs (JJC8-016, JJC8-088, and JJC8-091) with improved DAT affinities compared to their parent compd.  These compds. were investigated for their effects on the neurochem. (brain microdialysis and FSCV) and behavior (ambulatory activity) of male Swiss-Webster mice.  Our data indicate that these compds. have dissimilar effects on tonic and phasic dopamine in the nucleus accumbens shell and variability in producing ambulatory activity.  These results suggest that small changes in the chem. structure of a DAT inhibitor can cause compds. such as JJC8-088 to produce effects similar to abused psychostimulants like cocaine.  In contrast, other compds. like JJC8-091 do not share cocaine-like effects and have a more atypical DAT-inhibitor profile, which may prove to be an advancement in the treatment of psychostimulant use disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsciN_K_fZLVg90H21EOLACvtfcHk0lhTXRVZ6zmTMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVahtbw%253D&md5=8cf600df118f6a21c423e3b275007977</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00340%26sid%3Dliteratum%253Aachs%26aulast%3DKeighron%26aufirst%3DJ.%2BD.%26aulast%3DQuarterman%26aufirst%3DJ.%2BC.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDemarco%26aufirst%3DE.%2BM.%26aulast%3DCoggiano%26aufirst%3DM.%2BA.%26aulast%3DGleaves%26aufirst%3DA.%26aulast%3DSlack%26aufirst%3DR.%2BD.%26aulast%3DZanettini%26aufirst%3DC.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DTanda%26aufirst%3DG.%26atitle%3DEffects%2520of%2520%2528R%2529-modafinil%2520and%2520modafinil%2520analogues%2520on%2520dopamine%2520dynamics%2520assessed%2520by%2520voltammetry%2520and%2520microdialysis%2520in%2520the%2520mouse%2520nucleus%2520accumbens%2520Shell%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26issue%3D4%26spage%3D2012%26epage%3D2021%26doi%3D10.1021%2Facschemneuro.8b00340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aradska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feyissa, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragacevic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marouf, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span> <span> </span><span class="NLM_article-title">R-Modafinil exerts weak effects on spatial memory acquisition and dentate gyrus synaptic plasticity</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0179675</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0179675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1371%2Fjournal.pone.0179675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=28644892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisV2gtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0179675&author=B.+Shanmugasundaramauthor=Y.+D.+Aherauthor=J.+Aradskaauthor=M.+Ilicauthor=D.+D.+Feyissaauthor=P.+Kalabaauthor=N.+Y.+Aherauthor=V.+Dragacevicauthor=B.+S.+Maroufauthor=T.+Langerauthor=H.+H.+Sitteauthor=H.+Hoegerauthor=G.+Lubecauthor=V.+Korz&title=R-Modafinil+exerts+weak+effects+on+spatial+memory+acquisition+and+dentate+gyrus+synaptic+plasticity&doi=10.1371%2Fjournal.pone.0179675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">R-Modafinil exerts weak effects on spatial memory acquisition and dentate gyrus synaptic plasticity</span></div><div class="casAuthors">Shanmugasundaram, Bharanidharan; Aher, Yogesh D.; Aradska, Jana; Ilic, Marija; Feyissa, Daniel Daba; Kalaba, Predrag; Aher, Nilima Y.; Dragacevic, Vladimir; Marouf, Babak Saber; Langer, Thierry; Sitte, Harald H.; Hoeger, Harald; Lubec, Gert; Korz, Volker</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0179675/1-e0179675/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Modafinil is a wake promoting drug approved for clin. use and also has cognitive enhancing properties.  Its enantiomer R-Modafinil (R-MO) is not well studied in regard to cognitive enhancing properties.  Hence we studied its effect in a spatial memory paradigm and its possible effects on dentate gyrus long-term potentiation (DG-LTP).  Clin. relevant doses of R-MO, vehicle DMSO (DMSO) or saline were administered for three days during the hole-board test and in in vivo DG-LTP.  Synaptic levels of dopamine receptors D1R, D2R, dopamine transporter (DAT), and its phosphorylated form (ph-DAT) in DG tissue 4 h after LTP induction were quantified by western blot anal.  Monoamine reuptake and release assays were performed by using transfected HEK-293 cells.  Possible neurotoxic side effects on general behavior were also studied.  R-MO at both doses significantly enhanced spatial ref. memory during the last training session and during memory retrieval compared to DMSO vehicle but not when compared to saline treated rats.  Similarly, R-MO rescues DG-LTP from impairing effects of DMSO.  DMSO reduced memory performance and LTP magnitude when compared to saline treated groups.  The synaptic DR1 levels in R-MO groups were significantly decreased compared to DMSO group but were comparable with saline treated animals.  We found no effect of R-MO in neurotoxicity tests.  Thus, our results support the notion that LTP-like synaptic plasticity processes could be one of the factors contributing to the cognitive enhancing effects of spatial memory traces.  D1R may play an important regulatory role in these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBbnui-VBCzrVg90H21EOLACvtfcHk0lhTXRVZ6zmTMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisV2gtr8%253D&md5=f0399efa474641c52ee9d53cab5e45b7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0179675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0179675%26sid%3Dliteratum%253Aachs%26aulast%3DShanmugasundaram%26aufirst%3DB.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DAradska%26aufirst%3DJ.%26aulast%3DIlic%26aufirst%3DM.%26aulast%3DFeyissa%26aufirst%3DD.%2BD.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DDragacevic%26aufirst%3DV.%26aulast%3DMarouf%26aufirst%3DB.%2BS.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DHoeger%26aufirst%3DH.%26aulast%3DLubec%26aufirst%3DG.%26aulast%3DKorz%26aufirst%3DV.%26atitle%3DR-Modafinil%2520exerts%2520weak%2520effects%2520on%2520spatial%2520memory%2520acquisition%2520and%2520dentate%2520gyrus%2520synaptic%2520plasticity%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0179675%26doi%3D10.1371%2Fjournal.pone.0179675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bezu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span> <span> </span><span class="NLM_article-title">Repeated application of modafinil and levodopa reveals a drug-independent precise timing of spatial working memory modulation</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>312</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2016.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.bbr.2016.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=27268456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtValtrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2016&pages=9-13&author=M.+Bezuauthor=B.+Shanmugasundaramauthor=G.+Lubecauthor=V.+Korz&title=Repeated+application+of+modafinil+and+levodopa+reveals+a+drug-independent+precise+timing+of+spatial+working+memory+modulation&doi=10.1016%2Fj.bbr.2016.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated application of Modafinil and Levodopa reveals a drug-independent precise timing of spatial working memory modulation</span></div><div class="casAuthors">Bezu, M.; Shanmugasundaram, B.; Lubec, G.; Korz, V.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-13</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cognition enhancing drugs often target the dopaminergic system, which is involved in learning and memory, including working memory that in turn involves mainly the prefrontal cortex and the hippocampus.  In most animal models for modulations of working memory animals are pre-trained to a certain criterion and treated then acutely to test drugs effects on working memory.  Thus, little is known regarding subchronic or chronic application of cognition enhancing drugs and working memory performance.  Therefore we trained male rats over six days in a rewarded alternation test in a T-maze.  Rats received daily injections of either modafinil or Levodopa (L-Dopa) at a lower and a higher dose 30 min before training.  Levodopa but not modafinil increased working memory performance during early training significantly at day 3 when compared to vehicle controls.  Both drugs induced dose dependent differences in working memory with significantly better performance at low doses compared to high doses for modafinil, in contrast to L-Dopa where high dose treated rats performed better than low dose rats.  Strikingly, these effects appeared only at day 3 for both drugs, followed by a decline in behavioral performance.  Thus, a crit. drug independent time window for dopaminergic effects upon working memory could be revealed.  Evaluating the underlying mechanisms contributes to the understanding of temporal effects of dopamine on working memory performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6BSOLNYyEKrVg90H21EOLACvtfcHk0lheKd9iLzmuUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtValtrnE&md5=eca24c3926a92c70f92d76dbd49001d5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DBezu%26aufirst%3DM.%26aulast%3DShanmugasundaram%26aufirst%3DB.%26aulast%3DLubec%26aufirst%3DG.%26aulast%3DKorz%26aufirst%3DV.%26atitle%3DRepeated%2520application%2520of%2520modafinil%2520and%2520levodopa%2520reveals%2520a%2520drug-independent%2520precise%2520timing%2520of%2520spatial%2520working%2520memory%2520modulation%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D312%26spage%3D9%26epage%3D13%26doi%3D10.1016%2Fj.bbr.2016.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fendt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">Differential effects of wake promoting drug modafinil in aversive learning paradigms</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">220</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2015.00220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3389%2Ffnbeh.2015.00220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=26347629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFertb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=220&author=B.+Shanmugasundaramauthor=V.+Korzauthor=M.+Fendtauthor=K.+Braunauthor=G.+Lubec&title=Differential+effects+of+wake+promoting+drug+modafinil+in+aversive+learning+paradigms&doi=10.3389%2Ffnbeh.2015.00220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of wake promoting drug modafinil in aversive learning paradigms</span></div><div class="casAuthors">Shanmugasundaram, Bharanidharan; Korz, Volker; Fendt, Markus; Braun, Katharina; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">220/1-220/9</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Modafinil (MO) an inhibitor of the dopamine transporter was initially approved to treat narcolepsy, a sleep related disorder in humans.  One interesting "side-effect" of this drug, which emerged from preclin. and clin. studies, is the facilitation of cognitive performance.  So far, this was primarily shown in appetitive learning paradigms, but it is yet unclear whether MO exerts a more general cognitive enhancement effect.  Thus, the aim of the present study in rats was to extend these findings by testing the effects of MO in two aversive paradigms, Pavlovian fear conditioning (FC) and the operant two-way active avoidance (TWA) learning paradigms.  We discovered a differential, task-dependent effect of MO.  In the FC paradigm MO treated rats showed a dose-dependent enhancement of fear memory compared to vehicle treated rats, indicated by increased context-related freezing.  Cue related fear memory remained unaffected.  In the TWA paradigm MO induced a significant decrease of avoidance responses compared to vehicle treated animals, while the no. of escape reactions during the acquisition of the TWA task remained unaffected.  These findings expand the knowledge in the regulation of cognitive abilities and may contribute to the understanding of the contraindicative effects of MO in anxiety related mental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYA48t_-iWWbVg90H21EOLACvtfcHk0lheKd9iLzmuUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFertb0%253D&md5=3602b1538478316b972300d595376c1d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2015.00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2015.00220%26sid%3Dliteratum%253Aachs%26aulast%3DShanmugasundaram%26aufirst%3DB.%26aulast%3DKorz%26aufirst%3DV.%26aulast%3DFendt%26aufirst%3DM.%26aulast%3DBraun%26aufirst%3DK.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DDifferential%2520effects%2520of%2520wake%2520promoting%2520drug%2520modafinil%2520in%2520aversive%2520learning%2520paradigms%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D220%26doi%3D10.3389%2Ffnbeh.2015.00220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karabacak, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saroja, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicvaric, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakulev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monje, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">The effect of modafinil on the rat dopamine transporter and dopamine receptors D1–D3 paralleling cognitive enhancement in the radial arm maze</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">215</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2015.00215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3389%2Ffnbeh.2015.00215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=26347626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFertro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=215&author=Y.+Karabacakauthor=S.+Saseauthor=Y.+D.+Aherauthor=A.+Saseauthor=S.+R.+Sarojaauthor=A.+Cicvaricauthor=H.+H%C3%B6gerauthor=M.+Bergerauthor=V.+Bakulevauthor=H.+H.+Sitteauthor=J.+Lebanauthor=F.+J.+Monjeauthor=G.+Lubec&title=The+effect+of+modafinil+on+the+rat+dopamine+transporter+and+dopamine+receptors+D1%E2%80%93D3+paralleling+cognitive+enhancement+in+the+radial+arm+maze&doi=10.3389%2Ffnbeh.2015.00215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm maze</span></div><div class="casAuthors">Karabacak, Yasemin; Sase, Sunetra; Aher, Yogesh D.; Sase, Ajinkya; Saroja, Sivaprakasam R.; Cicvaric, Ana; Hoeger, Harald; Berger, Michael; Bakulev, Vasiliy; Sitte, Harald H.; Leban, Johann; Monje, Francisco J.; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">215/1-215/11</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A series of drugs have been reported to increase memory performance modulating the dopaminergic system and herein modafinil was tested for its working memory (WM) enhancing properties.  Reuptake inhibition of dopamine, serotonin (SERT) and norepinephrine (NET) by modafinil was tested.  Sixty male Sprague-Dawley rats were divided into six groups (modafinil-treated 1-5-10 mg/kg body wt., trained and untrained and vehicle treated trained and untrained rats; daily injected i.p. for a period of 10 days) and tested in a radial arm maze (RAM), a paradigm for testing spatial WM.  Hippocampi were taken 6 h following the last day of training and complexes contg. the unphosphorylated or phosphorylated dopamine transporter (DAT-CC and pDAT-CC) and complexes contg. the D1-3 dopamine receptor subunits (D1-D3-CC) were detd.  Modafinil was binding to the DAT but insignificantly to SERT or NET and dopamine reuptake was blocked specifically (IC50 = 11.11 μM; SERT 1547 μM; NET 182 μM).  From day 8 (day 9 for 1 mg/kg body wt.) modafinil was decreasing WM errors (WMEs) in the RAM significantly and remarkably at all doses tested as compared to the vehicle controls.  WMEs were linked to the D2R-CC and the pDAT-CC. pDAT and D1-D3-CC levels were modulated significantly and modafinil was shown to enhance spatial WM in the rat in a well-documented paradigm at all the three doses and dopamine reuptake inhibition with subsequent modulation of D1-3-CC is proposed as a possible mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkIy6Jc_gnrLVg90H21EOLACvtfcHk0lgzusrbt25QRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFertro%253D&md5=fa116eb13b947d8126c590100cb3c78f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2015.00215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2015.00215%26sid%3Dliteratum%253Aachs%26aulast%3DKarabacak%26aufirst%3DY.%26aulast%3DSase%26aufirst%3DS.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DSase%26aufirst%3DA.%26aulast%3DSaroja%26aufirst%3DS.%2BR.%26aulast%3DCicvaric%26aufirst%3DA.%26aulast%3DH%25C3%25B6ger%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DBakulev%26aufirst%3DV.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DMonje%26aufirst%3DF.%2BJ.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DThe%2520effect%2520of%2520modafinil%2520on%2520the%2520rat%2520dopamine%2520transporter%2520and%2520dopamine%2520receptors%2520D1%25E2%2580%2593D3%2520paralleling%2520cognitive%2520enhancement%2520in%2520the%2520radial%2520arm%2520maze%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D215%26doi%3D10.3389%2Ffnbeh.2015.00215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sialana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo-Schlaff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">Modafinil improves performance in the multiple T-Maze and modifies GluR1, GluR2, D2 and NR1 receptor complex levels in the C57BL/6J Mouse</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2285</span>– <span class="NLM_lpage">2292</span>, <span class="refDoi"> DOI: 10.1007/s00726-012-1306-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1007%2Fs00726-012-1306-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=22614872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ght7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2012&pages=2285-2292&issue=6&author=S.+Saseauthor=D.+Khanauthor=F.+Sialanaauthor=H.+H%C3%B6gerauthor=N.+Russo-Schlaffauthor=G.+Lubec&title=Modafinil+improves+performance+in+the+multiple+T-Maze+and+modifies+GluR1%2C+GluR2%2C+D2+and+NR1+receptor+complex+levels+in+the+C57BL%2F6J+Mouse&doi=10.1007%2Fs00726-012-1306-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil improves performance in the multiple T-Maze and modifies GluR1, GluR2, D2 and NR1 receptor complex levels in the C57BL/6J mouse</span></div><div class="casAuthors">Sase, Sunetra; Khan, Deeba; Sialana, Fernando; Hoeger, Harald; Russo-Schlaff, Nina; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2285-2292</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">SpringerWienNewYork</span>)
        </div><div class="casAbstract">Modafinil was shown to modify behavioral and cognitive functions and to effect several brain receptors.  Effects, however, were not obsd. at the receptor protein complex level and it was therefore the aim of the study to train mice in the multiple T-Maze (MTM) as a paradigm for spatial memory and to det. paralleling brain receptor complex levels.  Sixty C57BL/6J mice were used in the study and divided into 4 groups (trained drug injected; trained vehicle injected; yoked drug injected; yoked vehicle injected).  Animals obtained training for 4 days and were killed 6 h following the last training session on day 4.  Hippocampi were dissected from the brain, membrane fractions were prepd. by ultracentrifugation and were run on blue-native gels and immunoblotted with antibodies against major brain receptors.  Modafinil treatment led to decreased latency and increased av. speed, but not to changes in pathlength and no. of correct decisions in the MTM.  Drug effects were modifying receptor complexes of GluR1, GluR2, D2, and NR1.  Training effects on receptor complex levels were obsd. for GluR3, D1, and nicotinic acetylcholine receptor alpha 7 (Nic7).  GluR1 levels were correlating with GluR2 and D1 levels were correlating with D2 and NR1.  Involvement of the glutamatergic, NMDA, dopaminergic, and nicotinergic system in modafinil and memory training were herein described for the 1st time.  A brain receptor complex pattern was revealed showing the concerted action following modafinil treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLJ0tpDOw3q7Vg90H21EOLACvtfcHk0lgzusrbt25QRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ght7%252FM&md5=11b3623731e9191bcee14bbb70a5ef2c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00726-012-1306-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-012-1306-y%26sid%3Dliteratum%253Aachs%26aulast%3DSase%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DD.%26aulast%3DSialana%26aufirst%3DF.%26aulast%3DH%25C3%25B6ger%26aufirst%3DH.%26aulast%3DRusso-Schlaff%26aufirst%3DN.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DModafinil%2520improves%2520performance%2520in%2520the%2520multiple%2520T-Maze%2520and%2520modifies%2520GluR1%252C%2520GluR2%252C%2520D2%2520and%2520NR1%2520receptor%2520complex%2520levels%2520in%2520the%2520C57BL%252F6J%2520Mouse%26jtitle%3DAmino%2520Acids%26date%3D2012%26volume%3D43%26issue%3D6%26spage%3D2285%26epage%3D2292%26doi%3D10.1007%2Fs00726-012-1306-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saroja, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakulev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">A heterocyclic compound CE-103 inhibits dopamine reuptake and modulates dopamine transporter and dopamine D1-D3 containing receptor complexes</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.07.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.neuropharm.2015.07.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=26407764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWltLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2016&pages=186-196&author=A.+Saseauthor=Y.+D.+Aherauthor=S.+R.+Sarojaauthor=M.+K.+Ganesanauthor=S.+Saseauthor=M.+Holyauthor=H.+H%C3%B6gerauthor=V.+Bakulevauthor=G.+F.+Eckerauthor=T.+Langerauthor=H.+H.+Sitteauthor=J.+Lebanauthor=G.+Lubec&title=A+heterocyclic+compound+CE-103+inhibits+dopamine+reuptake+and+modulates+dopamine+transporter+and+dopamine+D1-D3+containing+receptor+complexes&doi=10.1016%2Fj.neuropharm.2015.07.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A heterocyclic compound CE-103 inhibits dopamine reuptake and modulates dopamine transporter and dopamine D1-D3 containing receptor complexes</span></div><div class="casAuthors">Sase, Ajinkya; Aher, Yogesh D.; Saroja, Sivaprakasam R.; Ganesan, Minu Karthika; Sase, Sunetra; Holy, Marion; Hoeger, Harald; Bakulev, Vasiliy; Ecker, Gerhard F.; Langer, Thierry; Sitte, Harald H.; Leban, Johann; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">186-196</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of compds. have been reported to enhance memory via the DA system and herein a heterocyclic compd. was tested for working memory (WM) enhancement.  2-((Benzhydrylsulfinyl)methyl)thiazole (CE-103) was synthesized in a six-step synthesis.  Binding of CE-103 to the dopamine (DAT), serotonin (SERT) and norepinephrine (NET) transporters and dopamine reuptake inhibition was tested as well as blood brain permeation and a screen for GPCR targets. 60 male Sprague Dawley rats were divided into six groups: CE-103 treated 1-10 mg/kg body wt., trained (TDI) and yoked (YDI) and vehicle treated, trained (TVI) and yoked (YVI) rats.  Daily single i.p. injections for a period of 10 days were administered and rats were tested in a radial arm maze (RAM).  Hippocampi were taken 6 h following the last day of training and complexes contg. the unphosphorylated or phosphorylated dopamine transporter (DAT) and complexes contg. the D1-3 dopamine receptor subunits were detd.  CE-103 was binding to the DAT but insignificantly to SERT or NET and dopamine reuptake was blocked specifically (IC50 = 14.73 μM).  From day eight the compd. was decreasing WM errors in the RAM significantly at both doses tested as compared to the vehicle controls.  In the trained CE-103-treated group levels of the complex contg. the phosphorylated dopamine transporter (pDAT) as well as D1R were decreased while levels of complexes contg. D2R and D3R were significantly increased.  CE-103 was shown to enhance spatial WM and DA reuptake inhibition with subsequent modulation of D1-3 receptors is proposed as a possible mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok9mWVCsTDErVg90H21EOLACvtfcHk0lgzusrbt25QRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWltLvL&md5=294205b7102eaf775a56b012c1c1434c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.07.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.07.039%26sid%3Dliteratum%253Aachs%26aulast%3DSase%26aufirst%3DA.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DSaroja%26aufirst%3DS.%2BR.%26aulast%3DGanesan%26aufirst%3DM.%2BK.%26aulast%3DSase%26aufirst%3DS.%26aulast%3DHoly%26aufirst%3DM.%26aulast%3DH%25C3%25B6ger%26aufirst%3DH.%26aulast%3DBakulev%26aufirst%3DV.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DA%2520heterocyclic%2520compound%2520CE-103%2520inhibits%2520dopamine%2520reuptake%2520and%2520modulates%2520dopamine%2520transporter%2520and%2520dopamine%2520D1-D3%2520containing%2520receptor%2520complexes%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D102%26spage%3D186%26epage%3D196%26doi%3D10.1016%2Fj.neuropharm.2015.07.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saroja, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniyan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miklosi, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">A novel heterocyclic compound targeting the dopamine transporter improves performance in the radial arm maze and modulates dopamine receptors D1-D3</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>312</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2016.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.bbr.2016.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=27288589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2gt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2016&pages=127-137&author=S.+R.+Sarojaauthor=Y.+D.+Aherauthor=P.+Kalabaauthor=N.+Y.+Aherauthor=M.+Zehlauthor=V.+Korzauthor=S.+Subramaniyanauthor=A.+G.+Miklosiauthor=L.+Zanonauthor=W.+Neuhausauthor=H.+H%C3%B6gerauthor=T.+Langerauthor=E.+Urbanauthor=J.+Lebanauthor=G.+Lubec&title=A+novel+heterocyclic+compound+targeting+the+dopamine+transporter+improves+performance+in+the+radial+arm+maze+and+modulates+dopamine+receptors+D1-D3&doi=10.1016%2Fj.bbr.2016.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A novel heterocyclic compound targeting the dopamine transporter improves performance in the radial arm maze and modulates dopamine receptors D1-D3</span></div><div class="casAuthors">Saroja, Sivaprakasam R.; Aher, Yogesh D.; Kalaba, Predrag; Aher, Nilima Y.; Zehl, Martin; Korz, Volker; Subramaniyan, Saraswathi; Miklosi, Andras G.; Zanon, Lisa; Neuhaus, Winfried; Hoeger, Harald; Langer, Thierry; Urban, Ernst; Leban, Johann; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-137</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of compds. targeting the dopamine transporter (DAT) haS been shown to improve memory performance most probably by re-uptake inhibition.  Although specific DAT inhibitors are available, there is limited information about specificity, mechanism and in particular the effect on dopamine receptors.  It was therefore the aim of the study to test the DAT inhibitor 4-(diphenyl-methanesulfinylmethyl)-2-methyl-thiazole (code: CE-111), synthesized in our lab. for the specificity to target DAT, for the effects upon spatial memory and for induced dopamine receptor modulation.  Re-uptake inhibition was tested for DAT (IC50 = 3.2 μM), serotonin transporter, SERT (IC50 = 272291 μM) and noradrenaline transporter, NET (IC50 = 174 μM).  Spatial memory was studied in the radial arm maze (RAM) in male Sprague-Dawley rats that were i.p. injected with CE-111 (1 or 10 mg/kg body wt.).  Performance in the RAM was improved using 1 and 10 mg/kg body wt. of CE-111.  Training and treatment effects on presynaptic, postsynaptic and extrasynaptic D1 and D2- receptors and dopamine receptor contg. complexes as well as on activated DAT were obsd.  CE-111 was crossing the blood-brain barrier comparable to modafinil and was identified as effective to improve memory performance in the RAM.  Dopamine re-uptake inhibition along with modulations in dopamine receptors are proposed as potential underlying mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx_C54Kjw8pLVg90H21EOLACvtfcHk0lgVNeXJScLYfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2gt7bE&md5=793da79675241e43aaa035788d8dc2d1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DSaroja%26aufirst%3DS.%2BR.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DZehl%26aufirst%3DM.%26aulast%3DKorz%26aufirst%3DV.%26aulast%3DSubramaniyan%26aufirst%3DS.%26aulast%3DMiklosi%26aufirst%3DA.%2BG.%26aulast%3DZanon%26aufirst%3DL.%26aulast%3DNeuhaus%26aufirst%3DW.%26aulast%3DH%25C3%25B6ger%26aufirst%3DH.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DUrban%26aufirst%3DE.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DA%2520novel%2520heterocyclic%2520compound%2520targeting%2520the%2520dopamine%2520transporter%2520improves%2520performance%2520in%2520the%2520radial%2520arm%2520maze%2520and%2520modulates%2520dopamine%2520receptors%2520D1-D3%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D312%26spage%3D127%26epage%3D137%26doi%3D10.1016%2Fj.bbr.2016.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragačević, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radoman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilić, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beryozkina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A. B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">A novel heterocyclic compound improves working memory in the radial arm maze and modulates the dopamine receptor D1R in frontal cortex of the Sprague-Dawley Rat</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>332</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2017.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.bbr.2017.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=28629964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKntrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2017&pages=308-315&author=A.+M.+Husseinauthor=Y.+D.+Aherauthor=P.+Kalabaauthor=N.+Y.+Aherauthor=V.+Draga%C4%8Devi%C4%87author=B.+Radomanauthor=M.+Ili%C4%87author=J.+Lebanauthor=T.+Beryozkinaauthor=A.+B.+M.+Ahmedauthor=E.+Urbanauthor=T.+Langerauthor=G.+Lubec&title=A+novel+heterocyclic+compound+improves+working+memory+in+the+radial+arm+maze+and+modulates+the+dopamine+receptor+D1R+in+frontal+cortex+of+the+Sprague-Dawley+Rat&doi=10.1016%2Fj.bbr.2017.06.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A novel heterocyclic compound improves working memory in the radial arm maze and modulates the dopamine receptor D1R in frontal cortex of the Sprague-Dawley rat</span></div><div class="casAuthors">Hussein, Ahmed M.; Aher, Yogesh D.; Kalaba, Predrag; Aher, Nilima Y.; Dragacevic, Vladimir; Radoman, Bojana; Ilic, Marija; Leban, Johann; Beryozkina, Tetyana; Ahmed, Abdel Baset M. A.; Urban, Ernst; Langer, Thierry; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">308-315</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of compds. have been shown to enhance cognitive function via the dopaminergic system and indeed the search for more active and less toxic compds. is continuing.  It was therefore the aim of the study to synthetise and test a novel heterocyclic compd. for cognitive enhancement in a paradigm for working memory.  Specific and effective dopamine re-uptake inhibition DAT (IC50 = 4,1 ± 0,8 μM) made us test this compd. in a radial arm maze (RAM) in the rat.  CE-125 (4-((benzhydrylsulfinyl)methyl)-2-cyclopropylthiazole), was tested for dopamine (DAT), serotonin and norepinephrine re-uptake inhibition by a well-established system.  The working memory index (WMI) was evaluated in male Sprague Dawley rats that were i.p. injected with CE-125 (1 or 10 mg/kg body wt.).  In order to evaluate basic neurotoxicity, the open field, elevated plus maze, rota rod studies and the forced swim test were carried out.  Frontal cortex was taken at the last day of the RAM test and dopamine receptors D1R and D2R, DAT and phosphorylated DAT protein levels were detd.  On the 10th day both doses were increasing the WMI as compared to the vehicle-treated group.  In both, trained and treated groups, D1R levels were significantly reduced while D2R levels were unchanged.  DAT levels were comparable between all groups while phosphorylated DAT levels were increased in the trained group treated with 1 mg/kg body wt.  CE-125 as a probably non-neurotoxic compd. and specific reuptake inhibitor was shown to increase performance (WMI) and modulation of the dopaminergic system is proposed as a possible mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1NG4VH9ymM7Vg90H21EOLACvtfcHk0lgVNeXJScLYfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKntrbO&md5=7cb65082b366d222bf5eb697a3269e94</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2017.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2017.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DHussein%26aufirst%3DA.%2BM.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DDraga%25C4%258Devi%25C4%2587%26aufirst%3DV.%26aulast%3DRadoman%26aufirst%3DB.%26aulast%3DIli%25C4%2587%26aufirst%3DM.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DBeryozkina%26aufirst%3DT.%26aulast%3DAhmed%26aufirst%3DA.%2BB.%2BM.%26aulast%3DUrban%26aufirst%3DE.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DA%2520novel%2520heterocyclic%2520compound%2520improves%2520working%2520memory%2520in%2520the%2520radial%2520arm%2520maze%2520and%2520modulates%2520the%2520dopamine%2520receptor%2520D1R%2520in%2520frontal%2520cortex%2520of%2520the%2520Sprague-Dawley%2520Rat%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2017%26volume%3D332%26spage%3D308%26epage%3D315%26doi%3D10.1016%2Fj.bbr.2017.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kristofova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radoman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragacevic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aradska, J.</span></span> <span> </span><span class="NLM_article-title">A daily single dose of a novel modafinil analogue CE-123 improves memory acquisition and memory retrieval</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2018.01.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.bbr.2018.01.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=29410048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1Ogsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2018&pages=83-94&author=M.+Kristofovaauthor=Y.+D.+Aherauthor=M.+Ilicauthor=B.+Radomanauthor=P.+Kalabaauthor=V.+Dragacevicauthor=N.+Y.+Aherauthor=J.+Lebanauthor=V.+Korzauthor=L.+Zanonauthor=W.+Neuhausauthor=M.+Wiederauthor=T.+Langerauthor=E.+Urbanauthor=H.+H.+Sitteauthor=H.+Hoegerauthor=G.+Lubecauthor=J.+Aradska&title=A+daily+single+dose+of+a+novel+modafinil+analogue+CE-123+improves+memory+acquisition+and+memory+retrieval&doi=10.1016%2Fj.bbr.2018.01.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A daily single dose of a novel modafinil analogue CE-123 improves memory acquisition and memory retrieval</span></div><div class="casAuthors">Kristofova, Martina; Aher, Yogesh D.; Ilic, Marija; Radoman, Bojana; Kalaba, Predrag; Dragacevic, Vladimir; Aher, Nilima Y.; Leban, Johann; Korz, Volker; Zanon, Lisa; Neuhaus, Winfried; Wieder, Marcus; Langer, Thierry; Urban, Ernst; Sitte, Harald H.; Hoeger, Harald; Lubec, Gert; Aradska, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-94</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dopamine reuptake inhibitors have been shown to improve cognitive parameters in various tasks and animal models.  We recently reported a series of modafinil analogs, of which the most promising, 5-((benzhydrylsulfinyl)methyl) thiazole (CE-123), was selected for further development.  The present study aims to characterize pharmacol. properties of CE-123 and to investigate the potential to enhance memory performance in a rat model.  In vitro transporter assays were performed in cells expressing human transporters.  CE-123 blocked uptake of [3H] dopamine (IC50 = 4.606 μM) while effects on serotonin (SERT) and the norepinephrine transporter (NET) were negligible.  Blood-brain barrier and pharmacokinetic studies showed that the compd. reached the brain and lower elimination than R-modafinil.  The Pro-cognitive effect was evaluated in a spatial hole-board task in male Sprague-Dawley rats and CE-123 enhances memory acquisition and memory retrieval, represented by significantly increased ref. memory indexes and shortened latency.  Since DAT blockers can be considered as indirect dopamine receptor agonists, western blotting was used to quantify protein levels of dopamine receptors D1R, D2R and D5R and DAT in the synaptosomal fraction of hippocampal subregions CA1, CA3 and dentate gyrus (DG).  CE-123 administration in rats increased total DAT levels and D1R protein levels were significantly increased in CA1 and CA3 in treated/trained groups.  The increase of D5R was obsd. in DG only.  Dopamine receptors, particularly D1R, seem to play a role in mediating CE-123-induced memory enhancement.  Dopamine reuptake inhibition by CE-123 may represent a novel and improved stimulant therapeutic for impairments of cognitive functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprz2p5563B_bVg90H21EOLACvtfcHk0lh9JjtEl-Fi7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1Ogsbw%253D&md5=0f3059aab891533f96b28d3529310a77</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2018.01.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2018.01.032%26sid%3Dliteratum%253Aachs%26aulast%3DKristofova%26aufirst%3DM.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DIlic%26aufirst%3DM.%26aulast%3DRadoman%26aufirst%3DB.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DDragacevic%26aufirst%3DV.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DKorz%26aufirst%3DV.%26aulast%3DZanon%26aufirst%3DL.%26aulast%3DNeuhaus%26aufirst%3DW.%26aulast%3DWieder%26aufirst%3DM.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DUrban%26aufirst%3DE.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DHoeger%26aufirst%3DH.%26aulast%3DLubec%26aufirst%3DG.%26aulast%3DAradska%26aufirst%3DJ.%26atitle%3DA%2520daily%2520single%2520dose%2520of%2520a%2520novel%2520modafinil%2520analogue%2520CE-123%2520improves%2520memory%2520acquisition%2520and%2520memory%2520retrieval%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2018%26volume%3D343%26spage%3D83%26epage%3D94%26doi%3D10.1016%2Fj.bbr.2018.01.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilić, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragačević, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miklosi, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wackerlig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beryozkina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radoman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saroja, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakulev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic analogues of modafinil as novel, atypical dopamine transporter inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9330</span>– <span class="NLM_lpage">9348</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGnu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9330-9348&issue=22&author=P.+Kalabaauthor=N.+Y.+Aherauthor=M.+Ili%C4%87author=V.+Draga%C4%8Devi%C4%87author=M.+Wiederauthor=A.+G.+Miklosiauthor=M.+Zehlauthor=J.+Wackerligauthor=A.+Rollerauthor=T.+Beryozkinaauthor=B.+Radomanauthor=S.+R.+Sarojaauthor=W.+Lindnerauthor=E.+P.+Gonzalezauthor=V.+Bakulevauthor=J.+J.+Lebanauthor=H.+H.+Sitteauthor=E.+Urbanauthor=T.+Langerauthor=G.+Lubec&title=Heterocyclic+analogues+of+modafinil+as+novel%2C+atypical+dopamine+transporter+inhibitors&doi=10.1021%2Facs.jmedchem.7b01313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic Analogues of Modafinil as Novel, Atypical Dopamine Transporter Inhibitors</span></div><div class="casAuthors">Kalaba, Predrag; Aher, Nilima Y.; Ilic, Marija; Dragacevic, Vladimir; Wieder, Marcus; Miklosi, Andras G.; Zehl, Martin; Wackerlig, Judith; Roller, Alexander; Beryozkina, Tetyana; Radoman, Bojana; Saroja, Sivaprakasam R.; Lindner, Wolfgang; Gonzalez, Eduardo Perez; Bakulev, Vasiliy; Leban, Johann Jakob; Sitte, Harald H.; Urban, Ernst; Langer, Thierry; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9330-9348</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modafinil is a wake promoting compd. with high potential for cognitive enhancement.  It is targeting the dopamine transporter (DAT) with moderate selectivity, thereby leading to reuptake inhibition and increased dopamine levels in the synaptic cleft.  A series of modafinil analogs have been reported so far, but more target-specific analogs remain to be discovered.  It was the aim of this study to synthesize and characterize such analogs and, indeed, a series of compds. were showing higher activities on the DAT and a higher selectivity toward DAT vs. serotonin and norepinephrine transporters than modafinil.  This was achieved by substituting the amide moiety by five- and six-membered arom. heterocycles.  In vitro studies indicated binding to the cocaine pocket on DAT, although mol. dynamics revealed binding different from that of cocaine.  Moreover, no release of dopamine was obsd., ruling out amphetamine-like effects.  The absence of neurotoxicity of a representative analog may encourage further preclin. studies of the above-mentioned compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxI4zZzeCZg7Vg90H21EOLACvtfcHk0lh9JjtEl-Fi7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGnu7fP&md5=f391cc57a70ae320ae11961b00575633</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01313%26sid%3Dliteratum%253Aachs%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DIli%25C4%2587%26aufirst%3DM.%26aulast%3DDraga%25C4%258Devi%25C4%2587%26aufirst%3DV.%26aulast%3DWieder%26aufirst%3DM.%26aulast%3DMiklosi%26aufirst%3DA.%2BG.%26aulast%3DZehl%26aufirst%3DM.%26aulast%3DWackerlig%26aufirst%3DJ.%26aulast%3DRoller%26aufirst%3DA.%26aulast%3DBeryozkina%26aufirst%3DT.%26aulast%3DRadoman%26aufirst%3DB.%26aulast%3DSaroja%26aufirst%3DS.%2BR.%26aulast%3DLindner%26aufirst%3DW.%26aulast%3DGonzalez%26aufirst%3DE.%2BP.%26aulast%3DBakulev%26aufirst%3DV.%26aulast%3DLeban%26aufirst%3DJ.%2BJ.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DUrban%26aufirst%3DE.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DHeterocyclic%2520analogues%2520of%2520modafinil%2520as%2520novel%252C%2520atypical%2520dopamine%2520transporter%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D22%26spage%3D9330%26epage%3D9348%26doi%3D10.1021%2Facs.jmedchem.7b01313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikiforuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragačević, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wackerlig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golebiowska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">A novel dopamine transporter inhibitor CE-123 improves cognitive flexibility and maintains impulsivity in healthy male rats</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">222</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2017.00222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3389%2Ffnbeh.2017.00222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=29230168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvVGktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=222&author=A.+Nikiforukauthor=P.+Kalabaauthor=M.+Ilicauthor=V.+Korzauthor=V.+Draga%C4%8Devi%C4%87author=J.+Wackerligauthor=T.+Langerauthor=H.+H%C3%B6gerauthor=J.+Golebiowskaauthor=P.+Popikauthor=G.+Lubec&title=A+novel+dopamine+transporter+inhibitor+CE-123+improves+cognitive+flexibility+and+maintains+impulsivity+in+healthy+male+rats&doi=10.3389%2Ffnbeh.2017.00222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel dopamine transporter inhibitor CE-123 improves cognitive flexibility and maintains impulsivity in healthy male rats</span></div><div class="casAuthors">Nikiforuk, Agnieszka; Kalaba, Predrag; Ilic, Marija; Korz, Volker; Dragacevic, Vladimir; Wackerlig, Judith; Langer, Thierry; Hoger, Harald; Golebiowska, Joanna; Popik, Piotr; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">222/1-222/11</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Reduced cognitive abilities are often characterized by an impairment of flexibility, i.e., the ability to switch from learned rules or categories that were important in certain contexts to different new modalities that rule the task.  Drugs targeting the dopamine transporter (DAT) are widely used for their potential to enhance cognitive abilities.  However, com. available drugs are of limited specificity for DAT, blocking also noradrenaline and serotonine transporters, that can lead to unwanted side effects in healthy subjects.  Therefore, we tested a newly synthesized compd. (CE-123) with higher specificity for DAT in male rats in an attentional set-shifting task (ASST), that proves for cognitive flexibility and a 5-choice serial-reaction time task (5-CSRTT) assessing visuospatial attention and impulsivity.  Treated rats at a dose of 0.3 and 1.0 but not 0.1 mg/kg bodyweight showed reduced extra-dimensional shifts in the ASST compared to controls indicating increased cognitive flexibility.  Rats treated with R-Modafinil, a com. available DAT inhibitor at a dose of 10 mg/kg bodyweight showed increased premature responses, an indicator of increased impulsivity, during a 10 s but not a 2.5, 5, or 7.5 s intertrial interval when compared to vehicle-treated rats in the 5-CSRTT.  This was not found in rats treated with CE-123 at the same dose as for R-Modafinil.  Visuospatial attention, except premature responses, did not differ between R-Modafinil and CE-123-treated rats and their resp. controls.  Thus, CE-123 increased cognitive flexibility with diminished impulsivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodBOAI4YQhFbVg90H21EOLACvtfcHk0ljewMSKNbMo3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvVGktLk%253D&md5=aa11518fbd668106be256ed104cb7240</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2017.00222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2017.00222%26sid%3Dliteratum%253Aachs%26aulast%3DNikiforuk%26aufirst%3DA.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DIlic%26aufirst%3DM.%26aulast%3DKorz%26aufirst%3DV.%26aulast%3DDraga%25C4%258Devi%25C4%2587%26aufirst%3DV.%26aulast%3DWackerlig%26aufirst%3DJ.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DH%25C3%25B6ger%26aufirst%3DH.%26aulast%3DGolebiowska%26aufirst%3DJ.%26aulast%3DPopik%26aufirst%3DP.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DA%2520novel%2520dopamine%2520transporter%2520inhibitor%2520CE-123%2520improves%2520cognitive%2520flexibility%2520and%2520maintains%2520impulsivity%2520in%2520healthy%2520male%2520rats%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2017%26volume%3D11%26spage%3D222%26doi%3D10.3389%2Ffnbeh.2017.00222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorengel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sündermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golovyashkina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewejohann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakota, L.</span></span> <span> </span><span class="NLM_article-title">DMSO modulates CNS function in a preclinical Alzheimers disease model</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.neuropharm.2016.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=27773645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSntrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2017&pages=434-444&author=L.+Penazziauthor=J.+Lorengelauthor=F.+S%C3%BCndermannauthor=N.+Golovyashkinaauthor=S.+Marreauthor=C.+M.+Mathisauthor=L.+Lewejohannauthor=R.+Brandtauthor=L.+Bakota&title=DMSO+modulates+CNS+function+in+a+preclinical+Alzheimers+disease+model&doi=10.1016%2Fj.neuropharm.2016.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">DMSO modulates CNS function in a preclinical Alzheimer's disease model</span></div><div class="casAuthors">Penazzi, Lorene; Lorengel, Julia; Suendermann, Frederik; Golovyashkina, Nataliya; Marre, Stefan; Mathis, Chantal M. B.; Lewejohann, Lars; Brandt, Roland; Bakota, Lidia</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">Part_A</span>),
    <span class="NLM_cas:pages">434-444</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">DMSO has a widespread use as a vehicle for water-insol. therapeutic drug candidates but may also exert disease-relevant pharmacol. effects by itself.  However, its influence on the CNS has hardly been addressed.  Here we examd. the brain structure and function following chronic exposure to low DMSO dose at a paradigm with flawed synaptic connectivity in a preclin. transgenic mouse model for Alzheimer's disease (APPSDL mice).  DMSO treatment increased spine d. in a region-specific manner in the hippocampus of APPSDL mice ex vivo and in vivo.  Moreover, DMSO exhibited clear influence on the behavior of this mouse line by enhancing hippocampal-dependent spatial memory accuracy, modulating hippocampal-independent olfactory habituation and displaying anxiolytic effect.  Despite that most of the action of DMSO was obsd. in animals with elevated Aβ levels, the drug did not exert its function via decreasing the oligomeric Aβ species.  However, challenging organotypic hippocampal slice cultures with NMDA receptor antagonist MK-801 recapitulated the effect of DMSO on spine d., indicating a tuning influence of DMSO on receptor signalization.  Our findings demonstrate that DMSO should be considered as a true bioactive compd., which has the potential to be a beneficial adjuvant to counteract Aβ-mediated synaptotoxicity and behavioral impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-DfKgAb4gbLVg90H21EOLACvtfcHk0ljewMSKNbMo3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSntrvP&md5=53678c50c24e70e7b77a3e5a1d1bb8be</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DPenazzi%26aufirst%3DL.%26aulast%3DLorengel%26aufirst%3DJ.%26aulast%3DS%25C3%25BCndermann%26aufirst%3DF.%26aulast%3DGolovyashkina%26aufirst%3DN.%26aulast%3DMarre%26aufirst%3DS.%26aulast%3DMathis%26aufirst%3DC.%2BM.%26aulast%3DLewejohann%26aufirst%3DL.%26aulast%3DBrandt%26aufirst%3DR.%26aulast%3DBakota%26aufirst%3DL.%26atitle%3DDMSO%2520modulates%2520CNS%2520function%2520in%2520a%2520preclinical%2520Alzheimers%2520disease%2520model%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D113%26spage%3D434%26epage%3D444%26doi%3D10.1016%2Fj.neuropharm.2016.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scullion, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, A. D.</span></span> <span> </span><span class="NLM_article-title">Low concentrations of the solvent dimethyl sulphoxide alter intrinsic excitability properties of cortical and hippocampal pyramidal cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e92557</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0092557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1371%2Fjournal.pone.0092557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=24647720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKisbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e92557&author=F.+Tamagniniauthor=S.+Scullionauthor=J.+T.+Brownauthor=A.+D.+Randall&title=Low+concentrations+of+the+solvent+dimethyl+sulphoxide+alter+intrinsic+excitability+properties+of+cortical+and+hippocampal+pyramidal+cells&doi=10.1371%2Fjournal.pone.0092557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Low concentrations of the solvent dimethyl sulphoxide alter intrinsic excitability properties of cortical and hippocampal pyramidal cells</span></div><div class="casAuthors">Tamagnini, Francesco; Scullion, Sarah; Brown, Jonathan T.; Randall, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e92557/1-e92557/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Dimethylsulfoxide (DMSO) is a widely used solvent in biol.  It has many applications perhaps the most common of which is in aiding the prepn. of drug solns. from hydrophobic chem. entities.  Recent studies have suggested that this mol. may be able to induce apoptosis in neural tissues urging caution regarding its introduction into humans, for example as part of stem cell transplants.  Here we have used in vitro electrophysiol. methods applied to murine brain slices to examine whether a few hours treatment with 0.05% DMSO (a concn. regarded by many as innocuous) alters intrinsic excitability properties of neurons.  We investigated pyramidal neurons in two distinct brain regions, namely area CA1 of the hippocampus and layer 2 of perirhinal cortex.  In the former there was no effect on resting potential but input resistance was decreased by DMSO pre-treatment.  In line with this action potential count for any level of depolarizing current stimulus was reduced by ∼25% following DMSO treatment.  Ih-mediated "sag" was also increased in CA1 pyramids and action potential waveform anal. demonstrated that DMSO treatment moved action potential threshold towards resting potential.  In perirhinal cortex a decreased action potential output for various depolarizing current stimuli was also seen.  In these cells action potential threshold was unaltered by DMSO but a significant increase in action potential width was apparent.  These data indicate that pre-treatment with this widely employed solvent can elicit multifaceted neurophysiol. changes in mammalian neurons at concns. below those frequently encountered in the published literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCWqZe6n0_nrVg90H21EOLACvtfcHk0ljewMSKNbMo3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKisbzJ&md5=822a00d7eda1c089ba188da1109d31f7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0092557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0092557%26sid%3Dliteratum%253Aachs%26aulast%3DTamagnini%26aufirst%3DF.%26aulast%3DScullion%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%2BT.%26aulast%3DRandall%26aufirst%3DA.%2BD.%26atitle%3DLow%2520concentrations%2520of%2520the%2520solvent%2520dimethyl%2520sulphoxide%2520alter%2520intrinsic%2520excitability%2520properties%2520of%2520cortical%2520and%2520hippocampal%2520pyramidal%2520cells%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De92557%26doi%3D10.1371%2Fjournal.pone.0092557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span> <span> </span><span class="NLM_article-title">A new cobalt–salen catalyst for asymmetric cyclopropanation. synthesis of the serotonin–norepinephrine repuptake inhibitor (+)-Synosutine</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">3880</span>– <span class="NLM_lpage">3883</span>, <span class="refDoi"> DOI: 10.1021/ol501549x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol501549x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=3880-3883&issue=15&author=J.+D.+Whiteauthor=S.+Shaw&title=A+new+cobalt%E2%80%93salen+catalyst+for+asymmetric+cyclopropanation.+synthesis+of+the+serotonin%E2%80%93norepinephrine+repuptake+inhibitor+%28%2B%29-Synosutine&doi=10.1021%2Fol501549x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A New Cobalt-Salen Catalyst for Asymmetric Cyclopropanation. Synthesis of the Serotonin-Norepinephrine Reuptake Inhibitor (+)-Synosutine</span></div><div class="casAuthors">White, James D.; Shaw, Subrata</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3880-3883</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new C2 sym. cobalt(II)-salen catalyst based on cis-2,5-diaminobicyclo[2.2.2]octane as the chiral scaffold was prepd. which, in the presence of potassium thioacetate as the promoter, catalyzed the formation of cyclopropanes from 1,1-disubstituted ethylenes and Et diazoacetate in high yield and with excellent diastereo- and enantioselectivity [e.g., α-methylstyrene + Et diazoacetate in presence of Co salen complex and KSAc in chlorinated solvent afforded cyclopropane (E)-I in dr(E/Z) = 30:1 and ee(E) > 90%].  Asym. cyclopropanation with the catalyst was used in a short, efficient synthesis of the dual serotonin-epinephrine reuptake inhibitor (+)-synosutine (II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsG2_hnNPrAbVg90H21EOLACvtfcHk0liSPLEfoQwzww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtb7O&md5=6edc263029b1a68391f2d3e003f613ab</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fol501549x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol501549x%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%2BD.%26aulast%3DShaw%26aufirst%3DS.%26atitle%3DA%2520new%2520cobalt%25E2%2580%2593salen%2520catalyst%2520for%2520asymmetric%2520cyclopropanation.%2520synthesis%2520of%2520the%2520serotonin%25E2%2580%2593norepinephrine%2520repuptake%2520inhibitor%2520%2528%252B%2529-Synosutine%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26issue%3D15%26spage%3D3880%26epage%3D3883%26doi%3D10.1021%2Fol501549x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span> <i>Bruker SAINT</i>, version <span class="NLM_edition">8.38A</span>; <span class="NLM_publisher-name">Bruker AXS</span>, <span class="NLM_year">2005–2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Bruker+SAINT%2C+version+8.38A%3B+Bruker+AXS%2C+2005%E2%80%932016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DBruker%2520SAINT%26pub%3DBruker%2520AXS%26date%3D2005%25E2%2580%25932016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <i>SADABS</i>; <span class="NLM_publisher-name">University of Göttingen</span>: <span class="NLM_publisher-loc">Göttingen, Germany</span>, <span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=G.+M.+Sheldrick&title=SADABS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26jtitle%3DSADABS%26pub%3DUniversity%2520of%2520G%25C3%25B6ttingen%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolomanov, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourhis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildea, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, J. A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puschmann, H.</span></span> <span> </span><span class="NLM_article-title">OLEX2. A rapid method for quantifying heavy atom derivatives for multiple isomorphous replacement in protein crystallography</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1107/S0021889808042726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1107%2FS0021889808042726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=339-341&author=O.+V.+Dolomanovauthor=L.+J.+Bourhisauthor=R.+J.+Gildeaauthor=J.+A.+K.+Howardauthor=H.+Puschmann&title=OLEX2.+A+rapid+method+for+quantifying+heavy+atom+derivatives+for+multiple+isomorphous+replacement+in+protein+crystallography&doi=10.1107%2FS0021889808042726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">OLEX2: a complete structure solution, refinement and analysis program</span></div><div class="casAuthors">Dolomanov, Oleg V.; Bourhis, Luc J.; Gildea, Richard J.; Howard, Judith A. K.; Puschmann, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-341</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">New software, OLEX2, was developed for the detn., visualization and anal. of mol. crystal structures.  The software has a portable mouse-driven workflow-oriented and fully comprehensive graphical user interface for structure soln., refinement and report generation, as well as novel tools for structure anal.  OLEX2 seamlessly links all aspects of the structure soln., refinement and publication process and presents them in a single workflow-driven package, with the ultimate goal of producing an application which will be useful to both chemists and crystallographers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIYSUbyzIgxbVg90H21EOLACvtfcHk0liSPLEfoQwzww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D&md5=7a2f9697b13b8e76de0e7dc5074ab229</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0021889808042726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889808042726%26sid%3Dliteratum%253Aachs%26aulast%3DDolomanov%26aufirst%3DO.%2BV.%26aulast%3DBourhis%26aufirst%3DL.%2BJ.%26aulast%3DGildea%26aufirst%3DR.%2BJ.%26aulast%3DHoward%26aufirst%3DJ.%2BA.%2BK.%26aulast%3DPuschmann%26aufirst%3DH.%26atitle%3DOLEX2.%2520A%2520rapid%2520method%2520for%2520quantifying%2520heavy%2520atom%2520derivatives%2520for%2520multiple%2520isomorphous%2520replacement%2520in%2520protein%2520crystallography%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2009%26volume%3D42%26spage%3D339%26epage%3D341%26doi%3D10.1107%2FS0021889808042726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huebschle, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittrich, B.</span></span> <span> </span><span class="NLM_article-title">ShelXle: a Qt graphical user interface for SHELXL</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1281</span>– <span class="NLM_lpage">1284</span>, <span class="refDoi"> DOI: 10.1107/S0021889811043202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1107%2FS0021889811043202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=22477785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFSisrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=1281-1284&author=C.+B.+Huebschleauthor=G.+M.+Sheldrickauthor=B.+Dittrich&title=ShelXle%3A+a+Qt+graphical+user+interface+for+SHELXL&doi=10.1107%2FS0021889811043202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">ShelXle: a Qt graphical user interface for SHELXL</span></div><div class="casAuthors">Huebschle, Christian B.; Sheldrick, George M.; Dittrich, Birger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1281-1284</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">ShelXle is a user-friendly graphical user interface for SHELXL.  It combines an editor with syntax highlighting for SHELXL-assocd. files with an interactive graphical display for visualization of a three-dimensional structure.  ShelXle is a graphical user interface for SHELXL [Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122], currently the most widely used program for small-mol. structure refinement.  It combines an editor with syntax highlighting for the SHELXL-assocd. (input) and (output) files with an interactive graphical display for visualization of a three-dimensional structure including the electron d. (Fo) and difference d. (Fo-Fc) maps.  Special features of ShelXle include intuitive atom (re-)naming, a strongly coupled editor, structure visualization in various mono and stereo modes, and a novel way of displaying disorder extending over special positions.  ShelXle is completely compatible with all features of SHELXL and is written entirely in C++ using the Qt4 and FFTW libraries.  It is available at no cost for Windows, Linux and Mac-OS X and as source code.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow_d-mylopt7Vg90H21EOLACvtfcHk0liSPLEfoQwzww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFSisrrF&md5=b9c11983c90116eaf0720fcdbf061ff3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0021889811043202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889811043202%26sid%3Dliteratum%253Aachs%26aulast%3DHuebschle%26aufirst%3DC.%2BB.%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26aulast%3DDittrich%26aufirst%3DB.%26atitle%3DShelXle%253A%2520a%2520Qt%2520graphical%2520user%2520interface%2520for%2520SHELXL%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2011%26volume%3D44%26spage%3D1281%26epage%3D1284%26doi%3D10.1107%2FS0021889811043202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">A short history of SHELX</span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1107/S0108767307043930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=18156677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=112-122&issue=1&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX&doi=10.1107%2FS0108767307043930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lhYqrJH-YD2Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2008%26volume%3D64%26issue%3D1%26spage%3D112%26epage%3D122%26doi%3D10.1107%2FS0108767307043930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure refinement with SHELXL</span>. <i>Acta Crystallogr., Sect. C: Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1107%2FS2053229614024218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&issue=1&author=G.+M.+Sheldrick&title=Crystal+structure+refinement+with+SHELXL&doi=10.1107%2FS2053229614024218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure refinement with SHELXL</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The improvements in the crystal structure refinement program SHELXL have been closely coupled with the development and increasing importance of the CIF (Crystallog. Information Framework) format for validating and archiving crystal structures.  An important simplification is that now only one file in CIF format (for convenience, referred to simply as 'a CIF') contg. embedded reflection data and SHELXL instructions is needed for a complete structure archive; the program SHREDCIF can be used to ext. the and files required for further refinement with SHELXL.  Recent developments in SHELXL facilitate refinement against neutron diffraction data, the treatment of H atoms, the detn. of abs. structure, the input of partial structure factors and the refinement of twinned and disordered structures.  SHELXL is available free to academics for the Windows, Linux and Mac OS X operating systems, and is particularly suitable for multiple-core processors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk1_pNHwXR7Vg90H21EOLACvtfcHk0lhYqrJH-YD2Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D&md5=4a860804b50fc183e8a701098b98ef59</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024218%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DCrystal%2520structure%2520refinement%2520with%2520SHELXL%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Struct.%2520Chem.%26date%3D2015%26volume%3D71%26issue%3D1%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053229614024218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spek, A. L.</span></span> <span> </span><span class="NLM_article-title">Structure validation in chemical crystallography</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1107/S090744490804362X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1107%2FS090744490804362X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=19171970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=148-155&issue=2&author=A.+L.+Spek&title=Structure+validation+in+chemical+crystallography&doi=10.1107%2FS090744490804362X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure validation in chemical crystallography</span></div><div class="casAuthors">Spek, Anthony L.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-155</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Automated structure validation was introduced in chem. crystallog. about 12 years ago as a tool to assist practitioners with the exponential growth in crystal structure analyses.  Validation has since evolved into an easy-to-use checkCIF/PLATON web-based IUCr service.  The result of a crystal structure detn. has to be supplied as a CIF-formatted computer-readable file.  The checking software tests the data in the CIF for completeness, quality, and consistency.  In addn., the reported structure is checked for incomplete anal., errors in the anal., and relevant issues to be verified.  A validation report is generated in the form of a list of ALERTS on the issues to be cor., checked, or commented on.  Structure validation has largely eliminated obvious problems with structure reports published in IUCr journals, such as refinement in a space group of too low symmetry.  This paper reports on the current status of structure validation and possible future extensions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8nVxgyQYutbVg90H21EOLACvtfcHk0lhYqrJH-YD2Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWhtL8%253D&md5=1cc05cd996f846a98b55ea09289af6a9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS090744490804362X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744490804362X%26sid%3Dliteratum%253Aachs%26aulast%3DSpek%26aufirst%3DA.%2BL.%26atitle%3DStructure%2520validation%2520in%2520chemical%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26issue%3D2%26spage%3D148%26epage%3D155%26doi%3D10.1107%2FS090744490804362X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sucic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zdrazil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissensteiner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudlacek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gether, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freissmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span> <span> </span><span class="NLM_article-title">The N-terminus of monoamine transporters is a lever required for the action of amphetamines</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">10924</span>– <span class="NLM_lpage">10938</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.083154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1074%2Fjbc.M109.083154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=20118234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFaisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=10924-10938&author=S.+Sucicauthor=S.+Dallingerauthor=B.+Zdrazilauthor=R.+Weissensteinerauthor=T.+N.+Jorgensenauthor=M.+Holyauthor=O.+Kudlacekauthor=S.+Seidelauthor=J.+H.+Chaauthor=U.+Getherauthor=A.+H.+Newmanauthor=G.+F.+Eckerauthor=M.+Freissmuthauthor=H.+H.+Sitte&title=The+N-terminus+of+monoamine+transporters+is+a+lever+required+for+the+action+of+amphetamines&doi=10.1074%2Fjbc.M109.083154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The N Terminus of Monoamine Transporters Is a Lever Required for the Action of Amphetamines</span></div><div class="casAuthors">Sucic, Sonja; Dallinger, Stefan; Zdrazil, Barbara; Weissensteiner, Rene; Jorgensen, Trine N.; Holy, Marion; Kudlacek, Oliver; Seidel, Stefan; Cha, Joo Hwan; Gether, Ulrik; Newman, Amy H.; Ecker, Gerhard F.; Freissmuth, Michael; Sitte, Harald H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10924-10938</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The serotonin transporter (SERT) terminates neurotransmission by removing serotonin from the synaptic cleft.  In addn., it is the site of action of antidepressants (which block the transporter) and of amphetamines (which induce substrate efflux).  We explored the functional importance of the N terminus in mediating the action of amphetamines by focusing initially on the highly conserved threonine residue at position 81, a candidate site for phosphorylation by protein kinase C.  Mol. dynamics simulations of the wild type SERT, compared with its mutations SERTT81A and SERTT81D, suggested structural changes in the inner vestibule indicative of an opening of the inner vestibule.  Predictions from this model (e.g. the preferential accumulation of SERTT81A in the inward conformation, its reduced turnover no., and a larger distance between its N and C termini) were verified.  Most importantly, SERTT81A (and the homologous mutations in noradrenaline and dopamine) failed to support amphetamine-induced efflux, and this was not remedied by aspartate at this position.  Amphetamine-induced currents through SERTT81A were comparable with those through the wild type transporter.  Both abundant Na+ entry and accumulation of SERTT81A in the inward facing conformation ought to favor amphetamine-induced efflux.  Thus, we surmised that the N terminus must play a direct role in driving the transporter into a state that supports amphetamine-induced efflux.  This hypothesis was verified by truncating the first 64 amino acids and by tethering the N terminus to an addnl. transmembrane helix.  Either modification abolished amphetamine-induced efflux.  We therefore conclude that the N terminus of monoamine transporters acts as a lever that sustains reverse transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBoS2MkOsfgLVg90H21EOLACvtfcHk0ljTzk9aM-LRrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFaisL4%253D&md5=4e93e69edd41b5eab9a8b3d6502a6b0d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.083154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.083154%26sid%3Dliteratum%253Aachs%26aulast%3DSucic%26aufirst%3DS.%26aulast%3DDallinger%26aufirst%3DS.%26aulast%3DZdrazil%26aufirst%3DB.%26aulast%3DWeissensteiner%26aufirst%3DR.%26aulast%3DJorgensen%26aufirst%3DT.%2BN.%26aulast%3DHoly%26aufirst%3DM.%26aulast%3DKudlacek%26aufirst%3DO.%26aulast%3DSeidel%26aufirst%3DS.%26aulast%3DCha%26aufirst%3DJ.%2BH.%26aulast%3DGether%26aufirst%3DU.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26aulast%3DFreissmuth%26aufirst%3DM.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26atitle%3DThe%2520N-terminus%2520of%2520monoamine%2520transporters%2520is%2520a%2520lever%2520required%2520for%2520the%2520action%2520of%2520amphetamines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D10924%26epage%3D10938%26doi%3D10.1074%2Fjbc.M109.083154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partilla, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehner, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seddik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandtner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, M. H.</span></span> <span> </span><span class="NLM_article-title">“Second-generation” mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1321</span>– <span class="NLM_lpage">1331</span>, <span class="refDoi"> DOI: 10.1038/npp.2014.325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1038%2Fnpp.2014.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=25502630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2015&pages=1321-1331&author=K.+Sahaauthor=J.+S.+Partillaauthor=K.+R.+Lehnerauthor=A.+Seddikauthor=T.+Stocknerauthor=M.+Holyauthor=W.+Sandtnerauthor=G.+F.+Eckerauthor=H.+H.+Sitteauthor=M.+H.+Baumann&title=%E2%80%9CSecond-generation%E2%80%9D+mephedrone+analogs%2C+4-MEC+and+4-MePPP%2C+differentially+affect+monoamine+transporter+function&doi=10.1038%2Fnpp.2014.325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">'Second-Generation' Mephedrone Analogs, 4-MEC and 4-MePPP, Differentially Affect Monoamine Transporter Function</span></div><div class="casAuthors">Saha, Kusumika; Partilla, John S.; Lehner, Kurt R.; Seddik, Amir; Stockner, Thomas; Holy, Marion; Sandtner, Walter; Ecker, Gerhard F.; Sitte, Harald H.; Baumann, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1321-1331</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The nonmedical use of synthetic cathinones is increasing on a global scale. 4-Methyl-N-methylcathinone (mephedrone) is a popular synthetic cathinone that is now illegal in the United States and other countries.  Since the legislative ban on mephedrone, a no. of 'second-generation' analogs have appeared in the street drug marketplace, including 4-methyl-N-ethylcathinone (4-MEC) and 4'-methyl-α-pyrrolidinopropiophenone (4-MePPP).  Here we characterized the interactions of 4-MEC and 4-MePPP with transporters for 5-HT (SERT) and dopamine (DAT) using mol., cellular, and whole-animal methods.  In vitro transporter assays revealed that 4-MEC displays unusual 'hybrid' activity as a SERT substrate (ie, 5-HT releaser) and DAT blocker, whereas 4-MePPP is a blocker at both transporters but more potent at DAT.  In vivo microdialysis expts. in rat brain demonstrated that 4-MEC (1-3 mg/kg, i.v.) produced large increases in extracellular 5-HT, small increases in dopamine, and minimal motor stimulation.  In contrast, 4-MePPP (1-3 mg/kg, i.v.) produced selective increases in dopamine and robust motor stimulation.  Consistent with its activity as a SERT substrate, 4-MEC evoked inward current in SERT-expressing Xenopus oocytes, whereas 4-MePPP was inactive in this regard.  To examine drug-transporter interactions at the mol. level, we modeled the fit of 4-MEC and 4-MePPP into the binding pockets for DAT and SERT.  Subtle distinctions in ligand-transporter binding were found that account for the differential effects of 4-MEC and 4-MePPP at SERT.  Collectively, our results provide key information about the pharmacol. of newly emerging mephedrone analogs, and give clues to structural requirements that govern drug selectivity at DAT vs SERT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ0DO89wZh7rVg90H21EOLACvtfcHk0ljTzk9aM-LRrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGrsrY%253D&md5=6e47114e4e107ce13331e25f5bb642c6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.325%26sid%3Dliteratum%253Aachs%26aulast%3DSaha%26aufirst%3DK.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DLehner%26aufirst%3DK.%2BR.%26aulast%3DSeddik%26aufirst%3DA.%26aulast%3DStockner%26aufirst%3DT.%26aulast%3DHoly%26aufirst%3DM.%26aulast%3DSandtner%26aufirst%3DW.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26atitle%3D%25E2%2580%259CSecond-generation%25E2%2580%259D%2520mephedrone%2520analogs%252C%25204-MEC%2520and%25204-MePPP%252C%2520differentially%2520affect%2520monoamine%2520transporter%2520function%26jtitle%3DNeuropsychopharmacology%26date%3D2015%26volume%3D40%26spage%3D1321%26epage%3D1331%26doi%3D10.1038%2Fnpp.2014.325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goehring, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penmatsa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ressler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouaux, E.</span></span> <span> </span><span class="NLM_article-title">Structural basis for action by diverse antidepressants on biogenic amine transporters</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1038/nature12648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1038%2Fnature12648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=24121440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSnsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=141-145&author=H.+Wangauthor=A.+Goehringauthor=K.+H.+Wangauthor=A.+Penmatsaauthor=R.+Resslerauthor=E.+Gouaux&title=Structural+basis+for+action+by+diverse+antidepressants+on+biogenic+amine+transporters&doi=10.1038%2Fnature12648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for action by diverse antidepressants on biogenic amine transporters</span></div><div class="casAuthors">Wang, Hui; Goehring, April; Wang, Kevin H.; Penmatsa, Aravind; Ressler, Ryan; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7474</span>),
    <span class="NLM_cas:pages">141-145</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The biogenic amine transporters (BATs) regulate endogenous neurotransmitter concns. and are targets for a broad range of therapeutic agents including selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and tricyclic antidepressants (TCAs).  Because eukaryotic BATs are recalcitrant to crystallog. anal., the authors' understanding of the mechanism of these inhibitors and antidepressants is limited.  LeuT is a bacterial homolog of BATs and has proven to be a valuable paradigm for understanding relationships between their structure and function.  However, because only approx. 25% of the amino acid sequence of LeuT is in common with that of BATs, and as LeuT is a promiscuous amino acid transporter, it does not recapitulate the pharmacol. properties of BATs.  Indeed, SSRIs and TCAs bind in the extracellular vestibule of LeuT and act as non-competitive inhibitors of transport.  By contrast, multiple studies demonstrate that both TCAs and SSRIs are competitive inhibitors for eukaryotic BATs and bind to the primary binding pocket.  Here the authors engineered LeuT to harbor human BAT-like pharmacol. by mutating key residues around the primary binding pocket.  The final LeuBAT mutant binds the SSRI sertraline with a binding const. of 18 nM and displays high-affinity binding to a range of SSRIs, SNRIs and a TCA.  The authors detd. 12 crystal structures of LeuBAT in complex with four classes of antidepressants.  The chem. diverse inhibitors have a remarkably similar mode of binding in which they straddle transmembrane helix (TM) 3, wedge between TM3/TM8 and TM1/TM6, and lock the transporter in a sodium- and chloride-bound outward-facing open conformation.  Together, these studies define common and simple principles for the action of SSRIs, SNRIs and TCAs on BATs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8AMnfh2-Af7Vg90H21EOLACvtfcHk0ljTzk9aM-LRrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSnsLrE&md5=26cc6cf173fdf20ec20d928d02f05193</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnature12648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12648%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DGoehring%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DK.%2BH.%26aulast%3DPenmatsa%26aufirst%3DA.%26aulast%3DRessler%26aufirst%3DR.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DStructural%2520basis%2520for%2520action%2520by%2520diverse%2520antidepressants%2520on%2520biogenic%2520amine%2520transporters%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D141%26epage%3D145%26doi%3D10.1038%2Fnature12648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+Improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lgYCfLYqvVFIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520Improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span> <span> </span><span class="NLM_article-title">LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1021/ci049885e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci049885e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FktVKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=160-169&author=G.+Wolberauthor=T.+Langer&title=LigandScout%3A+3-D+pharmacophores+derived+from+protein-bound+ligands+and+their+use+as+virtual+screening+filters&doi=10.1021%2Fci049885e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters</span></div><div class="casAuthors">Wolber Gerhard; Langer Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of chemical information and modeling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">160-9</span>
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    </div><div class="casAbstract">From the historically grown archive of protein-ligand complexes in the Protein Data Bank small organic ligands are extracted and interpreted in terms of their chemical characteristics and features.  Subsequently, pharmacophores representing ligand-receptor interaction are derived from each of these small molecules and its surrounding amino acids.  Based on a defined set of only six types of chemical features and volume constraints, three-dimensional pharmacophore models are constructed, which are sufficiently selective to identify the described binding mode and are thus a useful tool for in-silico screening of large compound databases.  The algorithms for ligand extraction and interpretation as well as the pharmacophore creation technique from the automatically interpreted data are presented and applied to a rhinovirus capsid complex as application example.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVi_-excgTX2BAiYWy6n3SfW6udTcc2eYWZ2InVMJLD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FktVKrtg%253D%253D&md5=31f8ff7a2fa4c9411d54b001b7e1da50</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fci049885e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci049885e%26sid%3Dliteratum%253Aachs%26aulast%3DWolber%26aufirst%3DG.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DLigandScout%253A%25203-D%2520pharmacophores%2520derived%2520from%2520protein-bound%2520ligands%2520and%2520their%2520use%2520as%2520virtual%2520screening%2520filters%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2005%26volume%3D45%26spage%3D160%26epage%3D169%26doi%3D10.1021%2Fci049885e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit50b"><span> <i>LigandScout</i>, versions <span class="NLM_edition">4.3</span>; <span class="NLM_publisher-name">Inte:Ligand GmbH</span>: <span class="NLM_publisher-loc">Vienna, Austria</span>; <a href="http://www.inteligand.com" class="extLink">www.inteligand.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+LigandScout%2C+versions+4.3%3B+Inte%3ALigand+GmbH%3A+Vienna%2C+Austria%3B+www.inteligand.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigandScout%26pub%3DInte%253ALigand%2520GmbH" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span> <i>IL Tox PharmDB</i>; <span class="NLM_publisher-name">Inte:Ligand
GmbH</span>: <span class="NLM_publisher-loc">Vienna Austria</span>; <a href="http://www.inteligand.com" class="extLink">www.inteligand.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+IL+Tox+PharmDB%3B+Inte%3ALigand%0AGmbH%3A+Vienna+Austria%3B+www.inteligand.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DIL%2520Tox%2520PharmDB%26pub%3DInte%253ALigand%250AGmbH" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berthold, M. R.</span>; <span class="NLM_string-name">Cebron, N.</span>; <span class="NLM_string-name">Dill, F.</span>; <span class="NLM_string-name">Gabriel, T. R.</span>; <span class="NLM_string-name">Kotter, T.</span>; <span class="NLM_string-name">Meinl, T.</span>; <span class="NLM_string-name">Ohl, P.</span>; <span class="NLM_string-name">Sieb, C.</span>; <span class="NLM_string-name">Thiel, K.</span>; <span class="NLM_string-name">Wiswedel, B.</span></span> <span> </span><span class="NLM_article-title">KNIME: The konstanz information miner</span>.  <i>Data Analysis, Machine Learning and Applications. Studies in Classification, Data Analysis, and Knowledge Organization</i>; <span class="NLM_publisher-name">Springer</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1007%2F978-3-540-78246-9_38" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+R.+Berthold&author=N.+Cebron&author=F.+Dill&author=T.+R.+Gabriel&author=T.+Kotter&author=T.+Meinl&author=P.+Ohl&author=C.+Sieb&author=K.+Thiel&author=B.+Wiswedel&title=Data+Analysis%2C+Machine+Learning+and+Applications.+Studies+in+Classification%2C+Data+Analysis%2C+and+Knowledge+Organization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-78246-9_38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-540-78246-9_38%26sid%3Dliteratum%253Aachs%26aulast%3DBerthold%26aufirst%3DM.%2BR.%26atitle%3DKNIME%253A%2520The%2520konstanz%2520information%2520miner%26btitle%3DData%2520Analysis%252C%2520Machine%2520Learning%2520and%2520Applications.%2520Studies%2520in%2520Classification%252C%2520Data%2520Analysis%252C%2520and%2520Knowledge%2520Organization%26pub%3DSpringer%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pifl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reither, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornykiewicz, O.</span></span> <span> </span><span class="NLM_article-title">The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>755</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2015.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.ejphar.2015.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=25771452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFWntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=755&publication_year=2015&pages=119-126&author=C.+Piflauthor=H.+Reitherauthor=O.+Hornykiewicz&title=The+profile+of+mephedrone+on+human+monoamine+transporters+differs+from+3%2C4-methylenedioxymethamphetamine+primarily+by+lower+potency+at+the+vesicular+monoamine+transporter&doi=10.1016%2Fj.ejphar.2015.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter</span></div><div class="casAuthors">Pifl, Christian; Reither, Harald; Hornykiewicz, Oleh</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">755</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-126</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mephedrone (4-methylmethcathinone, MMC) and 3,4-methylenedioxymethamphetamine (MDMA) are constituents of popular party drugs with psychoactive effects.  Structurally they are amphetamine-like substances with monoamine neurotransmitter enhancing actions.  We therefore compared their effects on the human monoamine transporters using human cell lines stably expressing the human noradrenaline, dopamine and serotonin transporter (NET, DAT and SERT); prepns. of synaptic vesicles from human striatum in uptake expts.; and a superfusion system where releasing effects can be reliably measured.  MMC and MDMA were equally potent in inhibiting noradrenaline uptake at NET, with IC50 values of 1.9 and 2.1 μM, resp.  Compared to their NET inhibition potency, both drugs were weaker uptake inhibitors at DAT and SERT, with MMC being more potent than MDMA at DAT (IC50: 5.9 vs 12.6 μM) and less potent than MDMA at SERT (IC50: 19.3 vs 7.6 μM).  MMC and MDMA both induced concn.-dependently [3H]1-methyl-4-phenylpyridinium-release from NET-, DAT or SERT-expressing cells which was clearly transporter-mediated release as demonstrated by the selective inhibitory effects of nmolar to low μmolar concns. of desipramine, GBR 12909 and fluoxetine, resp.  MMC and MDMA differed most in their inhibition of [3H]dopamine uptake by synaptic vesicles from human striatum with MDMA being 10-fold more potent than MMC (IC50: 20 vs 223 μM) and their ability to release [3H]dopamine from human vesicular monoamine transporter expressing SH-SY5Y neuroblastoma cells in which MDMA seems to have a stronger effect.  Our findings give a mol. explanation to the lower long-term neurotoxicity of MMC compared to MDMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPemcos_VlDLVg90H21EOLACvtfcHk0lisxv_cZb36Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFWntb8%253D&md5=ac9e76341be09ae33928d4b7c03cb978</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DPifl%26aufirst%3DC.%26aulast%3DReither%26aufirst%3DH.%26aulast%3DHornykiewicz%26aufirst%3DO.%26atitle%3DThe%2520profile%2520of%2520mephedrone%2520on%2520human%2520monoamine%2520transporters%2520differs%2520from%25203%252C4-methylenedioxymethamphetamine%2520primarily%2520by%2520lower%2520potency%2520at%2520the%2520vesicular%2520monoamine%2520transporter%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D755%26spage%3D119%26epage%3D126%26doi%3D10.1016%2Fj.ejphar.2015.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pifl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornykiewicz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giros, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>277</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=8667208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADyaK28XjslGltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1996&pages=1437-1443&issue=3&author=C.+Piflauthor=O.+Hornykiewiczauthor=B.+Girosauthor=M.+G.+Caron&title=Catecholamine+transporters+and+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+neurotoxicity%3A+studies+comparing+the+cloned+human+noradrenaline+and+human+dopamine+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter</span></div><div class="casAuthors">Pifl, Christian; Hornykiewicz, Oleh; Giros, Bruno; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1437-1443</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The uptake and cytotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic metabolite of the parkinsonism inducing agent MPTP, were studied in COS-7 cells transiently transfected with the cloned human noradrenaline and dopamine transporters and in permanently transfected SK-N-MC neuroblastoma cells.  MPP+ had a 10- to 20-fold lower Km value for the noradrenaline than for the dopamine transporter.  In dopamine transporter expressing cells, the maximal transport rate (Vmax) of MPP+, dopamine and noradrenaline was the same, but in noradrenaline transporter expressing cells the Vmax of MPP+ and dopamine was only one-half of the Vmax of noradrenaline.  The turnover nos. (Vmax of uptake/maximal binding sites of binding) were 5 times higher for the dopamine transporter (as measured with [3H]dopamine and [3H]-2β-carbomethoxy-3β-(4-fluorophenyl)) tropane than for the noradrenaline transporter (as measured with [3H]noradrenaline and [3H]nisoxetine).  In SK-N-MC cells with similar Vmax values for both catecholamines, noradrenaline transporter expressing cells were killed by lower concns. of MPP+ in the medium than dopamine transporter expressing cells.  Desipramine blocked the toxicity of MPP+ toward the noradrenaline transporter, but not the dopamine transporter expressing cells.  The authors conclude that the toxic effect of MPTP at the striatal dopamine system in the MPTP primate model of Parkinson's disease is not correlated with the affinity profile of MPP+ for catecholamine transporters, but rather with the higher turnover no. of MPP+ at the dopamine transporter.  In contradistinction, the toxicity of MPTP at the noradrenaline neurons in the primate cerebral cortex (Pifl et al., 1991) may involve the higher affinity of MPP+ for the noradrenaline transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojO_0QzJzI7LVg90H21EOLACvtfcHk0lisxv_cZb36Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjslGltLs%253D&md5=588acd8dd48fc8a1c9b85b2fadfaca5a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPifl%26aufirst%3DC.%26aulast%3DHornykiewicz%26aufirst%3DO.%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DCatecholamine%2520transporters%2520and%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520neurotoxicity%253A%2520studies%2520comparing%2520the%2520cloned%2520human%2520noradrenaline%2520and%2520human%2520dopamine%2520transporter%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1996%26volume%3D277%26issue%3D3%26spage%3D1437%26epage%3D1443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pifl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobny, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reither, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornykiewicz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, E. A.</span></span> <span> </span><span class="NLM_article-title">Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">368</span>– <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=7870046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADyaK2MXktVSlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1995&pages=368-373&issue=2&author=C.+Piflauthor=H.+Drobnyauthor=H.+Reitherauthor=O.+Hornykiewiczauthor=E.+A.+Singer&title=Mechanism+of+the+dopamine-releasing+actions+of+amphetamine+and+cocaine%3A+plasmalemmal+dopamine+transporter+versus+vesicular+monoamine+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter</span></div><div class="casAuthors">Pifl, Christian; Drobny, Helmut; Reither, Harald; Hornykiewicz, Oleh; Singer, Ernst A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">368-73</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The effects of amphetamine and cocaine were studied in [3H]-dopamine-loaded and superfused COS-7 cells transfected with either the cDNA of the plasmalemmal dopamine transporter ("DAT cells") or the cDNA of the vesicular amine transporter ("VAT cells"), or with both transporters ("DAT/VAT cells").  Amphetamine (0.01-100 μM, added for 4 min at superfusion) led to a concn.-dependent increase in dopamine release in DAT cells, as well as DAT/VAT cells.  The EC50 of the effect of amphetamine on DAT cells was 1.1 μM; the effect on DAT/VAT cells did not reach a plateau in the concn. range tested.  With longer exposure to amphetamine, dopamine efflux from DAT cells reached a peak and quickly returned to baseline, in spite of the continued presence of the drug, whereas in DAT/VAT cells and in VAT cells the effect was sustained.  Cocaine (≤100 μm) did not exert any effect of its own in DAT cells or VAT cells, but inhibited the amphetamine-induced release of dopamine from DAT cells in a competitive manner.  In DAT/VAT cells, cocaine and its analog (-)-2β-carbomethoxy-3β-(4-fluorophenyl)tropane caused an efflux of dopamine resembling that caused by amphetamine but quant. much smaller.  The rank order of potency was the same as in uptake expts. [(-)-2β-carbomethoxy-3β-(4-fluorophenyl)tropane > cocaine].  The effect of cocaine was mimicked by the redn. of chloride.  The results indicate that there is a plasmalemmal component and a vesicular component in the dopamine-releasing action of amphetamine.  The releasing action of cocaine is dependent on the existence of a vesicular pool of the neurotransmitter and seems to be linked to inhibition of the plasmalemmal dopamine transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD5D82QFFP6rVg90H21EOLACvtfcHk0lisxv_cZb36Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXktVSlsbw%253D&md5=f878da7769d4aed8f81f4162841a775e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPifl%26aufirst%3DC.%26aulast%3DDrobny%26aufirst%3DH.%26aulast%3DReither%26aufirst%3DH.%26aulast%3DHornykiewicz%26aufirst%3DO.%26aulast%3DSinger%26aufirst%3DE.%2BA.%26atitle%3DMechanism%2520of%2520the%2520dopamine-releasing%2520actions%2520of%2520amphetamine%2520and%2520cocaine%253A%2520plasmalemmal%2520dopamine%2520transporter%2520versus%2520vesicular%2520monoamine%2520transporter%26jtitle%3DMol.%2520Pharmacol.%26date%3D1995%26volume%3D47%26issue%3D2%26spage%3D368%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camats-Perna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartori, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuyyuru, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragačević, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singewald, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">Differential Effects of Novel Dopamine Reuptake Inhibitors on Interference With Long-Term Social Memory in Mice</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">63</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2019.00063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3389%2Ffnbeh.2019.00063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=31031603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlKgtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2019&pages=63&author=J.+Camats-Pernaauthor=P.+Kalabaauthor=K.+Ebnerauthor=S.+B.+Sartoriauthor=H.+Vuyyuruauthor=N.+Y.+Aherauthor=V.+Draga%C4%8Devi%C4%87author=N.+Singewaldauthor=M.+Engelmannauthor=G.+Lubec&title=Differential+Effects+of+Novel+Dopamine+Reuptake+Inhibitors+on+Interference+With+Long-Term+Social+Memory+in+Mice&doi=10.3389%2Ffnbeh.2019.00063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of novel dopamine reuptake inhibitors on interference with long-term social memory in mice</span></div><div class="casAuthors">Camats-Perna, Judith; Kalaba, Predrag; Ebner, Karl; Sartori, Simone B.; Vuyyuru, Harish; Aher, Nilima Y.; Dragacevic, Vladimir; Singewald, Nicolas; Engelmann, Mario; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">In the lab., long-term social recognition memory (SRM) in mice is highly susceptible to proactive and retroactive interference.  Here, we investigate the ability of novel designed dopamine (DA) re-uptake inhibitors (rac-CE-123 and S-CE-123) to block retroactive and proactive interference, resp.  Our data show that administration of rac-CE-123 30 min before learning blocks retroactive interference that has been exptl. induced at 3 h, but not at 6 h, post-learning.  In contrast, S-CE-123 treatment 30 min before learning blocked the induction of retroactive interference at 6 h, but not 3 h, post-learning.  Administration of S-CE-123 failed to interfere with proactive interference at both 3 h and 6 h.  Anal. of addnl. behavioral parameters collected during the memory task implies that the effects of the new DA re-uptake inhibitors on retroactive and proactive interference cannot easily be explained by non-specific effects on the animals' general social behavior.  Furthermore, we assessed the mechanisms of action of drugs using intracerebral in vivo-microdialysis technique.  The results revealed that administration of rac-CE-123 and S-CE-123 dose-dependently increased DA release within the nucleus accumbens of freely behaving mice.  Thus, the data from the present study suggests that the DA re-uptake inhibitors tested protect the consolidation of long-term social memory against interference for defined durations after learning.  In addn., the data implies that DA signaling in distinct brain areas including the nucleus accumbens is involved in the consolidation of SRM in lab. mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTzZr6XOtyS7Vg90H21EOLACvtfcHk0lgm_pCFnGZ0dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlKgtLbM&md5=21895e5683567828bc39993d3855b721</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2019.00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2019.00063%26sid%3Dliteratum%253Aachs%26aulast%3DCamats-Perna%26aufirst%3DJ.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DEbner%26aufirst%3DK.%26aulast%3DSartori%26aufirst%3DS.%2BB.%26aulast%3DVuyyuru%26aufirst%3DH.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DDraga%25C4%258Devi%25C4%2587%26aufirst%3DV.%26aulast%3DSingewald%26aufirst%3DN.%26aulast%3DEngelmann%26aufirst%3DM.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DDifferential%2520Effects%2520of%2520Novel%2520Dopamine%2520Reuptake%2520Inhibitors%2520on%2520Interference%2520With%2520Long-Term%2520Social%2520Memory%2520in%2520Mice%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2019%26volume%3D13%26spage%3D63%26doi%3D10.3389%2Ffnbeh.2019.00063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50','cit50b'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jana  Lubec</span>, <span class="hlFld-ContribAuthor ">Predrag  Kalaba</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Hussein</span>, <span class="hlFld-ContribAuthor ">Daniel Daba  Feyissa</span>, <span class="hlFld-ContribAuthor ">Mohamed H.  Kotob</span>, <span class="hlFld-ContribAuthor ">Rasha R.  Mahmmoud</span>, <span class="hlFld-ContribAuthor ">Oliver  Wieder</span>, <span class="hlFld-ContribAuthor ">Arthur  Garon</span>, <span class="hlFld-ContribAuthor ">Claudia  Sagheddu</span>, <span class="hlFld-ContribAuthor ">Marija  Ilic</span>, <span class="hlFld-ContribAuthor ">Vladimir  Dragačević</span>, <span class="hlFld-ContribAuthor ">Anita  Cybulska-Klosowicz</span>, <span class="hlFld-ContribAuthor ">Martin  Zehl</span>, <span class="hlFld-ContribAuthor ">Judith  Wackerlig</span>, <span class="hlFld-ContribAuthor ">Simone B.  Sartori</span>, <span class="hlFld-ContribAuthor ">Karl  Ebner</span>, <span class="hlFld-ContribAuthor ">Shima  Kouhnavardi</span>, <span class="hlFld-ContribAuthor ">Alexander  Roller</span>, <span class="hlFld-ContribAuthor ">Natalie  Gajic</span>, <span class="hlFld-ContribAuthor ">Marco  Pistis</span>, <span class="hlFld-ContribAuthor ">Nicolas  Singewald</span>, <span class="hlFld-ContribAuthor ">Johann Jakob  Leban</span>, <span class="hlFld-ContribAuthor ">Volker  Korz</span>, <span class="hlFld-ContribAuthor ">Jovana  Malikovic</span>, <span class="hlFld-ContribAuthor ">Roberto  Plasenzotti</span>, <span class="hlFld-ContribAuthor ">Harald H.  Sitte</span>, <span class="hlFld-ContribAuthor ">Francisco J.  Monje</span>, <span class="hlFld-ContribAuthor ">Thierry  Langer</span>, <span class="hlFld-ContribAuthor ">Ernst  Urban</span>, <span class="hlFld-ContribAuthor ">Christian  Pifl</span>, <span class="hlFld-ContribAuthor ">Gert  Lubec</span>. </span><span class="cited-content_cbyCitation_article-title">Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition. </span><span class="cited-content_cbyCitation_journal-name">Molecular Psychiatry</span><span> <strong>2021,</strong> <em>55 </em><a href="https://doi.org/10.1038/s41380-021-01214-x" title="DOI URL">https://doi.org/10.1038/s41380-021-01214-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41380-021-01214-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41380-021-01214-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Psychiatry%26atitle%3DReinstatement%252Bof%252Bsynaptic%252Bplasticity%252Bin%252Bthe%252Baging%252Bbrain%252Bthrough%252Bspecific%252Bdopamine%252Btransporter%252Binhibition%26aulast%3DLubec%26aufirst%3DJana%26date%3D2021%26date%3D2021%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ágoston  Patthy</span>, <span class="hlFld-ContribAuthor ">János  Murai</span>, <span class="hlFld-ContribAuthor ">János  Hanics</span>, <span class="hlFld-ContribAuthor ">Anna  Pintér</span>, <span class="hlFld-ContribAuthor ">Péter  Zahola</span>, <span class="hlFld-ContribAuthor ">Tomas G. M.  Hökfelt</span>, <span class="hlFld-ContribAuthor ">Tibor  Harkany</span>, <span class="hlFld-ContribAuthor ">Alán  Alpár</span>. </span><span class="cited-content_cbyCitation_article-title">Neuropathology of the Brainstem to Mechanistically Understand and to Treat Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2021,</strong> <em>10 </em>
                                    (8)
                                     , 1555. <a href="https://doi.org/10.3390/jcm10081555" title="DOI URL">https://doi.org/10.3390/jcm10081555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm10081555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm10081555%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DNeuropathology%252Bof%252Bthe%252BBrainstem%252Bto%252BMechanistically%252BUnderstand%252Band%252Bto%252BTreat%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPatthy%26aufirst%3D%25C3%2581goston%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D8%26spage%3D1555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluigi  Tanda</span>, <span class="hlFld-ContribAuthor ">Melinda  Hersey</span>, <span class="hlFld-ContribAuthor ">Briana  Hempel</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2021,</strong> <em>56 </em>, 13-21. <a href="https://doi.org/10.1016/j.coph.2020.07.007" title="DOI URL">https://doi.org/10.1016/j.coph.2020.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2020.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2020.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DModafinil%252Band%252Bits%252Bstructural%252Banalogs%252Bas%252Batypical%252Bdopamine%252Buptake%252Binhibitors%252Band%252Bpotential%252Bmedications%252Bfor%252Bpsychostimulant%252Buse%252Bdisorder%26aulast%3DTanda%26aufirst%3DGianluigi%26date%3D2021%26volume%3D56%26spage%3D13%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Therese  Ku</span>, <span class="hlFld-ContribAuthor ">Chloe J.  Jordan</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2021,</strong> <em>61 </em>
                                    (1)
                                     , 609-628. <a href="https://doi.org/10.1146/annurev-pharmtox-030220-124205" title="DOI URL">https://doi.org/10.1146/annurev-pharmtox-030220-124205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-pharmtox-030220-124205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-pharmtox-030220-124205%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3DNew%252BDrugs%25252C%252BOld%252BTargets%25253A%252BTweaking%252Bthe%252BDopamine%252BSystem%252Bto%252BTreat%252BPsychostimulant%252BUse%252BDisorders%26aulast%3DNewman%26aufirst%3DAmy%2BHauck%26date%3D2021%26volume%3D61%26issue%3D1%26spage%3D609%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JoLynn B.  Giancola</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Therese  Ku</span>, <span class="hlFld-ContribAuthor ">Alexandra J.  Haraczy</span>, <span class="hlFld-ContribAuthor ">Jenny  Lam</span>, <span class="hlFld-ContribAuthor ">Rana  Rais</span>, <span class="hlFld-ContribAuthor ">Mark A.  Coggiano</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Tanda</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships for a series of (Bis(4-fluorophenyl)methyl)sulfinylethyl-aminopiperidines and -piperidine amines at the dopamine transporter: Bioisosteric replacement of the piperazine improves metabolic stability. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112674. <a href="https://doi.org/10.1016/j.ejmech.2020.112674" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112674%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationships%252Bfor%252Ba%252Bseries%252Bof%252B%252528Bis%2525284-fluorophenyl%252529methyl%252529sulfinylethyl-aminopiperidines%252Band%252B-piperidine%252Bamines%252Bat%252Bthe%252Bdopamine%252Btransporter%25253A%252BBioisosteric%252Breplacement%252Bof%252Bthe%252Bpiperazine%252Bimproves%252Bmetabolic%252Bstability%26aulast%3DGiancola%26aufirst%3DJoLynn%2BB.%26date%3D2020%26volume%3D208%26spage%3D112674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renee A.  Rotolo</span>, <span class="hlFld-ContribAuthor ">Predrag  Kalaba</span>, <span class="hlFld-ContribAuthor ">Vladimir  Dragacevic</span>, <span class="hlFld-ContribAuthor ">Rose E.  Presby</span>, <span class="hlFld-ContribAuthor ">Julia  Neri</span>, <span class="hlFld-ContribAuthor ">Emily  Robertson</span>, <span class="hlFld-ContribAuthor ">Jen-Hau  Yang</span>, <span class="hlFld-ContribAuthor ">Merce  Correa</span>, <span class="hlFld-ContribAuthor ">Vasiliy  Bakulev</span>, <span class="hlFld-ContribAuthor ">Natalia N.  Volkova</span>, <span class="hlFld-ContribAuthor ">Christian  Pifl</span>, <span class="hlFld-ContribAuthor ">Gert  Lubec</span>, <span class="hlFld-ContribAuthor ">John D.  Salamone</span>. </span><span class="cited-content_cbyCitation_article-title">Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2020,</strong> <em>237 </em>
                                    (11)
                                     , 3459-3470. <a href="https://doi.org/10.1007/s00213-020-05625-6" title="DOI URL">https://doi.org/10.1007/s00213-020-05625-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-020-05625-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-020-05625-6%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DBehavioral%252Band%252Bdopamine%252Btransporter%252Bbinding%252Bproperties%252Bof%252Bthe%252Bmodafinil%252Banalog%252B%252528S%25252C%252BS%252529-CE-158%25253A%252Breversal%252Bof%252Bthe%252Bmotivational%252Beffects%252Bof%252Btetrabenazine%252Band%252Benhancement%252Bof%252Bprogressive%252Bratio%252Bresponding%26aulast%3DRotolo%26aufirst%3DRenee%2BA.%26date%3D2020%26date%3D2020%26volume%3D237%26issue%3D11%26spage%3D3459%26epage%3D3470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miljan N. M.  Milunović</span>, <span class="hlFld-ContribAuthor ">Oleg  Palamarciuc</span>, <span class="hlFld-ContribAuthor ">Angela  Sirbu</span>, <span class="hlFld-ContribAuthor ">Sergiu  Shova</span>, <span class="hlFld-ContribAuthor ">Dan  Dumitrescu</span>, <span class="hlFld-ContribAuthor ">Dana  Dvoranová</span>, <span class="hlFld-ContribAuthor ">Peter  Rapta</span>, <span class="hlFld-ContribAuthor ">Tatsiana V.  Petrasheuskaya</span>, <span class="hlFld-ContribAuthor ">Eva A.  Enyedy</span>, <span class="hlFld-ContribAuthor ">Gabriella  Spengler</span>, <span class="hlFld-ContribAuthor ">Marija  Ilic</span>, <span class="hlFld-ContribAuthor ">Harald H.  Sitte</span>, <span class="hlFld-ContribAuthor ">Gert  Lubec</span>, <span class="hlFld-ContribAuthor ">Vladimir B.  Arion</span>. </span><span class="cited-content_cbyCitation_article-title">Insight into the Anticancer Activity of Copper(II) 5-Methylenetrimethylammonium-Thiosemicarbazonates and Their Interaction with Organic Cation Transporters. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (9)
                                     , 1213. <a href="https://doi.org/10.3390/biom10091213" title="DOI URL">https://doi.org/10.3390/biom10091213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10091213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10091213%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DInsight%252Binto%252Bthe%252BAnticancer%252BActivity%252Bof%252BCopper%252528II%252529%252B5-Methylenetrimethylammonium-Thiosemicarbazonates%252Band%252BTheir%252BInteraction%252Bwith%252BOrganic%252BCation%252BTransporters%26aulast%3DMilunovi%25C4%2587%26aufirst%3DMiljan%2BN.%2BM.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D9%26spage%3D1213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of (±) modafinil (<b>1</b>), JJC8-016 (<b>2</b>), CE-103 (<b>3</b>), CE-111 (<b>4</b>), CE-125 (<b>5</b>), and CE-123 (<b>6</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>11a</b>–<b>s</b> and <b>12a</b>–<b>s</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 48% HBr, MeOH, reflux, 4 h; (b) MeOH, K<sub>2</sub>CO<sub>3</sub>, rt 48 h; (c) CH<sub>3</sub>COOH, 30% H<sub>2</sub>O<sub>2</sub>, rt overnight.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>16</b> and <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 48% HBr, H<sub>2</sub>O, 100–105 °C, 1 h; (b) 1,4-dioxane, NaOH, 70 °C, 5 h; (c) CH<sub>3</sub>COOH, 30% H<sub>2</sub>O<sub>2</sub>, rt 24 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>23a</b>–<b>m</b> and <b>24a</b>–<b>m</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, NaI, acetone, 35–40 °C, 3 h; (b) NaOH, EtOH, reflux, 2 h; (c) BF<sub>3</sub>·Et<sub>2</sub>O, CH<sub>3</sub>COOH, rt overnight; (d) CH<sub>3</sub>COOH, 30% H<sub>2</sub>O<sub>2</sub>, rt overnight.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>31c</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, NaI, acetone, 35–40 °C, 3 h; (b) NaOH, EtOH, reflux, 2 h; (c) BF<sub>3</sub>·Et<sub>2</sub>O, CH<sub>3</sub>COOH, rt overnight; (d) chiral separations, Chiralpak IA column, isocratic 100% ACN as mobile phase; (e) CH<sub>3</sub>COOH, H<sub>2</sub>O<sub>2</sub>, rt overnight; (f) chiral separations, Chiralpak IA column, isocratic absolute EtOH as mobile phase for <b>31c</b> and <b>31d</b>, isocratic 80% EtOAc, 20% hexane as mobile phase for <b>31e</b> and <b>31f</b>.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Strategy for Compounds <b>42a</b>–<b>f</b> to <b>45a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) BF<sub>3</sub>·Et<sub>2</sub>O, CH<sub>3</sub>COOH, reflux, 3 h; (b) chiral-phase HPLC; (c) CH<sub>3</sub>COOH, H<sub>2</sub>O<sub>2</sub>, rt overnight; (d) chiral-phase HPLC.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative reuptake inhibition curves of compounds <b>31c</b>–<b>f</b>. <b>31c</b>–<b>f</b> represent individual stereoisomers with significant difference in activity and selectivity toward DAT (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. The highest scored docked poses of <b>31c</b> (cyane), <b>31d</b> (yellow), <b>31e</b> (orange), <b>31f</b> (pink) are shown as overlay in the binding pocket of the hDAT homology model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Interactions of the highest scored pose of <b>31c</b>–<b>f</b> in the binding pocket of hDAT. Red lines indicate hydrogen bond donor interactions, and yellow highlights hydrophobic interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Heat map of compounds screened using the Inte:Ligand hERG eTox pharmacophore model, showing no relevant fit of any of the compounds to the query (white boxes).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Representable APs in control (black) and recorded 30 min after application of either vehicle (0.1% of DMSO) or test compounds <b>31c</b>–<b>f</b> at 10 μM (red). None of the drugs affected action potential parameters.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>31e</b> and <span class="smallcaps smallerCapital">d</span>-amphetamine, as well as their interaction, on release by human DAT. HEK293 cells stably expressing DAT were loaded with [<sup>3</sup>H]MPP<sup>+</sup> and superfused, and 4 min fractions of superfusate were collected. After two or three fractions of basal efflux, cells were exposed to buffers containing 10 μM <b>31e</b> (triangles), 3 μM <span class="smallcaps smallerCapital">d</span>-amphetamine (circles), or both (squares) for three or four fractions as indicated by the bars below. Symbols represent the mean ± SEM of seven to eight observations of three independent experiments: *<i>P</i> < 0.05, **<i>P</i> < 0.001 vs basal efflux (mean values of fractions at 0 and 5 min) by paired Student’s <i>t</i> test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/medium/jm9b01938_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Extracellular dopamine (DA) levels in the nucleus accumbens (NAcb) after systemic injection of <b>31e</b>. (A) Effect of local high potassium on DA concentrations in microdialysates. (B) The higher dose (10 mg/kg ip) but not the low dose (1 mg/kg ip) of <b>31e</b> increased extracellular DA levels peaking at 50 min after injection. The arrow denotes the time of injection. Data are relative to baseline DA levels and presented as the mean ± SEM: <i>N</i> = 9–10; <sup>a</sup><i>P</i> < 0.08, *<i>P</i> < 0.05, **<i>P</i> < 0.01 analyzed by two-way ANOVA with repeated measurements followed by a Fisher‘s LSD test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01938/20200106/images/large/jm9b01938_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01938&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i130">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 56 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minzenberg, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, C. S.</span></span> <span> </span><span class="NLM_article-title">Modafinil: A review of neurochemical actions and effects on cognition</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1477</span>– <span class="NLM_lpage">1502</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1301534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1038%2Fsj.npp.1301534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=17712350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=1477-1502&issue=7&author=M.+J.+Minzenbergauthor=C.+S.+Carter&title=Modafinil%3A+A+review+of+neurochemical+actions+and+effects+on+cognition&doi=10.1038%2Fsj.npp.1301534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil: A Review of Neurochemical Actions and Effects on Cognition</span></div><div class="casAuthors">Minzenberg, Michael J.; Carter, Cameron S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1477-1502</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Modafinil (2-[(Diphenylmethyl) sulfinyl] acetamide, Provigil) is an FDA-approved medication with wake-promoting properties.  Pre-clin. studies of modafinil suggest a complex profile of neurochem. and behavioral effects, distinct from those of amphetamine.  In addn., modafinil shows initial promise for a variety of off-label indications in psychiatry, including treatment-resistant depression, attention-deficit/hyperactivity disorder, and schizophrenia.  Cognitive dysfunction may be a particularly important emerging treatment target for modafinil, across these and other neuropsychiatric disorders.  We aimed to comprehensively review the empirical literature on neurochem. actions of modafinil, and effects on cognition in animal models, healthy adult humans, and clin. populations.  We searched PubMed with the search term modafinil' and reviewed all English-language articles for neurochem., neurophysiol., cognitive, or information-processing exptl. measures.  We addnl. summarized the pharmacokinetic profile of modafinil and clin. efficacy in psychiatric patients.  Modafinil exhibits robust effects on catecholamines, serotonin, glutamate, gamma amino-butyric acid, orexin, and histamine systems in the brain.  Many of these effects may be secondary to catecholamine effects, with some selectivity for cortical over subcortical sites of action.  In addn., modafinil (at well-tolerated doses) improves function in several cognitive domains, including working memory and episodic memory, and other processes dependent on prefrontal cortex and cognitive control.  These effects are obsd. in rodents, healthy adults, and across several psychiatric disorders.  Furthermore, modafinil appears to be well-tolerated, with a low rate of adverse events and a low liability to abuse.  Modafinil has a no. of neurochem. actions in the brain, which may be related to primary effects on catecholaminergic systems.  These effects are in general advantageous for cognitive processes.  Overall, modafinil is an excellent candidate agent for remediation of cognitive dysfunction in neuropsychiatric disorders.  Neuropsychopharmacol. (2008) 33, 1477-1502; doi:10.1038/sj.npp.1301534; published online 22 August 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHENkazvO_x7Vg90H21EOLACvtfcHk0lhapLF6xsFHjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSrtrc%253D&md5=b3f5ab7df9e6126e05e19a352900b482</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301534%26sid%3Dliteratum%253Aachs%26aulast%3DMinzenberg%26aufirst%3DM.%2BJ.%26aulast%3DCarter%26aufirst%3DC.%2BS.%26atitle%3DModafinil%253A%2520A%2520review%2520of%2520neurochemical%2520actions%2520and%2520effects%2520on%2520cognition%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26issue%3D7%26spage%3D1477%26epage%3D1502%26doi%3D10.1038%2Fsj.npp.1301534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerrard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, R.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of modafinil: a review of current research</span>. <i>Neuropsychiatr. Dis. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=19300566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1WnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=349-364&issue=3&author=P.+Gerrardauthor=R.+Malcolm&title=Mechanisms+of+modafinil%3A+a+review+of+current+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of modafinil: a review of current research</span></div><div class="casAuthors">Gerrard, Paul; Malcolm, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychiatric Disease and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-364</span>CODEN:
                <span class="NLM_cas:coden">NDTEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1176-6328</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  The novel wake-promoting agent modafinil has been in use for the treatment of several sleep disorders for a few years and is now undergoing clin. trials for its use in the treatment of stimulant addiction, but its primary mechanism of action remains elusive.  Previous lab. studies have shown that modafinil has antioxidative and neuroprotective effects, which have not previously been suggested to be related to its wake-promoting effects.  However, recent research indicates that free radicals may be related to sleep induction as well as cellular damage, suggesting that a common target of action may mediate modafinil's ability to oppose both of these effects.  In this review we summarize and discuss previously published research on modafinil's neural, cytoprotective, and cognitive effects, and we propose possible primary biochem. targets that could underlie the effects of modafinil obsd. in these studies.  We also suggest neurocognitive mechanisms responsible for modafinil's cognitive enhancing effects and its therapeutic potential in the treatment of stimulant addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbxuHCZ8GqFbVg90H21EOLACvtfcHk0lhapLF6xsFHjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1WnsLw%253D&md5=3b9d1c81db02be3d8ecf8c370208bddf</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerrard%26aufirst%3DP.%26aulast%3DMalcolm%26aufirst%3DR.%26atitle%3DMechanisms%2520of%2520modafinil%253A%2520a%2520review%2520of%2520current%2520research%26jtitle%3DNeuropsychiatr.%2520Dis.%2520Treat.%26date%3D2007%26volume%3D3%26issue%3D3%26spage%3D349%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urban, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W. J.</span></span> <span> </span><span class="NLM_article-title">Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain</span>. <i>Front. Syst. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">38</span>, <span class="refDoi"> DOI: 10.3389/fnsys.2014.00038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3389%2Ffnsys.2014.00038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=24860437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A280%3ADC%252BC2cflvFamsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=38&author=K.+R.+Urbanauthor=W.+J.+Gao&title=Performance+enhancement+at+the+cost+of+potential+brain+plasticity%3A+neural+ramifications+of+nootropic+drugs+in+the+healthy+developing+brain&doi=10.3389%2Ffnsys.2014.00038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain</span></div><div class="casAuthors">Urban Kimberly R; Gao Wen-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in systems neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38</span>
        ISSN:<span class="NLM_cas:issn">1662-5137</span>.
    </div><div class="casAbstract">Cognitive enhancement is perhaps one of the most intriguing and controversial topics in neuroscience today.  Currently, the main classes of drugs used as potential cognitive enhancers include psychostimulants (methylphenidate (MPH), amphetamine), but wakefulness-promoting agents (modafinil) and glutamate activators (ampakine) are also frequently used.  Pharmacologically, substances that enhance the components of the memory/learning circuits-dopamine, glutamate (neuronal excitation), and/or norepinephrine-stand to improve brain function in healthy individuals beyond their baseline functioning.  In particular, non-medical use of prescription stimulants such as MPH and illicit use of psychostimulants for cognitive enhancement have seen a recent rise among teens and young adults in schools and college campuses.  However, this enhancement likely comes with a neuronal, as well as ethical, cost.  Altering glutamate function via the use of psychostimulants may impair behavioral flexibility, leading to the development and/or potentiation of addictive behaviors.  Furthermore, dopamine and norepinephrine do not display linear effects; instead, their modulation of cognitive and neuronal function maps on an inverted-U curve.  Healthy individuals run the risk of pushing themselves beyond optimal levels into hyperdopaminergic and hypernoradrenergic states, thus vitiating the very behaviors they are striving to improve.  Finally, recent studies have begun to highlight potential damaging effects of stimulant exposure in healthy juveniles.  This review explains how the main classes of cognitive enhancing drugs affect the learning and memory circuits, and highlights the potential risks and concerns in healthy individuals, particularly juveniles and adolescents.  We emphasize the performance enhancement at the potential cost of brain plasticity that is associated with the neural ramifications of nootropic drugs in the healthy developing brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9mMH7P4hI_--MdeMhXAHkfW6udTcc2eakMSEBh4gFrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflvFamsg%253D%253D&md5=d552cabbeece23291f10b62d98deb3fc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffnsys.2014.00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnsys.2014.00038%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DK.%2BR.%26aulast%3DGao%26aufirst%3DW.%2BJ.%26atitle%3DPerformance%2520enhancement%2520at%2520the%2520cost%2520of%2520potential%2520brain%2520plasticity%253A%2520neural%2520ramifications%2520of%2520nootropic%2520drugs%2520in%2520the%2520healthy%2520developing%2520brain%26jtitle%3DFront.%2520Syst.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D38%26doi%3D10.3389%2Ffnsys.2014.00038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarchick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wideman, C. H.</span></span> <span> </span><span class="NLM_article-title">Modafinil as a cognitive enhancer of spatial working memory in rats</span>. <i>Physiol. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/j.physbeh.2015.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.physbeh.2015.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=25656691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitl2lu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2015&pages=126-130&author=H.+M.+Murphyauthor=D.+Ekstrandauthor=M.+Tarchickauthor=C.+H.+Wideman&title=Modafinil+as+a+cognitive+enhancer+of+spatial+working+memory+in+rats&doi=10.1016%2Fj.physbeh.2015.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil as a cognitive enhancer of spatial working memory in rats</span></div><div class="casAuthors">Murphy, Helen M.; Ekstrand, Dylan; Tarchick, Matthew; Wideman, Cyrilla H.</div><div class="citationInfo"><span class="NLM_cas:title">Physiology & Behavior</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">126-130</span>CODEN:
                <span class="NLM_cas:coden">PHBHA4</span>;
        ISSN:<span class="NLM_cas:issn">0031-9384</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The present expt. examd. the influence of modafinil on working memory in rats.  Control and exptl. rats were placed in cages equipped with a running wheel.  The study was divided into three periods: 1. habituation, 2. exptl. - in which modafinil was orally administered to exptl. animals, and 3. withdrawal.  Spatial working memory was tested utilizing the Morris Water Maze.  Animals were given two trials in each session: 1. a sample trial in which they discovered the location of the platform and 2. a test trial in which they recalled the location of the platform.  Platform placement and starting place location of the rats were changed every session.  Performance of control animals during sample trials and test trials showed no difference in time to reach the platform; whereas, exptl. animals demonstrated faster attainment of the goal during the test trial.  In withdrawal, there was no difference in time between the two trials for exptl. animals.  Wheel running activity of the exptl. group was lower than that of the control group during the exptl. period.  This study supports the hypothesis that modafinil has a pos. effect on working memory in rats.  It is suggested that benefits of modafinil can extend beyond its prescribed usage; however, these advantages of modafinil use should be addressed in discussions related to ethical concerns assocd. with neuroenhancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBq28Wmv2ueLVg90H21EOLACvtfcHk0lhnl2YZ9dZ9fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitl2lu7k%253D&md5=b6b9fb7ea0d0af6d21fcb3129d074638</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.physbeh.2015.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.physbeh.2015.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DH.%2BM.%26aulast%3DEkstrand%26aufirst%3DD.%26aulast%3DTarchick%26aufirst%3DM.%26aulast%3DWideman%26aufirst%3DC.%2BH.%26atitle%3DModafinil%2520as%2520a%2520cognitive%2520enhancer%2520of%2520spatial%2520working%2520memory%2520in%2520rats%26jtitle%3DPhysiol.%2520Behav.%26date%3D2015%26volume%3D142%26spage%3D126%26epage%3D130%26doi%3D10.1016%2Fj.physbeh.2015.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, J.</span></span> <span> </span><span class="NLM_article-title">Chess study revives debate over cognition-enhancing drugs</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>318</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">784</span>, <span class="refDoi"> DOI: 10.1001/jama.2017.8114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1001%2Fjama.2017.8114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=28813563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A280%3ADC%252BC1cfovFSlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2017&pages=784&issue=9&author=J.+Lyon&title=Chess+study+revives+debate+over+cognition-enhancing+drugs&doi=10.1001%2Fjama.2017.8114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Chess Study Revives Debate Over Cognition-Enhancing Drugs</span></div><div class="casAuthors">Lyon Jeff</div><div class="citationInfo"><span class="NLM_cas:title">JAMA</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">784-786</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwWQ1vrgND9DToTC3aBaesfW6udTcc2eZGfaMAViOfBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfovFSlug%253D%253D&md5=dc08297ecb8337f635813973c423f89c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Fjama.2017.8114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2017.8114%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DJ.%26atitle%3DChess%2520study%2520revives%2520debate%2520over%2520cognition-enhancing%2520drugs%26jtitle%3DJAMA%26date%3D2017%26volume%3D318%26issue%3D9%26spage%3D784%26doi%3D10.1001%2Fjama.2017.8114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakare, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burzynski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loland, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Novel and high affinity 2-[(diphenylmethyl)sulfynil]acetamide (modafinil) analogues as atypical dopamine transporter inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10676</span>– <span class="NLM_lpage">10691</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01373</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFelu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10676-10691&author=J.+Caoauthor=R.+D.+Slackauthor=O.+M.+Bakareauthor=C.+Burzynskiauthor=R.+Raisauthor=B.+S.+Slusherauthor=T.+Kopajticauthor=A.+Bonifaziauthor=M.+P.+Ellenbergerauthor=H.+Yanoauthor=Y.+Heauthor=G.+H.+Biauthor=Z.+H.+Xiauthor=C.+J.+Lolandauthor=A.+H.+Newman&title=Novel+and+high+affinity+2-%5B%28diphenylmethyl%29sulfynil%5Dacetamide+%28modafinil%29+analogues+as+atypical+dopamine+transporter+inhibitors&doi=10.1021%2Facs.jmedchem.6b01373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors</span></div><div class="casAuthors">Cao, Jianjing; Slack, Rachel D.; Bakare, Oluyomi M.; Burzynski, Caitlin; Rais, Rana; Slusher, Barbara S.; Kopajtic, Theresa; Bonifazi, Alessandro; Ellenberger, Michael P.; Yano, Hideaki; He, Yi; Bi, Guo-Hua; Xi, Zheng-Xiong; Loland, Claus J.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10676-10691</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of pharmacotherapeutic treatments of psychostimulant abuse has remained a challenge, despite significant efforts made toward relevant mechanistic targets, such as the dopamine transporter (DAT).  The atypical DAT inhibitors have received attention due to their promising pharmacol. profiles in animal models of cocaine and methamphetamine abuse.  Herein the authors report a series of modafinil analogs that have an atypical DAT inhibitor profile.  The authors extended SAR by chem. manipulating the oxidn. states of the sulfoxide and the amide functional groups, halogenating the Ph rings, and/or functionalizing the terminal nitrogen with substituted piperazines, resulting in several novel leads such as 1-(4-(2-((bis(4-fluorophenyl)methyl)sulfinyl)ethyl)piperazin-1-yl)-3-phenylpropan-2-ol (compd. 11b), which demonstrated high DAT affinity (Ki = 2.5 nM) and selectivity without producing concomitant locomotor stimulation in mice, as compared to cocaine.  These results are consistent with an atypical DAT inhibitor profile and suggest that 11b may be a potential lead for development as a psychostimulant abuse medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0BwESHNuRbVg90H21EOLACvtfcHk0lhnl2YZ9dZ9fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFelu7bP&md5=e912f256c764249ad606d83ac9c570fb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01373%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DSlack%26aufirst%3DR.%2BD.%26aulast%3DBakare%26aufirst%3DO.%2BM.%26aulast%3DBurzynski%26aufirst%3DC.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DEllenberger%26aufirst%3DM.%2BP.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DBi%26aufirst%3DG.%2BH.%26aulast%3DXi%26aufirst%3DZ.%2BH.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520and%2520high%2520affinity%25202-%255B%2528diphenylmethyl%2529sulfynil%255Dacetamide%2520%2528modafinil%2529%2520analogues%2520as%2520atypical%2520dopamine%2520transporter%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10676%26epage%3D10691%26doi%3D10.1021%2Facs.jmedchem.6b01373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murillo-Rodríguez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veras, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budde, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, S.</span></span> <span> </span><span class="NLM_article-title">An overview of the clinical uses, pharmacology, and safety of modafinil</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOns7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=151-158&issue=2&author=E.+Murillo-Rodr%C3%ADguezauthor=A.+B.+Verasauthor=N.+B.+Rochaauthor=H.+Buddeauthor=S.+Machado&title=An+overview+of+the+clinical+uses%2C+pharmacology%2C+and+safety+of+modafinil&doi=10.1021%2Facschemneuro.7b00374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil</span></div><div class="casAuthors">Murillo-Rodriguez, Eric; Barciela Veras, Andre; Barbosa Rocha, Nuno; Budde, Henning; Machado, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-158</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Modafinil (MOD) is a drug used for the management of excessive daytime sleepiness obsd. in several sleep disturbances such as shift work sleep disorder, obstructive sleep apnea, restless leg syndrome and narcolepsy.  Addnl., a wide scope of medical uses of MOD have been described such as fatigue in subjects with depression as well as patients under chemotherapy.  Moreover, there also appear to be a cognitive enhancer drug.  In contrast, recent reports have indicated the risk of developing addiction to MOD.  Furthermore, interest of studying potential long-term effects of MOD have raised.  Here, the authors highlight the evidence concerning the medical uses of MOD in the management of sleepiness, fatigue assocd. with depression and cancer as well as combat depletion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF9fHdDuinErVg90H21EOLACvtfcHk0ljByimZeBnm7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOns7vJ&md5=22926ef163bb11f0e42dcf1d640a2154</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00374%26sid%3Dliteratum%253Aachs%26aulast%3DMurillo-Rodr%25C3%25ADguez%26aufirst%3DE.%26aulast%3DVeras%26aufirst%3DA.%2BB.%26aulast%3DRocha%26aufirst%3DN.%2BB.%26aulast%3DBudde%26aufirst%3DH.%26aulast%3DMachado%26aufirst%3DS.%26atitle%3DAn%2520overview%2520of%2520the%2520clinical%2520uses%252C%2520pharmacology%252C%2520and%2520safety%2520of%2520modafinil%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26issue%3D2%26spage%3D151%26epage%3D158%26doi%3D10.1021%2Facschemneuro.7b00374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Risi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollini, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanganelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronese, A. C.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis and biological evaluation of two modafinil analogues</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9904</span>– <span class="NLM_lpage">9910</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.bmc.2008.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=18954992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSgt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=9904-9910&issue=23&author=C.+De%0ARisiauthor=L.+Ferraroauthor=G.+P.+Polliniauthor=S.+Tanganelliauthor=F.+Valenteauthor=A.+C.+Veronese&title=Efficient+synthesis+and+biological+evaluation+of+two+modafinil+analogues&doi=10.1016%2Fj.bmc.2008.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis and biological evaluation of two modafinil analogues</span></div><div class="casAuthors">De Risi, Carmela; Ferraro, Luca; Pollini, Gian P.; Tanganelli, Sergio; Valente, Filippo; Veronese, Augusto C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9904-9910</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Non classical bioisosters of modafinil featuring interesting biol. profile have been easily produced through replacement of the sulfoxide function with a carbonyl group and modification of the carboxylic acid amide functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIeZRxMkP6rbVg90H21EOLACvtfcHk0ljByimZeBnm7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSgt7fP&md5=b1d3ca4987f3a7b2febc08c4cfe13f6a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRisi%26aufirst%3DC.%26aulast%3DFerraro%26aufirst%3DL.%26aulast%3DPollini%26aufirst%3DG.%2BP.%26aulast%3DTanganelli%26aufirst%3DS.%26aulast%3DValente%26aufirst%3DF.%26aulast%3DVeronese%26aufirst%3DA.%2BC.%26atitle%3DEfficient%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520two%2520modafinil%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26issue%3D23%26spage%3D9904%26epage%3D9910%26doi%3D10.1016%2Fj.bmc.2008.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinges, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darwish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niebler, G. E.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss</span>. <i>Curr. Med. Res. Opin.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1185/030079906X80378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1185%2F030079906X80378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=16393442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFGqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=159-167&issue=1&author=D.+F.+Dingesauthor=S.+Aroraauthor=M.+Darwishauthor=G.+E.+Niebler&title=Pharmacodynamic+effects+on+alertness+of+single+doses+of+armodafinil+in+healthy+subjects+during+a+nocturnal+period+of+acute+sleep+loss&doi=10.1185%2F030079906X80378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss</span></div><div class="casAuthors">Dinges, David F.; Arora, Sanjay; Darwish, Mona; Niebler, Gwendolyn E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">159-167</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">To assess the pharmacodynamics of armodafinil compared with modafinil and placebo on measures of alertness in healthy volunteers undergoing sleep loss, a double-blind, active- and placebo-controlled, parallel-group study was conducted on, 107 healthy male volunteers (aged 18-40 years) randomized to receive a single oral dose of armodafinil (100, 150, 200, or 300 mg), modafinil (200 mg) or placebo administered at 19:25 h.  The primary outcome was the Maintenance of Wakefulness Test (MWT), administered every 2 h from 22:00-08:00 h.  Secondary outcomes included the Psychomotor Vigilance Task (PVT) and the Karolinska Sleepiness Scale.  Blood samples for pharmacokinetic anal. were collected hourly.  Adverse events were evaluated throughout the 2-day lab. stay and by telephone on day 9.  All four doses of armodafinil and the 200 mg dose of modafinil improved wakefulness as measured by increased MWT latencies (treatment effect, p < 0.0001) and reduced PVT lapses of attention (treatment effect, p < 0.0001).  The magnitude and duration of these effects at the later time points appeared to be dose- and concn.-dependent.  Armodafinil at 200 mg resulted in comparable Cmax, a later tmax, and higher plasma concns. 6-14 h post-drug administration than with 200 mg modafinil.  Following armodafinil, longer MWT latencies and fewer PVT lapses 6-14 h post-drug administration were obsd. compared with modafinil.  Armodafinil doses were well tolerated, with the most common adverse events including abdominal pain, nausea, and headache.  There were reports of tachycardia/palpitations.  Decreased mean sleep efficiency and increased mean blood pressure were also obsd.  Armodafinil improved alertness at all doses studied.  Relative to modafinil 200 mg, armodafinil 200 mg showed a comparable peak plasma concn. with higher concns. 6-14 h post-drug, and improved wakefulness and sustained attention for a longer time post-dose.  Both drugs were well tolerated; however, further research on the efficacy, safety, and tolerability of armodafinil in patients with disorders of excessive sleepiness (ES) is required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpVhC6ONgDNbVg90H21EOLACvtfcHk0ljUPl97cqD2GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFGqurw%253D&md5=fbe3ad588478d7e18908649a06be3e7c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1185%2F030079906X80378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079906X80378%26sid%3Dliteratum%253Aachs%26aulast%3DDinges%26aufirst%3DD.%2BF.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DDarwish%26aufirst%3DM.%26aulast%3DNiebler%26aufirst%3DG.%2BE.%26atitle%3DPharmacodynamic%2520effects%2520on%2520alertness%2520of%2520single%2520doses%2520of%2520armodafinil%2520in%2520healthy%2520subjects%2520during%2520a%2520nocturnal%2520period%2520of%2520acute%2520sleep%2520loss%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2006%26volume%3D22%26issue%3D1%26spage%3D159%26epage%3D167%26doi%3D10.1185%2F030079906X80378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volkow, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muench, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apelskog-Torres, K.</span></span> <span> </span><span class="NLM_article-title">Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">1148</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1001/jama.2009.351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1001%2Fjama.2009.351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=19293415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVOlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2009&pages=1148-1154&author=N.+D.+Volkowauthor=J.+S.+Fowlerauthor=J.+Loganauthor=D.+Alexoffauthor=W.+Zhuauthor=F.+Telangauthor=G.+J.+Wangauthor=M.+Jayneauthor=J.+M.+Hookerauthor=C.+Wongauthor=+Hubbardauthor=P.+Carterauthor=D.+Warnerauthor=P.+Kingauthor=C.+Sheaauthor=Y.+Xuauthor=L.+Muenchauthor=K.+Apelskog-Torres&title=Effects+of+modafinil+on+dopamine+and+dopamine+transporters+in+the+male+human+brain%3A+clinical+implications&doi=10.1001%2Fjama.2009.351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of modafinil on dopamine and dopamine transporters in the male human brain. Clinical implications</span></div><div class="casAuthors">Volkow, Nora D.; Fowler, Joanna S.; Logan, Jean; Alexoff, David; Zhu, Wei; Telang, Frank; Wang, Gene-Jack; Jayne, Millard; Hooker, Jacob M.; Wong, Christopher; Hubbard, Barbara; Carter, Pauline; Warner, Donald; King, Payton; Shea, Colleen; Xu, Youwen; Muench, Lisa; Apelskog-Torres, Karen</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1148-1154</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Modafinil, a wake-promoting drug used to treat narcolepsy, is increasingly being used as a cognitive enhancer.  Although initially launched as distinct from stimulants that increase extracellular dopamine by targeting dopamine transporters, recent preclin. studies suggest otherwise.  Objective was to measure the acute effects of modafinil at doses used therapeutically (200 mg and 400 mg given orally) on extracellular dopamine and on dopamine transporters in the male human brain.  Design, Setting, and Participants Positron emission tomog. with [11C]raclopride (D2/D3 radioligand sensitive to changes in endogenous dopamine) and [11C]cocaine (dopamine transporter radioligand) was used to measure the effects of modafinil on extracellular dopamine and on dopamine transporters in 10 healthy male participants.  The study took place over an 8-mo period (2007-2008) at Brookhaven National Lab.  Main Outcome Measures Primary outcomes were changes in dopamine D2/D3 receptor and dopamine transporter availability (measured by changes in binding potential) after modafinil when compared with after placebo.  Modafinil decreased mean (SD) [11C]raclopride binding potential in caudate (6.1% [6.5%]; 95% confidence interval [CI], 1.5% to 10.8%; P =.02), putamen (6.7% [4.9%]; 95% CI, 3.2% to 10.3%; P =.002), and nucleus accumbens (19.4% [20%]; 95% CI, 5% to 35%; P =.02), reflecting increases in extracellular dopamine.  Modafinil also decreased [11C]cocaine binding potential in caudate (53.8% [13.8%]; 95% CI, 43.9% to 63.6%; P <.001), putamen (47.2% [11.4%]; 95% CI, 39.1% to 55.4%; P <.001), and nucleus accumbens (39.3% [10%]; 95% CI, 30% to 49%; P =.001), reflecting occupancy of dopamine transporters.  In this pilot study, modafinil blocked dopamine transporters and increased dopamine in the human brain (including the nucleus accumbens).  Because drugs that increase dopamine in the nucleus accumbens have the potential for abuse, and considering the increasing use of modafinil, these results highlight the need for heightened awareness for potential abuse of and dependence on modafinil in vulnerable populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2VFxKbKbpArVg90H21EOLACvtfcHk0ljUPl97cqD2GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVOlsbY%253D&md5=a8f5a22cc75df00230c83eb666f7e9de</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1001%2Fjama.2009.351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2009.351%26sid%3Dliteratum%253Aachs%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DAlexoff%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DTelang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DJayne%26aufirst%3DM.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DC.%26aulast%3DHubbard%26aulast%3DCarter%26aufirst%3DP.%26aulast%3DWarner%26aufirst%3DD.%26aulast%3DKing%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMuench%26aufirst%3DL.%26aulast%3DApelskog-Torres%26aufirst%3DK.%26atitle%3DEffects%2520of%2520modafinil%2520on%2520dopamine%2520and%2520dopamine%2520transporters%2520in%2520the%2520male%2520human%2520brain%253A%2520clinical%2520implications%26jtitle%3DJAMA%26date%3D2009%26volume%3D301%26spage%3D1148%26epage%3D1154%26doi%3D10.1001%2Fjama.2009.351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mignot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilleminault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dement, W. C.</span></span> <span> </span><span class="NLM_article-title">Modafinil binds to the dopamine uptake carrier site with low affinity</span>. <i>Sleep</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1093/sleep/17.5.436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1093%2Fsleep%2F17.5.436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=7991954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A280%3ADyaK2M%252FosVSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1994&pages=436-437&author=E.+Mignotauthor=S.+Nishinoauthor=C.+Guilleminaultauthor=W.+C.+Dement&title=Modafinil+binds+to+the+dopamine+uptake+carrier+site+with+low+affinity&doi=10.1093%2Fsleep%2F17.5.436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil binds to the dopamine uptake carrier site with low affinity</span></div><div class="casAuthors">Mignot E; Nishino S; Guilleminault C; Dement W C</div><div class="citationInfo"><span class="NLM_cas:title">Sleep</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">436-7</span>
        ISSN:<span class="NLM_cas:issn">0161-8105</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIGv6cQ4HX-Rjv2lLSLOxFfW6udTcc2eZODE6w0lKCi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FosVSmsA%253D%253D&md5=888ee2341f4b1a375f0ffa25f3d8523d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fsleep%2F17.5.436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fsleep%252F17.5.436%26sid%3Dliteratum%253Aachs%26aulast%3DMignot%26aufirst%3DE.%26aulast%3DNishino%26aufirst%3DS.%26aulast%3DGuilleminault%26aufirst%3DC.%26aulast%3DDement%26aufirst%3DW.%2BC.%26atitle%3DModafinil%2520binds%2520to%2520the%2520dopamine%2520uptake%2520carrier%2520site%2520with%2520low%2520affinity%26jtitle%3DSleep%26date%3D1994%26volume%3D17%26spage%3D436%26epage%3D437%26doi%3D10.1093%2Fsleep%2F17.5.436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madras, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jassen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonab, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischman, A. J.</span></span> <span> </span><span class="NLM_article-title">Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>319</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.106583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1124%2Fjpet.106.106583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=16885432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=561-569&issue=2&author=B.+K.+Madrasauthor=Z.+Xieauthor=Z.+Linauthor=A.+Jassenauthor=H.+Panasauthor=L.+Lynchauthor=R.+Johnsonauthor=E.+Livniauthor=T.+J.+Spencerauthor=A.+A.+Bonabauthor=G.+M.+Millerauthor=A.+J.+Fischman&title=Modafinil+occupies+dopamine+and+norepinephrine+transporters+in+vivo+and+modulates+the+transporters+and+trace+amine+activity+in+vitro&doi=10.1124%2Fjpet.106.106583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro</span></div><div class="casAuthors">Madras, Bertha K.; Xie, Zhihua; Lin, Zhicheng; Jassen, Amy; Panas, Helen; Lynch, Laurie; Johnson, Ryan; Livni, Eli; Spencer, Thomas J.; Bonab, Ali A.; Miller, Gregory M.; Fischman, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">561-569</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">2-[(Diphenylmethyl)sulfinyl]acetamide (modafinil), prescribed principally to treat narcolepsy, is undergoing assessment for other neuropsychiatric disorders and medical conditions.  The neurochem. substrates of modafinil are unresolved.  We postulated that modafinil enhances wakefulness by modulating dopamine (DAT), norepinephrine (NET), or serotonin (SERT) transporter activities.  In vivo, we detd. DAT and NET occupancy by modafinil by positron emission tomog. imaging; in vitro, we detd. modafinil activity at the DAT, NET, SERT, and rhesus monkey trace amine receptor 1 (TA1).  In rhesus monkey, modafinil occupancy of striatal DAT was detected by [11C]2β-carbomethoxy-3β-4-(fluorophenyl)tropane and of thalamic NET by [11C](S,S)-2-(α-(2-methoxyphenoxy)-benzyl)morpholine.  In vitro, modafinil effects in DAT-human embryonic kidney (HEK), NET-HEK, and SERT-HEK cells were investigated alone or combined with the TA1 receptor.  Modafinil (i.v.) occupied striatal DAT sites (5 mg/kg: 35±12%, n = 4; 8 mg/kg: 54±3%, n = 3).  In thalamus, modafinil occupied NET sites (5 mg/kg: 16±7.8%, n = 6; 8 mg/kg: 44±12%; n = 2).  In vitro, modafinil inhibited [3H]dopamine (IC50 = 6.4 μM), [3H]norepinephrine (IC50 = 35.6 μM), and [3H]serotonin (IC50 > 500 μM) transport via the human DAT, NET, and SERT.  Modafinil did not activate the TA1 receptor in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but not in TA1-SERT cells.  The present data provide compelling evidence that modafinil occupies the DAT and NET in living brain of rhesus monkeys and raise the possibility that modafinil affects wakefulness by interacting with catecholamine transporters in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouuXxc1kVsYbVg90H21EOLACvtfcHk0lgxkxHXWHHRGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkur3N&md5=6e0b14f53f5bb138f63f21e19e3939ac</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.106583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.106583%26sid%3Dliteratum%253Aachs%26aulast%3DMadras%26aufirst%3DB.%2BK.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DJassen%26aufirst%3DA.%26aulast%3DPanas%26aufirst%3DH.%26aulast%3DLynch%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DLivni%26aufirst%3DE.%26aulast%3DSpencer%26aufirst%3DT.%2BJ.%26aulast%3DBonab%26aufirst%3DA.%2BA.%26aulast%3DMiller%26aufirst%3DG.%2BM.%26aulast%3DFischman%26aufirst%3DA.%2BJ.%26atitle%3DModafinil%2520occupies%2520dopamine%2520and%2520norepinephrine%2520transporters%2520in%2520vivo%2520and%2520modulates%2520the%2520transporters%2520and%2520trace%2520amine%2520activity%2520in%2520vitro%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26issue%3D2%26spage%3D561%26epage%3D569%26doi%3D10.1124%2Fjpet.106.106583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zolkowska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partilla, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisinzano, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, M. H.</span></span> <span> </span><span class="NLM_article-title">Evidence for the involvement of dopamine transporters in the behavioral stimulant effects of modafinil</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">738</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.146142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1124%2Fjpet.108.146142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=19197004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1OlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=738-746&author=D.+Zolkowskaauthor=R.+Jainauthor=R.+B.+Rothmanauthor=J.+S.+Partillaauthor=B.+L.+Rothauthor=V.+Setolaauthor=T.+E.+Prisinzanoauthor=M.+H.+Baumann&title=Evidence+for+the+involvement+of+dopamine+transporters+in+the+behavioral+stimulant+effects+of+modafinil&doi=10.1124%2Fjpet.108.146142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil</span></div><div class="casAuthors">Zolkowska, Dorota; Jain, Raka; Rothman, Richard B.; Partilla, John S.; Roth, Bryan L.; Setola, Vincent; Prisinzano, Thomas E.; Baumann, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">738-746</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Modafinil is prescribed for numerous medical conditions, but the drug's mechanism of action is unclear.  Here, we examd. the interaction of modafinil with receptors and transporters in vitro and compared pharmacol. effects of the drug with those produced by indirect dopamine (DA) agonists 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) and (+)-methamphetamine (METH).  Modafinil was screened at various receptors and transporters using binding assays.  Transporter-mediated uptake and release were examd. in rat brain synaptosomes.  Effects of modafinil on motor activity and neurochem. were detd. in rats undergoing in vivo microdialysis in nucleus accumbens.  Of the receptors and transporters assayed, modafinil displayed measurable potency only at DA transporters (DAT), inhibiting [3H]DA uptake, with an IC50 value of 4.0 μM.  Accordingly, modafinil pretreatment (10 μM) antagonized METH-induced release of the DAT substrate [3H]1-methyl-4-phenylpyridinium.  I.v. modafinil (20 and 60 mg/kg) produced dose-dependent increases in motor activity and extracellular DA, without affecting serotonin (5-HT).  Analogous results were obsd. for GBR12909 (1 and 3 mg/kg), whereas METH (0.3 and 1 mg/kg) increased DA and 5-HT.  Locomotor effects of all drugs were pos. correlated with dialyzate DA (P < 0.001).  Interestingly, modafinil pretreatment reduced METH-induced ambulation and DA release.  Our data show that modafinil interacts with DAT sites in rat brain, a property shared with agonist medications under investigation for treating cocaine dependence.  Nondopaminergic mechanisms may also contribute to the pharmacol. of modafinil.  Finally, the results suggest that modafinil should be tested as an adjunct for treating METH addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhab522ik-NrVg90H21EOLACvtfcHk0lgxkxHXWHHRGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1OlsL4%253D&md5=0c5af6285ed23382c46a0d35bafbaa3b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.146142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.146142%26sid%3Dliteratum%253Aachs%26aulast%3DZolkowska%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26atitle%3DEvidence%2520for%2520the%2520involvement%2520of%2520dopamine%2520transporters%2520in%2520the%2520behavioral%2520stimulant%2520effects%2520of%2520modafinil%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D738%26epage%3D746%26doi%3D10.1124%2Fjpet.108.146142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loland, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mereu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okunola, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisinzano, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">R-Modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2012.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.biopsych.2012.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=22537794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFelt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=405-413&author=J.+C.+Lolandauthor=M.+Mereuauthor=O.+Okunolaauthor=J.+Caoauthor=T.+E.+Prisinzanoauthor=S.+Mazierauthor=T.+Kopajticauthor=L.+Shiauthor=J.+L.+Katzauthor=G.+Tandaauthor=A.+H.+Newman&title=R-Modafinil+%28armodafinil%29%3A+a+unique+dopamine+uptake+inhibitor+and+potential+medication+for+psychostimulant+abuse&doi=10.1016%2Fj.biopsych.2012.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse</span></div><div class="casAuthors">Loland, Claus J.; Mereu, Maddalena; Okunola, Oluyomi M.; Cao, Jianjing; Prisinzano, Thomas E.; Mazier, Sonia; Kopajtic, Theresa; Shi, Lei; Katz, Jonathan L.; Tanda, Gianluigi; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">405-413</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">(±)-Modafinil has piqued interest as a treatment for attention-deficit/hyperactivity disorder and stimulant dependence.  The R-enantiomer of modafinil might have unique pharmacol. properties that should be further investigated.  (±)-Modafinil and its R-(-)- and S-(+)-enantiomers were synthesized and tested for inhibition of [3H] dopamine (DA) uptake and [3H]WIN 35428 binding in human dopamine transporter (DAT) wild-type and mutants with altered conformational equil.  Data were compared with cocaine and the atypical DA uptake inhibitor, JHW 007.  R- and S-modafinil were also evaluated in microdialysis studies in the mouse nucleus accumbens shell and in a cocaine discrimination procedure.  (±)-, R-, and S-modafinil bind to the DAT and inhibit DA uptake less potently than cocaine, with R-modafinil having approx. threefold higher affinity than its S-enantiomer.  Mol. docking studies revealed subtle differences in binding modes for the enantiomers.  R-modafinil was significantly less potent in the DAT Y156F mutant compared with wild-type DAT, whereas S-modafinil was affected less.  Studies with the Y335A DAT mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than cocaine, which was further supported by [2-(trimethylammonium)ethyl]-methanethiosulfonate reactivity on the DAT E2C I159C.  Microdialysis studies demonstrated that both R- and S-modafinil produced increases in extracellular DA concns. in the nucleus accumbens shell less efficaciously than cocaine and with a longer duration of action.  Both enantiomers fully substituted in mice trained to discriminate cocaine from saline.R-modafinil displays an in vitro profile different from cocaine.  Future trials with R-modafinil as a substitute therapy with the potential benefit of cognitive enhancement for psychostimulant addiction are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjL4KiRs4PUbVg90H21EOLACvtfcHk0lgxkxHXWHHRGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFelt74%253D&md5=78808210fc68d2fbcdd97190f03b63d0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DLoland%26aufirst%3DJ.%2BC.%26aulast%3DMereu%26aufirst%3DM.%26aulast%3DOkunola%26aufirst%3DO.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DMazier%26aufirst%3DS.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DR-Modafinil%2520%2528armodafinil%2529%253A%2520a%2520unique%2520dopamine%2520uptake%2520inhibitor%2520and%2520potential%2520medication%2520for%2520psychostimulant%2520abuse%26jtitle%3DBiol.%2520Psychiatry%26date%3D2012%26volume%3D72%26spage%3D405%26epage%3D413%26doi%3D10.1016%2Fj.biopsych.2012.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattay, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stankevich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skjei, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambataro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrillaga-Romany, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callicott, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apud, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberger, D. R.</span></span> <span> </span><span class="NLM_article-title">Modulatory effects of modafinil on neural circuits regulating emotion and cognition</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2101</span>– <span class="NLM_lpage">2109</span>, <span class="refDoi"> DOI: 10.1038/npp.2010.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1038%2Fnpp.2010.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=20555311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVajs7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=2101-2109&issue=10&author=R.+Rasettiauthor=V.+S.+Mattayauthor=B.+Stankevichauthor=K.+Skjeiauthor=G.+Blasiauthor=F.+Sambataroauthor=I.+C.+Arrillaga-Romanyauthor=T.+E.+Goldbergauthor=J.+H.+Callicottauthor=J.+A.+Apudauthor=D.+R.+Weinberger&title=Modulatory+effects+of+modafinil+on+neural+circuits+regulating+emotion+and+cognition&doi=10.1038%2Fnpp.2010.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Modulatory Effects of Modafinil on Neural Circuits Regulating Emotion and Cognition</span></div><div class="casAuthors">Rasetti, Roberta; Mattay, Venkata S.; Stankevich, Beth; Skjei, Kelsey; Blasi, Giuseppe; Sambataro, Fabio; Arrillaga-Romany, Isabel C.; Goldberg, Terry E.; Callicott, Joseph H.; Apud, Jose A.; Weinberger, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2101-2109</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Modafinil differs from other arousal-enhancing agents in chem. structure, neurochem. profile, and behavioral effects.  Most functional neuroimaging studies to date examd. the effect of modafinil only on information processing underlying executive cognition, but cognitive enhancers in general have been shown to have pronounced effects on emotional behavior, too.  We examd. the effect of modafinil on neural circuits underlying affective processing and cognitive functions.  Healthy volunteers were enrolled in this double-blinded placebo-controlled trial (100 mg/day for 7 days).  They underwent BOLD fMRI while performing an emotion information-processing task that activates the amygdala and two prefrontally dependent cognitive tasks-a working memory (WM) task and a variable attentional control (VAC) task.  A clin. assessment that included measurement of blood pressure, heart rate, the Hamilton anxiety scale, and the profile of mood state (POMS) questionnaire was also performed on each test day.  BOLD fMRI revealed significantly decreased amygdala reactivity to fearful stimuli on modafinil compared with the placebo condition.  During executive cognition tasks, a WM task and a VAC task, modafinil reduced BOLD signal in the prefrontal cortex and anterior cingulate.  Although not statistically significant, there were trends for reduced anxiety, for decreased fatigue-inertia and increased vigor-activity, as well as decreased anger-hostility on modafinil.  Modafinil in low doses has a unique physiol. profile compared with stimulant drugs: it enhances the efficiency of prefrontal cortical cognitive information processing, while dampening reactivity to threatening stimuli in the amygdala, a brain region implicated in anxiety.  Neuropsychopharmacol. (2010) 35, 2101-2109; doi:10.1038/npp.2010.83; published online 16 June 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS8KusPPpSpLVg90H21EOLACvtfcHk0lgLLaG0SbmjSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVajs7nM&md5=858c640f72c28500903e23ec8691c32e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2010.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2010.83%26sid%3Dliteratum%253Aachs%26aulast%3DRasetti%26aufirst%3DR.%26aulast%3DMattay%26aufirst%3DV.%2BS.%26aulast%3DStankevich%26aufirst%3DB.%26aulast%3DSkjei%26aufirst%3DK.%26aulast%3DBlasi%26aufirst%3DG.%26aulast%3DSambataro%26aufirst%3DF.%26aulast%3DArrillaga-Romany%26aufirst%3DI.%2BC.%26aulast%3DGoldberg%26aufirst%3DT.%2BE.%26aulast%3DCallicott%26aufirst%3DJ.%2BH.%26aulast%3DApud%26aufirst%3DJ.%2BA.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DModulatory%2520effects%2520of%2520modafinil%2520on%2520neural%2520circuits%2520regulating%2520emotion%2520and%2520cognition%26jtitle%3DNeuropsychopharmacology%26date%3D2010%26volume%3D35%26issue%3D10%26spage%3D2101%26epage%3D2109%26doi%3D10.1038%2Fnpp.2010.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gervasoni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanni-Mercier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frydman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouvet, M.</span></span> <span> </span><span class="NLM_article-title">Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat</span>. <i>Journal of Sleep Research</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2869.2000.00181.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1046%2Fj.1365-2869.2000.00181.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10733694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A280%3ADC%252BD3c7pvVGisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=89-96&issue=1&author=J.+S.+Linauthor=D.+Gervasoniauthor=Y.+Houauthor=G.+Vanni-Mercierauthor=F.+Rambertauthor=A.+Frydmanauthor=M.+Jouvet&title=Effects+of+amphetamine+and+modafinil+on+the+sleep%2Fwake+cycle+during+experimental+hypersomnia+induced+by+sleep+deprivation+in+the+cat&doi=10.1046%2Fj.1365-2869.2000.00181.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat</span></div><div class="casAuthors">Lin J S; Gervasoni D; Hou Y; Vanni-Mercier G; Rambert F; Frydman A; Jouvet M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of sleep research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-96</span>
        ISSN:<span class="NLM_cas:issn">0962-1105</span>.
    </div><div class="casAbstract">Modafinil is a newly discovered waking substance now being used in the treatment of hypersomnia and narcolepsy.  We have shown previously in the cat that, unlike amphetamine, modafinil induces long-lasting wakefulness (W) without behavioral excitation and subsequent sleep rebound, and that its waking effect does not depend on endogenous catecholamines.  To further characterize the awakening properties of modafinil and current psychostimulants in experimental models of hypersomnia, we examined the effect of oral administration of placebo, modafinil (5 mg kg-1) or amphetamine (1 mg kg-1) on the sleep/wake cycle and power spectral density (PSD) in cats after an 18-h water-tank sleep deprivation period.  We found that the placebo had no effect on the dynamics of sleep recovery, while both modafinil and amphetamine induced suppression of cortical slow activity and a waking state lasting 6-8 h.  After the amphetamine-induced waking period, both deep slow wave sleep (SWS2) and paradoxical sleep (PS) occurred in greater amounts than after placebo and the PSD during SWS was also increased.  Thus, the cumulative time spent in W during a 48-h period was similar to that with placebo, indicating enhanced sleep rebound.  In contrast, after the modafinil-induced W, the occurrence and evolution of SWS2 or PS, as well as the PSD during SWS, were similar to those seen with placebo during the same period, so that the total time spent in W in a 48-h period remained significantly higher than the control level, indicating no additional sleep rebound.  These results indicate that modafinil is effective against somnolence and hypersomnia and does not produce a subsequent increase in sleep and suggest that the pharmacological profile of modafinil is different from that of amphetamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREVEdoXPjOmSEJCPKhJPuqfW6udTcc2ebKJHQoZoukcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7pvVGisQ%253D%253D&md5=a4cbd00ad9ad933bd9fbbef887a23861</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2869.2000.00181.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2869.2000.00181.x%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BS.%26aulast%3DGervasoni%26aufirst%3DD.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DVanni-Mercier%26aufirst%3DG.%26aulast%3DRambert%26aufirst%3DF.%26aulast%3DFrydman%26aufirst%3DA.%26aulast%3DJouvet%26aufirst%3DM.%26atitle%3DEffects%2520of%2520amphetamine%2520and%2520modafinil%2520on%2520the%2520sleep%252Fwake%2520cycle%2520during%2520experimental%2520hypersomnia%2520induced%2520by%2520sleep%2520deprivation%2520in%2520the%2520cat%26jtitle%3DJournal%2520of%2520Sleep%2520Research%26date%3D2000%26volume%3D9%26issue%3D1%26spage%3D89%26epage%3D96%26doi%3D10.1046%2Fj.1365-2869.2000.00181.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span> <span> </span><span class="NLM_article-title">Practical use and risk of modafinil, a novel waking drug</span>. <i>Environ. Health Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">e2012007</span>, <span class="refDoi"> DOI: 10.5620/eht.2012.27.e2012007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.5620%2Feht.2012.27.e2012007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=22375280" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=e2012007&author=D.+Kim&title=Practical+use+and+risk+of+modafinil%2C+a+novel+waking+drug&doi=10.5620%2Feht.2012.27.e2012007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.5620%2Feht.2012.27.e2012007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5620%252Feht.2012.27.e2012007%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26atitle%3DPractical%2520use%2520and%2520risk%2520of%2520modafinil%252C%2520a%2520novel%2520waking%2520drug%26jtitle%3DEnviron.%2520Health%2520Toxicol.%26date%3D2012%26volume%3D27%26spage%3De2012007%26doi%3D10.5620%2Feht.2012.27.e2012007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avelar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckstead, M. J.</span></span> <span> </span><span class="NLM_article-title">Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.neuropharm.2017.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=28625719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2017&pages=410-419&author=A.+J.+Avelarauthor=J.+Caoauthor=A.+H.+Newmanauthor=M.+J.+Beckstead&title=Atypical+dopamine+transporter+inhibitors+R-modafinil+and+JHW+007+differentially+affect+D2+autoreceptor+neurotransmission+and+the+firing+rate+of+midbrain+dopamine+neurons&doi=10.1016%2Fj.neuropharm.2017.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons</span></div><div class="casAuthors">Avelar, Alicia J.; Cao, Jianjing; Newman, Amy Hauck; Beckstead, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">410-419</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Abuse of psychostimulants like cocaine that inhibit dopamine (DA) reuptake through the dopamine transporter (DAT) represents a major public health issue, however FDA-approved pharmacotherapies have yet to be developed.  Recently a class of ligands termed "atypical DAT inhibitors" has gained attention due to their range of effectiveness in increasing extracellular DA levels without demonstrating significant abuse liability.  These compds. not only hold promise as therapeutic agents to treat stimulant use disorders but also as exptl. tools to improve our understanding of DAT function.  Here we used patch clamp electrophysiol. in mouse brain slices to explore the effects of two atypical DAT inhibitors (R-modafinil and JHW 007) on the physiol. of single DA neurons in the substantia nigra and ventral tegmental area.  Despite their commonalities of being DAT inhibitors that lack cocaine-like behavioral profiles, these compds. exhibited surprisingly divergent cellular effects.  Similar to cocaine, R-modafinil slowed DA neuron firing in a D2 receptor-dependent manner and rapidly enhanced the amplitude and duration of D2 receptor-mediated currents in the midbrain.  In contrast, JHW 007 exhibited little effect on firing, slow DAT blockade, and an unexpected inhibition of D2 receptor-mediated currents that may be due to direct D2 receptor antagonism.  Furthermore, pretreatment with JHW 007 blunted the cellular effects of cocaine, suggesting that it may be valuable to investigate similar DAT inhibitors as potential therapeutic agents.  Further exploration of these and other atypical DAT inhibitors may reveal important cellular effects of compds. that will have potential as pharmacotherapies for treating cocaine use disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozyn-HOG4w-rVg90H21EOLACvtfcHk0ljdmZBJRoUBKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt7zN&md5=6001c7f27aa797f25eae9fe3ee9884a7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DAvelar%26aufirst%3DA.%2BJ.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBeckstead%26aufirst%3DM.%2BJ.%26atitle%3DAtypical%2520dopamine%2520transporter%2520inhibitors%2520R-modafinil%2520and%2520JHW%2520007%2520differentially%2520affect%2520D2%2520autoreceptor%2520neurotransmission%2520and%2520the%2520firing%2520rate%2520of%2520midbrain%2520dopamine%2520neurons%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D123%26spage%3D410%26epage%3D419%26doi%3D10.1016%2Fj.neuropharm.2017.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisinzano, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okunola, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">SARs at the monoamine transporters for a novel series of modafinil analogues</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1021/ml1002025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1002025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12lt7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=48-52&author=J.+Caoauthor=T.+E.+Prisinzanoauthor=O.+M.+Okunolaauthor=T.+Kopajticauthor=M.+Shookauthor=J.+L.+Katzauthor=A.+H.+Newman&title=SARs+at+the+monoamine+transporters+for+a+novel+series+of+modafinil+analogues&doi=10.1021%2Fml1002025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">SARs at the Monoamine Transporters for a Novel Series of Modafinil Analogues</span></div><div class="casAuthors">Cao, Jianjing; Prisinzano, Thomas E.; Okunola, Oluyomi M.; Kopajtic, Theresa; Shook, Matthew; Katz, Jonathan L.; Hauck Newman, Amy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-52</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of modafinil (1) analogs were synthesized wherein (1) para-halo-substitutents were added to the aryl rings, (2) the sulfoxide function was removed, and (3) the primary amide group was replaced with secondary and tertiary amides and amines to investigate the effects of these chem. modifications on dopamine transporter, serotonin transporter, and norepinephrine transporter binding.  In addn., the locomotor-stimulant effects in mice of (±)-modafinil (1) (I), its R- and S-enantiomers, and its para-chloro sulfinylacetamide analog (5c) (II) were compared to those of cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDr9ac-J7nqbVg90H21EOLACvtfcHk0ljdmZBJRoUBKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12lt7bN&md5=660e546e8524b2e5e8b448ee5bf0e567</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml1002025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002025%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DOkunola%26aufirst%3DO.%2BM.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DShook%26aufirst%3DM.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DSARs%2520at%2520the%2520monoamine%2520transporters%2520for%2520a%2520novel%2520series%2520of%2520modafinil%2520analogues%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D48%26epage%3D52%26doi%3D10.1021%2Fml1002025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okunola-Bakare, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopajtic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loland, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)- sulfynil]acetamide (modafinil) analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.1021/jm401754x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401754x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1000-1013&author=O.+M.+Okunola-Bakareauthor=J.+Caoauthor=T.+Kopajticauthor=L.+J.+Katzauthor=C.+J.+Lolandauthor=L.+Shiauthor=A.+H.+Newman&title=Elucidation+of+structural+elements+for+selectivity+across+monoamine+transporters%3A+novel+2-%5B%28diphenylmethyl%29-+sulfynil%5Dacetamide+%28modafinil%29+analogues&doi=10.1021%2Fjm401754x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of Structural Elements for Selectivity across Monoamine Transporters: Novel 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues</span></div><div class="casAuthors">Okunola-Bakare, Oluyomi M.; Cao, Jianjing; Kopajtic, Theresa; Katz, Jonathan L.; Loland, Claus J.; Shi, Lei; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1000-1013</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-[(Diphenylmethyl)sulfinyl]acetamide (modafinil, (±)-1) is a unique dopamine uptake inhibitor that binds the dopamine transporter (DAT) differently than cocaine and may have potential for the treatment of psychostimulant abuse.  To further investigate structural requirements for this divergent binding mode, novel thio- and sulfinylacetamide and ethanamine analogs of (±)-1 were synthesized wherein (1) the di-Ph rings were substituted with Me, trifluoromethyl, and halogen substituents and (2) substituents were added to the terminal amide/amine nitrogen.  Halogen substitution of the di-Ph rings of (±)-1 gave several amide analogs with improved binding affinity for DAT and robust selectivity over the serotonin transporter (SERT), whereas affinity improved at SERT over DAT for the p-halo-substituted amine analogs.  Mol. docking studies, using a subset of analogs with DAT and SERT homol. models, and functional data obtained with DAT (A480T) and SERT (T497A) mutants defined a role for TM10 in the substrate/inhibitor S1 binding sites of DAT and SERT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjxRhiOBM-ErVg90H21EOLACvtfcHk0lj79R75d_1VOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyhtrY%253D&md5=8c9679d83c0101e335bd59867b0c2863</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm401754x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401754x%26sid%3Dliteratum%253Aachs%26aulast%3DOkunola-Bakare%26aufirst%3DO.%2BM.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DL.%2BJ.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DElucidation%2520of%2520structural%2520elements%2520for%2520selectivity%2520across%2520monoamine%2520transporters%253A%2520novel%25202-%255B%2528diphenylmethyl%2529-%2520sulfynil%255Dacetamide%2520%2528modafinil%2529%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1000%26epage%3D1013%26doi%3D10.1021%2Fjm401754x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span> <span> </span><span class="NLM_article-title">Simple synthesis of modafinil derivatives and their anti-inflammatory activity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">10446</span>– <span class="NLM_lpage">10458</span>, <span class="refDoi"> DOI: 10.3390/molecules170910446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3390%2Fmolecules170910446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=22945025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlartrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=10446-10458&issue=12&author=J.-C.+Jungauthor=Y.+Leeauthor=J.-Y.+Sonauthor=E.+Limauthor=M.+Jungauthor=S.+Oh&title=Simple+synthesis+of+modafinil+derivatives+and+their+anti-inflammatory+activity&doi=10.3390%2Fmolecules170910446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Simple synthesis of modafinil derivatives and their antiinflammatory activity</span></div><div class="casAuthors">Jung, Jae-Chul; Lee, Yeonju; Son, Jee-Young; Lim, Eunyoung; Jung, Mankil; Oh, Seikwan</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10446-10458</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Simple synthesis of modafinil derivs. [2-[(diphenylmethyl)sulfinyl]acetamide derivs. and analogs] and their biol. activity are described.  The key synthetic strategies involve substitution and coupling reactions.  The authors detd. the antiinflammatory effects of modafinil derivs. in cultured BV2 cells by measuring the inhibition of nitrite prodn. and expression of iNOS (nitric oxide synthase-2) and COX-2 (prostaglandin endoperoxide synthase-2) after LPS stimulation.  It was found that for sulfide analogs introduction of aliph. groups on the amide part resulted in lower antiinflammatory activity compared with cyclic or arom. moieties.  However, for the sulfoxide analogs, introduction of aliph. moieties showed higher antiinflammatory activity than cyclic or arom. fragments in BV-2 microglia cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8z_enCxo33rVg90H21EOLACvtfcHk0lj79R75d_1VOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlartrnL&md5=204969ba0e0e91784aa49e1bec4c6b94</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3390%2Fmolecules170910446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules170910446%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DJ.-C.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DSon%26aufirst%3DJ.-Y.%26aulast%3DLim%26aufirst%3DE.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DOh%26aufirst%3DS.%26atitle%3DSimple%2520synthesis%2520of%2520modafinil%2520derivatives%2520and%2520their%2520anti-inflammatory%2520activity%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26issue%3D12%26spage%3D10446%26epage%3D10458%26doi%3D10.3390%2Fmolecules170910446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakulev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beryozkina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dianova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berseneva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slepukhin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of N-sulfonylamidines of modafinic acid</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">07</span>),  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1054</span>, <span class="refDoi"> DOI: 10.1055/s-0035-1561350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1055%2Fs-0035-1561350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=1046-1054&issue=07&author=V.+Bakulevauthor=G.+Lubecauthor=T.+Beryozkinaauthor=L.+Dianovaauthor=V.+Bersenevaauthor=P.+Slepukhinauthor=J.+Lebanauthor=P.+Kalabaauthor=N.+Aherauthor=M.+Ilicauthor=H.+Sitte&title=Design+and+synthesis+of+N-sulfonylamidines+of+modafinic+acid&doi=10.1055%2Fs-0035-1561350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of N-Sulfonylamidines of Modafinic Acid</span></div><div class="casAuthors">Beryozkina, Tetyana; Bakulev, Vasiliy; Dianova, Lidia; Berseneva, Vera; Slepukhin, Pavel; Leban, Johann; Kalaba, Predrag; Aher, Nilima Yogesh; Ilic, Marija; Sitte, Harald H.; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1046-1054</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">1437-210X</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A design and a convenient approach for the synthesis of novel N-sulfonyl-2-diphenylmethylsulfinylacetamidines have been demonstrated by starting from benzhydrylsulfanylacetic (BSA) acid.  This approach involves a sequential amidation with amines, thionation with Lawesson's reagent, iminosulfonylation with sulfonyl azides, and oxidn. of sulfide fragment with hydrogen peroxide.  The key step of this transformation (reaction of thioamides with sulfonyl azides) was carried out either in ethanol or in the absence of any solvent.  The synthesized compds. were tested in cells for inhibition of dopamine transporter.  Among the synthesized compds., two products were found to be in a similar range of activity as the well-known dopamine transporter inhibitor, modafinil.  The synthesis of the target compds. was achieved using 2-[(diphenylmethyl)thio]-1-(4-morpholinyl)ethanone, 2-[(diphenylmethyl)thio]-1-(1-piperidinyl)ethanone, 2-[(diphenylmethyl)thio]acetamide and azides such as methanesulfonyl azide, 4-(methyl)benzenesulfonyl azide, 2,1,3-benzothiadiazole-4-sulfonyl azide as starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj5VNJAJTPSLVg90H21EOLACvtfcHk0lj79R75d_1VOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWisbk%253D&md5=1877d91dd3650ad251ac1c7537bea624</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1055%2Fs-0035-1561350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0035-1561350%26sid%3Dliteratum%253Aachs%26aulast%3DBakulev%26aufirst%3DV.%26aulast%3DLubec%26aufirst%3DG.%26aulast%3DBeryozkina%26aufirst%3DT.%26aulast%3DDianova%26aufirst%3DL.%26aulast%3DBerseneva%26aufirst%3DV.%26aulast%3DSlepukhin%26aufirst%3DP.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DAher%26aufirst%3DN.%26aulast%3DIlic%26aufirst%3DM.%26aulast%3DSitte%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520N-sulfonylamidines%2520of%2520modafinic%2520acid%26jtitle%3DSynthesis%26date%3D2016%26volume%3D48%26issue%3D07%26spage%3D1046%26epage%3D1054%26doi%3D10.1055%2Fs-0035-1561350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Z.-X.</span></span> <span> </span><span class="NLM_article-title">The novel modafinil analog, JJC8-016, as a potential cocaine abuse pharmacotherapeutic</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1871</span>– <span class="NLM_lpage">1883</span>, <span class="refDoi"> DOI: 10.1038/npp.2017.41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1038%2Fnpp.2017.41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=28266501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt1Srtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=1871-1883&issue=9&author=H.-Y.+Zhangauthor=G.-H.+Biauthor=H.-J.+Yangauthor=Y.+Heauthor=G.+Xueauthor=J.+Caoauthor=G.+Tandaauthor=E.+L.+Gardnerauthor=A.+H.+Newmanauthor=Z.-X.+Xi&title=The+novel+modafinil+analog%2C+JJC8-016%2C+as+a+potential+cocaine+abuse+pharmacotherapeutic&doi=10.1038%2Fnpp.2017.41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic</span></div><div class="casAuthors">Zhang, Hai-Ying; Bi, Guo-Hua; Yang, Hong-Ju; He, Yi; Xue, Gilbert; Cao, Jiajing; Tanda, Gianluigi; Gardner, Eliot L.; Newman, Amy Hauck; Xi, Zheng-Xiong</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1871-1883</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">(±)Modafinil ((±)MOD) and its R-enantiomer (R-modafinil; R-MOD) have been investigated for their potential as treatments for psychostimulant addiction.  We recently reported a series of (±)MOD analogs, of which JJC8-016 (N-(2-((bis(4-fluorophenyl)methyl)thio)ethyl)-3-phenylpropan-1-amine) was selected for further development.  JJC8-016 and R-MOD were evaluated for binding across ∼70 receptors, transporters, and enzymes.  Although at a concn. of 10 μM, there were many hits for JJC8-016, binding affinities in the range of its DAT affinity were only obsd. at the serotonin transporter (SERT), dopamine D2-like, and sigma1 receptors.  R-MOD was more selective, but had much lower affinity at the DAT (Ki=3 μM) than JJC8-016 (Ki=116 nM).  In rats, systemic administration of R-MOD alone (10-30 mg/kg i.p.) dose-dependently increased locomotor activity and elec. brain-stimulation reward, whereas JJC8-016 (10-30 mg/kg i.p.) did not produce these effects.  Strikingly, pretreatment with JJC8-016 dose-dependently inhibited cocaine-enhanced locomotion, cocaine self-administration, and cocaine-induced reinstatement of drug-seeking behavior, whereas R-MOD inhibited cocaine-induced reinstatement only at the high dose of 100 mg/kg.  Notably, JJC8-016 alone neither altered extracellular dopamine in the nucleus accumbens nor maintained self-administration.  It also failed to induce reinstatement of drug-seeking behavior.  These findings suggest that JJC8-016 is a unique DAT inhibitor that has no cocaine-like abuse potential by itself.  Moreover, pretreatment with JJC8-016 significantly inhibits cocaine-taking and cocaine-seeking behavior likely by interfering with cocaine binding to DAT.  In addn., off-target actions may also contribute to its potential therapeutic utility in the treatment of cocaine abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobJMW--ayf-bVg90H21EOLACvtfcHk0lhf37nb3YgCzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt1Srtbo%253D&md5=339baa4c98b255f923fb2e5cb0c22cda</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2017.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2017.41%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Y.%26aulast%3DBi%26aufirst%3DG.-H.%26aulast%3DYang%26aufirst%3DH.-J.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DG.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DXi%26aufirst%3DZ.-X.%26atitle%3DThe%2520novel%2520modafinil%2520analog%252C%2520JJC8-016%252C%2520as%2520a%2520potential%2520cocaine%2520abuse%2520pharmacotherapeutic%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26issue%3D9%26spage%3D1871%26epage%3D1883%26doi%3D10.1038%2Fnpp.2017.41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keighron, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quarterman, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarco, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coggiano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleaves, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanettini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanda, G.</span></span> <span> </span><span class="NLM_article-title">Effects of (R)-modafinil and modafinil analogues on dopamine dynamics assessed by voltammetry and microdialysis in the mouse nucleus accumbens Shell</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2012</span>– <span class="NLM_lpage">2021</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00340</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00340" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVahtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2012-2021&issue=4&author=J.+D.+Keighronauthor=J.+C.+Quartermanauthor=J.+Caoauthor=E.+M.+Demarcoauthor=M.+A.+Coggianoauthor=A.+Gleavesauthor=R.+D.+Slackauthor=C.+Zanettiniauthor=A.+H.+Newmanauthor=G.+Tanda&title=Effects+of+%28R%29-modafinil+and+modafinil+analogues+on+dopamine+dynamics+assessed+by+voltammetry+and+microdialysis+in+the+mouse+nucleus+accumbens+Shell&doi=10.1021%2Facschemneuro.8b00340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of (R)-Modafinil and Modafinil Analogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell</span></div><div class="casAuthors">Keighron, Jacqueline D.; Quarterman, Juliana C.; Cao, Jianjing; De Marco, Emily M.; Coggiano, Mark A.; Gleaves, Apre; Slack, Rachel D.; Zanettini, Claudio; Newman, Amy Hauck; Tanda, Gianluigi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2012-2021</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent discoveries have improved our understanding of the physiol. and pathol. roles of the dopamine transporter (DAT); however, only a few drugs are clin. available for DAT-implicated disorders.  Among those drugs, modafinil (MOD) and its (R)-enantiomer (R-MOD) have been used off-label as therapies for psychostimulant use disorders, but they have shown limited effectiveness in clin. trials.  Recent preclin. studies on MOD and R-MOD have led to chem. modified structures aimed toward improving their neurobiol. properties that might lead to more effective therapeutics for stimulant use disorders.  This study examines three MOD analogs (JJC8-016, JJC8-088, and JJC8-091) with improved DAT affinities compared to their parent compd.  These compds. were investigated for their effects on the neurochem. (brain microdialysis and FSCV) and behavior (ambulatory activity) of male Swiss-Webster mice.  Our data indicate that these compds. have dissimilar effects on tonic and phasic dopamine in the nucleus accumbens shell and variability in producing ambulatory activity.  These results suggest that small changes in the chem. structure of a DAT inhibitor can cause compds. such as JJC8-088 to produce effects similar to abused psychostimulants like cocaine.  In contrast, other compds. like JJC8-091 do not share cocaine-like effects and have a more atypical DAT-inhibitor profile, which may prove to be an advancement in the treatment of psychostimulant use disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsciN_K_fZLVg90H21EOLACvtfcHk0lhf37nb3YgCzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVahtbw%253D&md5=8cf600df118f6a21c423e3b275007977</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00340%26sid%3Dliteratum%253Aachs%26aulast%3DKeighron%26aufirst%3DJ.%2BD.%26aulast%3DQuarterman%26aufirst%3DJ.%2BC.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDemarco%26aufirst%3DE.%2BM.%26aulast%3DCoggiano%26aufirst%3DM.%2BA.%26aulast%3DGleaves%26aufirst%3DA.%26aulast%3DSlack%26aufirst%3DR.%2BD.%26aulast%3DZanettini%26aufirst%3DC.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DTanda%26aufirst%3DG.%26atitle%3DEffects%2520of%2520%2528R%2529-modafinil%2520and%2520modafinil%2520analogues%2520on%2520dopamine%2520dynamics%2520assessed%2520by%2520voltammetry%2520and%2520microdialysis%2520in%2520the%2520mouse%2520nucleus%2520accumbens%2520Shell%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26issue%3D4%26spage%3D2012%26epage%3D2021%26doi%3D10.1021%2Facschemneuro.8b00340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aradska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feyissa, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragacevic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marouf, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span> <span> </span><span class="NLM_article-title">R-Modafinil exerts weak effects on spatial memory acquisition and dentate gyrus synaptic plasticity</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0179675</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0179675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1371%2Fjournal.pone.0179675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=28644892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisV2gtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0179675&author=B.+Shanmugasundaramauthor=Y.+D.+Aherauthor=J.+Aradskaauthor=M.+Ilicauthor=D.+D.+Feyissaauthor=P.+Kalabaauthor=N.+Y.+Aherauthor=V.+Dragacevicauthor=B.+S.+Maroufauthor=T.+Langerauthor=H.+H.+Sitteauthor=H.+Hoegerauthor=G.+Lubecauthor=V.+Korz&title=R-Modafinil+exerts+weak+effects+on+spatial+memory+acquisition+and+dentate+gyrus+synaptic+plasticity&doi=10.1371%2Fjournal.pone.0179675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">R-Modafinil exerts weak effects on spatial memory acquisition and dentate gyrus synaptic plasticity</span></div><div class="casAuthors">Shanmugasundaram, Bharanidharan; Aher, Yogesh D.; Aradska, Jana; Ilic, Marija; Feyissa, Daniel Daba; Kalaba, Predrag; Aher, Nilima Y.; Dragacevic, Vladimir; Marouf, Babak Saber; Langer, Thierry; Sitte, Harald H.; Hoeger, Harald; Lubec, Gert; Korz, Volker</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0179675/1-e0179675/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Modafinil is a wake promoting drug approved for clin. use and also has cognitive enhancing properties.  Its enantiomer R-Modafinil (R-MO) is not well studied in regard to cognitive enhancing properties.  Hence we studied its effect in a spatial memory paradigm and its possible effects on dentate gyrus long-term potentiation (DG-LTP).  Clin. relevant doses of R-MO, vehicle DMSO (DMSO) or saline were administered for three days during the hole-board test and in in vivo DG-LTP.  Synaptic levels of dopamine receptors D1R, D2R, dopamine transporter (DAT), and its phosphorylated form (ph-DAT) in DG tissue 4 h after LTP induction were quantified by western blot anal.  Monoamine reuptake and release assays were performed by using transfected HEK-293 cells.  Possible neurotoxic side effects on general behavior were also studied.  R-MO at both doses significantly enhanced spatial ref. memory during the last training session and during memory retrieval compared to DMSO vehicle but not when compared to saline treated rats.  Similarly, R-MO rescues DG-LTP from impairing effects of DMSO.  DMSO reduced memory performance and LTP magnitude when compared to saline treated groups.  The synaptic DR1 levels in R-MO groups were significantly decreased compared to DMSO group but were comparable with saline treated animals.  We found no effect of R-MO in neurotoxicity tests.  Thus, our results support the notion that LTP-like synaptic plasticity processes could be one of the factors contributing to the cognitive enhancing effects of spatial memory traces.  D1R may play an important regulatory role in these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBbnui-VBCzrVg90H21EOLACvtfcHk0lhf37nb3YgCzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisV2gtr8%253D&md5=f0399efa474641c52ee9d53cab5e45b7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0179675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0179675%26sid%3Dliteratum%253Aachs%26aulast%3DShanmugasundaram%26aufirst%3DB.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DAradska%26aufirst%3DJ.%26aulast%3DIlic%26aufirst%3DM.%26aulast%3DFeyissa%26aufirst%3DD.%2BD.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DDragacevic%26aufirst%3DV.%26aulast%3DMarouf%26aufirst%3DB.%2BS.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DHoeger%26aufirst%3DH.%26aulast%3DLubec%26aufirst%3DG.%26aulast%3DKorz%26aufirst%3DV.%26atitle%3DR-Modafinil%2520exerts%2520weak%2520effects%2520on%2520spatial%2520memory%2520acquisition%2520and%2520dentate%2520gyrus%2520synaptic%2520plasticity%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0179675%26doi%3D10.1371%2Fjournal.pone.0179675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bezu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span> <span> </span><span class="NLM_article-title">Repeated application of modafinil and levodopa reveals a drug-independent precise timing of spatial working memory modulation</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>312</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2016.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.bbr.2016.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=27268456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtValtrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2016&pages=9-13&author=M.+Bezuauthor=B.+Shanmugasundaramauthor=G.+Lubecauthor=V.+Korz&title=Repeated+application+of+modafinil+and+levodopa+reveals+a+drug-independent+precise+timing+of+spatial+working+memory+modulation&doi=10.1016%2Fj.bbr.2016.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated application of Modafinil and Levodopa reveals a drug-independent precise timing of spatial working memory modulation</span></div><div class="casAuthors">Bezu, M.; Shanmugasundaram, B.; Lubec, G.; Korz, V.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-13</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cognition enhancing drugs often target the dopaminergic system, which is involved in learning and memory, including working memory that in turn involves mainly the prefrontal cortex and the hippocampus.  In most animal models for modulations of working memory animals are pre-trained to a certain criterion and treated then acutely to test drugs effects on working memory.  Thus, little is known regarding subchronic or chronic application of cognition enhancing drugs and working memory performance.  Therefore we trained male rats over six days in a rewarded alternation test in a T-maze.  Rats received daily injections of either modafinil or Levodopa (L-Dopa) at a lower and a higher dose 30 min before training.  Levodopa but not modafinil increased working memory performance during early training significantly at day 3 when compared to vehicle controls.  Both drugs induced dose dependent differences in working memory with significantly better performance at low doses compared to high doses for modafinil, in contrast to L-Dopa where high dose treated rats performed better than low dose rats.  Strikingly, these effects appeared only at day 3 for both drugs, followed by a decline in behavioral performance.  Thus, a crit. drug independent time window for dopaminergic effects upon working memory could be revealed.  Evaluating the underlying mechanisms contributes to the understanding of temporal effects of dopamine on working memory performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6BSOLNYyEKrVg90H21EOLACvtfcHk0lh8DBneRqmzZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtValtrnE&md5=eca24c3926a92c70f92d76dbd49001d5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DBezu%26aufirst%3DM.%26aulast%3DShanmugasundaram%26aufirst%3DB.%26aulast%3DLubec%26aufirst%3DG.%26aulast%3DKorz%26aufirst%3DV.%26atitle%3DRepeated%2520application%2520of%2520modafinil%2520and%2520levodopa%2520reveals%2520a%2520drug-independent%2520precise%2520timing%2520of%2520spatial%2520working%2520memory%2520modulation%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D312%26spage%3D9%26epage%3D13%26doi%3D10.1016%2Fj.bbr.2016.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fendt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">Differential effects of wake promoting drug modafinil in aversive learning paradigms</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">220</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2015.00220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3389%2Ffnbeh.2015.00220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=26347629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFertb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=220&author=B.+Shanmugasundaramauthor=V.+Korzauthor=M.+Fendtauthor=K.+Braunauthor=G.+Lubec&title=Differential+effects+of+wake+promoting+drug+modafinil+in+aversive+learning+paradigms&doi=10.3389%2Ffnbeh.2015.00220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of wake promoting drug modafinil in aversive learning paradigms</span></div><div class="casAuthors">Shanmugasundaram, Bharanidharan; Korz, Volker; Fendt, Markus; Braun, Katharina; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">220/1-220/9</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Modafinil (MO) an inhibitor of the dopamine transporter was initially approved to treat narcolepsy, a sleep related disorder in humans.  One interesting "side-effect" of this drug, which emerged from preclin. and clin. studies, is the facilitation of cognitive performance.  So far, this was primarily shown in appetitive learning paradigms, but it is yet unclear whether MO exerts a more general cognitive enhancement effect.  Thus, the aim of the present study in rats was to extend these findings by testing the effects of MO in two aversive paradigms, Pavlovian fear conditioning (FC) and the operant two-way active avoidance (TWA) learning paradigms.  We discovered a differential, task-dependent effect of MO.  In the FC paradigm MO treated rats showed a dose-dependent enhancement of fear memory compared to vehicle treated rats, indicated by increased context-related freezing.  Cue related fear memory remained unaffected.  In the TWA paradigm MO induced a significant decrease of avoidance responses compared to vehicle treated animals, while the no. of escape reactions during the acquisition of the TWA task remained unaffected.  These findings expand the knowledge in the regulation of cognitive abilities and may contribute to the understanding of the contraindicative effects of MO in anxiety related mental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYA48t_-iWWbVg90H21EOLACvtfcHk0lh8DBneRqmzZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFertb0%253D&md5=3602b1538478316b972300d595376c1d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2015.00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2015.00220%26sid%3Dliteratum%253Aachs%26aulast%3DShanmugasundaram%26aufirst%3DB.%26aulast%3DKorz%26aufirst%3DV.%26aulast%3DFendt%26aufirst%3DM.%26aulast%3DBraun%26aufirst%3DK.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DDifferential%2520effects%2520of%2520wake%2520promoting%2520drug%2520modafinil%2520in%2520aversive%2520learning%2520paradigms%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D220%26doi%3D10.3389%2Ffnbeh.2015.00220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karabacak, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saroja, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicvaric, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakulev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monje, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">The effect of modafinil on the rat dopamine transporter and dopamine receptors D1–D3 paralleling cognitive enhancement in the radial arm maze</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">215</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2015.00215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3389%2Ffnbeh.2015.00215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=26347626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFertro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=215&author=Y.+Karabacakauthor=S.+Saseauthor=Y.+D.+Aherauthor=A.+Saseauthor=S.+R.+Sarojaauthor=A.+Cicvaricauthor=H.+H%C3%B6gerauthor=M.+Bergerauthor=V.+Bakulevauthor=H.+H.+Sitteauthor=J.+Lebanauthor=F.+J.+Monjeauthor=G.+Lubec&title=The+effect+of+modafinil+on+the+rat+dopamine+transporter+and+dopamine+receptors+D1%E2%80%93D3+paralleling+cognitive+enhancement+in+the+radial+arm+maze&doi=10.3389%2Ffnbeh.2015.00215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm maze</span></div><div class="casAuthors">Karabacak, Yasemin; Sase, Sunetra; Aher, Yogesh D.; Sase, Ajinkya; Saroja, Sivaprakasam R.; Cicvaric, Ana; Hoeger, Harald; Berger, Michael; Bakulev, Vasiliy; Sitte, Harald H.; Leban, Johann; Monje, Francisco J.; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">215/1-215/11</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A series of drugs have been reported to increase memory performance modulating the dopaminergic system and herein modafinil was tested for its working memory (WM) enhancing properties.  Reuptake inhibition of dopamine, serotonin (SERT) and norepinephrine (NET) by modafinil was tested.  Sixty male Sprague-Dawley rats were divided into six groups (modafinil-treated 1-5-10 mg/kg body wt., trained and untrained and vehicle treated trained and untrained rats; daily injected i.p. for a period of 10 days) and tested in a radial arm maze (RAM), a paradigm for testing spatial WM.  Hippocampi were taken 6 h following the last day of training and complexes contg. the unphosphorylated or phosphorylated dopamine transporter (DAT-CC and pDAT-CC) and complexes contg. the D1-3 dopamine receptor subunits (D1-D3-CC) were detd.  Modafinil was binding to the DAT but insignificantly to SERT or NET and dopamine reuptake was blocked specifically (IC50 = 11.11 μM; SERT 1547 μM; NET 182 μM).  From day 8 (day 9 for 1 mg/kg body wt.) modafinil was decreasing WM errors (WMEs) in the RAM significantly and remarkably at all doses tested as compared to the vehicle controls.  WMEs were linked to the D2R-CC and the pDAT-CC. pDAT and D1-D3-CC levels were modulated significantly and modafinil was shown to enhance spatial WM in the rat in a well-documented paradigm at all the three doses and dopamine reuptake inhibition with subsequent modulation of D1-3-CC is proposed as a possible mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkIy6Jc_gnrLVg90H21EOLACvtfcHk0ljZpe3yZ5p5zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFertro%253D&md5=fa116eb13b947d8126c590100cb3c78f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2015.00215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2015.00215%26sid%3Dliteratum%253Aachs%26aulast%3DKarabacak%26aufirst%3DY.%26aulast%3DSase%26aufirst%3DS.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DSase%26aufirst%3DA.%26aulast%3DSaroja%26aufirst%3DS.%2BR.%26aulast%3DCicvaric%26aufirst%3DA.%26aulast%3DH%25C3%25B6ger%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DBakulev%26aufirst%3DV.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DMonje%26aufirst%3DF.%2BJ.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DThe%2520effect%2520of%2520modafinil%2520on%2520the%2520rat%2520dopamine%2520transporter%2520and%2520dopamine%2520receptors%2520D1%25E2%2580%2593D3%2520paralleling%2520cognitive%2520enhancement%2520in%2520the%2520radial%2520arm%2520maze%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D215%26doi%3D10.3389%2Ffnbeh.2015.00215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sialana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo-Schlaff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">Modafinil improves performance in the multiple T-Maze and modifies GluR1, GluR2, D2 and NR1 receptor complex levels in the C57BL/6J Mouse</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2285</span>– <span class="NLM_lpage">2292</span>, <span class="refDoi"> DOI: 10.1007/s00726-012-1306-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1007%2Fs00726-012-1306-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=22614872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ght7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2012&pages=2285-2292&issue=6&author=S.+Saseauthor=D.+Khanauthor=F.+Sialanaauthor=H.+H%C3%B6gerauthor=N.+Russo-Schlaffauthor=G.+Lubec&title=Modafinil+improves+performance+in+the+multiple+T-Maze+and+modifies+GluR1%2C+GluR2%2C+D2+and+NR1+receptor+complex+levels+in+the+C57BL%2F6J+Mouse&doi=10.1007%2Fs00726-012-1306-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil improves performance in the multiple T-Maze and modifies GluR1, GluR2, D2 and NR1 receptor complex levels in the C57BL/6J mouse</span></div><div class="casAuthors">Sase, Sunetra; Khan, Deeba; Sialana, Fernando; Hoeger, Harald; Russo-Schlaff, Nina; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2285-2292</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">SpringerWienNewYork</span>)
        </div><div class="casAbstract">Modafinil was shown to modify behavioral and cognitive functions and to effect several brain receptors.  Effects, however, were not obsd. at the receptor protein complex level and it was therefore the aim of the study to train mice in the multiple T-Maze (MTM) as a paradigm for spatial memory and to det. paralleling brain receptor complex levels.  Sixty C57BL/6J mice were used in the study and divided into 4 groups (trained drug injected; trained vehicle injected; yoked drug injected; yoked vehicle injected).  Animals obtained training for 4 days and were killed 6 h following the last training session on day 4.  Hippocampi were dissected from the brain, membrane fractions were prepd. by ultracentrifugation and were run on blue-native gels and immunoblotted with antibodies against major brain receptors.  Modafinil treatment led to decreased latency and increased av. speed, but not to changes in pathlength and no. of correct decisions in the MTM.  Drug effects were modifying receptor complexes of GluR1, GluR2, D2, and NR1.  Training effects on receptor complex levels were obsd. for GluR3, D1, and nicotinic acetylcholine receptor alpha 7 (Nic7).  GluR1 levels were correlating with GluR2 and D1 levels were correlating with D2 and NR1.  Involvement of the glutamatergic, NMDA, dopaminergic, and nicotinergic system in modafinil and memory training were herein described for the 1st time.  A brain receptor complex pattern was revealed showing the concerted action following modafinil treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLJ0tpDOw3q7Vg90H21EOLACvtfcHk0ljZpe3yZ5p5zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ght7%252FM&md5=11b3623731e9191bcee14bbb70a5ef2c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00726-012-1306-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-012-1306-y%26sid%3Dliteratum%253Aachs%26aulast%3DSase%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DD.%26aulast%3DSialana%26aufirst%3DF.%26aulast%3DH%25C3%25B6ger%26aufirst%3DH.%26aulast%3DRusso-Schlaff%26aufirst%3DN.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DModafinil%2520improves%2520performance%2520in%2520the%2520multiple%2520T-Maze%2520and%2520modifies%2520GluR1%252C%2520GluR2%252C%2520D2%2520and%2520NR1%2520receptor%2520complex%2520levels%2520in%2520the%2520C57BL%252F6J%2520Mouse%26jtitle%3DAmino%2520Acids%26date%3D2012%26volume%3D43%26issue%3D6%26spage%3D2285%26epage%3D2292%26doi%3D10.1007%2Fs00726-012-1306-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saroja, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakulev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">A heterocyclic compound CE-103 inhibits dopamine reuptake and modulates dopamine transporter and dopamine D1-D3 containing receptor complexes</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.07.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.neuropharm.2015.07.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=26407764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWltLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2016&pages=186-196&author=A.+Saseauthor=Y.+D.+Aherauthor=S.+R.+Sarojaauthor=M.+K.+Ganesanauthor=S.+Saseauthor=M.+Holyauthor=H.+H%C3%B6gerauthor=V.+Bakulevauthor=G.+F.+Eckerauthor=T.+Langerauthor=H.+H.+Sitteauthor=J.+Lebanauthor=G.+Lubec&title=A+heterocyclic+compound+CE-103+inhibits+dopamine+reuptake+and+modulates+dopamine+transporter+and+dopamine+D1-D3+containing+receptor+complexes&doi=10.1016%2Fj.neuropharm.2015.07.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A heterocyclic compound CE-103 inhibits dopamine reuptake and modulates dopamine transporter and dopamine D1-D3 containing receptor complexes</span></div><div class="casAuthors">Sase, Ajinkya; Aher, Yogesh D.; Saroja, Sivaprakasam R.; Ganesan, Minu Karthika; Sase, Sunetra; Holy, Marion; Hoeger, Harald; Bakulev, Vasiliy; Ecker, Gerhard F.; Langer, Thierry; Sitte, Harald H.; Leban, Johann; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">186-196</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of compds. have been reported to enhance memory via the DA system and herein a heterocyclic compd. was tested for working memory (WM) enhancement.  2-((Benzhydrylsulfinyl)methyl)thiazole (CE-103) was synthesized in a six-step synthesis.  Binding of CE-103 to the dopamine (DAT), serotonin (SERT) and norepinephrine (NET) transporters and dopamine reuptake inhibition was tested as well as blood brain permeation and a screen for GPCR targets. 60 male Sprague Dawley rats were divided into six groups: CE-103 treated 1-10 mg/kg body wt., trained (TDI) and yoked (YDI) and vehicle treated, trained (TVI) and yoked (YVI) rats.  Daily single i.p. injections for a period of 10 days were administered and rats were tested in a radial arm maze (RAM).  Hippocampi were taken 6 h following the last day of training and complexes contg. the unphosphorylated or phosphorylated dopamine transporter (DAT) and complexes contg. the D1-3 dopamine receptor subunits were detd.  CE-103 was binding to the DAT but insignificantly to SERT or NET and dopamine reuptake was blocked specifically (IC50 = 14.73 μM).  From day eight the compd. was decreasing WM errors in the RAM significantly at both doses tested as compared to the vehicle controls.  In the trained CE-103-treated group levels of the complex contg. the phosphorylated dopamine transporter (pDAT) as well as D1R were decreased while levels of complexes contg. D2R and D3R were significantly increased.  CE-103 was shown to enhance spatial WM and DA reuptake inhibition with subsequent modulation of D1-3 receptors is proposed as a possible mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok9mWVCsTDErVg90H21EOLACvtfcHk0lilnQ1YJeBUCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWltLvL&md5=294205b7102eaf775a56b012c1c1434c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.07.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.07.039%26sid%3Dliteratum%253Aachs%26aulast%3DSase%26aufirst%3DA.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DSaroja%26aufirst%3DS.%2BR.%26aulast%3DGanesan%26aufirst%3DM.%2BK.%26aulast%3DSase%26aufirst%3DS.%26aulast%3DHoly%26aufirst%3DM.%26aulast%3DH%25C3%25B6ger%26aufirst%3DH.%26aulast%3DBakulev%26aufirst%3DV.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DA%2520heterocyclic%2520compound%2520CE-103%2520inhibits%2520dopamine%2520reuptake%2520and%2520modulates%2520dopamine%2520transporter%2520and%2520dopamine%2520D1-D3%2520containing%2520receptor%2520complexes%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D102%26spage%3D186%26epage%3D196%26doi%3D10.1016%2Fj.neuropharm.2015.07.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saroja, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniyan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miklosi, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">A novel heterocyclic compound targeting the dopamine transporter improves performance in the radial arm maze and modulates dopamine receptors D1-D3</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>312</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2016.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.bbr.2016.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=27288589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2gt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2016&pages=127-137&author=S.+R.+Sarojaauthor=Y.+D.+Aherauthor=P.+Kalabaauthor=N.+Y.+Aherauthor=M.+Zehlauthor=V.+Korzauthor=S.+Subramaniyanauthor=A.+G.+Miklosiauthor=L.+Zanonauthor=W.+Neuhausauthor=H.+H%C3%B6gerauthor=T.+Langerauthor=E.+Urbanauthor=J.+Lebanauthor=G.+Lubec&title=A+novel+heterocyclic+compound+targeting+the+dopamine+transporter+improves+performance+in+the+radial+arm+maze+and+modulates+dopamine+receptors+D1-D3&doi=10.1016%2Fj.bbr.2016.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A novel heterocyclic compound targeting the dopamine transporter improves performance in the radial arm maze and modulates dopamine receptors D1-D3</span></div><div class="casAuthors">Saroja, Sivaprakasam R.; Aher, Yogesh D.; Kalaba, Predrag; Aher, Nilima Y.; Zehl, Martin; Korz, Volker; Subramaniyan, Saraswathi; Miklosi, Andras G.; Zanon, Lisa; Neuhaus, Winfried; Hoeger, Harald; Langer, Thierry; Urban, Ernst; Leban, Johann; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-137</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of compds. targeting the dopamine transporter (DAT) haS been shown to improve memory performance most probably by re-uptake inhibition.  Although specific DAT inhibitors are available, there is limited information about specificity, mechanism and in particular the effect on dopamine receptors.  It was therefore the aim of the study to test the DAT inhibitor 4-(diphenyl-methanesulfinylmethyl)-2-methyl-thiazole (code: CE-111), synthesized in our lab. for the specificity to target DAT, for the effects upon spatial memory and for induced dopamine receptor modulation.  Re-uptake inhibition was tested for DAT (IC50 = 3.2 μM), serotonin transporter, SERT (IC50 = 272291 μM) and noradrenaline transporter, NET (IC50 = 174 μM).  Spatial memory was studied in the radial arm maze (RAM) in male Sprague-Dawley rats that were i.p. injected with CE-111 (1 or 10 mg/kg body wt.).  Performance in the RAM was improved using 1 and 10 mg/kg body wt. of CE-111.  Training and treatment effects on presynaptic, postsynaptic and extrasynaptic D1 and D2- receptors and dopamine receptor contg. complexes as well as on activated DAT were obsd.  CE-111 was crossing the blood-brain barrier comparable to modafinil and was identified as effective to improve memory performance in the RAM.  Dopamine re-uptake inhibition along with modulations in dopamine receptors are proposed as potential underlying mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx_C54Kjw8pLVg90H21EOLACvtfcHk0lilnQ1YJeBUCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2gt7bE&md5=793da79675241e43aaa035788d8dc2d1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DSaroja%26aufirst%3DS.%2BR.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DZehl%26aufirst%3DM.%26aulast%3DKorz%26aufirst%3DV.%26aulast%3DSubramaniyan%26aufirst%3DS.%26aulast%3DMiklosi%26aufirst%3DA.%2BG.%26aulast%3DZanon%26aufirst%3DL.%26aulast%3DNeuhaus%26aufirst%3DW.%26aulast%3DH%25C3%25B6ger%26aufirst%3DH.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DUrban%26aufirst%3DE.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DA%2520novel%2520heterocyclic%2520compound%2520targeting%2520the%2520dopamine%2520transporter%2520improves%2520performance%2520in%2520the%2520radial%2520arm%2520maze%2520and%2520modulates%2520dopamine%2520receptors%2520D1-D3%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D312%26spage%3D127%26epage%3D137%26doi%3D10.1016%2Fj.bbr.2016.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragačević, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radoman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilić, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beryozkina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A. B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">A novel heterocyclic compound improves working memory in the radial arm maze and modulates the dopamine receptor D1R in frontal cortex of the Sprague-Dawley Rat</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>332</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2017.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.bbr.2017.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=28629964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKntrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2017&pages=308-315&author=A.+M.+Husseinauthor=Y.+D.+Aherauthor=P.+Kalabaauthor=N.+Y.+Aherauthor=V.+Draga%C4%8Devi%C4%87author=B.+Radomanauthor=M.+Ili%C4%87author=J.+Lebanauthor=T.+Beryozkinaauthor=A.+B.+M.+Ahmedauthor=E.+Urbanauthor=T.+Langerauthor=G.+Lubec&title=A+novel+heterocyclic+compound+improves+working+memory+in+the+radial+arm+maze+and+modulates+the+dopamine+receptor+D1R+in+frontal+cortex+of+the+Sprague-Dawley+Rat&doi=10.1016%2Fj.bbr.2017.06.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A novel heterocyclic compound improves working memory in the radial arm maze and modulates the dopamine receptor D1R in frontal cortex of the Sprague-Dawley rat</span></div><div class="casAuthors">Hussein, Ahmed M.; Aher, Yogesh D.; Kalaba, Predrag; Aher, Nilima Y.; Dragacevic, Vladimir; Radoman, Bojana; Ilic, Marija; Leban, Johann; Beryozkina, Tetyana; Ahmed, Abdel Baset M. A.; Urban, Ernst; Langer, Thierry; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">308-315</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of compds. have been shown to enhance cognitive function via the dopaminergic system and indeed the search for more active and less toxic compds. is continuing.  It was therefore the aim of the study to synthetise and test a novel heterocyclic compd. for cognitive enhancement in a paradigm for working memory.  Specific and effective dopamine re-uptake inhibition DAT (IC50 = 4,1 ± 0,8 μM) made us test this compd. in a radial arm maze (RAM) in the rat.  CE-125 (4-((benzhydrylsulfinyl)methyl)-2-cyclopropylthiazole), was tested for dopamine (DAT), serotonin and norepinephrine re-uptake inhibition by a well-established system.  The working memory index (WMI) was evaluated in male Sprague Dawley rats that were i.p. injected with CE-125 (1 or 10 mg/kg body wt.).  In order to evaluate basic neurotoxicity, the open field, elevated plus maze, rota rod studies and the forced swim test were carried out.  Frontal cortex was taken at the last day of the RAM test and dopamine receptors D1R and D2R, DAT and phosphorylated DAT protein levels were detd.  On the 10th day both doses were increasing the WMI as compared to the vehicle-treated group.  In both, trained and treated groups, D1R levels were significantly reduced while D2R levels were unchanged.  DAT levels were comparable between all groups while phosphorylated DAT levels were increased in the trained group treated with 1 mg/kg body wt.  CE-125 as a probably non-neurotoxic compd. and specific reuptake inhibitor was shown to increase performance (WMI) and modulation of the dopaminergic system is proposed as a possible mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1NG4VH9ymM7Vg90H21EOLACvtfcHk0ljQZc4aID704Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKntrbO&md5=7cb65082b366d222bf5eb697a3269e94</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2017.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2017.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DHussein%26aufirst%3DA.%2BM.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DDraga%25C4%258Devi%25C4%2587%26aufirst%3DV.%26aulast%3DRadoman%26aufirst%3DB.%26aulast%3DIli%25C4%2587%26aufirst%3DM.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DBeryozkina%26aufirst%3DT.%26aulast%3DAhmed%26aufirst%3DA.%2BB.%2BM.%26aulast%3DUrban%26aufirst%3DE.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DA%2520novel%2520heterocyclic%2520compound%2520improves%2520working%2520memory%2520in%2520the%2520radial%2520arm%2520maze%2520and%2520modulates%2520the%2520dopamine%2520receptor%2520D1R%2520in%2520frontal%2520cortex%2520of%2520the%2520Sprague-Dawley%2520Rat%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2017%26volume%3D332%26spage%3D308%26epage%3D315%26doi%3D10.1016%2Fj.bbr.2017.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kristofova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radoman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragacevic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aradska, J.</span></span> <span> </span><span class="NLM_article-title">A daily single dose of a novel modafinil analogue CE-123 improves memory acquisition and memory retrieval</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2018.01.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.bbr.2018.01.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=29410048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1Ogsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2018&pages=83-94&author=M.+Kristofovaauthor=Y.+D.+Aherauthor=M.+Ilicauthor=B.+Radomanauthor=P.+Kalabaauthor=V.+Dragacevicauthor=N.+Y.+Aherauthor=J.+Lebanauthor=V.+Korzauthor=L.+Zanonauthor=W.+Neuhausauthor=M.+Wiederauthor=T.+Langerauthor=E.+Urbanauthor=H.+H.+Sitteauthor=H.+Hoegerauthor=G.+Lubecauthor=J.+Aradska&title=A+daily+single+dose+of+a+novel+modafinil+analogue+CE-123+improves+memory+acquisition+and+memory+retrieval&doi=10.1016%2Fj.bbr.2018.01.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A daily single dose of a novel modafinil analogue CE-123 improves memory acquisition and memory retrieval</span></div><div class="casAuthors">Kristofova, Martina; Aher, Yogesh D.; Ilic, Marija; Radoman, Bojana; Kalaba, Predrag; Dragacevic, Vladimir; Aher, Nilima Y.; Leban, Johann; Korz, Volker; Zanon, Lisa; Neuhaus, Winfried; Wieder, Marcus; Langer, Thierry; Urban, Ernst; Sitte, Harald H.; Hoeger, Harald; Lubec, Gert; Aradska, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-94</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dopamine reuptake inhibitors have been shown to improve cognitive parameters in various tasks and animal models.  We recently reported a series of modafinil analogs, of which the most promising, 5-((benzhydrylsulfinyl)methyl) thiazole (CE-123), was selected for further development.  The present study aims to characterize pharmacol. properties of CE-123 and to investigate the potential to enhance memory performance in a rat model.  In vitro transporter assays were performed in cells expressing human transporters.  CE-123 blocked uptake of [3H] dopamine (IC50 = 4.606 μM) while effects on serotonin (SERT) and the norepinephrine transporter (NET) were negligible.  Blood-brain barrier and pharmacokinetic studies showed that the compd. reached the brain and lower elimination than R-modafinil.  The Pro-cognitive effect was evaluated in a spatial hole-board task in male Sprague-Dawley rats and CE-123 enhances memory acquisition and memory retrieval, represented by significantly increased ref. memory indexes and shortened latency.  Since DAT blockers can be considered as indirect dopamine receptor agonists, western blotting was used to quantify protein levels of dopamine receptors D1R, D2R and D5R and DAT in the synaptosomal fraction of hippocampal subregions CA1, CA3 and dentate gyrus (DG).  CE-123 administration in rats increased total DAT levels and D1R protein levels were significantly increased in CA1 and CA3 in treated/trained groups.  The increase of D5R was obsd. in DG only.  Dopamine receptors, particularly D1R, seem to play a role in mediating CE-123-induced memory enhancement.  Dopamine reuptake inhibition by CE-123 may represent a novel and improved stimulant therapeutic for impairments of cognitive functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprz2p5563B_bVg90H21EOLACvtfcHk0ljQZc4aID704Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1Ogsbw%253D&md5=0f3059aab891533f96b28d3529310a77</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2018.01.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2018.01.032%26sid%3Dliteratum%253Aachs%26aulast%3DKristofova%26aufirst%3DM.%26aulast%3DAher%26aufirst%3DY.%2BD.%26aulast%3DIlic%26aufirst%3DM.%26aulast%3DRadoman%26aufirst%3DB.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DDragacevic%26aufirst%3DV.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DKorz%26aufirst%3DV.%26aulast%3DZanon%26aufirst%3DL.%26aulast%3DNeuhaus%26aufirst%3DW.%26aulast%3DWieder%26aufirst%3DM.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DUrban%26aufirst%3DE.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DHoeger%26aufirst%3DH.%26aulast%3DLubec%26aufirst%3DG.%26aulast%3DAradska%26aufirst%3DJ.%26atitle%3DA%2520daily%2520single%2520dose%2520of%2520a%2520novel%2520modafinil%2520analogue%2520CE-123%2520improves%2520memory%2520acquisition%2520and%2520memory%2520retrieval%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2018%26volume%3D343%26spage%3D83%26epage%3D94%26doi%3D10.1016%2Fj.bbr.2018.01.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilić, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragačević, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miklosi, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wackerlig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beryozkina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radoman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saroja, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakulev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic analogues of modafinil as novel, atypical dopamine transporter inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9330</span>– <span class="NLM_lpage">9348</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGnu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9330-9348&issue=22&author=P.+Kalabaauthor=N.+Y.+Aherauthor=M.+Ili%C4%87author=V.+Draga%C4%8Devi%C4%87author=M.+Wiederauthor=A.+G.+Miklosiauthor=M.+Zehlauthor=J.+Wackerligauthor=A.+Rollerauthor=T.+Beryozkinaauthor=B.+Radomanauthor=S.+R.+Sarojaauthor=W.+Lindnerauthor=E.+P.+Gonzalezauthor=V.+Bakulevauthor=J.+J.+Lebanauthor=H.+H.+Sitteauthor=E.+Urbanauthor=T.+Langerauthor=G.+Lubec&title=Heterocyclic+analogues+of+modafinil+as+novel%2C+atypical+dopamine+transporter+inhibitors&doi=10.1021%2Facs.jmedchem.7b01313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic Analogues of Modafinil as Novel, Atypical Dopamine Transporter Inhibitors</span></div><div class="casAuthors">Kalaba, Predrag; Aher, Nilima Y.; Ilic, Marija; Dragacevic, Vladimir; Wieder, Marcus; Miklosi, Andras G.; Zehl, Martin; Wackerlig, Judith; Roller, Alexander; Beryozkina, Tetyana; Radoman, Bojana; Saroja, Sivaprakasam R.; Lindner, Wolfgang; Gonzalez, Eduardo Perez; Bakulev, Vasiliy; Leban, Johann Jakob; Sitte, Harald H.; Urban, Ernst; Langer, Thierry; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9330-9348</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modafinil is a wake promoting compd. with high potential for cognitive enhancement.  It is targeting the dopamine transporter (DAT) with moderate selectivity, thereby leading to reuptake inhibition and increased dopamine levels in the synaptic cleft.  A series of modafinil analogs have been reported so far, but more target-specific analogs remain to be discovered.  It was the aim of this study to synthesize and characterize such analogs and, indeed, a series of compds. were showing higher activities on the DAT and a higher selectivity toward DAT vs. serotonin and norepinephrine transporters than modafinil.  This was achieved by substituting the amide moiety by five- and six-membered arom. heterocycles.  In vitro studies indicated binding to the cocaine pocket on DAT, although mol. dynamics revealed binding different from that of cocaine.  Moreover, no release of dopamine was obsd., ruling out amphetamine-like effects.  The absence of neurotoxicity of a representative analog may encourage further preclin. studies of the above-mentioned compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxI4zZzeCZg7Vg90H21EOLACvtfcHk0ljQZc4aID704Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGnu7fP&md5=f391cc57a70ae320ae11961b00575633</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01313%26sid%3Dliteratum%253Aachs%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DIli%25C4%2587%26aufirst%3DM.%26aulast%3DDraga%25C4%258Devi%25C4%2587%26aufirst%3DV.%26aulast%3DWieder%26aufirst%3DM.%26aulast%3DMiklosi%26aufirst%3DA.%2BG.%26aulast%3DZehl%26aufirst%3DM.%26aulast%3DWackerlig%26aufirst%3DJ.%26aulast%3DRoller%26aufirst%3DA.%26aulast%3DBeryozkina%26aufirst%3DT.%26aulast%3DRadoman%26aufirst%3DB.%26aulast%3DSaroja%26aufirst%3DS.%2BR.%26aulast%3DLindner%26aufirst%3DW.%26aulast%3DGonzalez%26aufirst%3DE.%2BP.%26aulast%3DBakulev%26aufirst%3DV.%26aulast%3DLeban%26aufirst%3DJ.%2BJ.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DUrban%26aufirst%3DE.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DHeterocyclic%2520analogues%2520of%2520modafinil%2520as%2520novel%252C%2520atypical%2520dopamine%2520transporter%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D22%26spage%3D9330%26epage%3D9348%26doi%3D10.1021%2Facs.jmedchem.7b01313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikiforuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragačević, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wackerlig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golebiowska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">A novel dopamine transporter inhibitor CE-123 improves cognitive flexibility and maintains impulsivity in healthy male rats</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">222</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2017.00222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3389%2Ffnbeh.2017.00222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=29230168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvVGktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=222&author=A.+Nikiforukauthor=P.+Kalabaauthor=M.+Ilicauthor=V.+Korzauthor=V.+Draga%C4%8Devi%C4%87author=J.+Wackerligauthor=T.+Langerauthor=H.+H%C3%B6gerauthor=J.+Golebiowskaauthor=P.+Popikauthor=G.+Lubec&title=A+novel+dopamine+transporter+inhibitor+CE-123+improves+cognitive+flexibility+and+maintains+impulsivity+in+healthy+male+rats&doi=10.3389%2Ffnbeh.2017.00222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel dopamine transporter inhibitor CE-123 improves cognitive flexibility and maintains impulsivity in healthy male rats</span></div><div class="casAuthors">Nikiforuk, Agnieszka; Kalaba, Predrag; Ilic, Marija; Korz, Volker; Dragacevic, Vladimir; Wackerlig, Judith; Langer, Thierry; Hoger, Harald; Golebiowska, Joanna; Popik, Piotr; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">222/1-222/11</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Reduced cognitive abilities are often characterized by an impairment of flexibility, i.e., the ability to switch from learned rules or categories that were important in certain contexts to different new modalities that rule the task.  Drugs targeting the dopamine transporter (DAT) are widely used for their potential to enhance cognitive abilities.  However, com. available drugs are of limited specificity for DAT, blocking also noradrenaline and serotonine transporters, that can lead to unwanted side effects in healthy subjects.  Therefore, we tested a newly synthesized compd. (CE-123) with higher specificity for DAT in male rats in an attentional set-shifting task (ASST), that proves for cognitive flexibility and a 5-choice serial-reaction time task (5-CSRTT) assessing visuospatial attention and impulsivity.  Treated rats at a dose of 0.3 and 1.0 but not 0.1 mg/kg bodyweight showed reduced extra-dimensional shifts in the ASST compared to controls indicating increased cognitive flexibility.  Rats treated with R-Modafinil, a com. available DAT inhibitor at a dose of 10 mg/kg bodyweight showed increased premature responses, an indicator of increased impulsivity, during a 10 s but not a 2.5, 5, or 7.5 s intertrial interval when compared to vehicle-treated rats in the 5-CSRTT.  This was not found in rats treated with CE-123 at the same dose as for R-Modafinil.  Visuospatial attention, except premature responses, did not differ between R-Modafinil and CE-123-treated rats and their resp. controls.  Thus, CE-123 increased cognitive flexibility with diminished impulsivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodBOAI4YQhFbVg90H21EOLACvtfcHk0lh8y-PKhbx3Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvVGktLk%253D&md5=aa11518fbd668106be256ed104cb7240</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2017.00222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2017.00222%26sid%3Dliteratum%253Aachs%26aulast%3DNikiforuk%26aufirst%3DA.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DIlic%26aufirst%3DM.%26aulast%3DKorz%26aufirst%3DV.%26aulast%3DDraga%25C4%258Devi%25C4%2587%26aufirst%3DV.%26aulast%3DWackerlig%26aufirst%3DJ.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DH%25C3%25B6ger%26aufirst%3DH.%26aulast%3DGolebiowska%26aufirst%3DJ.%26aulast%3DPopik%26aufirst%3DP.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DA%2520novel%2520dopamine%2520transporter%2520inhibitor%2520CE-123%2520improves%2520cognitive%2520flexibility%2520and%2520maintains%2520impulsivity%2520in%2520healthy%2520male%2520rats%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2017%26volume%3D11%26spage%3D222%26doi%3D10.3389%2Ffnbeh.2017.00222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorengel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sündermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golovyashkina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewejohann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakota, L.</span></span> <span> </span><span class="NLM_article-title">DMSO modulates CNS function in a preclinical Alzheimers disease model</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.neuropharm.2016.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=27773645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSntrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2017&pages=434-444&author=L.+Penazziauthor=J.+Lorengelauthor=F.+S%C3%BCndermannauthor=N.+Golovyashkinaauthor=S.+Marreauthor=C.+M.+Mathisauthor=L.+Lewejohannauthor=R.+Brandtauthor=L.+Bakota&title=DMSO+modulates+CNS+function+in+a+preclinical+Alzheimers+disease+model&doi=10.1016%2Fj.neuropharm.2016.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">DMSO modulates CNS function in a preclinical Alzheimer's disease model</span></div><div class="casAuthors">Penazzi, Lorene; Lorengel, Julia; Suendermann, Frederik; Golovyashkina, Nataliya; Marre, Stefan; Mathis, Chantal M. B.; Lewejohann, Lars; Brandt, Roland; Bakota, Lidia</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">Part_A</span>),
    <span class="NLM_cas:pages">434-444</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">DMSO has a widespread use as a vehicle for water-insol. therapeutic drug candidates but may also exert disease-relevant pharmacol. effects by itself.  However, its influence on the CNS has hardly been addressed.  Here we examd. the brain structure and function following chronic exposure to low DMSO dose at a paradigm with flawed synaptic connectivity in a preclin. transgenic mouse model for Alzheimer's disease (APPSDL mice).  DMSO treatment increased spine d. in a region-specific manner in the hippocampus of APPSDL mice ex vivo and in vivo.  Moreover, DMSO exhibited clear influence on the behavior of this mouse line by enhancing hippocampal-dependent spatial memory accuracy, modulating hippocampal-independent olfactory habituation and displaying anxiolytic effect.  Despite that most of the action of DMSO was obsd. in animals with elevated Aβ levels, the drug did not exert its function via decreasing the oligomeric Aβ species.  However, challenging organotypic hippocampal slice cultures with NMDA receptor antagonist MK-801 recapitulated the effect of DMSO on spine d., indicating a tuning influence of DMSO on receptor signalization.  Our findings demonstrate that DMSO should be considered as a true bioactive compd., which has the potential to be a beneficial adjuvant to counteract Aβ-mediated synaptotoxicity and behavioral impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-DfKgAb4gbLVg90H21EOLACvtfcHk0lh8y-PKhbx3Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSntrvP&md5=53678c50c24e70e7b77a3e5a1d1bb8be</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DPenazzi%26aufirst%3DL.%26aulast%3DLorengel%26aufirst%3DJ.%26aulast%3DS%25C3%25BCndermann%26aufirst%3DF.%26aulast%3DGolovyashkina%26aufirst%3DN.%26aulast%3DMarre%26aufirst%3DS.%26aulast%3DMathis%26aufirst%3DC.%2BM.%26aulast%3DLewejohann%26aufirst%3DL.%26aulast%3DBrandt%26aufirst%3DR.%26aulast%3DBakota%26aufirst%3DL.%26atitle%3DDMSO%2520modulates%2520CNS%2520function%2520in%2520a%2520preclinical%2520Alzheimers%2520disease%2520model%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D113%26spage%3D434%26epage%3D444%26doi%3D10.1016%2Fj.neuropharm.2016.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scullion, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, A. D.</span></span> <span> </span><span class="NLM_article-title">Low concentrations of the solvent dimethyl sulphoxide alter intrinsic excitability properties of cortical and hippocampal pyramidal cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e92557</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0092557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1371%2Fjournal.pone.0092557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=24647720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKisbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e92557&author=F.+Tamagniniauthor=S.+Scullionauthor=J.+T.+Brownauthor=A.+D.+Randall&title=Low+concentrations+of+the+solvent+dimethyl+sulphoxide+alter+intrinsic+excitability+properties+of+cortical+and+hippocampal+pyramidal+cells&doi=10.1371%2Fjournal.pone.0092557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Low concentrations of the solvent dimethyl sulphoxide alter intrinsic excitability properties of cortical and hippocampal pyramidal cells</span></div><div class="casAuthors">Tamagnini, Francesco; Scullion, Sarah; Brown, Jonathan T.; Randall, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e92557/1-e92557/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Dimethylsulfoxide (DMSO) is a widely used solvent in biol.  It has many applications perhaps the most common of which is in aiding the prepn. of drug solns. from hydrophobic chem. entities.  Recent studies have suggested that this mol. may be able to induce apoptosis in neural tissues urging caution regarding its introduction into humans, for example as part of stem cell transplants.  Here we have used in vitro electrophysiol. methods applied to murine brain slices to examine whether a few hours treatment with 0.05% DMSO (a concn. regarded by many as innocuous) alters intrinsic excitability properties of neurons.  We investigated pyramidal neurons in two distinct brain regions, namely area CA1 of the hippocampus and layer 2 of perirhinal cortex.  In the former there was no effect on resting potential but input resistance was decreased by DMSO pre-treatment.  In line with this action potential count for any level of depolarizing current stimulus was reduced by ∼25% following DMSO treatment.  Ih-mediated "sag" was also increased in CA1 pyramids and action potential waveform anal. demonstrated that DMSO treatment moved action potential threshold towards resting potential.  In perirhinal cortex a decreased action potential output for various depolarizing current stimuli was also seen.  In these cells action potential threshold was unaltered by DMSO but a significant increase in action potential width was apparent.  These data indicate that pre-treatment with this widely employed solvent can elicit multifaceted neurophysiol. changes in mammalian neurons at concns. below those frequently encountered in the published literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCWqZe6n0_nrVg90H21EOLACvtfcHk0li_cXBL3d1lXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKisbzJ&md5=822a00d7eda1c089ba188da1109d31f7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0092557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0092557%26sid%3Dliteratum%253Aachs%26aulast%3DTamagnini%26aufirst%3DF.%26aulast%3DScullion%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%2BT.%26aulast%3DRandall%26aufirst%3DA.%2BD.%26atitle%3DLow%2520concentrations%2520of%2520the%2520solvent%2520dimethyl%2520sulphoxide%2520alter%2520intrinsic%2520excitability%2520properties%2520of%2520cortical%2520and%2520hippocampal%2520pyramidal%2520cells%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De92557%26doi%3D10.1371%2Fjournal.pone.0092557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span> <span> </span><span class="NLM_article-title">A new cobalt–salen catalyst for asymmetric cyclopropanation. synthesis of the serotonin–norepinephrine repuptake inhibitor (+)-Synosutine</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">3880</span>– <span class="NLM_lpage">3883</span>, <span class="refDoi"> DOI: 10.1021/ol501549x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol501549x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=3880-3883&issue=15&author=J.+D.+Whiteauthor=S.+Shaw&title=A+new+cobalt%E2%80%93salen+catalyst+for+asymmetric+cyclopropanation.+synthesis+of+the+serotonin%E2%80%93norepinephrine+repuptake+inhibitor+%28%2B%29-Synosutine&doi=10.1021%2Fol501549x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A New Cobalt-Salen Catalyst for Asymmetric Cyclopropanation. Synthesis of the Serotonin-Norepinephrine Reuptake Inhibitor (+)-Synosutine</span></div><div class="casAuthors">White, James D.; Shaw, Subrata</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3880-3883</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new C2 sym. cobalt(II)-salen catalyst based on cis-2,5-diaminobicyclo[2.2.2]octane as the chiral scaffold was prepd. which, in the presence of potassium thioacetate as the promoter, catalyzed the formation of cyclopropanes from 1,1-disubstituted ethylenes and Et diazoacetate in high yield and with excellent diastereo- and enantioselectivity [e.g., α-methylstyrene + Et diazoacetate in presence of Co salen complex and KSAc in chlorinated solvent afforded cyclopropane (E)-I in dr(E/Z) = 30:1 and ee(E) > 90%].  Asym. cyclopropanation with the catalyst was used in a short, efficient synthesis of the dual serotonin-epinephrine reuptake inhibitor (+)-synosutine (II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsG2_hnNPrAbVg90H21EOLACvtfcHk0li_cXBL3d1lXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtb7O&md5=6edc263029b1a68391f2d3e003f613ab</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fol501549x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol501549x%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%2BD.%26aulast%3DShaw%26aufirst%3DS.%26atitle%3DA%2520new%2520cobalt%25E2%2580%2593salen%2520catalyst%2520for%2520asymmetric%2520cyclopropanation.%2520synthesis%2520of%2520the%2520serotonin%25E2%2580%2593norepinephrine%2520repuptake%2520inhibitor%2520%2528%252B%2529-Synosutine%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26issue%3D15%26spage%3D3880%26epage%3D3883%26doi%3D10.1021%2Fol501549x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span> <i>Bruker SAINT</i>, version <span class="NLM_edition">8.38A</span>; <span class="NLM_publisher-name">Bruker AXS</span>, <span class="NLM_year">2005–2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Bruker+SAINT%2C+version+8.38A%3B+Bruker+AXS%2C+2005%E2%80%932016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DBruker%2520SAINT%26pub%3DBruker%2520AXS%26date%3D2005%25E2%2580%25932016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <i>SADABS</i>; <span class="NLM_publisher-name">University of Göttingen</span>: <span class="NLM_publisher-loc">Göttingen, Germany</span>, <span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=G.+M.+Sheldrick&title=SADABS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26jtitle%3DSADABS%26pub%3DUniversity%2520of%2520G%25C3%25B6ttingen%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolomanov, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourhis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildea, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, J. A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puschmann, H.</span></span> <span> </span><span class="NLM_article-title">OLEX2. A rapid method for quantifying heavy atom derivatives for multiple isomorphous replacement in protein crystallography</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1107/S0021889808042726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1107%2FS0021889808042726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=339-341&author=O.+V.+Dolomanovauthor=L.+J.+Bourhisauthor=R.+J.+Gildeaauthor=J.+A.+K.+Howardauthor=H.+Puschmann&title=OLEX2.+A+rapid+method+for+quantifying+heavy+atom+derivatives+for+multiple+isomorphous+replacement+in+protein+crystallography&doi=10.1107%2FS0021889808042726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">OLEX2: a complete structure solution, refinement and analysis program</span></div><div class="casAuthors">Dolomanov, Oleg V.; Bourhis, Luc J.; Gildea, Richard J.; Howard, Judith A. K.; Puschmann, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-341</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">New software, OLEX2, was developed for the detn., visualization and anal. of mol. crystal structures.  The software has a portable mouse-driven workflow-oriented and fully comprehensive graphical user interface for structure soln., refinement and report generation, as well as novel tools for structure anal.  OLEX2 seamlessly links all aspects of the structure soln., refinement and publication process and presents them in a single workflow-driven package, with the ultimate goal of producing an application which will be useful to both chemists and crystallographers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIYSUbyzIgxbVg90H21EOLACvtfcHk0liSilP4HK5_cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D&md5=7a2f9697b13b8e76de0e7dc5074ab229</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0021889808042726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889808042726%26sid%3Dliteratum%253Aachs%26aulast%3DDolomanov%26aufirst%3DO.%2BV.%26aulast%3DBourhis%26aufirst%3DL.%2BJ.%26aulast%3DGildea%26aufirst%3DR.%2BJ.%26aulast%3DHoward%26aufirst%3DJ.%2BA.%2BK.%26aulast%3DPuschmann%26aufirst%3DH.%26atitle%3DOLEX2.%2520A%2520rapid%2520method%2520for%2520quantifying%2520heavy%2520atom%2520derivatives%2520for%2520multiple%2520isomorphous%2520replacement%2520in%2520protein%2520crystallography%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2009%26volume%3D42%26spage%3D339%26epage%3D341%26doi%3D10.1107%2FS0021889808042726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huebschle, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittrich, B.</span></span> <span> </span><span class="NLM_article-title">ShelXle: a Qt graphical user interface for SHELXL</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1281</span>– <span class="NLM_lpage">1284</span>, <span class="refDoi"> DOI: 10.1107/S0021889811043202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1107%2FS0021889811043202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=22477785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFSisrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=1281-1284&author=C.+B.+Huebschleauthor=G.+M.+Sheldrickauthor=B.+Dittrich&title=ShelXle%3A+a+Qt+graphical+user+interface+for+SHELXL&doi=10.1107%2FS0021889811043202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">ShelXle: a Qt graphical user interface for SHELXL</span></div><div class="casAuthors">Huebschle, Christian B.; Sheldrick, George M.; Dittrich, Birger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1281-1284</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">ShelXle is a user-friendly graphical user interface for SHELXL.  It combines an editor with syntax highlighting for SHELXL-assocd. files with an interactive graphical display for visualization of a three-dimensional structure.  ShelXle is a graphical user interface for SHELXL [Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122], currently the most widely used program for small-mol. structure refinement.  It combines an editor with syntax highlighting for the SHELXL-assocd. (input) and (output) files with an interactive graphical display for visualization of a three-dimensional structure including the electron d. (Fo) and difference d. (Fo-Fc) maps.  Special features of ShelXle include intuitive atom (re-)naming, a strongly coupled editor, structure visualization in various mono and stereo modes, and a novel way of displaying disorder extending over special positions.  ShelXle is completely compatible with all features of SHELXL and is written entirely in C++ using the Qt4 and FFTW libraries.  It is available at no cost for Windows, Linux and Mac-OS X and as source code.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow_d-mylopt7Vg90H21EOLACvtfcHk0liSilP4HK5_cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFSisrrF&md5=b9c11983c90116eaf0720fcdbf061ff3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0021889811043202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889811043202%26sid%3Dliteratum%253Aachs%26aulast%3DHuebschle%26aufirst%3DC.%2BB.%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26aulast%3DDittrich%26aufirst%3DB.%26atitle%3DShelXle%253A%2520a%2520Qt%2520graphical%2520user%2520interface%2520for%2520SHELXL%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2011%26volume%3D44%26spage%3D1281%26epage%3D1284%26doi%3D10.1107%2FS0021889811043202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">A short history of SHELX</span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1107/S0108767307043930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=18156677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=112-122&issue=1&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX&doi=10.1107%2FS0108767307043930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0liSilP4HK5_cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2008%26volume%3D64%26issue%3D1%26spage%3D112%26epage%3D122%26doi%3D10.1107%2FS0108767307043930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure refinement with SHELXL</span>. <i>Acta Crystallogr., Sect. C: Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1107%2FS2053229614024218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&issue=1&author=G.+M.+Sheldrick&title=Crystal+structure+refinement+with+SHELXL&doi=10.1107%2FS2053229614024218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure refinement with SHELXL</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The improvements in the crystal structure refinement program SHELXL have been closely coupled with the development and increasing importance of the CIF (Crystallog. Information Framework) format for validating and archiving crystal structures.  An important simplification is that now only one file in CIF format (for convenience, referred to simply as 'a CIF') contg. embedded reflection data and SHELXL instructions is needed for a complete structure archive; the program SHREDCIF can be used to ext. the and files required for further refinement with SHELXL.  Recent developments in SHELXL facilitate refinement against neutron diffraction data, the treatment of H atoms, the detn. of abs. structure, the input of partial structure factors and the refinement of twinned and disordered structures.  SHELXL is available free to academics for the Windows, Linux and Mac OS X operating systems, and is particularly suitable for multiple-core processors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk1_pNHwXR7Vg90H21EOLACvtfcHk0liSilP4HK5_cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D&md5=4a860804b50fc183e8a701098b98ef59</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024218%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DCrystal%2520structure%2520refinement%2520with%2520SHELXL%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Struct.%2520Chem.%26date%3D2015%26volume%3D71%26issue%3D1%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053229614024218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spek, A. L.</span></span> <span> </span><span class="NLM_article-title">Structure validation in chemical crystallography</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1107/S090744490804362X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1107%2FS090744490804362X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=19171970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=148-155&issue=2&author=A.+L.+Spek&title=Structure+validation+in+chemical+crystallography&doi=10.1107%2FS090744490804362X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure validation in chemical crystallography</span></div><div class="casAuthors">Spek, Anthony L.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-155</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Automated structure validation was introduced in chem. crystallog. about 12 years ago as a tool to assist practitioners with the exponential growth in crystal structure analyses.  Validation has since evolved into an easy-to-use checkCIF/PLATON web-based IUCr service.  The result of a crystal structure detn. has to be supplied as a CIF-formatted computer-readable file.  The checking software tests the data in the CIF for completeness, quality, and consistency.  In addn., the reported structure is checked for incomplete anal., errors in the anal., and relevant issues to be verified.  A validation report is generated in the form of a list of ALERTS on the issues to be cor., checked, or commented on.  Structure validation has largely eliminated obvious problems with structure reports published in IUCr journals, such as refinement in a space group of too low symmetry.  This paper reports on the current status of structure validation and possible future extensions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8nVxgyQYutbVg90H21EOLACvtfcHk0lg-QhnskSFL3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWhtL8%253D&md5=1cc05cd996f846a98b55ea09289af6a9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS090744490804362X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744490804362X%26sid%3Dliteratum%253Aachs%26aulast%3DSpek%26aufirst%3DA.%2BL.%26atitle%3DStructure%2520validation%2520in%2520chemical%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26issue%3D2%26spage%3D148%26epage%3D155%26doi%3D10.1107%2FS090744490804362X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sucic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zdrazil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissensteiner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudlacek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gether, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freissmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span> <span> </span><span class="NLM_article-title">The N-terminus of monoamine transporters is a lever required for the action of amphetamines</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">10924</span>– <span class="NLM_lpage">10938</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.083154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1074%2Fjbc.M109.083154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=20118234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFaisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=10924-10938&author=S.+Sucicauthor=S.+Dallingerauthor=B.+Zdrazilauthor=R.+Weissensteinerauthor=T.+N.+Jorgensenauthor=M.+Holyauthor=O.+Kudlacekauthor=S.+Seidelauthor=J.+H.+Chaauthor=U.+Getherauthor=A.+H.+Newmanauthor=G.+F.+Eckerauthor=M.+Freissmuthauthor=H.+H.+Sitte&title=The+N-terminus+of+monoamine+transporters+is+a+lever+required+for+the+action+of+amphetamines&doi=10.1074%2Fjbc.M109.083154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The N Terminus of Monoamine Transporters Is a Lever Required for the Action of Amphetamines</span></div><div class="casAuthors">Sucic, Sonja; Dallinger, Stefan; Zdrazil, Barbara; Weissensteiner, Rene; Jorgensen, Trine N.; Holy, Marion; Kudlacek, Oliver; Seidel, Stefan; Cha, Joo Hwan; Gether, Ulrik; Newman, Amy H.; Ecker, Gerhard F.; Freissmuth, Michael; Sitte, Harald H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10924-10938</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The serotonin transporter (SERT) terminates neurotransmission by removing serotonin from the synaptic cleft.  In addn., it is the site of action of antidepressants (which block the transporter) and of amphetamines (which induce substrate efflux).  We explored the functional importance of the N terminus in mediating the action of amphetamines by focusing initially on the highly conserved threonine residue at position 81, a candidate site for phosphorylation by protein kinase C.  Mol. dynamics simulations of the wild type SERT, compared with its mutations SERTT81A and SERTT81D, suggested structural changes in the inner vestibule indicative of an opening of the inner vestibule.  Predictions from this model (e.g. the preferential accumulation of SERTT81A in the inward conformation, its reduced turnover no., and a larger distance between its N and C termini) were verified.  Most importantly, SERTT81A (and the homologous mutations in noradrenaline and dopamine) failed to support amphetamine-induced efflux, and this was not remedied by aspartate at this position.  Amphetamine-induced currents through SERTT81A were comparable with those through the wild type transporter.  Both abundant Na+ entry and accumulation of SERTT81A in the inward facing conformation ought to favor amphetamine-induced efflux.  Thus, we surmised that the N terminus must play a direct role in driving the transporter into a state that supports amphetamine-induced efflux.  This hypothesis was verified by truncating the first 64 amino acids and by tethering the N terminus to an addnl. transmembrane helix.  Either modification abolished amphetamine-induced efflux.  We therefore conclude that the N terminus of monoamine transporters acts as a lever that sustains reverse transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBoS2MkOsfgLVg90H21EOLACvtfcHk0lg-QhnskSFL3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFaisL4%253D&md5=4e93e69edd41b5eab9a8b3d6502a6b0d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.083154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.083154%26sid%3Dliteratum%253Aachs%26aulast%3DSucic%26aufirst%3DS.%26aulast%3DDallinger%26aufirst%3DS.%26aulast%3DZdrazil%26aufirst%3DB.%26aulast%3DWeissensteiner%26aufirst%3DR.%26aulast%3DJorgensen%26aufirst%3DT.%2BN.%26aulast%3DHoly%26aufirst%3DM.%26aulast%3DKudlacek%26aufirst%3DO.%26aulast%3DSeidel%26aufirst%3DS.%26aulast%3DCha%26aufirst%3DJ.%2BH.%26aulast%3DGether%26aufirst%3DU.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26aulast%3DFreissmuth%26aufirst%3DM.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26atitle%3DThe%2520N-terminus%2520of%2520monoamine%2520transporters%2520is%2520a%2520lever%2520required%2520for%2520the%2520action%2520of%2520amphetamines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D10924%26epage%3D10938%26doi%3D10.1074%2Fjbc.M109.083154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partilla, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehner, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seddik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandtner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitte, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, M. H.</span></span> <span> </span><span class="NLM_article-title">“Second-generation” mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1321</span>– <span class="NLM_lpage">1331</span>, <span class="refDoi"> DOI: 10.1038/npp.2014.325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1038%2Fnpp.2014.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=25502630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2015&pages=1321-1331&author=K.+Sahaauthor=J.+S.+Partillaauthor=K.+R.+Lehnerauthor=A.+Seddikauthor=T.+Stocknerauthor=M.+Holyauthor=W.+Sandtnerauthor=G.+F.+Eckerauthor=H.+H.+Sitteauthor=M.+H.+Baumann&title=%E2%80%9CSecond-generation%E2%80%9D+mephedrone+analogs%2C+4-MEC+and+4-MePPP%2C+differentially+affect+monoamine+transporter+function&doi=10.1038%2Fnpp.2014.325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">'Second-Generation' Mephedrone Analogs, 4-MEC and 4-MePPP, Differentially Affect Monoamine Transporter Function</span></div><div class="casAuthors">Saha, Kusumika; Partilla, John S.; Lehner, Kurt R.; Seddik, Amir; Stockner, Thomas; Holy, Marion; Sandtner, Walter; Ecker, Gerhard F.; Sitte, Harald H.; Baumann, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1321-1331</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The nonmedical use of synthetic cathinones is increasing on a global scale. 4-Methyl-N-methylcathinone (mephedrone) is a popular synthetic cathinone that is now illegal in the United States and other countries.  Since the legislative ban on mephedrone, a no. of 'second-generation' analogs have appeared in the street drug marketplace, including 4-methyl-N-ethylcathinone (4-MEC) and 4'-methyl-α-pyrrolidinopropiophenone (4-MePPP).  Here we characterized the interactions of 4-MEC and 4-MePPP with transporters for 5-HT (SERT) and dopamine (DAT) using mol., cellular, and whole-animal methods.  In vitro transporter assays revealed that 4-MEC displays unusual 'hybrid' activity as a SERT substrate (ie, 5-HT releaser) and DAT blocker, whereas 4-MePPP is a blocker at both transporters but more potent at DAT.  In vivo microdialysis expts. in rat brain demonstrated that 4-MEC (1-3 mg/kg, i.v.) produced large increases in extracellular 5-HT, small increases in dopamine, and minimal motor stimulation.  In contrast, 4-MePPP (1-3 mg/kg, i.v.) produced selective increases in dopamine and robust motor stimulation.  Consistent with its activity as a SERT substrate, 4-MEC evoked inward current in SERT-expressing Xenopus oocytes, whereas 4-MePPP was inactive in this regard.  To examine drug-transporter interactions at the mol. level, we modeled the fit of 4-MEC and 4-MePPP into the binding pockets for DAT and SERT.  Subtle distinctions in ligand-transporter binding were found that account for the differential effects of 4-MEC and 4-MePPP at SERT.  Collectively, our results provide key information about the pharmacol. of newly emerging mephedrone analogs, and give clues to structural requirements that govern drug selectivity at DAT vs SERT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ0DO89wZh7rVg90H21EOLACvtfcHk0liI5Y1EiWzr4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGrsrY%253D&md5=6e47114e4e107ce13331e25f5bb642c6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.325%26sid%3Dliteratum%253Aachs%26aulast%3DSaha%26aufirst%3DK.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DLehner%26aufirst%3DK.%2BR.%26aulast%3DSeddik%26aufirst%3DA.%26aulast%3DStockner%26aufirst%3DT.%26aulast%3DHoly%26aufirst%3DM.%26aulast%3DSandtner%26aufirst%3DW.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26atitle%3D%25E2%2580%259CSecond-generation%25E2%2580%259D%2520mephedrone%2520analogs%252C%25204-MEC%2520and%25204-MePPP%252C%2520differentially%2520affect%2520monoamine%2520transporter%2520function%26jtitle%3DNeuropsychopharmacology%26date%3D2015%26volume%3D40%26spage%3D1321%26epage%3D1331%26doi%3D10.1038%2Fnpp.2014.325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goehring, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penmatsa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ressler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouaux, E.</span></span> <span> </span><span class="NLM_article-title">Structural basis for action by diverse antidepressants on biogenic amine transporters</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1038/nature12648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1038%2Fnature12648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=24121440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSnsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=141-145&author=H.+Wangauthor=A.+Goehringauthor=K.+H.+Wangauthor=A.+Penmatsaauthor=R.+Resslerauthor=E.+Gouaux&title=Structural+basis+for+action+by+diverse+antidepressants+on+biogenic+amine+transporters&doi=10.1038%2Fnature12648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for action by diverse antidepressants on biogenic amine transporters</span></div><div class="casAuthors">Wang, Hui; Goehring, April; Wang, Kevin H.; Penmatsa, Aravind; Ressler, Ryan; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7474</span>),
    <span class="NLM_cas:pages">141-145</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The biogenic amine transporters (BATs) regulate endogenous neurotransmitter concns. and are targets for a broad range of therapeutic agents including selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and tricyclic antidepressants (TCAs).  Because eukaryotic BATs are recalcitrant to crystallog. anal., the authors' understanding of the mechanism of these inhibitors and antidepressants is limited.  LeuT is a bacterial homolog of BATs and has proven to be a valuable paradigm for understanding relationships between their structure and function.  However, because only approx. 25% of the amino acid sequence of LeuT is in common with that of BATs, and as LeuT is a promiscuous amino acid transporter, it does not recapitulate the pharmacol. properties of BATs.  Indeed, SSRIs and TCAs bind in the extracellular vestibule of LeuT and act as non-competitive inhibitors of transport.  By contrast, multiple studies demonstrate that both TCAs and SSRIs are competitive inhibitors for eukaryotic BATs and bind to the primary binding pocket.  Here the authors engineered LeuT to harbor human BAT-like pharmacol. by mutating key residues around the primary binding pocket.  The final LeuBAT mutant binds the SSRI sertraline with a binding const. of 18 nM and displays high-affinity binding to a range of SSRIs, SNRIs and a TCA.  The authors detd. 12 crystal structures of LeuBAT in complex with four classes of antidepressants.  The chem. diverse inhibitors have a remarkably similar mode of binding in which they straddle transmembrane helix (TM) 3, wedge between TM3/TM8 and TM1/TM6, and lock the transporter in a sodium- and chloride-bound outward-facing open conformation.  Together, these studies define common and simple principles for the action of SSRIs, SNRIs and TCAs on BATs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8AMnfh2-Af7Vg90H21EOLACvtfcHk0liI5Y1EiWzr4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSnsLrE&md5=26cc6cf173fdf20ec20d928d02f05193</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnature12648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12648%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DGoehring%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DK.%2BH.%26aulast%3DPenmatsa%26aufirst%3DA.%26aulast%3DRessler%26aufirst%3DR.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DStructural%2520basis%2520for%2520action%2520by%2520diverse%2520antidepressants%2520on%2520biogenic%2520amine%2520transporters%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D141%26epage%3D145%26doi%3D10.1038%2Fnature12648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+Improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0liI5Y1EiWzr4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520Improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span> <span> </span><span class="NLM_article-title">LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1021/ci049885e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci049885e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FktVKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=160-169&author=G.+Wolberauthor=T.+Langer&title=LigandScout%3A+3-D+pharmacophores+derived+from+protein-bound+ligands+and+their+use+as+virtual+screening+filters&doi=10.1021%2Fci049885e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters</span></div><div class="casAuthors">Wolber Gerhard; Langer Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of chemical information and modeling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">160-9</span>
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    </div><div class="casAbstract">From the historically grown archive of protein-ligand complexes in the Protein Data Bank small organic ligands are extracted and interpreted in terms of their chemical characteristics and features.  Subsequently, pharmacophores representing ligand-receptor interaction are derived from each of these small molecules and its surrounding amino acids.  Based on a defined set of only six types of chemical features and volume constraints, three-dimensional pharmacophore models are constructed, which are sufficiently selective to identify the described binding mode and are thus a useful tool for in-silico screening of large compound databases.  The algorithms for ligand extraction and interpretation as well as the pharmacophore creation technique from the automatically interpreted data are presented and applied to a rhinovirus capsid complex as application example.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVi_-excgTX2BAiYWy6n3SfW6udTcc2eaG8ESSLgGDMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FktVKrtg%253D%253D&md5=31f8ff7a2fa4c9411d54b001b7e1da50</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fci049885e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci049885e%26sid%3Dliteratum%253Aachs%26aulast%3DWolber%26aufirst%3DG.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DLigandScout%253A%25203-D%2520pharmacophores%2520derived%2520from%2520protein-bound%2520ligands%2520and%2520their%2520use%2520as%2520virtual%2520screening%2520filters%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2005%26volume%3D45%26spage%3D160%26epage%3D169%26doi%3D10.1021%2Fci049885e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit50b"><span> <i>LigandScout</i>, versions <span class="NLM_edition">4.3</span>; <span class="NLM_publisher-name">Inte:Ligand GmbH</span>: <span class="NLM_publisher-loc">Vienna, Austria</span>; <a href="http://www.inteligand.com" class="extLink">www.inteligand.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+LigandScout%2C+versions+4.3%3B+Inte%3ALigand+GmbH%3A+Vienna%2C+Austria%3B+www.inteligand.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigandScout%26pub%3DInte%253ALigand%2520GmbH" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span> <i>IL Tox PharmDB</i>; <span class="NLM_publisher-name">Inte:Ligand
GmbH</span>: <span class="NLM_publisher-loc">Vienna Austria</span>; <a href="http://www.inteligand.com" class="extLink">www.inteligand.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+IL+Tox+PharmDB%3B+Inte%3ALigand%0AGmbH%3A+Vienna+Austria%3B+www.inteligand.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DIL%2520Tox%2520PharmDB%26pub%3DInte%253ALigand%250AGmbH" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berthold, M. R.</span>; <span class="NLM_string-name">Cebron, N.</span>; <span class="NLM_string-name">Dill, F.</span>; <span class="NLM_string-name">Gabriel, T. R.</span>; <span class="NLM_string-name">Kotter, T.</span>; <span class="NLM_string-name">Meinl, T.</span>; <span class="NLM_string-name">Ohl, P.</span>; <span class="NLM_string-name">Sieb, C.</span>; <span class="NLM_string-name">Thiel, K.</span>; <span class="NLM_string-name">Wiswedel, B.</span></span> <span> </span><span class="NLM_article-title">KNIME: The konstanz information miner</span>.  <i>Data Analysis, Machine Learning and Applications. Studies in Classification, Data Analysis, and Knowledge Organization</i>; <span class="NLM_publisher-name">Springer</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1007%2F978-3-540-78246-9_38" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+R.+Berthold&author=N.+Cebron&author=F.+Dill&author=T.+R.+Gabriel&author=T.+Kotter&author=T.+Meinl&author=P.+Ohl&author=C.+Sieb&author=K.+Thiel&author=B.+Wiswedel&title=Data+Analysis%2C+Machine+Learning+and+Applications.+Studies+in+Classification%2C+Data+Analysis%2C+and+Knowledge+Organization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-78246-9_38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-540-78246-9_38%26sid%3Dliteratum%253Aachs%26aulast%3DBerthold%26aufirst%3DM.%2BR.%26atitle%3DKNIME%253A%2520The%2520konstanz%2520information%2520miner%26btitle%3DData%2520Analysis%252C%2520Machine%2520Learning%2520and%2520Applications.%2520Studies%2520in%2520Classification%252C%2520Data%2520Analysis%252C%2520and%2520Knowledge%2520Organization%26pub%3DSpringer%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pifl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reither, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornykiewicz, O.</span></span> <span> </span><span class="NLM_article-title">The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>755</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2015.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.1016%2Fj.ejphar.2015.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=25771452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFWntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=755&publication_year=2015&pages=119-126&author=C.+Piflauthor=H.+Reitherauthor=O.+Hornykiewicz&title=The+profile+of+mephedrone+on+human+monoamine+transporters+differs+from+3%2C4-methylenedioxymethamphetamine+primarily+by+lower+potency+at+the+vesicular+monoamine+transporter&doi=10.1016%2Fj.ejphar.2015.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter</span></div><div class="casAuthors">Pifl, Christian; Reither, Harald; Hornykiewicz, Oleh</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">755</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-126</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mephedrone (4-methylmethcathinone, MMC) and 3,4-methylenedioxymethamphetamine (MDMA) are constituents of popular party drugs with psychoactive effects.  Structurally they are amphetamine-like substances with monoamine neurotransmitter enhancing actions.  We therefore compared their effects on the human monoamine transporters using human cell lines stably expressing the human noradrenaline, dopamine and serotonin transporter (NET, DAT and SERT); prepns. of synaptic vesicles from human striatum in uptake expts.; and a superfusion system where releasing effects can be reliably measured.  MMC and MDMA were equally potent in inhibiting noradrenaline uptake at NET, with IC50 values of 1.9 and 2.1 μM, resp.  Compared to their NET inhibition potency, both drugs were weaker uptake inhibitors at DAT and SERT, with MMC being more potent than MDMA at DAT (IC50: 5.9 vs 12.6 μM) and less potent than MDMA at SERT (IC50: 19.3 vs 7.6 μM).  MMC and MDMA both induced concn.-dependently [3H]1-methyl-4-phenylpyridinium-release from NET-, DAT or SERT-expressing cells which was clearly transporter-mediated release as demonstrated by the selective inhibitory effects of nmolar to low μmolar concns. of desipramine, GBR 12909 and fluoxetine, resp.  MMC and MDMA differed most in their inhibition of [3H]dopamine uptake by synaptic vesicles from human striatum with MDMA being 10-fold more potent than MMC (IC50: 20 vs 223 μM) and their ability to release [3H]dopamine from human vesicular monoamine transporter expressing SH-SY5Y neuroblastoma cells in which MDMA seems to have a stronger effect.  Our findings give a mol. explanation to the lower long-term neurotoxicity of MMC compared to MDMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPemcos_VlDLVg90H21EOLACvtfcHk0liNofbTUIoMmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFWntb8%253D&md5=ac9e76341be09ae33928d4b7c03cb978</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DPifl%26aufirst%3DC.%26aulast%3DReither%26aufirst%3DH.%26aulast%3DHornykiewicz%26aufirst%3DO.%26atitle%3DThe%2520profile%2520of%2520mephedrone%2520on%2520human%2520monoamine%2520transporters%2520differs%2520from%25203%252C4-methylenedioxymethamphetamine%2520primarily%2520by%2520lower%2520potency%2520at%2520the%2520vesicular%2520monoamine%2520transporter%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D755%26spage%3D119%26epage%3D126%26doi%3D10.1016%2Fj.ejphar.2015.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pifl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornykiewicz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giros, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>277</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=8667208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADyaK28XjslGltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1996&pages=1437-1443&issue=3&author=C.+Piflauthor=O.+Hornykiewiczauthor=B.+Girosauthor=M.+G.+Caron&title=Catecholamine+transporters+and+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+neurotoxicity%3A+studies+comparing+the+cloned+human+noradrenaline+and+human+dopamine+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter</span></div><div class="casAuthors">Pifl, Christian; Hornykiewicz, Oleh; Giros, Bruno; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1437-1443</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The uptake and cytotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic metabolite of the parkinsonism inducing agent MPTP, were studied in COS-7 cells transiently transfected with the cloned human noradrenaline and dopamine transporters and in permanently transfected SK-N-MC neuroblastoma cells.  MPP+ had a 10- to 20-fold lower Km value for the noradrenaline than for the dopamine transporter.  In dopamine transporter expressing cells, the maximal transport rate (Vmax) of MPP+, dopamine and noradrenaline was the same, but in noradrenaline transporter expressing cells the Vmax of MPP+ and dopamine was only one-half of the Vmax of noradrenaline.  The turnover nos. (Vmax of uptake/maximal binding sites of binding) were 5 times higher for the dopamine transporter (as measured with [3H]dopamine and [3H]-2β-carbomethoxy-3β-(4-fluorophenyl)) tropane than for the noradrenaline transporter (as measured with [3H]noradrenaline and [3H]nisoxetine).  In SK-N-MC cells with similar Vmax values for both catecholamines, noradrenaline transporter expressing cells were killed by lower concns. of MPP+ in the medium than dopamine transporter expressing cells.  Desipramine blocked the toxicity of MPP+ toward the noradrenaline transporter, but not the dopamine transporter expressing cells.  The authors conclude that the toxic effect of MPTP at the striatal dopamine system in the MPTP primate model of Parkinson's disease is not correlated with the affinity profile of MPP+ for catecholamine transporters, but rather with the higher turnover no. of MPP+ at the dopamine transporter.  In contradistinction, the toxicity of MPTP at the noradrenaline neurons in the primate cerebral cortex (Pifl et al., 1991) may involve the higher affinity of MPP+ for the noradrenaline transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojO_0QzJzI7LVg90H21EOLACvtfcHk0ljoEM8kbvqhAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjslGltLs%253D&md5=588acd8dd48fc8a1c9b85b2fadfaca5a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPifl%26aufirst%3DC.%26aulast%3DHornykiewicz%26aufirst%3DO.%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DCatecholamine%2520transporters%2520and%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520neurotoxicity%253A%2520studies%2520comparing%2520the%2520cloned%2520human%2520noradrenaline%2520and%2520human%2520dopamine%2520transporter%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1996%26volume%3D277%26issue%3D3%26spage%3D1437%26epage%3D1443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pifl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobny, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reither, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornykiewicz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, E. A.</span></span> <span> </span><span class="NLM_article-title">Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">368</span>– <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=7870046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADyaK2MXktVSlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1995&pages=368-373&issue=2&author=C.+Piflauthor=H.+Drobnyauthor=H.+Reitherauthor=O.+Hornykiewiczauthor=E.+A.+Singer&title=Mechanism+of+the+dopamine-releasing+actions+of+amphetamine+and+cocaine%3A+plasmalemmal+dopamine+transporter+versus+vesicular+monoamine+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter</span></div><div class="casAuthors">Pifl, Christian; Drobny, Helmut; Reither, Harald; Hornykiewicz, Oleh; Singer, Ernst A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">368-73</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The effects of amphetamine and cocaine were studied in [3H]-dopamine-loaded and superfused COS-7 cells transfected with either the cDNA of the plasmalemmal dopamine transporter ("DAT cells") or the cDNA of the vesicular amine transporter ("VAT cells"), or with both transporters ("DAT/VAT cells").  Amphetamine (0.01-100 μM, added for 4 min at superfusion) led to a concn.-dependent increase in dopamine release in DAT cells, as well as DAT/VAT cells.  The EC50 of the effect of amphetamine on DAT cells was 1.1 μM; the effect on DAT/VAT cells did not reach a plateau in the concn. range tested.  With longer exposure to amphetamine, dopamine efflux from DAT cells reached a peak and quickly returned to baseline, in spite of the continued presence of the drug, whereas in DAT/VAT cells and in VAT cells the effect was sustained.  Cocaine (≤100 μm) did not exert any effect of its own in DAT cells or VAT cells, but inhibited the amphetamine-induced release of dopamine from DAT cells in a competitive manner.  In DAT/VAT cells, cocaine and its analog (-)-2β-carbomethoxy-3β-(4-fluorophenyl)tropane caused an efflux of dopamine resembling that caused by amphetamine but quant. much smaller.  The rank order of potency was the same as in uptake expts. [(-)-2β-carbomethoxy-3β-(4-fluorophenyl)tropane > cocaine].  The effect of cocaine was mimicked by the redn. of chloride.  The results indicate that there is a plasmalemmal component and a vesicular component in the dopamine-releasing action of amphetamine.  The releasing action of cocaine is dependent on the existence of a vesicular pool of the neurotransmitter and seems to be linked to inhibition of the plasmalemmal dopamine transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD5D82QFFP6rVg90H21EOLACvtfcHk0ljoEM8kbvqhAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXktVSlsbw%253D&md5=f878da7769d4aed8f81f4162841a775e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPifl%26aufirst%3DC.%26aulast%3DDrobny%26aufirst%3DH.%26aulast%3DReither%26aufirst%3DH.%26aulast%3DHornykiewicz%26aufirst%3DO.%26aulast%3DSinger%26aufirst%3DE.%2BA.%26atitle%3DMechanism%2520of%2520the%2520dopamine-releasing%2520actions%2520of%2520amphetamine%2520and%2520cocaine%253A%2520plasmalemmal%2520dopamine%2520transporter%2520versus%2520vesicular%2520monoamine%2520transporter%26jtitle%3DMol.%2520Pharmacol.%26date%3D1995%26volume%3D47%26issue%3D2%26spage%3D368%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camats-Perna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartori, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuyyuru, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aher, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragačević, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singewald, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubec, G.</span></span> <span> </span><span class="NLM_article-title">Differential Effects of Novel Dopamine Reuptake Inhibitors on Interference With Long-Term Social Memory in Mice</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">63</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2019.00063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=10.3389%2Ffnbeh.2019.00063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=31031603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlKgtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2019&pages=63&author=J.+Camats-Pernaauthor=P.+Kalabaauthor=K.+Ebnerauthor=S.+B.+Sartoriauthor=H.+Vuyyuruauthor=N.+Y.+Aherauthor=V.+Draga%C4%8Devi%C4%87author=N.+Singewaldauthor=M.+Engelmannauthor=G.+Lubec&title=Differential+Effects+of+Novel+Dopamine+Reuptake+Inhibitors+on+Interference+With+Long-Term+Social+Memory+in+Mice&doi=10.3389%2Ffnbeh.2019.00063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of novel dopamine reuptake inhibitors on interference with long-term social memory in mice</span></div><div class="casAuthors">Camats-Perna, Judith; Kalaba, Predrag; Ebner, Karl; Sartori, Simone B.; Vuyyuru, Harish; Aher, Nilima Y.; Dragacevic, Vladimir; Singewald, Nicolas; Engelmann, Mario; Lubec, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">In the lab., long-term social recognition memory (SRM) in mice is highly susceptible to proactive and retroactive interference.  Here, we investigate the ability of novel designed dopamine (DA) re-uptake inhibitors (rac-CE-123 and S-CE-123) to block retroactive and proactive interference, resp.  Our data show that administration of rac-CE-123 30 min before learning blocks retroactive interference that has been exptl. induced at 3 h, but not at 6 h, post-learning.  In contrast, S-CE-123 treatment 30 min before learning blocked the induction of retroactive interference at 6 h, but not 3 h, post-learning.  Administration of S-CE-123 failed to interfere with proactive interference at both 3 h and 6 h.  Anal. of addnl. behavioral parameters collected during the memory task implies that the effects of the new DA re-uptake inhibitors on retroactive and proactive interference cannot easily be explained by non-specific effects on the animals' general social behavior.  Furthermore, we assessed the mechanisms of action of drugs using intracerebral in vivo-microdialysis technique.  The results revealed that administration of rac-CE-123 and S-CE-123 dose-dependently increased DA release within the nucleus accumbens of freely behaving mice.  Thus, the data from the present study suggests that the DA re-uptake inhibitors tested protect the consolidation of long-term social memory against interference for defined durations after learning.  In addn., the data implies that DA signaling in distinct brain areas including the nucleus accumbens is involved in the consolidation of SRM in lab. mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTzZr6XOtyS7Vg90H21EOLACvtfcHk0ljoEM8kbvqhAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlKgtLbM&md5=21895e5683567828bc39993d3855b721</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2019.00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2019.00063%26sid%3Dliteratum%253Aachs%26aulast%3DCamats-Perna%26aufirst%3DJ.%26aulast%3DKalaba%26aufirst%3DP.%26aulast%3DEbner%26aufirst%3DK.%26aulast%3DSartori%26aufirst%3DS.%2BB.%26aulast%3DVuyyuru%26aufirst%3DH.%26aulast%3DAher%26aufirst%3DN.%2BY.%26aulast%3DDraga%25C4%258Devi%25C4%2587%26aufirst%3DV.%26aulast%3DSingewald%26aufirst%3DN.%26aulast%3DEngelmann%26aufirst%3DM.%26aulast%3DLubec%26aufirst%3DG.%26atitle%3DDifferential%2520Effects%2520of%2520Novel%2520Dopamine%2520Reuptake%2520Inhibitors%2520on%2520Interference%2520With%2520Long-Term%2520Social%2520Memory%2520in%2520Mice%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2019%26volume%3D13%26spage%3D63%26doi%3D10.3389%2Ffnbeh.2019.00063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M48" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M48','PDB','4M48'); return false;">PDB: 4M48</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i126"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01938">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88868"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01938?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01938</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">High-resolution mass spectrometry data (pp 2–145), <sup>1</sup>H, <sup>13</sup>C, and 2D NMR spectra (pp 146–1357), HPLC-determined purity data (pp 1358–1428), chiral HPLC data (pp 1429–1468), reuptake inhibition curves (pp 1469–1479), X-ray measurements data (pp 1480–1624), and pharmacokinetic study report (pp 1625–1645) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_001.pdf">jm9b01938_si_001.pdf (57.28 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01938/suppl_file/jm9b01938_si_002.csv">jm9b01938_si_002.csv (5.11 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01938&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01938%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-1%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01938" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991528bf012483","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
